[
  {
    "input": "<ce:legend xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\">\n<ce:simple-para id=\"spara010\"><ce:italic>Definitions of abbreviations: HP = hypersensitivity pneumonitis; ATS/JRS/ALAT = American Thoracic Society, Japanese Respiratory Society, and Asociación Latinoamericana de Tórax; ACCP = American College of Chest Physicians; GGO = ground glass opacity</ce:italic></ce:simple-para>\n</ce:legend>",
    "output": "<ce:legend xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\">\n<ce:simple-para id=\"spara010\">Definitions of abbreviations: HP = hypersensitivity pneumonitis; ATS/JRS/ALAT = American Thoracic Society, Japanese Respiratory Society, and Asociación Latinoamericana de Tórax; ACCP = American College of Chest Physicians; GGO = ground glass opacity</ce:simple-para>\n</ce:legend>",
    "error_message": "Element 'ce:legend' may not consist solely of a font-changing element.",
    "error_position": "147:12",
    "error_id": "FOS502b",
    "folder_name": "YSROE50950"
  },
  {
    "input": "<ce:legend xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\">\n<ce:simple-para id=\"spara012\"><ce:italic>Definitions of abbreviations: HP = hypersensitivity pneumonitis; ATS/JRS/ALAT = American Thoracic Society, Japanese Respiratory Society, and Asociación Latinoamericana de Tórax; ACCP = American College of Chest Physicians; GGO = ground glass opacity; UIP = usual interstitial pneumonia</ce:italic></ce:simple-para>\n</ce:legend>",
    "output": "<ce:legend xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\">\n<ce:simple-para id=\"spara012\">Definitions of abbreviations: HP = hypersensitivity pneumonitis; ATS/JRS/ALAT = American Thoracic Society, Japanese Respiratory Society, and Asociación Latinoamericana de Tórax; ACCP = American College of Chest Physicians; GGO = ground glass opacity; UIP = usual interstitial pneumonia</ce:simple-para>\n</ce:legend>",
    "error_message": "Element 'ce:legend' may not consist solely of a font-changing element.",
    "error_position": "235:12",
    "error_id": "FOS502b",
    "folder_name": "YSROE50950"
  },
  {
    "input": "<ce:legend xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\">\n<ce:simple-para id=\"spara014\"><ce:italic>Definitions of abbreviations: IPF = Idiopathic pulmonary fibrosis; GGO = ground glass opacity; UIP = Usual interstitial pneumonia</ce:italic></ce:simple-para>\n</ce:legend>",
    "output": "<ce:legend xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\">\n<ce:simple-para id=\"spara014\">Definitions of abbreviations: IPF = Idiopathic pulmonary fibrosis; GGO = ground glass opacity; UIP = Usual interstitial pneumonia</ce:simple-para>\n</ce:legend>",
    "error_message": "Element 'ce:legend' may not consist solely of a font-changing element.",
    "error_position": "263:12",
    "error_id": "FOS502b",
    "folder_name": "YSROE50950"
  },
  {
    "input": "<ce:legend xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\">\n<ce:simple-para id=\"spara016\"><ce:italic>* ATS/JRS/ALAT guidelines</ce:italic></ce:simple-para>\n<ce:simple-para id=\"spara017\"><ce:italic>† ACCP guidelines</ce:italic></ce:simple-para>\n<ce:simple-para id=\"spara018\"><ce:italic>Criteria for “Indeterminate for UIP” and “Indeterminate for HP” categories were intentionally omitted for clarity and brevity</ce:italic></ce:simple-para>\n<ce:simple-para id=\"spara019\"><ce:italic>Definitions of abbreviations: UIP = Usual interstitial pneumonia; HP = Hypersensitivity pneumonitis; GGO = Ground-glass opacity</ce:italic></ce:simple-para>\n</ce:legend>",
    "output": "<ce:legend xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\">\n<ce:simple-para id=\"spara016\">* ATS/JRS/ALAT guidelines</ce:simple-para>\n<ce:simple-para id=\"spara017\">† ACCP guidelines</ce:simple-para>\n<ce:simple-para id=\"spara018\">Criteria for “Indeterminate for UIP” and “Indeterminate for HP” categories were intentionally omitted for clarity and brevity</ce:simple-para>\n<ce:simple-para id=\"spara019\">Definitions of abbreviations: UIP = Usual interstitial pneumonia; HP = Hypersensitivity pneumonitis; GGO = Ground-glass opacity</ce:simple-para>\n</ce:legend>",
    "error_message": "Element 'ce:legend' may not consist solely of a font-changing element.",
    "error_position": "352:12",
    "error_id": "FOS502b",
    "folder_name": "YSROE50950"
  },
  {
    "input": "<ce:table xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"tbl0005\" rowsep=\"0\" colsep=\"0\" frame=\"topbot\">\n<ce:caption id=\"cap0010\">\n<ce:simple-para id=\"spara037\">Table 5. ACMG/AMP guideline scoring of identified CHST6 variants.</ce:simple-para>\n</ce:caption>\n<ce:alt-text id=\"alt0010\" role=\"short\"/>\n<tgroup cols=\"6\">\n<colspec colnum=\"1\" colname=\"col1\" align=\"left\"/>\n<colspec colnum=\"2\" colname=\"col2\" align=\"left\"/>\n<colspec colnum=\"3\" colname=\"col3\" align=\"left\"/>\n<colspec colnum=\"4\" colname=\"col4\" align=\"left\"/>\n<colspec colnum=\"5\" colname=\"col5\" align=\"left\"/>\n<colspec colnum=\"6\" colname=\"col6\" align=\"left\"/>\n<thead>\n<row rowsep=\"1\">\n<entry id=\"en0655\" colname=\"col1\" valign=\"top\"><ce:bold>Identified</ce:bold><ce:br/><ce:bold><ce:italic>CHST6</ce:italic> Variant</ce:bold></entry>\n<entry id=\"en0656\" colname=\"col2\" valign=\"top\"><ce:bold>Pathogenic</ce:bold><ce:br/><ce:bold>Criteria Satisfied</ce:bold></entry>\n<entry id=\"en0657\" colname=\"col3\" valign=\"top\"><ce:bold>Benign</ce:bold><ce:br/><ce:bold>Criteria Satisfied</ce:bold></entry>\n<entry id=\"en0658\" colname=\"col4\" valign=\"top\"><ce:bold>Combined <ce:italic>OddsPath</ce:italic></ce:bold><ce:sup>1</ce:sup></entry>\n<entry id=\"en0659\" colname=\"col5\" valign=\"top\"><ce:bold><ce:italic>Post_P</ce:italic></ce:bold></entry>\n<entry id=\"en0660\" colname=\"col6\" valign=\"top\"><ce:bold>Classification Determination</ce:bold></entry>\n</row>\n</thead>\n<tbody>\n<row>\n<entry id=\"en0661\" colname=\"col1\" valign=\"top\">c.-792C&gt;T</entry>\n<entry id=\"en0662\" colname=\"col2\" valign=\"top\">PP1, PP3, PP4</entry>\n<entry id=\"en0663\" colname=\"col3\" valign=\"top\">BA1</entry>\n<entry id=\"en0664\" colname=\"col4\" valign=\"top\">0.001</entry>\n<entry id=\"en0665\" colname=\"col5\" valign=\"top\">0.000</entry>\n<entry id=\"en0666\" colname=\"col6\" valign=\"top\">Benign</entry>\n</row>\n<row>\n<entry id=\"en0667\" colname=\"col1\" valign=\"top\">c.-690G&gt;C</entry>\n<entry id=\"en0668\" colname=\"col2\" valign=\"top\">PS3, PS4, PM3, PP1, PP3, PP4</entry>\n<entry id=\"en0669\" colname=\"col3\" valign=\"top\"/>\n<entry id=\"en0670\" colname=\"col4\" valign=\"top\">13617.914</entry>\n<entry id=\"en0671\" colname=\"col5\" valign=\"top\">0.999</entry>\n<entry id=\"en0672\" colname=\"col6\" valign=\"top\">Pathogenic</entry>\n</row>\n<row>\n<entry id=\"en0673\" colname=\"col1\" valign=\"top\">c.-668C&gt;T</entry>\n<entry id=\"en0674\" colname=\"col2\" valign=\"top\">PP1, PP4</entry>\n<entry id=\"en0675\" colname=\"col3\" valign=\"top\">BS1, BP4</entry>\n<entry id=\"en0676\" colname=\"col4\" valign=\"top\">0.053</entry>\n<entry id=\"en0677\" colname=\"col5\" valign=\"top\">0.006</entry>\n<entry id=\"en0678\" colname=\"col6\" valign=\"top\">Likely benign</entry>\n</row>\n<row>\n<entry id=\"en0679\" colname=\"col1\" valign=\"top\">c.632G&gt;A, p.Arg211Gln</entry>\n<entry id=\"en0680\" colname=\"col2\" valign=\"top\">PS1, PS4, PM2, PP1, PP3, PP4</entry>\n<entry id=\"en0681\" colname=\"col3\" valign=\"top\"/>\n<entry id=\"en0682\" colname=\"col4\" valign=\"top\">13617.914</entry>\n<entry id=\"en0683\" colname=\"col5\" valign=\"top\">0.999</entry>\n<entry id=\"en0684\" colname=\"col6\" valign=\"top\">Pathogenic</entry>\n</row>\n<row>\n<entry id=\"en0685\" colname=\"col1\" valign=\"top\">c.803A&gt;G, p.Tyr268Cys</entry>\n<entry id=\"en0686\" colname=\"col2\" valign=\"top\">PS1, PS4, PM2, PP1, PP3, PP4</entry>\n<entry id=\"en0687\" colname=\"col3\" valign=\"top\"/>\n<entry id=\"en0688\" colname=\"col4\" valign=\"top\">13617.914</entry>\n<entry id=\"en0689\" colname=\"col5\" valign=\"top\">0.999</entry>\n<entry id=\"en0690\" colname=\"col6\" valign=\"top\">Pathogenic</entry>\n</row>\n<row>\n<entry id=\"en0691\" colname=\"col1\" valign=\"top\">c.839C&gt;T, p.Pro280Leu</entry>\n<entry id=\"en0692\" colname=\"col2\" valign=\"top\">PS3, PS4, PM2, PP1, PP3, PP4</entry>\n<entry id=\"en0693\" colname=\"col3\" valign=\"top\"/>\n<entry id=\"en0694\" colname=\"col4\" valign=\"top\">13617.914</entry>\n<entry id=\"en0695\" colname=\"col5\" valign=\"top\">0.999</entry>\n<entry id=\"en0696\" colname=\"col6\" valign=\"top\">Pathogenic</entry>\n</row>\n</tbody>\n</tgroup>\n<ce:legend>\n<ce:simple-para id=\"spara038\"><ce:sup>1</ce:sup>OddsPath ratio cut-off values for Supporting, Moderate, Strong, and Very Strong pathogenic evidence are 2, 4.3, 18.7, and 350, respectively<ce:sup>13</ce:sup></ce:simple-para>\n</ce:legend>\n</ce:table>",
    "output": "<ce:table xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"tbl0005\" rowsep=\"0\" colsep=\"0\" frame=\"topbot\">\n<ce:label>Table 5</ce:label>\n<ce:caption id=\"cap0010\">\n<ce:simple-para id=\"spara037\">Table 5. ACMG/AMP guideline scoring of identified CHST6 variants.</ce:simple-para>\n</ce:caption>\n<ce:alt-text id=\"alt0010\" role=\"short\">Table 5</ce:alt-text>\n<tgroup cols=\"6\">\n<colspec colnum=\"1\" colname=\"col1\" align=\"left\"/>\n<colspec colnum=\"2\" colname=\"col2\" align=\"left\"/>\n<colspec colnum=\"3\" colname=\"col3\" align=\"left\"/>\n<colspec colnum=\"4\" colname=\"col4\" align=\"left\"/>\n<colspec colnum=\"5\" colname=\"col5\" align=\"left\"/>\n<colspec colnum=\"6\" colname=\"col6\" align=\"left\"/>\n<thead>\n<row rowsep=\"1\">\n<entry id=\"en0655\" colname=\"col1\" valign=\"top\"><ce:bold>Identified</ce:bold><ce:br/><ce:bold><ce:italic>CHST6</ce:italic> Variant</ce:bold></entry>\n<entry id=\"en0656\" colname=\"col2\" valign=\"top\"><ce:bold>Pathogenic</ce:bold><ce:br/><ce:bold>Criteria Satisfied</ce:bold></entry>\n<entry id=\"en0657\" colname=\"col3\" valign=\"top\"><ce:bold>Benign</ce:bold><ce:br/><ce:bold>Criteria Satisfied</ce:bold></entry>\n<entry id=\"en0658\" colname=\"col4\" valign=\"top\"><ce:bold>Combined <ce:italic>OddsPath</ce:italic></ce:bold><ce:sup>1</ce:sup></entry>\n<entry id=\"en0659\" colname=\"col5\" valign=\"top\"><ce:bold><ce:italic>Post_P</ce:italic></ce:bold></entry>\n<entry id=\"en0660\" colname=\"col6\" valign=\"top\"><ce:bold>Classification Determination</ce:bold></entry>\n</row>\n</thead>\n<tbody>\n<row>\n<entry id=\"en0661\" colname=\"col1\" valign=\"top\">c.-792C&gt;T</entry>\n<entry id=\"en0662\" colname=\"col2\" valign=\"top\">PP1, PP3, PP4</entry>\n<entry id=\"en0663\" colname=\"col3\" valign=\"top\">BA1</entry>\n<entry id=\"en0664\" colname=\"col4\" valign=\"top\">0.001</entry>\n<entry id=\"en0665\" colname=\"col5\" valign=\"top\">0.000</entry>\n<entry id=\"en0666\" colname=\"col6\" valign=\"top\">Benign</entry>\n</row>\n<row>\n<entry id=\"en0667\" colname=\"col1\" valign=\"top\">c.-690G&gt;C</entry>\n<entry id=\"en0668\" colname=\"col2\" valign=\"top\">PS3, PS4, PM3, PP1, PP3, PP4</entry>\n<entry id=\"en0669\" colname=\"col3\" valign=\"top\"/>\n<entry id=\"en0670\" colname=\"col4\" valign=\"top\">13617.914</entry>\n<entry id=\"en0671\" colname=\"col5\" valign=\"top\">0.999</entry>\n<entry id=\"en0672\" colname=\"col6\" valign=\"top\">Pathogenic</entry>\n</row>\n<row>\n<entry id=\"en0673\" colname=\"col1\" valign=\"top\">c.-668C&gt;T</entry>\n<entry id=\"en0674\" colname=\"col2\" valign=\"top\">PP1, PP4</entry>\n<entry id=\"en0675\" colname=\"col3\" valign=\"top\">BS1, BP4</entry>\n<entry id=\"en0676\" colname=\"col4\" valign=\"top\">0.053</entry>\n<entry id=\"en0677\" colname=\"col5\" valign=\"top\">0.006</entry>\n<entry id=\"en0678\" colname=\"col6\" valign=\"top\">Likely benign</entry>\n</row>\n<row>\n<entry id=\"en0679\" colname=\"col1\" valign=\"top\">c.632G&gt;A, p.Arg211Gln</entry>\n<entry id=\"en0680\" colname=\"col2\" valign=\"top\">PS1, PS4, PM2, PP1, PP3, PP4</entry>\n<entry id=\"en0681\" colname=\"col3\" valign=\"top\"/>\n<entry id=\"en0682\" colname=\"col4\" valign=\"top\">13617.914</entry>\n<entry id=\"en0683\" colname=\"col5\" valign=\"top\">0.999</entry>\n<entry id=\"en0684\" colname=\"col6\" valign=\"top\">Pathogenic</entry>\n</row>\n<row>\n<entry id=\"en0685\" colname=\"col1\" valign=\"top\">c.803A&gt;G, p.Tyr268Cys</entry>\n<entry id=\"en0686\" colname=\"col2\" valign=\"top\">PS1, PS4, PM2, PP1, PP3, PP4</entry>\n<entry id=\"en0687\" colname=\"col3\" valign=\"top\"/>\n<entry id=\"en0688\" colname=\"col4\" valign=\"top\">13617.914</entry>\n<entry id=\"en0689\" colname=\"col5\" valign=\"top\">0.999</entry>\n<entry id=\"en0690\" colname=\"col6\" valign=\"top\">Pathogenic</entry>\n</row>\n<row>\n<entry id=\"en0691\" colname=\"col1\" valign=\"top\">c.839C&gt;T, p.Pro280Leu</entry>\n<entry id=\"en0692\" colname=\"col2\" valign=\"top\">PS3, PS4, PM2, PP1, PP3, PP4</entry>\n<entry id=\"en0693\" colname=\"col3\" valign=\"top\"/>\n<entry id=\"en0694\" colname=\"col4\" valign=\"top\">13617.914</entry>\n<entry id=\"en0695\" colname=\"col5\" valign=\"top\">0.999</entry>\n<entry id=\"en0696\" colname=\"col6\" valign=\"top\">Pathogenic</entry>\n</row>\n</tbody>\n</tgroup>\n<ce:legend>\n<ce:simple-para id=\"spara038\"><ce:sup>1</ce:sup>OddsPath ratio cut-off values for Supporting, Moderate, Strong, and Very Strong pathogenic evidence are 2, 4.3, 18.7, and 350, respectively<ce:sup>13</ce:sup></ce:simple-para>\n</ce:legend>\n</ce:table>",
    "error_message": "Element 'ce:alt-text' may not have empty content.",
    "error_position": "925:41",
    "error_id": "EMC501",
    "folder_name": "AJOPHT13510"
  },
  {
    "input": "<ce:section xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"sec0019\">\n<ce:section-title id=\"cesectitle0021\">Asymmetric breast uptake on Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography (18–F FDG PET)</ce:section-title>\n<ce:para id=\"para0017\">Normal breasts show homogeneous symmetric uptake on PET with SUVmax values less than 2.5. The uptake is higher in younger females with increased breast density and during the ovulation and secretory phase.<ce:cross-ref id=\"crf0088\" refid=\"bib0054\"><ce:sup>54</ce:sup></ce:cross-ref> Asymmetric uptake can be physiological, due to differential response to hormonal stimulation, single breast lactation, or can be due to pathological causes such as masses, mastitis, and edema. Lactating breasts show breast enlargement with cord- or mass-like hyperattenuating tissue on CT. There is increased glucose transporter (GLUT 1) expression in the lactating breast, which causes increased FDG uptake (<ce:cross-ref id=\"crf0089\" refid=\"fig0013\">Figure 13</ce:cross-ref>). Preferentially, single breast lactation can lead to asymmetric uptake, which can be confused with inflammatory breast carcinoma (IBC). Detection of breast malignancies in lactating breasts also becomes difficult due to the physiologically increased uptake.<ce:cross-ref id=\"crf0090\" refid=\"bib0055\"><ce:sup>55</ce:sup></ce:cross-ref> Breast malignancies like IBC, lymphoma, and lymphangitic metastases can all present with unilateral breast edema<ce:cross-ref id=\"crf0091\" refid=\"bib0032\"><ce:sup>32</ce:sup></ce:cross-ref>. Asymmetric FDG uptake with breast enlargement can also be due to causes outside the breast, such as congestive cardiac failure (dependent side), lymphatic or venous obstruction, or as a complication of arteriovenous dialysis fistula. Although an appropriate clinical history and negative imaging findings can rule out malignancy, histopathological confirmation may be required in ambiguous cases.(<ce:cross-ref id=\"crf0092\" refid=\"tbl0001\">Table 1</ce:cross-ref><ce:float-anchor refid=\"tbl0001\"/>\n<Query/>)</ce:para>\n</ce:section>",
    "output": "<ce:section xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"sec0019\">\n<ce:section-title id=\"cesectitle0021\">Asymmetric breast uptake on Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography (18–F FDG PET)</ce:section-title>\n<ce:para id=\"para0017\">Normal breasts show homogeneous symmetric uptake on PET with SUVmax values less than 2.5. The uptake is higher in younger females with increased breast density and during the ovulation and secretory phase.<ce:cross-ref id=\"crf0088\" refid=\"bib0054\"><ce:sup>54</ce:sup></ce:cross-ref> Asymmetric uptake can be physiological, due to differential response to hormonal stimulation, single breast lactation, or can be due to pathological causes such as masses, mastitis, and edema. Lactating breasts show breast enlargement with cord- or mass-like hyperattenuating tissue on CT. There is increased glucose transporter (GLUT 1) expression in the lactating breast, which causes increased FDG uptake (<ce:cross-ref id=\"crf0089\" refid=\"fig0013\">Figure 13</ce:cross-ref>). Preferentially, single breast lactation can lead to asymmetric uptake, which can be confused with inflammatory breast carcinoma (IBC). Detection of breast malignancies in lactating breasts also becomes difficult due to the physiologically increased uptake.<ce:cross-ref id=\"crf0090\" refid=\"bib0055\"><ce:sup>55</ce:sup></ce:cross-ref> Breast malignancies like IBC, lymphoma, and lymphangitic metastases can all present with unilateral breast edema<ce:cross-ref id=\"crf0091\" refid=\"bib0032\"><ce:sup>32</ce:sup></ce:cross-ref>. Asymmetric FDG uptake with breast enlargement can also be due to causes outside the breast, such as congestive cardiac failure (dependent side), lymphatic or venous obstruction, or as a complication of arteriovenous dialysis fistula. Although an appropriate clinical history and negative imaging findings can rule out malignancy, histopathological confirmation may be required in ambiguous cases.(<ce:cross-ref id=\"crf0092\" refid=\"tbl0001\">Table 1</ce:cross-ref><ce:float-anchor refid=\"tbl0001\"/><?Qry msg=\"CE: dummy citation of table 1 is inserted please check.\"?>)</ce:para>\n</ce:section>",
    "error_message": "Element 'Query' may not have empty content.",
    "error_position": "385:9",
    "error_id": "EMC501",
    "folder_name": "YMDR1409"
  },
  {
    "input": "<ce:bibliography-sec xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"cebibsec1\">\n<?att type=\"article\"?><ce:bib-reference id=\"bib0001\">\n<ce:label>1</ce:label>\n<sb:reference id=\"sbref0001\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>E.B.</ce:given-name>\n<ce:surname>Mendelson</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Böhm-Vélez</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>W.A.</ce:given-name>\n<ce:surname>Berg</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Whitman</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Feldman</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Madjar</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Acr bi-rads® Ultrasound</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>ACR BI-RADS® Atlas Breast Imaging Report Data Syst</sb:maintitle>\n</sb:title>\n</sb:series>\n<sb:date>2013</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>149</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0001\">Mendelson EB, Böhm-Vélez M, Berg WA, Whitman G, Feldman M, Madjar H. Acr bi-rads® Ultrasound. ACR BI-RADS® Atlas Breast Imaging Report Data Syst. 2013;149.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0002\">\n<ce:label>2</ce:label>\n<sb:reference id=\"sbref0002\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>P.W.</ce:given-name>\n<ce:surname>Leong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.C.</ce:given-name>\n<ce:surname>Chotai</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Kulkarni</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Imaging Features of Inflammatory Breast Disorders: A Pictorial Essay</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Korean J Radiol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>19</sb:volume-nr>\n</sb:series>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>5</sb:first-page>\n<sb:last-page>14</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0002\">Leong PW, Chotai NC, Kulkarni S. Imaging Features of Inflammatory Breast Disorders: A Pictorial Essay. Korean J Radiol. 2018;19:5–14.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"inbook\"?><ce:bib-reference id=\"bib0003\">\n<ce:label>3</ce:label>\n<sb:reference id=\"sbref0003\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Gauba</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Dhamija</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>SR.</ce:given-name>\n<ce:surname>Mathur</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Radiological–Pathological Correlation</sb:maintitle>\n</sb:title>\n<sb:title>\n<sb:maintitle>Overview of Modalities [Internet]</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:edited-book>\n<sb:editors>\n<sb:editor>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Dhamija</ce:surname>\n</sb:editor>\n<sb:editor>\n<ce:given-name>S.V.S.</ce:given-name>\n<ce:surname>Deo</ce:surname>\n</sb:editor>\n</sb:editors>\n<sb:title>\n<sb:maintitle>editors. Imaging in Management of Breast Diseases</sb:maintitle>\n</sb:title>\n<sb:book-series>\n<sb:series>\n<sb:title>\n<sb:maintitle>editors. Imaging in Management of Breast Diseases</sb:maintitle>\n</sb:title>\n<sb:volume-nr>Volume 1</sb:volume-nr>\n</sb:series>\n</sb:book-series>\n<sb:date>2025 Aug 2</sb:date>\n<sb:publisher>\n<sb:name>Springer Nature</sb:name>\n<sb:location>Singapore</sb:location>\n</sb:publisher>\n</sb:edited-book>\n<sb:pages>\n<sb:first-page>225</sb:first-page>\n<sb:last-page>246</sb:last-page>\n</sb:pages>\n<ce:doi>10.1007/978-981-97-9847-6_13</ce:doi>\n</sb:host>\n<sb:comment>2025 [citedAvailable from</sb:comment>\n</sb:reference>\n<ce:source-text id=\"srctxt0003\">Gauba R, Dhamija E, Mathur SR. Radiological–Pathological Correlation. In: Dhamija E, Deo SVS, editors. Imaging in Management of Breast Diseases: Volume 1, Overview of Modalities [Internet]. Singapore: Springer Nature; 2025 [cited 2025 Aug 2]. p. 225–46. Available from: https://doi.org/10.1007/978-981-97-9847-6_13</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0004\">\n<ce:label>4</ce:label>\n<sb:reference id=\"sbref0004\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Wolfrum</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Kümmel</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>I.</ce:given-name>\n<ce:surname>Theuerkauf</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Pelz</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Reinisch</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Granulomatous Mastitis: A Therapeutic and Diagnostic Challenge</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Breast Care</sb:maintitle>\n</sb:title>\n<sb:volume-nr>13</sb:volume-nr>\n</sb:series>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>413</sb:first-page>\n<sb:last-page>418</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0004\">Wolfrum A, Kümmel S, Theuerkauf I, Pelz E, Reinisch M. Granulomatous Mastitis: A Therapeutic and Diagnostic Challenge. Breast Care. 2018;13:413–8.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0005\">\n<ce:label>5</ce:label>\n<sb:reference id=\"sbref0005\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Manogna</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Dev</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.D.</ce:given-name>\n<ce:surname>Joseph</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Ramakrishnan</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Idiopathic granulomatous mastitis: our experience</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Egypt J Radiol Nucl Med</sb:maintitle>\n</sb:title>\n<sb:volume-nr>51</sb:volume-nr>\n</sb:series>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>15</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0005\">Manogna P, Dev B, Joseph LD, Ramakrishnan R. Idiopathic granulomatous mastitis: our experience. Egypt J Radiol Nucl Med. 2020;51:15.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0006\">\n<ce:label>6</ce:label>\n<sb:reference id=\"sbref0006\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>F.</ce:given-name>\n<ce:surname>Altintoprak</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.</ce:given-name>\n<ce:surname>Kivilcim</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>OV.</ce:given-name>\n<ce:surname>Ozkan</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Aetiology of idiopathic granulomatous mastitis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World J Clin Cases WJCC</sb:maintitle>\n</sb:title>\n<sb:volume-nr>2</sb:volume-nr>\n</sb:series>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>852</sb:first-page>\n<sb:last-page>858</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0006\">Altintoprak F, Kivilcim T, Ozkan OV. Aetiology of idiopathic granulomatous mastitis. World J Clin Cases WJCC. 2014;2:852–8.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0007\">\n<ce:label>7</ce:label>\n<sb:reference id=\"sbref0007\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>C.W.</ce:given-name>\n<ce:surname>Pluguez-Turull</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.E.</ce:given-name>\n<ce:surname>Nanyes</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.J.</ce:given-name>\n<ce:surname>Quintero</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Alizai</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.D.</ce:given-name>\n<ce:surname>Mais</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.A.</ce:given-name>\n<ce:surname>Kist</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Idiopathic Granulomatous Mastitis: Manifestations at Multimodality Imaging and Pitfalls</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>RadioGraphics</sb:maintitle>\n</sb:title>\n<sb:volume-nr>38</sb:volume-nr>\n</sb:series>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>330</sb:first-page>\n<sb:last-page>356</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0007\">Pluguez-Turull CW, Nanyes JE, Quintero CJ, Alizai H, Mais DD, Kist KA, et al. Idiopathic Granulomatous Mastitis: Manifestations at Multimodality Imaging and Pitfalls. RadioGraphics. 2018;38:330–56.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0008\">\n<ce:label>8</ce:label>\n<sb:reference id=\"sbref0008\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.T.</ce:given-name>\n<ce:surname>Fazzio</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.S.</ce:given-name>\n<ce:surname>Shah</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.P.</ce:given-name>\n<ce:surname>Sandhu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>KN.</ce:given-name>\n<ce:surname>Glazebrook</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Idiopathic granulomatous mastitis: imaging update and review</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Insights Imaging</sb:maintitle>\n</sb:title>\n<sb:volume-nr>7</sb:volume-nr>\n</sb:series>\n<sb:date>2016</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>531</sb:first-page>\n<sb:last-page>539</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0008\">Fazzio RT, Shah SS, Sandhu NP, Glazebrook KN. Idiopathic granulomatous mastitis: imaging update and review. Insights Imaging. 2016;7:531–9.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0009\">\n<ce:label>9</ce:label>\n<sb:reference id=\"sbref0009\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Dhamija</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Gulati</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Hari</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Imaging spectrum in tropical breast infections</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Br J Radiol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>97</sb:volume-nr>\n</sb:series>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>315</sb:first-page>\n<sb:last-page>323</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0009\">Dhamija E, Gulati S, Hari S. Imaging spectrum in tropical breast infections. Br J Radiol. 2024;97:315–23.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0010\">\n<ce:label>10</ce:label>\n<sb:reference id=\"sbref0010\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Yağcı</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>I.</ce:given-name>\n<ce:surname>Erdem Toslak</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Çekiç</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Öz</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.R.</ce:given-name>\n<ce:surname>Karakaş</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Akdemir</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Differentiation between idiopathic granulomatous mastitis and malignant breast lesions using strain ratio on ultrasonic elastography</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Diagn Interv Imaging</sb:maintitle>\n</sb:title>\n<sb:volume-nr>98</sb:volume-nr>\n</sb:series>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>685</sb:first-page>\n<sb:last-page>691</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0010\">Yağcı B, Erdem Toslak I, Çekiç B, Öz M, Karakaş BR, Akdemir M, et al. Differentiation between idiopathic granulomatous mastitis and malignant breast lesions using strain ratio on ultrasonic elastography. Diagn Interv Imaging. 2017;98:685–91.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0011\">\n<ce:label>11</ce:label>\n<sb:reference id=\"sbref0011\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.K.</ce:given-name>\n<ce:surname>Shaffrey</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>F.B.</ce:given-name>\n<ce:surname>Askin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.M.B.</ce:given-name>\n<ce:surname>Gatewood</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Brem</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Diabetic Fibrous Mastopathy: Case Reports and Radiologic-Pathologic Correlation</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Breast J</sb:maintitle>\n</sb:title>\n<sb:volume-nr>6</sb:volume-nr>\n</sb:series>\n<sb:date>2000</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>414</sb:first-page>\n<sb:last-page>417</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0011\">Shaffrey JK, Askin FB, Gatewood OMB, Brem R. Diabetic Fibrous Mastopathy: Case Reports and Radiologic-Pathologic Correlation. Breast J. 2000;6:414–7.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0012\">\n<ce:label>12</ce:label>\n<sb:reference id=\"sbref0012\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Kim</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.K.</ce:given-name>\n<ce:surname>Kim</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Kim</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.J.</ce:given-name>\n<ce:surname>Moon</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>JH.</ce:given-name>\n<ce:surname>Yoon</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Diabetic mastopathy: imaging features and the role of image-guided biopsy in its diagnosis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Ultrasonography</sb:maintitle>\n</sb:title>\n<sb:volume-nr>35</sb:volume-nr>\n</sb:series>\n<sb:date>2016</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>140</sb:first-page>\n<sb:last-page>147</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0012\">Kim J, Kim EK, Kim MJ, Moon HJ, Yoon JH. Diabetic mastopathy: imaging features and the role of image-guided biopsy in its diagnosis. Ultrasonography. 2016;35:140–7.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0013\">\n<ce:label>13</ce:label>\n<sb:reference id=\"sbref0013\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.M.</ce:given-name>\n<ce:surname>Ferris-James</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Iuanow</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.S.</ce:given-name>\n<ce:surname>Mehta</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.M.</ce:given-name>\n<ce:surname>Shaheen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>PJ.</ce:given-name>\n<ce:surname>Slanetz</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Imaging Approaches to Diagnosis and Management of Common Ductal Abnormalities</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>RadioGraphics</sb:maintitle>\n</sb:title>\n<sb:volume-nr>32</sb:volume-nr>\n</sb:series>\n<sb:date>2012</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1009</sb:first-page>\n<sb:last-page>1030</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0013\">Ferris-James DM, Iuanow E, Mehta TS, Shaheen RM, Slanetz PJ. Imaging Approaches to Diagnosis and Management of Common Ductal Abnormalities. RadioGraphics. 2012;32:1009–30.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0014\">\n<ce:label>14</ce:label>\n<sb:reference id=\"sbref0014\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.J.</ce:given-name>\n<ce:surname>Lee</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.D.</ce:given-name>\n<ce:surname>Sobel</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Shamis</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>MC.</ce:given-name>\n<ce:surname>Mahoney</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Asymmetric Ductal Ectasia: An Often Overlooked Sign of Malignancy</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Roentgenol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>213</sb:volume-nr>\n</sb:series>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>473</sb:first-page>\n<sb:last-page>481</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0014\">Lee SJ, Sobel LD, Shamis M, Mahoney MC. Asymmetric Ductal Ectasia: An Often Overlooked Sign of Malignancy. Am J Roentgenol. 2019;213:473–81.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"inbook\"?><ce:bib-reference id=\"bib0015\">\n<ce:label>15</ce:label>\n<sb:reference id=\"sbref0015\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>V.M.</ce:given-name>\n<ce:surname>R.Siva Nathan</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.C.</ce:given-name>\n<ce:surname>Lau</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.B.</ce:given-name>\n<ce:surname>Samri</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>W.F.</ce:given-name>\n<ce:surname>Wan Abdul Rahman</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.S.</ce:given-name>\n<ce:surname>Md Salleh</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>F.A.</ce:given-name>\n<ce:surname>Hussain</ce:surname>\n</sb:author>\n</sb:authors>\n</sb:contribution>\n<sb:host>\n<sb:book>\n<sb:book-series>\n<sb:series>\n<sb:title>\n<sb:maintitle>Chronic mastitis manifest as complex breast cyst in ultrasound and the role of elastography: A case series</sb:maintitle>\n</sb:title>\n<sb:volume-nr>19</sb:volume-nr>\n</sb:series>\n</sb:book-series>\n<sb:date>2024</sb:date>\n<sb:publisher>\n<sb:name>Radiol Case Rep</sb:name>\n</sb:publisher>\n</sb:book>\n<sb:pages>\n<sb:first-page>5501</sb:first-page>\n<sb:last-page>5506</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0015\">R.Siva Nathan VM, Lau CC, Samri SB, Wan Abdul Rahman WF, Md Salleh MS, Hussain FA. Chronic mastitis manifest as complex breast cyst in ultrasound and the role of elastography: A case series. Radiol Case Rep. 2024;19:5501–6.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0016\">\n<ce:label>16</ce:label>\n<sb:reference id=\"sbref0016\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Samreen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.B.</ce:given-name>\n<ce:surname>Madsen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Chacko</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>SL.</ce:given-name>\n<ce:surname>Heller</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Magnetic resonance imaging in the evaluation of pathologic nipple discharge: indications and imaging findings</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Br J Radiol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>94</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:article-number>20201013</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0016\">Samreen N, Madsen LB, Chacko C, Heller SL. Magnetic resonance imaging in the evaluation of pathologic nipple discharge: indications and imaging findings. Br J Radiol. 2021;94:20201013.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0017\">\n<ce:label>17</ce:label>\n<sb:reference id=\"sbref0017\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>I.</ce:given-name>\n<ce:surname>Günhan-Bilgen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Memiş</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.E.</ce:given-name>\n<ce:surname>Üstün</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Özdemir</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Erhan</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Sclerosing adenosis: mammographic and ultrasonographic findings with clinical and histopathological correlation</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Eur J Radiol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>44</sb:volume-nr>\n</sb:series>\n<sb:date>2002</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>232</sb:first-page>\n<sb:last-page>238</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0017\">Günhan-Bilgen I, Memiş A, Üstün EE, Özdemir N, Erhan Y. Sclerosing adenosis: mammographic and ultrasonographic findings with clinical and histopathological correlation. Eur J Radiol. 2002;44:232–8.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0018\">\n<ce:label>18</ce:label>\n<sb:reference id=\"sbref0018\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.L.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.J.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Chang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Gao</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Wu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>W.T.</ce:given-name>\n<ce:surname>Yang</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Sclerosing adenosis: Ultrasonographic and mammographic findings and correlation with histopathology</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Mol Clin Oncol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>6</sb:volume-nr>\n</sb:series>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>157</sb:first-page>\n<sb:last-page>162</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0018\">Chen YL, Chen JJ, Chang C, Gao Y, Wu J, Yang WT, et al. Sclerosing adenosis: Ultrasonographic and mammographic findings and correlation with histopathology. Mol Clin Oncol. 2017;6:157–62.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0019\">\n<ce:label>19</ce:label>\n<sb:reference id=\"sbref0019\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>B.Z.</ce:given-name>\n<ce:surname>Manzar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Phillips</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.H.</ce:given-name>\n<ce:surname>Dibble</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.M.</ce:given-name>\n<ce:surname>Quintana</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>AP.</ce:given-name>\n<ce:surname>Lourenco</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Imaging and Management of Radial Scars and Complex Sclerosing Lesions</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>RadioGraphics</sb:maintitle>\n</sb:title>\n<sb:volume-nr>43</sb:volume-nr>\n</sb:series>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:article-number>e230022</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0019\">Manzar BZ, Phillips J, Dibble EH, Quintana LM, Lourenco AP. Imaging and Management of Radial Scars and Complex Sclerosing Lesions. RadioGraphics. 2023;43:e230022.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0020\">\n<ce:label>20</ce:label>\n<sb:reference id=\"sbref0020\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.M.</ce:given-name>\n<ce:surname>Ha</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.H.</ce:given-name>\n<ce:surname>Cha</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.J.</ce:given-name>\n<ce:surname>Shin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.Y.</ce:given-name>\n<ce:surname>Chae</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>W.J.</ce:given-name>\n<ce:surname>Choi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.H.</ce:given-name>\n<ce:surname>Kim</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Radial scars/complex sclerosing lesions of the breast: radiologic and clinicopathologic correlation</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>BMC Med Imaging</sb:maintitle>\n</sb:title>\n<sb:volume-nr>18</sb:volume-nr>\n</sb:series>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>39</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0020\">Ha SM, Cha JH, Shin HJ, Chae EY, Choi WJ, Kim HH, et al. Radial scars/complex sclerosing lesions of the breast: radiologic and clinicopathologic correlation. BMC Med Imaging. 2018;18:39.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0021\">\n<ce:label>21</ce:label>\n<sb:reference id=\"sbref0021\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.A.</ce:given-name>\n<ce:surname>Jesinger</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.E.</ce:given-name>\n<ce:surname>Lattin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.A.</ce:given-name>\n<ce:surname>Ballard</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.M.</ce:given-name>\n<ce:surname>Zelasko</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>LM.</ce:given-name>\n<ce:surname>Glassman</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Vascular Abnormalities of the Breast: Arterial and Venous Disorders, Vascular Masses, and Mimic Lesions with Radiologic-Pathologic Correlation</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>RadioGraphics</sb:maintitle>\n</sb:title>\n<sb:volume-nr>31</sb:volume-nr>\n</sb:series>\n<sb:date>2011</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>E117</sb:first-page>\n<sb:last-page>E136</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0021\">Jesinger RA, Lattin GE, Ballard EA, Zelasko SM, Glassman LM. Vascular Abnormalities of the Breast: Arterial and Venous Disorders, Vascular Masses, and Mimic Lesions with Radiologic-Pathologic Correlation. RadioGraphics. 2011;31:E117–36.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0022\">\n<ce:label>22</ce:label>\n<sb:reference id=\"sbref0022\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>G.O.</ce:given-name>\n<ce:surname>Ogun</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Oyetunde</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Akang</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Cavernous lymphangioma of the breast</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World J Surg Oncol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>5</sb:volume-nr>\n</sb:series>\n<sb:date>2007</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>69</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0022\">Ogun GO, Oyetunde O, Akang E. Cavernous lymphangioma of the breast. World J Surg Oncol. 2007;5:69.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0023\">\n<ce:label>23</ce:label>\n<sb:reference id=\"sbref0023\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Balaji</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Ramachandran</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Cystic Lymphangioma of the Breast: Magnetic Resonance Imaging Features</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Breast Care</sb:maintitle>\n</sb:title>\n<sb:volume-nr>5</sb:volume-nr>\n</sb:series>\n<sb:date>2010</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>250</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0023\">Balaji R, Ramachandran K. Cystic Lymphangioma of the Breast: Magnetic Resonance Imaging Features. Breast Care. 2010;5:250.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0024\">\n<ce:label>24</ce:label>\n<sb:reference id=\"sbref0024\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Sklair-Levy</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.</ce:given-name>\n<ce:surname>Sella</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.</ce:given-name>\n<ce:surname>Alweiss</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>I.</ce:given-name>\n<ce:surname>Craciun</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Libson</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Mally</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Incidence and Management of Complex Fibroadenomas</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Roentgenol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>190</sb:volume-nr>\n</sb:series>\n<sb:date>2008</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>214</sb:first-page>\n<sb:last-page>218</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0024\">Sklair-Levy M, Sella T, Alweiss T, Craciun I, Libson E, Mally B. Incidence and Management of Complex Fibroadenomas. Am J Roentgenol. 2008;190:214–8.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0025\">\n<ce:label>25</ce:label>\n<sb:reference id=\"sbref0025\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>DÇ</ce:given-name>\n<ce:surname>Olgun</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Korkmazer</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>F.</ce:given-name>\n<ce:surname>Kılıç</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.S.</ce:given-name>\n<ce:surname>Dikici</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Velidedeoğlu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>F.</ce:given-name>\n<ce:surname>Aydoğan</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Use of shear wave elastography to differentiate benign and malignant breast lesions</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Diagn Interv Radiol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>20</sb:volume-nr>\n</sb:series>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>239</sb:first-page>\n<sb:last-page>244</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0025\">Olgun DÇ, Korkmazer B, Kılıç F, Dikici AS, Velidedeoğlu M, Aydoğan F, et al. Use of shear wave elastography to differentiate benign and malignant breast lesions. Diagn Interv Radiol. 2014;20:239–44.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0026\">\n<ce:label>26</ce:label>\n<sb:reference id=\"sbref0026\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>K.D.</ce:given-name>\n<ce:surname>Maglione</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.Y.</ce:given-name>\n<ce:surname>Lee</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.M.</ce:given-name>\n<ce:surname>Ray</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.N.</ce:given-name>\n<ce:surname>Joe</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Balassanian</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Radiologic-Pathologic Correlation for Benign Results after MRI-Guided Breast Biopsy</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>AJR Am J Roentgenol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>209</sb:volume-nr>\n</sb:series>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>442</sb:first-page>\n<sb:last-page>453</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0026\">Maglione KD, Lee AY, Ray KM, Joe BN, Balassanian R. Radiologic-Pathologic Correlation for Benign Results after MRI-Guided Breast Biopsy. AJR Am J Roentgenol. 2017;209:442–53.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0027\">\n<ce:label>27</ce:label>\n<sb:reference id=\"sbref0027\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Pinto</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.T.</ce:given-name>\n<ce:surname>Aguiar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Duarte</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>F.</ce:given-name>\n<ce:surname>Vilaverde</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Â</ce:given-name>\n<ce:surname>Rodrigues</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>JL.</ce:given-name>\n<ce:surname>Krug</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Simple and complex fibroadenomas: are there any distinguishing sonographic features?</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Ultrasound Med Off J Am Inst Ultrasound Med</sb:maintitle>\n</sb:title>\n<sb:volume-nr>33</sb:volume-nr>\n</sb:series>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>415</sb:first-page>\n<sb:last-page>419</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0027\">Pinto J, Aguiar AT, Duarte H, Vilaverde F, Rodrigues Â, Krug JL. Simple and complex fibroadenomas: are there any distinguishing sonographic features? J Ultrasound Med Off J Am Inst Ultrasound Med. 2014;33:415–9.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0028\">\n<ce:label>28</ce:label>\n<sb:reference id=\"sbref0028\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>E.D.</ce:given-name>\n<ce:surname>Yeh</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.A.</ce:given-name>\n<ce:surname>Jacene</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.R.</ce:given-name>\n<ce:surname>Bellon</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>F.</ce:given-name>\n<ce:surname>Nakhlis</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.L.</ce:given-name>\n<ce:surname>Birdwell</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Georgian-Smith</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>What Radiologists Need to Know about Diagnosis and Treatment of Inflammatory Breast Cancer: A Multidisciplinary Approach</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>RadioGraphics</sb:maintitle>\n</sb:title>\n<sb:volume-nr>33</sb:volume-nr>\n</sb:series>\n<sb:date>2013</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>2003</sb:first-page>\n<sb:last-page>2017</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0028\">Yeh ED, Jacene HA, Bellon JR, Nakhlis F, Birdwell RL, Georgian-Smith D, et al. What Radiologists Need to Know about Diagnosis and Treatment of Inflammatory Breast Cancer: A Multidisciplinary Approach. RadioGraphics. 2013;33:2003–17.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0029\">\n<ce:label>29</ce:label>\n<sb:reference id=\"sbref0029\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>JP.</ce:given-name>\n<ce:surname>Alunni</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Imaging inflammatory breast cancer</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Diagn Interv Imaging</sb:maintitle>\n</sb:title>\n<sb:volume-nr>93</sb:volume-nr>\n</sb:series>\n<sb:date>2012</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>95</sb:first-page>\n<sb:last-page>103</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0029\">Alunni JP. Imaging inflammatory breast cancer. Diagn Interv Imaging. 2012;93:95–103.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0030\">\n<ce:label>30</ce:label>\n<sb:reference id=\"sbref0030\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Balleyguier</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Ciolovan</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Ammari</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Canale</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Sethom</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Al Rouhbane</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Breast elastography: The technical process and its applications</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Diagn Interv Imaging</sb:maintitle>\n</sb:title>\n<sb:volume-nr>94</sb:volume-nr>\n</sb:series>\n<sb:date>2013</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>503</sb:first-page>\n<sb:last-page>513</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0030\">Balleyguier C, Ciolovan L, Ammari S, Canale S, Sethom S, Al Rouhbane R, et al. Breast elastography: The technical process and its applications. Diagn Interv Imaging. 2013;94:503–13.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0031\">\n<ce:label>31</ce:label>\n<sb:reference id=\"sbref0031\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Le-Petross</ce:given-name>\n<ce:surname>HT</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Cristofanilli</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Carkaci</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Krishnamurthy</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.F.</ce:given-name>\n<ce:surname>Jackson</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.K.</ce:given-name>\n<ce:surname>Harrell</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>MRI Features of Inflammatory Breast Cancer</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Roentgenol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>197</sb:volume-nr>\n</sb:series>\n<sb:date>2011</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>W769</sb:first-page>\n<sb:last-page>W776</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0031\">Le-Petross HT, Cristofanilli M, Carkaci S, Krishnamurthy S, Jackson EF, Harrell RK, et al. MRI Features of Inflammatory Breast Cancer. Am J Roentgenol. 2011;197:W769–76.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0032\">\n<ce:label>32</ce:label>\n<sb:reference id=\"sbref0032\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.Y.</ce:given-name>\n<ce:surname>Kwak</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.K.</ce:given-name>\n<ce:surname>Kim</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.Y.</ce:given-name>\n<ce:surname>Chung</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.K.</ce:given-name>\n<ce:surname>You</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.K.</ce:given-name>\n<ce:surname>Oh</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.H.</ce:given-name>\n<ce:surname>Lee</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Unilateral Breast Edema: Spectrum of Etiologies and Imaging Appearances</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Yonsei Med J</sb:maintitle>\n</sb:title>\n<sb:volume-nr>46</sb:volume-nr>\n</sb:series>\n<sb:date>2005</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1</sb:first-page>\n<sb:last-page>7</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0032\">Kwak JY, Kim EK, Chung SY, You JK, Oh KK, Lee YH, et al. Unilateral Breast Edema: Spectrum of Etiologies and Imaging Appearances. Yonsei Med J. 2005;46:1–7.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0033\">\n<ce:label>33</ce:label>\n<sb:reference id=\"sbref0033\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>I.</ce:given-name>\n<ce:surname>Günhan-Bilgen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Oktay</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Tubular carcinoma of the breast: Mammographic, sonographic, clinical and pathologic findings</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Eur J Radiol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>61</sb:volume-nr>\n</sb:series>\n<sb:date>2007</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>158</sb:first-page>\n<sb:last-page>162</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0033\">Günhan-Bilgen I, Oktay A. Tubular carcinoma of the breast: Mammographic, sonographic, clinical and pathologic findings. Eur J Radiol. 2007;61:158–62.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0034\">\n<ce:label>34</ce:label>\n<sb:reference id=\"sbref0034\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Makki</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Diversity of Breast Carcinoma: Histological Subtypes and Clinical Relevance</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Clin Med Insights Pathol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>8</sb:volume-nr>\n</sb:series>\n<sb:date>2015</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>23</sb:first-page>\n<sb:last-page>31</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0034\">Makki J. Diversity of Breast Carcinoma: Histological Subtypes and Clinical Relevance. Clin Med Insights Pathol. 2015;8:23–31.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0035\">\n<ce:label>35</ce:label>\n<sb:reference id=\"sbref0035\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.G.</ce:given-name>\n<ce:surname>Sheppard</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.J.</ce:given-name>\n<ce:surname>Whitman</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.D.</ce:given-name>\n<ce:surname>Fornage</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.B.</ce:given-name>\n<ce:surname>Stelling</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.T.</ce:given-name>\n<ce:surname>Huynh</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>AA.</ce:given-name>\n<ce:surname>Sahin</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Tubular Carcinoma of the Breast</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Roentgenol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>174</sb:volume-nr>\n</sb:series>\n<sb:date>2000</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>253</sb:first-page>\n<sb:last-page>257</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0035\">Sheppard DG, Whitman GJ, Fornage BD, Stelling CB, Huynh PT, Sahin AA. Tubular Carcinoma of the Breast. Am J Roentgenol. 2000;174:253–7.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0036\">\n<ce:label>36</ce:label>\n<sb:reference id=\"sbref0036\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Evans</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.T.</ce:given-name>\n<ce:surname>Sim</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Thomson</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Jordan</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Purdie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>SJ.</ce:given-name>\n<ce:surname>Vinnicombe</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Shear wave elastography of breast cancer: Sensitivity according to histological type in a large cohort</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Breast Edinb Scotl</sb:maintitle>\n</sb:title>\n<sb:volume-nr>26</sb:volume-nr>\n</sb:series>\n<sb:date>2016</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>115</sb:first-page>\n<sb:last-page>118</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0036\">Evans A, Sim YT, Thomson K, Jordan L, Purdie C, Vinnicombe SJ. Shear wave elastography of breast cancer: Sensitivity according to histological type in a large cohort. Breast Edinb Scotl. 2016;26:115–8.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0037\">\n<ce:label>37</ce:label>\n<sb:reference id=\"sbref0037\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Yılmaz</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.</ce:given-name>\n<ce:surname>Bayramoğlu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Emirikçi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Önder</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Salmaslıoğlu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Dursun</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>MR Imaging Features of Tubular Carcinoma: Preliminary Experience in Twelve Masses</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Eur J Breast Health</sb:maintitle>\n</sb:title>\n<sb:volume-nr>14</sb:volume-nr>\n</sb:series>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>39</sb:first-page>\n<sb:last-page>45</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0037\">Yılmaz R, Bayramoğlu Z, Emirikçi S, Önder S, Salmaslıoğlu A, Dursun M, et al. MR Imaging Features of Tubular Carcinoma: Preliminary Experience in Twelve Masses. Eur J Breast Health. 2018;14:39–45.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0038\">\n<ce:label>38</ce:label>\n<sb:reference id=\"sbref0038\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Aydin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Guner</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>I.</ce:given-name>\n<ce:surname>Esen Bostanci</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.S.</ce:given-name>\n<ce:surname>Cosar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>F.T.</ce:given-name>\n<ce:surname>Kiziltepe</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.K.</ce:given-name>\n<ce:surname>Aribas</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Unusual presentation of tubular breast carcinoma as non-mass enhancement</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Egypt J Radiol Nucl Med</sb:maintitle>\n</sb:title>\n<sb:volume-nr>49</sb:volume-nr>\n</sb:series>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>281</sb:first-page>\n<sb:last-page>283</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0038\">Aydin H, Guner B, Esen Bostanci I, Cosar ZS, Kiziltepe FT, Aribas BK, et al. Unusual presentation of tubular breast carcinoma as non-mass enhancement. Egypt J Radiol Nucl Med. 2018;49:281–3.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0039\">\n<ce:label>39</ce:label>\n<sb:reference id=\"sbref0039\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.S.</ce:given-name>\n<ce:surname>Soo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Dash</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Bentley</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.H.</ce:given-name>\n<ce:surname>Lee</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Nathan</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Tubular Adenomas of the Breast</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Roentgenol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>174</sb:volume-nr>\n</sb:series>\n<sb:date>2000</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>757</sb:first-page>\n<sb:last-page>761</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0039\">Soo MS, Dash N, Bentley R, Lee LH, Nathan G. Tubular Adenomas of the Breast. Am J Roentgenol. 2000;174:757–61.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0040\">\n<ce:label>40</ce:label>\n<sb:reference id=\"sbref0040\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Sun</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Dai</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Xu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Liu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Yu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.</ce:given-name>\n<ce:surname>Sun</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Primary Neuroendocrine Tumor of the Breast: Current Understanding and Future Perspectives</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Front Oncol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>12</sb:volume-nr>\n</sb:series>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:article-number>848485</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0040\">Sun H, Dai S, Xu J, Liu L, Yu J, Sun T. Primary Neuroendocrine Tumor of the Breast: Current Understanding and Future Perspectives. Front Oncol. 2022;12:848485.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0041\">\n<ce:label>41</ce:label>\n<sb:reference id=\"sbref0041\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Trevisi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>La Salvia</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Daniele</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.P.</ce:given-name>\n<ce:surname>Brizzi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>De Rosa</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.V.</ce:given-name>\n<ce:surname>Scagliotti</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Neuroendocrine breast carcinoma: a rare but challenging entity</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Med Oncol Northwood Lond Engl</sb:maintitle>\n</sb:title>\n<sb:volume-nr>37</sb:volume-nr>\n</sb:series>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>70</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0041\">Trevisi E, La Salvia A, Daniele L, Brizzi MP, De Rosa G, Scagliotti GV, et al. Neuroendocrine breast carcinoma: a rare but challenging entity. Med Oncol Northwood Lond Engl. 2020;37:70.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"others\"?><ce:bib-reference id=\"bib0042\">\n<ce:label>42</ce:label>\n<ce:other-ref id=\"sbref0042\">\n<ce:textref>Vorburger SA, Xing Y, Hunt KK, Lakin GE, Benjamin RS, Feig BW, et al. Angiosarcoma of the breast. Cancer. 2005;104:2682–8.</ce:textref>\n</ce:other-ref>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0043\">\n<ce:label>43</ce:label>\n<sb:reference id=\"sbref0043\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>T.</ce:given-name>\n<ce:surname>Pai</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.</ce:given-name>\n<ce:surname>Shet</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Patil</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Parmar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.</ce:given-name>\n<ce:surname>Wadasadawala</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>SB.</ce:given-name>\n<ce:surname>Desai</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Epithelioid hemangioendothelioma of breast with nodal metastasis masquerading as breast carcinoma: An unusual case with review of literature</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Hum Pathol Case Rep</sb:maintitle>\n</sb:title>\n<sb:volume-nr>23</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:article-number>200465</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0043\">Pai T, Shet T, Patil A, Parmar V, Wadasadawala T, Desai SB. Epithelioid hemangioendothelioma of breast with nodal metastasis masquerading as breast carcinoma: An unusual case with review of literature. Hum Pathol Case Rep. 2021;23:200465.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0044\">\n<ce:label>44</ce:label>\n<sb:reference id=\"sbref0044\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.G.</ce:given-name>\n<ce:surname>Kim</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.S.</ce:given-name>\n<ce:surname>Choi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.J.</ce:given-name>\n<ce:surname>Park</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>SM.</ce:given-name>\n<ce:surname>Chong</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Kaposiform hemangioendothelioma of the breast in an adult female</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Clin Breast Cancer</sb:maintitle>\n</sb:title>\n<sb:volume-nr>11</sb:volume-nr>\n</sb:series>\n<sb:date>2011</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>135</sb:first-page>\n<sb:last-page>137</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0044\">Kim MG, Choi YS, Park SJ, Chong SM. Kaposiform hemangioendothelioma of the breast in an adult female. Clin Breast Cancer. 2011;11:135–7.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0045\">\n<ce:label>45</ce:label>\n<sb:reference id=\"sbref0045\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.F.</ce:given-name>\n<ce:surname>Lim</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Goei</ce:surname>\n</sb:author>\n</sb:authors>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Angiosarcoma of the Breast. RadioGraphics.</sb:maintitle>\n</sb:title>\n<sb:volume-nr>27</sb:volume-nr>\n</sb:series>\n<sb:date>2007</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>S125</sb:first-page>\n<sb:last-page>S130</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0045\">Lim RF, Goei R. Angiosarcoma of the Breast. RadioGraphics. 2007;27:S125–30.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0046\">\n<ce:label>46</ce:label>\n<sb:reference id=\"sbref0046\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.R.</ce:given-name>\n<ce:surname>Marak</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Raj</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Verma</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Gandhi</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Primary hepatic epithelioid hemangioendothelioma masquerading as metastases: A rare case report</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Radiol Case Rep</sb:maintitle>\n</sb:title>\n<sb:volume-nr>18</sb:volume-nr>\n</sb:series>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>3739</sb:first-page>\n<sb:last-page>3747</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0046\">Marak JR, Raj G, Verma S, Gandhi A. Primary hepatic epithelioid hemangioendothelioma masquerading as metastases: A rare case report. Radiol Case Rep. 2023;18:3739–47.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0047\">\n<ce:label>47</ce:label>\n<sb:reference id=\"sbref0047\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.M.</ce:given-name>\n<ce:surname>Sabate</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Clotet</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Torrubia</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Gomez</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Guerrero</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Las</ce:given-name>\n<ce:surname>de</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Heras</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Radiologic Evaluation of Breast Disorders Related to Pregnancy and Lactation</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>RadioGraphics</sb:maintitle>\n</sb:title>\n<sb:volume-nr>27</sb:volume-nr>\n</sb:series>\n<sb:date>2007</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>S101</sb:first-page>\n<sb:last-page>S124</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0047\">Sabate JM, Clotet M, Torrubia S, Gomez A, Guerrero R, de Las Heras P, et al. Radiologic Evaluation of Breast Disorders Related to Pregnancy and Lactation. RadioGraphics. 2007;27:S101–24.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0048\">\n<ce:label>48</ce:label>\n<sb:reference id=\"sbref0048\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Destek</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Gul</ce:given-name>\n<ce:surname>VO</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Ahioglu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>KR.</ce:given-name>\n<ce:surname>Serin</ce:surname>\n</sb:author>\n</sb:authors>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Pituitary Adenoma and Hyperprolactinemia Accompanied by Idiopathic Granulomatous Mastitis. Case Rep Endocrinol.</sb:maintitle>\n</sb:title>\n</sb:series>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:article-number>e3974291</sb:article-number>\n</sb:host>\n<sb:comment>2017</sb:comment>\n</sb:reference>\n<ce:source-text id=\"srctxt0048\">Destek S, Gul VO, Ahioglu S, Serin KR. Pituitary Adenoma and Hyperprolactinemia Accompanied by Idiopathic Granulomatous Mastitis. Case Rep Endocrinol. 2017;2017:e3974291.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0049\">\n<ce:label>49</ce:label>\n<sb:reference id=\"sbref0049\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Cong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Zou</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Qiao</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Lin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Bilateral mammary duct ectasia induced by sulpiride-associated hyperprolactinemia: A case report</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Oncol Lett</sb:maintitle>\n</sb:title>\n<sb:volume-nr>9</sb:volume-nr>\n</sb:series>\n<sb:date>2015</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>2181</sb:first-page>\n<sb:last-page>2184</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0049\">Cong Y, Zou H, Qiao G, Lin J, Wang X, Li X, et al. Bilateral mammary duct ectasia induced by sulpiride-associated hyperprolactinemia: A case report. Oncol Lett. 2015;9:2181–4.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0050\">\n<ce:label>50</ce:label>\n<sb:reference id=\"sbref0050\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.K.</ce:given-name>\n<ce:surname>Bhattacharjee</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.R.</ce:given-name>\n<ce:surname>Ramman</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>ARGARWAL</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Nain</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Thomas</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Isolated cysticercosis of the breast masquerading as a breast tumour: report of a case and review of literature</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Ann Trop Med Parasitol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>105</sb:volume-nr>\n</sb:series>\n<sb:date>2011</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>455</sb:first-page>\n<sb:last-page>461</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0050\">Bhattacharjee HK, Ramman TR, ARGARWAL L, Nain M, Thomas S. Isolated cysticercosis of the breast masquerading as a breast tumour: report of a case and review of literature. Ann Trop Med Parasitol. 2011;105:455–61.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0051\">\n<ce:label>51</ce:label>\n<sb:reference id=\"sbref0051\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Kala</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Khare</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Fine-needle aspiration cytology as a diagnostic modality for cysticercosis: A clinicocytological study of 137 cases</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Cytol Indian Acad Cytol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>31</sb:volume-nr>\n</sb:series>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>68</sb:first-page>\n<sb:last-page>72</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0051\">Kala P, Khare P. Fine-needle aspiration cytology as a diagnostic modality for cysticercosis: A clinicocytological study of 137 cases. J Cytol Indian Acad Cytol. 2014;31:68–72.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0052\">\n<ce:label>52</ce:label>\n<sb:reference id=\"sbref0052\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>N.R.S.</ce:given-name>\n<ce:surname>Surendrababu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Thomas</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Rajinikanth</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>SN.</ce:given-name>\n<ce:surname>Keshava</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Breast filariasis: Real-time sonographic imaging of the filarial dance</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Clin Ultrasound</sb:maintitle>\n</sb:title>\n<sb:volume-nr>36</sb:volume-nr>\n</sb:series>\n<sb:date>2008</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>567</sb:first-page>\n<sb:last-page>569</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0052\">Surendrababu NRS, Thomas E, Rajinikanth J, Keshava SN. Breast filariasis: Real-time sonographic imaging of the filarial dance. J Clin Ultrasound. 2008;36:567–9.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0053\">\n<ce:label>53</ce:label>\n<sb:reference id=\"sbref0053\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.K.</ce:given-name>\n<ce:surname>Barry</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>WG.</ce:given-name>\n<ce:surname>Schucany</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Dracunculiasis of the Breast: Radiological Manifestations of a Rare Disease</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Radiol Case Rep</sb:maintitle>\n</sb:title>\n<sb:volume-nr>6</sb:volume-nr>\n</sb:series>\n<sb:date>2012</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>29</sb:first-page>\n<sb:last-page>33</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0053\">Barry SK, Schucany WG. Dracunculiasis of the Breast: Radiological Manifestations of a Rare Disease. J Radiol Case Rep. 2012;6:29–33.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0054\">\n<ce:label>54</ce:label>\n<sb:reference id=\"sbref0054\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Dong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Lu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Zuo</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Spectrum of the Breast Lesions With Increased 18F-FDG Uptake on PET/CT</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Clin Nucl Med</sb:maintitle>\n</sb:title>\n<sb:volume-nr>41</sb:volume-nr>\n</sb:series>\n<sb:date>2016</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>543</sb:first-page>\n<sb:last-page>557</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0054\">Dong A, Wang Y, Lu J, Zuo C. Spectrum of the Breast Lesions With Increased 18F-FDG Uptake on PET/CT. Clin Nucl Med. 2016;41:543–57.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0055\">\n<ce:label>55</ce:label>\n<sb:reference id=\"sbref0055\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>K.H.</ce:given-name>\n<ce:surname>Ko</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.K.</ce:given-name>\n<ce:surname>Jung</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>TJ.</ce:given-name>\n<ce:surname>Jeon</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Diffuse Intense 18F-FDG Uptake at PET in Unilateral Breast Related to Breastfeeding Practice</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Korean J Radiol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>14</sb:volume-nr>\n</sb:series>\n<sb:date>2013</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>400</sb:first-page>\n<sb:last-page>402</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0055\">Ko KH, Jung HK, Jeon TJ. Diffuse Intense 18F-FDG Uptake at PET in Unilateral Breast Related to Breastfeeding Practice. Korean J Radiol. 2013;14:400–2.</ce:source-text>\n</ce:bib-reference>\n</ce:bibliography-sec>",
    "output": "<ce:bibliography-sec xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"cebibsec1\">\n<?att type=\"article\"?><ce:bib-reference id=\"bib0001\">\n<ce:label>1</ce:label>\n<sb:reference id=\"sbref0001\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>E.B.</ce:given-name>\n<ce:surname>Mendelson</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Böhm-Vélez</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>W.A.</ce:given-name>\n<ce:surname>Berg</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Whitman</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Feldman</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Madjar</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Acr bi-rads® Ultrasound</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>ACR BI-RADS® Atlas Breast Imaging Report Data Syst</sb:maintitle>\n</sb:title>\n</sb:series>\n<sb:date>2013</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>149</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0001\">Mendelson EB, Böhm-Vélez M, Berg WA, Whitman G, Feldman M, Madjar H. Acr bi-rads® Ultrasound. ACR BI-RADS® Atlas Breast Imaging Report Data Syst. 2013;149.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0002\">\n<ce:label>2</ce:label>\n<sb:reference id=\"sbref0002\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>P.W.</ce:given-name>\n<ce:surname>Leong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.C.</ce:given-name>\n<ce:surname>Chotai</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Kulkarni</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Imaging Features of Inflammatory Breast Disorders: A Pictorial Essay</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Korean J Radiol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>19</sb:volume-nr>\n</sb:series>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>5</sb:first-page>\n<sb:last-page>14</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0002\">Leong PW, Chotai NC, Kulkarni S. Imaging Features of Inflammatory Breast Disorders: A Pictorial Essay. Korean J Radiol. 2018;19:5–14.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"inbook\"?><ce:bib-reference id=\"bib0003\">\n<ce:label>3</ce:label>\n<sb:reference id=\"sbref0003\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Gauba</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Dhamija</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>SR.</ce:given-name>\n<ce:surname>Mathur</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Radiological–Pathological Correlation</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:edited-book>\n<sb:editors>\n<sb:editor>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Dhamija</ce:surname>\n</sb:editor>\n<sb:editor>\n<ce:given-name>S.V.S.</ce:given-name>\n<ce:surname>Deo</ce:surname>\n</sb:editor>\n</sb:editors>\n<sb:title>\n<sb:maintitle>editors. Imaging in Management of Breast Diseases</sb:maintitle>\n</sb:title>\n<sb:book-series>\n<sb:series>\n<sb:title>\n<sb:maintitle>editors. Imaging in Management of Breast Diseases</sb:maintitle>\n</sb:title>\n<sb:volume-nr>Volume 1</sb:volume-nr>\n</sb:series>\n</sb:book-series>\n<sb:date>2025 Aug 2</sb:date>\n<sb:publisher>\n<sb:name>Springer Nature</sb:name>\n<sb:location>Singapore</sb:location>\n</sb:publisher>\n</sb:edited-book>\n<sb:pages>\n<sb:first-page>225</sb:first-page>\n<sb:last-page>246</sb:last-page>\n</sb:pages>\n<ce:doi>10.1007/978-981-97-9847-6_13</ce:doi>\n</sb:host>\n<sb:comment>Overview of Modalities [Internet]2025 [citedAvailable from</sb:comment>\n</sb:reference>\n<ce:source-text id=\"srctxt0003\">Gauba R, Dhamija E, Mathur SR. Radiological–Pathological Correlation. In: Dhamija E, Deo SVS, editors. Imaging in Management of Breast Diseases: Volume 1, Overview of Modalities [Internet]. Singapore: Springer Nature; 2025 [cited 2025 Aug 2]. p. 225–46. Available from: https://doi.org/10.1007/978-981-97-9847-6_13</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0004\">\n<ce:label>4</ce:label>\n<sb:reference id=\"sbref0004\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Wolfrum</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Kümmel</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>I.</ce:given-name>\n<ce:surname>Theuerkauf</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Pelz</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Reinisch</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Granulomatous Mastitis: A Therapeutic and Diagnostic Challenge</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Breast Care</sb:maintitle>\n</sb:title>\n<sb:volume-nr>13</sb:volume-nr>\n</sb:series>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>413</sb:first-page>\n<sb:last-page>418</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0004\">Wolfrum A, Kümmel S, Theuerkauf I, Pelz E, Reinisch M. Granulomatous Mastitis: A Therapeutic and Diagnostic Challenge. Breast Care. 2018;13:413–8.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0005\">\n<ce:label>5</ce:label>\n<sb:reference id=\"sbref0005\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Manogna</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Dev</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.D.</ce:given-name>\n<ce:surname>Joseph</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Ramakrishnan</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Idiopathic granulomatous mastitis: our experience</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Egypt J Radiol Nucl Med</sb:maintitle>\n</sb:title>\n<sb:volume-nr>51</sb:volume-nr>\n</sb:series>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>15</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0005\">Manogna P, Dev B, Joseph LD, Ramakrishnan R. Idiopathic granulomatous mastitis: our experience. Egypt J Radiol Nucl Med. 2020;51:15.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0006\">\n<ce:label>6</ce:label>\n<sb:reference id=\"sbref0006\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>F.</ce:given-name>\n<ce:surname>Altintoprak</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.</ce:given-name>\n<ce:surname>Kivilcim</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>OV.</ce:given-name>\n<ce:surname>Ozkan</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Aetiology of idiopathic granulomatous mastitis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World J Clin Cases WJCC</sb:maintitle>\n</sb:title>\n<sb:volume-nr>2</sb:volume-nr>\n</sb:series>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>852</sb:first-page>\n<sb:last-page>858</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0006\">Altintoprak F, Kivilcim T, Ozkan OV. Aetiology of idiopathic granulomatous mastitis. World J Clin Cases WJCC. 2014;2:852–8.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0007\">\n<ce:label>7</ce:label>\n<sb:reference id=\"sbref0007\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>C.W.</ce:given-name>\n<ce:surname>Pluguez-Turull</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.E.</ce:given-name>\n<ce:surname>Nanyes</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.J.</ce:given-name>\n<ce:surname>Quintero</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Alizai</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.D.</ce:given-name>\n<ce:surname>Mais</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.A.</ce:given-name>\n<ce:surname>Kist</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Idiopathic Granulomatous Mastitis: Manifestations at Multimodality Imaging and Pitfalls</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>RadioGraphics</sb:maintitle>\n</sb:title>\n<sb:volume-nr>38</sb:volume-nr>\n</sb:series>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>330</sb:first-page>\n<sb:last-page>356</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0007\">Pluguez-Turull CW, Nanyes JE, Quintero CJ, Alizai H, Mais DD, Kist KA, et al. Idiopathic Granulomatous Mastitis: Manifestations at Multimodality Imaging and Pitfalls. RadioGraphics. 2018;38:330–56.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0008\">\n<ce:label>8</ce:label>\n<sb:reference id=\"sbref0008\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.T.</ce:given-name>\n<ce:surname>Fazzio</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.S.</ce:given-name>\n<ce:surname>Shah</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.P.</ce:given-name>\n<ce:surname>Sandhu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>KN.</ce:given-name>\n<ce:surname>Glazebrook</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Idiopathic granulomatous mastitis: imaging update and review</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Insights Imaging</sb:maintitle>\n</sb:title>\n<sb:volume-nr>7</sb:volume-nr>\n</sb:series>\n<sb:date>2016</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>531</sb:first-page>\n<sb:last-page>539</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0008\">Fazzio RT, Shah SS, Sandhu NP, Glazebrook KN. Idiopathic granulomatous mastitis: imaging update and review. Insights Imaging. 2016;7:531–9.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0009\">\n<ce:label>9</ce:label>\n<sb:reference id=\"sbref0009\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Dhamija</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Gulati</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Hari</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Imaging spectrum in tropical breast infections</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Br J Radiol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>97</sb:volume-nr>\n</sb:series>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>315</sb:first-page>\n<sb:last-page>323</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0009\">Dhamija E, Gulati S, Hari S. Imaging spectrum in tropical breast infections. Br J Radiol. 2024;97:315–23.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0010\">\n<ce:label>10</ce:label>\n<sb:reference id=\"sbref0010\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Yağcı</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>I.</ce:given-name>\n<ce:surname>Erdem Toslak</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Çekiç</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Öz</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.R.</ce:given-name>\n<ce:surname>Karakaş</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Akdemir</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Differentiation between idiopathic granulomatous mastitis and malignant breast lesions using strain ratio on ultrasonic elastography</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Diagn Interv Imaging</sb:maintitle>\n</sb:title>\n<sb:volume-nr>98</sb:volume-nr>\n</sb:series>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>685</sb:first-page>\n<sb:last-page>691</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0010\">Yağcı B, Erdem Toslak I, Çekiç B, Öz M, Karakaş BR, Akdemir M, et al. Differentiation between idiopathic granulomatous mastitis and malignant breast lesions using strain ratio on ultrasonic elastography. Diagn Interv Imaging. 2017;98:685–91.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0011\">\n<ce:label>11</ce:label>\n<sb:reference id=\"sbref0011\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.K.</ce:given-name>\n<ce:surname>Shaffrey</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>F.B.</ce:given-name>\n<ce:surname>Askin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.M.B.</ce:given-name>\n<ce:surname>Gatewood</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Brem</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Diabetic Fibrous Mastopathy: Case Reports and Radiologic-Pathologic Correlation</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Breast J</sb:maintitle>\n</sb:title>\n<sb:volume-nr>6</sb:volume-nr>\n</sb:series>\n<sb:date>2000</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>414</sb:first-page>\n<sb:last-page>417</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0011\">Shaffrey JK, Askin FB, Gatewood OMB, Brem R. Diabetic Fibrous Mastopathy: Case Reports and Radiologic-Pathologic Correlation. Breast J. 2000;6:414–7.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0012\">\n<ce:label>12</ce:label>\n<sb:reference id=\"sbref0012\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Kim</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.K.</ce:given-name>\n<ce:surname>Kim</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Kim</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.J.</ce:given-name>\n<ce:surname>Moon</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>JH.</ce:given-name>\n<ce:surname>Yoon</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Diabetic mastopathy: imaging features and the role of image-guided biopsy in its diagnosis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Ultrasonography</sb:maintitle>\n</sb:title>\n<sb:volume-nr>35</sb:volume-nr>\n</sb:series>\n<sb:date>2016</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>140</sb:first-page>\n<sb:last-page>147</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0012\">Kim J, Kim EK, Kim MJ, Moon HJ, Yoon JH. Diabetic mastopathy: imaging features and the role of image-guided biopsy in its diagnosis. Ultrasonography. 2016;35:140–7.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0013\">\n<ce:label>13</ce:label>\n<sb:reference id=\"sbref0013\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.M.</ce:given-name>\n<ce:surname>Ferris-James</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Iuanow</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.S.</ce:given-name>\n<ce:surname>Mehta</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.M.</ce:given-name>\n<ce:surname>Shaheen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>PJ.</ce:given-name>\n<ce:surname>Slanetz</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Imaging Approaches to Diagnosis and Management of Common Ductal Abnormalities</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>RadioGraphics</sb:maintitle>\n</sb:title>\n<sb:volume-nr>32</sb:volume-nr>\n</sb:series>\n<sb:date>2012</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1009</sb:first-page>\n<sb:last-page>1030</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0013\">Ferris-James DM, Iuanow E, Mehta TS, Shaheen RM, Slanetz PJ. Imaging Approaches to Diagnosis and Management of Common Ductal Abnormalities. RadioGraphics. 2012;32:1009–30.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0014\">\n<ce:label>14</ce:label>\n<sb:reference id=\"sbref0014\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.J.</ce:given-name>\n<ce:surname>Lee</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.D.</ce:given-name>\n<ce:surname>Sobel</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Shamis</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>MC.</ce:given-name>\n<ce:surname>Mahoney</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Asymmetric Ductal Ectasia: An Often Overlooked Sign of Malignancy</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Roentgenol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>213</sb:volume-nr>\n</sb:series>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>473</sb:first-page>\n<sb:last-page>481</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0014\">Lee SJ, Sobel LD, Shamis M, Mahoney MC. Asymmetric Ductal Ectasia: An Often Overlooked Sign of Malignancy. Am J Roentgenol. 2019;213:473–81.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"inbook\"?><ce:bib-reference id=\"bib0015\">\n<ce:label>15</ce:label>\n<sb:reference id=\"sbref0015\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>V.M.</ce:given-name>\n<ce:surname>R.Siva Nathan</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.C.</ce:given-name>\n<ce:surname>Lau</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.B.</ce:given-name>\n<ce:surname>Samri</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>W.F.</ce:given-name>\n<ce:surname>Wan Abdul Rahman</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.S.</ce:given-name>\n<ce:surname>Md Salleh</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>F.A.</ce:given-name>\n<ce:surname>Hussain</ce:surname>\n</sb:author>\n</sb:authors>\n</sb:contribution>\n<sb:host>\n<sb:book>\n<sb:book-series>\n<sb:series>\n<sb:title>\n<sb:maintitle>Chronic mastitis manifest as complex breast cyst in ultrasound and the role of elastography: A case series</sb:maintitle>\n</sb:title>\n<sb:volume-nr>19</sb:volume-nr>\n</sb:series>\n</sb:book-series>\n<sb:date>2024</sb:date>\n<sb:publisher>\n<sb:name>Radiol Case Rep</sb:name>\n</sb:publisher>\n</sb:book>\n<sb:pages>\n<sb:first-page>5501</sb:first-page>\n<sb:last-page>5506</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0015\">R.Siva Nathan VM, Lau CC, Samri SB, Wan Abdul Rahman WF, Md Salleh MS, Hussain FA. Chronic mastitis manifest as complex breast cyst in ultrasound and the role of elastography: A case series. Radiol Case Rep. 2024;19:5501–6.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0016\">\n<ce:label>16</ce:label>\n<sb:reference id=\"sbref0016\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Samreen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.B.</ce:given-name>\n<ce:surname>Madsen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Chacko</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>SL.</ce:given-name>\n<ce:surname>Heller</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Magnetic resonance imaging in the evaluation of pathologic nipple discharge: indications and imaging findings</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Br J Radiol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>94</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:article-number>20201013</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0016\">Samreen N, Madsen LB, Chacko C, Heller SL. Magnetic resonance imaging in the evaluation of pathologic nipple discharge: indications and imaging findings. Br J Radiol. 2021;94:20201013.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0017\">\n<ce:label>17</ce:label>\n<sb:reference id=\"sbref0017\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>I.</ce:given-name>\n<ce:surname>Günhan-Bilgen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Memiş</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.E.</ce:given-name>\n<ce:surname>Üstün</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Özdemir</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Erhan</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Sclerosing adenosis: mammographic and ultrasonographic findings with clinical and histopathological correlation</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Eur J Radiol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>44</sb:volume-nr>\n</sb:series>\n<sb:date>2002</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>232</sb:first-page>\n<sb:last-page>238</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0017\">Günhan-Bilgen I, Memiş A, Üstün EE, Özdemir N, Erhan Y. Sclerosing adenosis: mammographic and ultrasonographic findings with clinical and histopathological correlation. Eur J Radiol. 2002;44:232–8.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0018\">\n<ce:label>18</ce:label>\n<sb:reference id=\"sbref0018\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.L.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.J.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Chang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Gao</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Wu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>W.T.</ce:given-name>\n<ce:surname>Yang</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Sclerosing adenosis: Ultrasonographic and mammographic findings and correlation with histopathology</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Mol Clin Oncol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>6</sb:volume-nr>\n</sb:series>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>157</sb:first-page>\n<sb:last-page>162</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0018\">Chen YL, Chen JJ, Chang C, Gao Y, Wu J, Yang WT, et al. Sclerosing adenosis: Ultrasonographic and mammographic findings and correlation with histopathology. Mol Clin Oncol. 2017;6:157–62.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0019\">\n<ce:label>19</ce:label>\n<sb:reference id=\"sbref0019\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>B.Z.</ce:given-name>\n<ce:surname>Manzar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Phillips</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.H.</ce:given-name>\n<ce:surname>Dibble</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.M.</ce:given-name>\n<ce:surname>Quintana</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>AP.</ce:given-name>\n<ce:surname>Lourenco</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Imaging and Management of Radial Scars and Complex Sclerosing Lesions</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>RadioGraphics</sb:maintitle>\n</sb:title>\n<sb:volume-nr>43</sb:volume-nr>\n</sb:series>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:article-number>e230022</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0019\">Manzar BZ, Phillips J, Dibble EH, Quintana LM, Lourenco AP. Imaging and Management of Radial Scars and Complex Sclerosing Lesions. RadioGraphics. 2023;43:e230022.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0020\">\n<ce:label>20</ce:label>\n<sb:reference id=\"sbref0020\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.M.</ce:given-name>\n<ce:surname>Ha</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.H.</ce:given-name>\n<ce:surname>Cha</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.J.</ce:given-name>\n<ce:surname>Shin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.Y.</ce:given-name>\n<ce:surname>Chae</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>W.J.</ce:given-name>\n<ce:surname>Choi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.H.</ce:given-name>\n<ce:surname>Kim</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Radial scars/complex sclerosing lesions of the breast: radiologic and clinicopathologic correlation</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>BMC Med Imaging</sb:maintitle>\n</sb:title>\n<sb:volume-nr>18</sb:volume-nr>\n</sb:series>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>39</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0020\">Ha SM, Cha JH, Shin HJ, Chae EY, Choi WJ, Kim HH, et al. Radial scars/complex sclerosing lesions of the breast: radiologic and clinicopathologic correlation. BMC Med Imaging. 2018;18:39.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0021\">\n<ce:label>21</ce:label>\n<sb:reference id=\"sbref0021\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.A.</ce:given-name>\n<ce:surname>Jesinger</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.E.</ce:given-name>\n<ce:surname>Lattin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.A.</ce:given-name>\n<ce:surname>Ballard</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.M.</ce:given-name>\n<ce:surname>Zelasko</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>LM.</ce:given-name>\n<ce:surname>Glassman</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Vascular Abnormalities of the Breast: Arterial and Venous Disorders, Vascular Masses, and Mimic Lesions with Radiologic-Pathologic Correlation</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>RadioGraphics</sb:maintitle>\n</sb:title>\n<sb:volume-nr>31</sb:volume-nr>\n</sb:series>\n<sb:date>2011</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>E117</sb:first-page>\n<sb:last-page>E136</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0021\">Jesinger RA, Lattin GE, Ballard EA, Zelasko SM, Glassman LM. Vascular Abnormalities of the Breast: Arterial and Venous Disorders, Vascular Masses, and Mimic Lesions with Radiologic-Pathologic Correlation. RadioGraphics. 2011;31:E117–36.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0022\">\n<ce:label>22</ce:label>\n<sb:reference id=\"sbref0022\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>G.O.</ce:given-name>\n<ce:surname>Ogun</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Oyetunde</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Akang</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Cavernous lymphangioma of the breast</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World J Surg Oncol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>5</sb:volume-nr>\n</sb:series>\n<sb:date>2007</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>69</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0022\">Ogun GO, Oyetunde O, Akang E. Cavernous lymphangioma of the breast. World J Surg Oncol. 2007;5:69.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0023\">\n<ce:label>23</ce:label>\n<sb:reference id=\"sbref0023\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Balaji</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Ramachandran</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Cystic Lymphangioma of the Breast: Magnetic Resonance Imaging Features</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Breast Care</sb:maintitle>\n</sb:title>\n<sb:volume-nr>5</sb:volume-nr>\n</sb:series>\n<sb:date>2010</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>250</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0023\">Balaji R, Ramachandran K. Cystic Lymphangioma of the Breast: Magnetic Resonance Imaging Features. Breast Care. 2010;5:250.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0024\">\n<ce:label>24</ce:label>\n<sb:reference id=\"sbref0024\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Sklair-Levy</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.</ce:given-name>\n<ce:surname>Sella</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.</ce:given-name>\n<ce:surname>Alweiss</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>I.</ce:given-name>\n<ce:surname>Craciun</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Libson</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Mally</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Incidence and Management of Complex Fibroadenomas</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Roentgenol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>190</sb:volume-nr>\n</sb:series>\n<sb:date>2008</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>214</sb:first-page>\n<sb:last-page>218</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0024\">Sklair-Levy M, Sella T, Alweiss T, Craciun I, Libson E, Mally B. Incidence and Management of Complex Fibroadenomas. Am J Roentgenol. 2008;190:214–8.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0025\">\n<ce:label>25</ce:label>\n<sb:reference id=\"sbref0025\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>DÇ</ce:given-name>\n<ce:surname>Olgun</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Korkmazer</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>F.</ce:given-name>\n<ce:surname>Kılıç</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.S.</ce:given-name>\n<ce:surname>Dikici</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Velidedeoğlu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>F.</ce:given-name>\n<ce:surname>Aydoğan</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Use of shear wave elastography to differentiate benign and malignant breast lesions</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Diagn Interv Radiol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>20</sb:volume-nr>\n</sb:series>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>239</sb:first-page>\n<sb:last-page>244</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0025\">Olgun DÇ, Korkmazer B, Kılıç F, Dikici AS, Velidedeoğlu M, Aydoğan F, et al. Use of shear wave elastography to differentiate benign and malignant breast lesions. Diagn Interv Radiol. 2014;20:239–44.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0026\">\n<ce:label>26</ce:label>\n<sb:reference id=\"sbref0026\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>K.D.</ce:given-name>\n<ce:surname>Maglione</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.Y.</ce:given-name>\n<ce:surname>Lee</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.M.</ce:given-name>\n<ce:surname>Ray</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.N.</ce:given-name>\n<ce:surname>Joe</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Balassanian</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Radiologic-Pathologic Correlation for Benign Results after MRI-Guided Breast Biopsy</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>AJR Am J Roentgenol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>209</sb:volume-nr>\n</sb:series>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>442</sb:first-page>\n<sb:last-page>453</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0026\">Maglione KD, Lee AY, Ray KM, Joe BN, Balassanian R. Radiologic-Pathologic Correlation for Benign Results after MRI-Guided Breast Biopsy. AJR Am J Roentgenol. 2017;209:442–53.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0027\">\n<ce:label>27</ce:label>\n<sb:reference id=\"sbref0027\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Pinto</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.T.</ce:given-name>\n<ce:surname>Aguiar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Duarte</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>F.</ce:given-name>\n<ce:surname>Vilaverde</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Â</ce:given-name>\n<ce:surname>Rodrigues</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>JL.</ce:given-name>\n<ce:surname>Krug</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Simple and complex fibroadenomas: are there any distinguishing sonographic features?</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Ultrasound Med Off J Am Inst Ultrasound Med</sb:maintitle>\n</sb:title>\n<sb:volume-nr>33</sb:volume-nr>\n</sb:series>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>415</sb:first-page>\n<sb:last-page>419</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0027\">Pinto J, Aguiar AT, Duarte H, Vilaverde F, Rodrigues Â, Krug JL. Simple and complex fibroadenomas: are there any distinguishing sonographic features? J Ultrasound Med Off J Am Inst Ultrasound Med. 2014;33:415–9.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0028\">\n<ce:label>28</ce:label>\n<sb:reference id=\"sbref0028\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>E.D.</ce:given-name>\n<ce:surname>Yeh</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.A.</ce:given-name>\n<ce:surname>Jacene</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.R.</ce:given-name>\n<ce:surname>Bellon</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>F.</ce:given-name>\n<ce:surname>Nakhlis</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.L.</ce:given-name>\n<ce:surname>Birdwell</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Georgian-Smith</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>What Radiologists Need to Know about Diagnosis and Treatment of Inflammatory Breast Cancer: A Multidisciplinary Approach</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>RadioGraphics</sb:maintitle>\n</sb:title>\n<sb:volume-nr>33</sb:volume-nr>\n</sb:series>\n<sb:date>2013</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>2003</sb:first-page>\n<sb:last-page>2017</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0028\">Yeh ED, Jacene HA, Bellon JR, Nakhlis F, Birdwell RL, Georgian-Smith D, et al. What Radiologists Need to Know about Diagnosis and Treatment of Inflammatory Breast Cancer: A Multidisciplinary Approach. RadioGraphics. 2013;33:2003–17.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0029\">\n<ce:label>29</ce:label>\n<sb:reference id=\"sbref0029\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>JP.</ce:given-name>\n<ce:surname>Alunni</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Imaging inflammatory breast cancer</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Diagn Interv Imaging</sb:maintitle>\n</sb:title>\n<sb:volume-nr>93</sb:volume-nr>\n</sb:series>\n<sb:date>2012</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>95</sb:first-page>\n<sb:last-page>103</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0029\">Alunni JP. Imaging inflammatory breast cancer. Diagn Interv Imaging. 2012;93:95–103.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0030\">\n<ce:label>30</ce:label>\n<sb:reference id=\"sbref0030\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Balleyguier</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Ciolovan</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Ammari</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Canale</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Sethom</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Al Rouhbane</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Breast elastography: The technical process and its applications</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Diagn Interv Imaging</sb:maintitle>\n</sb:title>\n<sb:volume-nr>94</sb:volume-nr>\n</sb:series>\n<sb:date>2013</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>503</sb:first-page>\n<sb:last-page>513</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0030\">Balleyguier C, Ciolovan L, Ammari S, Canale S, Sethom S, Al Rouhbane R, et al. Breast elastography: The technical process and its applications. Diagn Interv Imaging. 2013;94:503–13.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0031\">\n<ce:label>31</ce:label>\n<sb:reference id=\"sbref0031\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Le-Petross</ce:given-name>\n<ce:surname>HT</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Cristofanilli</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Carkaci</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Krishnamurthy</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.F.</ce:given-name>\n<ce:surname>Jackson</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.K.</ce:given-name>\n<ce:surname>Harrell</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>MRI Features of Inflammatory Breast Cancer</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Roentgenol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>197</sb:volume-nr>\n</sb:series>\n<sb:date>2011</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>W769</sb:first-page>\n<sb:last-page>W776</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0031\">Le-Petross HT, Cristofanilli M, Carkaci S, Krishnamurthy S, Jackson EF, Harrell RK, et al. MRI Features of Inflammatory Breast Cancer. Am J Roentgenol. 2011;197:W769–76.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0032\">\n<ce:label>32</ce:label>\n<sb:reference id=\"sbref0032\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.Y.</ce:given-name>\n<ce:surname>Kwak</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.K.</ce:given-name>\n<ce:surname>Kim</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.Y.</ce:given-name>\n<ce:surname>Chung</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.K.</ce:given-name>\n<ce:surname>You</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.K.</ce:given-name>\n<ce:surname>Oh</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.H.</ce:given-name>\n<ce:surname>Lee</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Unilateral Breast Edema: Spectrum of Etiologies and Imaging Appearances</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Yonsei Med J</sb:maintitle>\n</sb:title>\n<sb:volume-nr>46</sb:volume-nr>\n</sb:series>\n<sb:date>2005</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1</sb:first-page>\n<sb:last-page>7</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0032\">Kwak JY, Kim EK, Chung SY, You JK, Oh KK, Lee YH, et al. Unilateral Breast Edema: Spectrum of Etiologies and Imaging Appearances. Yonsei Med J. 2005;46:1–7.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0033\">\n<ce:label>33</ce:label>\n<sb:reference id=\"sbref0033\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>I.</ce:given-name>\n<ce:surname>Günhan-Bilgen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Oktay</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Tubular carcinoma of the breast: Mammographic, sonographic, clinical and pathologic findings</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Eur J Radiol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>61</sb:volume-nr>\n</sb:series>\n<sb:date>2007</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>158</sb:first-page>\n<sb:last-page>162</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0033\">Günhan-Bilgen I, Oktay A. Tubular carcinoma of the breast: Mammographic, sonographic, clinical and pathologic findings. Eur J Radiol. 2007;61:158–62.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0034\">\n<ce:label>34</ce:label>\n<sb:reference id=\"sbref0034\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Makki</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Diversity of Breast Carcinoma: Histological Subtypes and Clinical Relevance</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Clin Med Insights Pathol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>8</sb:volume-nr>\n</sb:series>\n<sb:date>2015</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>23</sb:first-page>\n<sb:last-page>31</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0034\">Makki J. Diversity of Breast Carcinoma: Histological Subtypes and Clinical Relevance. Clin Med Insights Pathol. 2015;8:23–31.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0035\">\n<ce:label>35</ce:label>\n<sb:reference id=\"sbref0035\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.G.</ce:given-name>\n<ce:surname>Sheppard</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.J.</ce:given-name>\n<ce:surname>Whitman</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.D.</ce:given-name>\n<ce:surname>Fornage</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.B.</ce:given-name>\n<ce:surname>Stelling</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.T.</ce:given-name>\n<ce:surname>Huynh</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>AA.</ce:given-name>\n<ce:surname>Sahin</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Tubular Carcinoma of the Breast</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Roentgenol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>174</sb:volume-nr>\n</sb:series>\n<sb:date>2000</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>253</sb:first-page>\n<sb:last-page>257</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0035\">Sheppard DG, Whitman GJ, Fornage BD, Stelling CB, Huynh PT, Sahin AA. Tubular Carcinoma of the Breast. Am J Roentgenol. 2000;174:253–7.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0036\">\n<ce:label>36</ce:label>\n<sb:reference id=\"sbref0036\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Evans</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.T.</ce:given-name>\n<ce:surname>Sim</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Thomson</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Jordan</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Purdie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>SJ.</ce:given-name>\n<ce:surname>Vinnicombe</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Shear wave elastography of breast cancer: Sensitivity according to histological type in a large cohort</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Breast Edinb Scotl</sb:maintitle>\n</sb:title>\n<sb:volume-nr>26</sb:volume-nr>\n</sb:series>\n<sb:date>2016</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>115</sb:first-page>\n<sb:last-page>118</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0036\">Evans A, Sim YT, Thomson K, Jordan L, Purdie C, Vinnicombe SJ. Shear wave elastography of breast cancer: Sensitivity according to histological type in a large cohort. Breast Edinb Scotl. 2016;26:115–8.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0037\">\n<ce:label>37</ce:label>\n<sb:reference id=\"sbref0037\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Yılmaz</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.</ce:given-name>\n<ce:surname>Bayramoğlu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Emirikçi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Önder</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Salmaslıoğlu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Dursun</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>MR Imaging Features of Tubular Carcinoma: Preliminary Experience in Twelve Masses</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Eur J Breast Health</sb:maintitle>\n</sb:title>\n<sb:volume-nr>14</sb:volume-nr>\n</sb:series>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>39</sb:first-page>\n<sb:last-page>45</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0037\">Yılmaz R, Bayramoğlu Z, Emirikçi S, Önder S, Salmaslıoğlu A, Dursun M, et al. MR Imaging Features of Tubular Carcinoma: Preliminary Experience in Twelve Masses. Eur J Breast Health. 2018;14:39–45.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0038\">\n<ce:label>38</ce:label>\n<sb:reference id=\"sbref0038\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Aydin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Guner</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>I.</ce:given-name>\n<ce:surname>Esen Bostanci</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.S.</ce:given-name>\n<ce:surname>Cosar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>F.T.</ce:given-name>\n<ce:surname>Kiziltepe</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.K.</ce:given-name>\n<ce:surname>Aribas</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Unusual presentation of tubular breast carcinoma as non-mass enhancement</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Egypt J Radiol Nucl Med</sb:maintitle>\n</sb:title>\n<sb:volume-nr>49</sb:volume-nr>\n</sb:series>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>281</sb:first-page>\n<sb:last-page>283</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0038\">Aydin H, Guner B, Esen Bostanci I, Cosar ZS, Kiziltepe FT, Aribas BK, et al. Unusual presentation of tubular breast carcinoma as non-mass enhancement. Egypt J Radiol Nucl Med. 2018;49:281–3.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0039\">\n<ce:label>39</ce:label>\n<sb:reference id=\"sbref0039\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.S.</ce:given-name>\n<ce:surname>Soo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Dash</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Bentley</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.H.</ce:given-name>\n<ce:surname>Lee</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Nathan</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Tubular Adenomas of the Breast</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Roentgenol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>174</sb:volume-nr>\n</sb:series>\n<sb:date>2000</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>757</sb:first-page>\n<sb:last-page>761</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0039\">Soo MS, Dash N, Bentley R, Lee LH, Nathan G. Tubular Adenomas of the Breast. Am J Roentgenol. 2000;174:757–61.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0040\">\n<ce:label>40</ce:label>\n<sb:reference id=\"sbref0040\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Sun</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Dai</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Xu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Liu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Yu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.</ce:given-name>\n<ce:surname>Sun</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Primary Neuroendocrine Tumor of the Breast: Current Understanding and Future Perspectives</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Front Oncol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>12</sb:volume-nr>\n</sb:series>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:article-number>848485</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0040\">Sun H, Dai S, Xu J, Liu L, Yu J, Sun T. Primary Neuroendocrine Tumor of the Breast: Current Understanding and Future Perspectives. Front Oncol. 2022;12:848485.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0041\">\n<ce:label>41</ce:label>\n<sb:reference id=\"sbref0041\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Trevisi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>La Salvia</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Daniele</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.P.</ce:given-name>\n<ce:surname>Brizzi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>De Rosa</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.V.</ce:given-name>\n<ce:surname>Scagliotti</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Neuroendocrine breast carcinoma: a rare but challenging entity</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Med Oncol Northwood Lond Engl</sb:maintitle>\n</sb:title>\n<sb:volume-nr>37</sb:volume-nr>\n</sb:series>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>70</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0041\">Trevisi E, La Salvia A, Daniele L, Brizzi MP, De Rosa G, Scagliotti GV, et al. Neuroendocrine breast carcinoma: a rare but challenging entity. Med Oncol Northwood Lond Engl. 2020;37:70.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"others\"?><ce:bib-reference id=\"bib0042\">\n<ce:label>42</ce:label>\n<ce:other-ref id=\"sbref0042\">\n<ce:textref>Vorburger SA, Xing Y, Hunt KK, Lakin GE, Benjamin RS, Feig BW, et al. Angiosarcoma of the breast. Cancer. 2005;104:2682–8.</ce:textref>\n</ce:other-ref>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0043\">\n<ce:label>43</ce:label>\n<sb:reference id=\"sbref0043\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>T.</ce:given-name>\n<ce:surname>Pai</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.</ce:given-name>\n<ce:surname>Shet</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Patil</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Parmar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.</ce:given-name>\n<ce:surname>Wadasadawala</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>SB.</ce:given-name>\n<ce:surname>Desai</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Epithelioid hemangioendothelioma of breast with nodal metastasis masquerading as breast carcinoma: An unusual case with review of literature</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Hum Pathol Case Rep</sb:maintitle>\n</sb:title>\n<sb:volume-nr>23</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:article-number>200465</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0043\">Pai T, Shet T, Patil A, Parmar V, Wadasadawala T, Desai SB. Epithelioid hemangioendothelioma of breast with nodal metastasis masquerading as breast carcinoma: An unusual case with review of literature. Hum Pathol Case Rep. 2021;23:200465.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0044\">\n<ce:label>44</ce:label>\n<sb:reference id=\"sbref0044\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.G.</ce:given-name>\n<ce:surname>Kim</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.S.</ce:given-name>\n<ce:surname>Choi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.J.</ce:given-name>\n<ce:surname>Park</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>SM.</ce:given-name>\n<ce:surname>Chong</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Kaposiform hemangioendothelioma of the breast in an adult female</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Clin Breast Cancer</sb:maintitle>\n</sb:title>\n<sb:volume-nr>11</sb:volume-nr>\n</sb:series>\n<sb:date>2011</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>135</sb:first-page>\n<sb:last-page>137</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0044\">Kim MG, Choi YS, Park SJ, Chong SM. Kaposiform hemangioendothelioma of the breast in an adult female. Clin Breast Cancer. 2011;11:135–7.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0045\">\n<ce:label>45</ce:label>\n<sb:reference id=\"sbref0045\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.F.</ce:given-name>\n<ce:surname>Lim</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Goei</ce:surname>\n</sb:author>\n</sb:authors>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Angiosarcoma of the Breast. RadioGraphics.</sb:maintitle>\n</sb:title>\n<sb:volume-nr>27</sb:volume-nr>\n</sb:series>\n<sb:date>2007</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>S125</sb:first-page>\n<sb:last-page>S130</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0045\">Lim RF, Goei R. Angiosarcoma of the Breast. RadioGraphics. 2007;27:S125–30.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0046\">\n<ce:label>46</ce:label>\n<sb:reference id=\"sbref0046\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.R.</ce:given-name>\n<ce:surname>Marak</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Raj</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Verma</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Gandhi</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Primary hepatic epithelioid hemangioendothelioma masquerading as metastases: A rare case report</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Radiol Case Rep</sb:maintitle>\n</sb:title>\n<sb:volume-nr>18</sb:volume-nr>\n</sb:series>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>3739</sb:first-page>\n<sb:last-page>3747</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0046\">Marak JR, Raj G, Verma S, Gandhi A. Primary hepatic epithelioid hemangioendothelioma masquerading as metastases: A rare case report. Radiol Case Rep. 2023;18:3739–47.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0047\">\n<ce:label>47</ce:label>\n<sb:reference id=\"sbref0047\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.M.</ce:given-name>\n<ce:surname>Sabate</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Clotet</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Torrubia</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Gomez</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Guerrero</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Las</ce:given-name>\n<ce:surname>de</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Heras</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Radiologic Evaluation of Breast Disorders Related to Pregnancy and Lactation</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>RadioGraphics</sb:maintitle>\n</sb:title>\n<sb:volume-nr>27</sb:volume-nr>\n</sb:series>\n<sb:date>2007</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>S101</sb:first-page>\n<sb:last-page>S124</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0047\">Sabate JM, Clotet M, Torrubia S, Gomez A, Guerrero R, de Las Heras P, et al. Radiologic Evaluation of Breast Disorders Related to Pregnancy and Lactation. RadioGraphics. 2007;27:S101–24.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0048\">\n<ce:label>48</ce:label>\n<sb:reference id=\"sbref0048\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Destek</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Gul</ce:given-name>\n<ce:surname>VO</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Ahioglu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>KR.</ce:given-name>\n<ce:surname>Serin</ce:surname>\n</sb:author>\n</sb:authors>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Pituitary Adenoma and Hyperprolactinemia Accompanied by Idiopathic Granulomatous Mastitis. Case Rep Endocrinol.</sb:maintitle>\n</sb:title>\n</sb:series>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:article-number>e3974291</sb:article-number>\n</sb:host>\n<sb:comment>2017</sb:comment>\n</sb:reference>\n<ce:source-text id=\"srctxt0048\">Destek S, Gul VO, Ahioglu S, Serin KR. Pituitary Adenoma and Hyperprolactinemia Accompanied by Idiopathic Granulomatous Mastitis. Case Rep Endocrinol. 2017;2017:e3974291.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0049\">\n<ce:label>49</ce:label>\n<sb:reference id=\"sbref0049\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Cong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Zou</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Qiao</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Lin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Bilateral mammary duct ectasia induced by sulpiride-associated hyperprolactinemia: A case report</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Oncol Lett</sb:maintitle>\n</sb:title>\n<sb:volume-nr>9</sb:volume-nr>\n</sb:series>\n<sb:date>2015</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>2181</sb:first-page>\n<sb:last-page>2184</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0049\">Cong Y, Zou H, Qiao G, Lin J, Wang X, Li X, et al. Bilateral mammary duct ectasia induced by sulpiride-associated hyperprolactinemia: A case report. Oncol Lett. 2015;9:2181–4.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0050\">\n<ce:label>50</ce:label>\n<sb:reference id=\"sbref0050\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.K.</ce:given-name>\n<ce:surname>Bhattacharjee</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.R.</ce:given-name>\n<ce:surname>Ramman</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>ARGARWAL</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Nain</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Thomas</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Isolated cysticercosis of the breast masquerading as a breast tumour: report of a case and review of literature</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Ann Trop Med Parasitol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>105</sb:volume-nr>\n</sb:series>\n<sb:date>2011</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>455</sb:first-page>\n<sb:last-page>461</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0050\">Bhattacharjee HK, Ramman TR, ARGARWAL L, Nain M, Thomas S. Isolated cysticercosis of the breast masquerading as a breast tumour: report of a case and review of literature. Ann Trop Med Parasitol. 2011;105:455–61.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0051\">\n<ce:label>51</ce:label>\n<sb:reference id=\"sbref0051\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Kala</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Khare</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Fine-needle aspiration cytology as a diagnostic modality for cysticercosis: A clinicocytological study of 137 cases</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Cytol Indian Acad Cytol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>31</sb:volume-nr>\n</sb:series>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>68</sb:first-page>\n<sb:last-page>72</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0051\">Kala P, Khare P. Fine-needle aspiration cytology as a diagnostic modality for cysticercosis: A clinicocytological study of 137 cases. J Cytol Indian Acad Cytol. 2014;31:68–72.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0052\">\n<ce:label>52</ce:label>\n<sb:reference id=\"sbref0052\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>N.R.S.</ce:given-name>\n<ce:surname>Surendrababu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Thomas</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Rajinikanth</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>SN.</ce:given-name>\n<ce:surname>Keshava</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Breast filariasis: Real-time sonographic imaging of the filarial dance</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Clin Ultrasound</sb:maintitle>\n</sb:title>\n<sb:volume-nr>36</sb:volume-nr>\n</sb:series>\n<sb:date>2008</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>567</sb:first-page>\n<sb:last-page>569</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0052\">Surendrababu NRS, Thomas E, Rajinikanth J, Keshava SN. Breast filariasis: Real-time sonographic imaging of the filarial dance. J Clin Ultrasound. 2008;36:567–9.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0053\">\n<ce:label>53</ce:label>\n<sb:reference id=\"sbref0053\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.K.</ce:given-name>\n<ce:surname>Barry</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>WG.</ce:given-name>\n<ce:surname>Schucany</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Dracunculiasis of the Breast: Radiological Manifestations of a Rare Disease</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Radiol Case Rep</sb:maintitle>\n</sb:title>\n<sb:volume-nr>6</sb:volume-nr>\n</sb:series>\n<sb:date>2012</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>29</sb:first-page>\n<sb:last-page>33</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0053\">Barry SK, Schucany WG. Dracunculiasis of the Breast: Radiological Manifestations of a Rare Disease. J Radiol Case Rep. 2012;6:29–33.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0054\">\n<ce:label>54</ce:label>\n<sb:reference id=\"sbref0054\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Dong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Lu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Zuo</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Spectrum of the Breast Lesions With Increased 18F-FDG Uptake on PET/CT</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Clin Nucl Med</sb:maintitle>\n</sb:title>\n<sb:volume-nr>41</sb:volume-nr>\n</sb:series>\n<sb:date>2016</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>543</sb:first-page>\n<sb:last-page>557</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0054\">Dong A, Wang Y, Lu J, Zuo C. Spectrum of the Breast Lesions With Increased 18F-FDG Uptake on PET/CT. Clin Nucl Med. 2016;41:543–57.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0055\">\n<ce:label>55</ce:label>\n<sb:reference id=\"sbref0055\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>K.H.</ce:given-name>\n<ce:surname>Ko</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.K.</ce:given-name>\n<ce:surname>Jung</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>TJ.</ce:given-name>\n<ce:surname>Jeon</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Diffuse Intense 18F-FDG Uptake at PET in Unilateral Breast Related to Breastfeeding Practice</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Korean J Radiol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>14</sb:volume-nr>\n</sb:series>\n<sb:date>2013</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>400</sb:first-page>\n<sb:last-page>402</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0055\">Ko KH, Jung HK, Jeon TJ. Diffuse Intense 18F-FDG Uptake at PET in Unilateral Breast Related to Breastfeeding Practice. Korean J Radiol. 2013;14:400–2.</ce:source-text>\n</ce:bib-reference>\n</ce:bibliography-sec>",
    "error_message": "All bibliographic references within 'ce:bibliography' must be referred to.",
    "error_position": "654:63",
    "error_id": "IDS503a",
    "folder_name": "YMDR1409"
  },
  {
    "input": "<ce:section xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"sec0019\">\n<ce:section-title id=\"cesectitle0021\">Asymmetric breast uptake on Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography (18–F FDG PET)</ce:section-title>\n<ce:para id=\"para0017\">Normal breasts show homogeneous symmetric uptake on PET with SUVmax values less than 2.5. The uptake is higher in younger females with increased breast density and during the ovulation and secretory phase.<ce:cross-ref id=\"crf0088\" refid=\"bib0054\"><ce:sup>54</ce:sup></ce:cross-ref> Asymmetric uptake can be physiological, due to differential response to hormonal stimulation, single breast lactation, or can be due to pathological causes such as masses, mastitis, and edema. Lactating breasts show breast enlargement with cord- or mass-like hyperattenuating tissue on CT. There is increased glucose transporter (GLUT 1) expression in the lactating breast, which causes increased FDG uptake (<ce:cross-ref id=\"crf0089\" refid=\"fig0013\">Figure 13</ce:cross-ref>). Preferentially, single breast lactation can lead to asymmetric uptake, which can be confused with inflammatory breast carcinoma (IBC). Detection of breast malignancies in lactating breasts also becomes difficult due to the physiologically increased uptake.<ce:cross-ref id=\"crf0090\" refid=\"bib0055\"><ce:sup>55</ce:sup></ce:cross-ref> Breast malignancies like IBC, lymphoma, and lymphangitic metastases can all present with unilateral breast edema<ce:cross-ref id=\"crf0091\" refid=\"bib0032\"><ce:sup>32</ce:sup></ce:cross-ref>. Asymmetric FDG uptake with breast enlargement can also be due to causes outside the breast, such as congestive cardiac failure (dependent side), lymphatic or venous obstruction, or as a complication of arteriovenous dialysis fistula. Although an appropriate clinical history and negative imaging findings can rule out malignancy, histopathological confirmation may be required in ambiguous cases.(<ce:cross-ref id=\"crf0092\" refid=\"tbl0001\">Table 1</ce:cross-ref><ce:float-anchor refid=\"tbl0001\"/>\n<Query/>)</ce:para>\n</ce:section>",
    "output": "<ce:section xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"sec0019\">\n<ce:section-title id=\"cesectitle0021\">Asymmetric breast uptake on Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography (18–F FDG PET)</ce:section-title>\n<ce:para id=\"para0017\">Normal breasts show homogeneous symmetric uptake on PET with SUVmax values less than 2.5. The uptake is higher in younger females with increased breast density and during the ovulation and secretory phase.<ce:cross-ref id=\"crf0088\" refid=\"bib0054\"><ce:sup>54</ce:sup></ce:cross-ref> Asymmetric uptake can be physiological, due to differential response to hormonal stimulation, single breast lactation, or can be due to pathological causes such as masses, mastitis, and edema. Lactating breasts show breast enlargement with cord- or mass-like hyperattenuating tissue on CT. There is increased glucose transporter (GLUT 1) expression in the lactating breast, which causes increased FDG uptake (<ce:cross-ref id=\"crf0089\" refid=\"fig0013\">Figure 13</ce:cross-ref>). Preferentially, single breast lactation can lead to asymmetric uptake, which can be confused with inflammatory breast carcinoma (IBC). Detection of breast malignancies in lactating breasts also becomes difficult due to the physiologically increased uptake.<ce:cross-ref id=\"crf0090\" refid=\"bib0055\"><ce:sup>55</ce:sup></ce:cross-ref> Breast malignancies like IBC, lymphoma, and lymphangitic metastases can all present with unilateral breast edema<ce:cross-ref id=\"crf0091\" refid=\"bib0032\"><ce:sup>32</ce:sup></ce:cross-ref>. Asymmetric FDG uptake with breast enlargement can also be due to causes outside the breast, such as congestive cardiac failure (dependent side), lymphatic or venous obstruction, or as a complication of arteriovenous dialysis fistula. Although an appropriate clinical history and negative imaging findings can rule out malignancy, histopathological confirmation may be required in ambiguous cases.(<ce:cross-ref id=\"crf0092\" refid=\"tbl0001\">Table 1</ce:cross-ref><ce:float-anchor refid=\"tbl0001\"/><?Qry msg=\"CE: dummy citation of table 1 is inserted please check.\"?>)</ce:para>\n</ce:section>",
    "error_message": "Error: The content of element type \"ce:para\" must match \"(ce:glyph|ce:bold|ce:italic|ce:monospace|ce:sans-serif|ce:small-caps|ce:color|ce:sup|ce:inf|ce:underline|ce:cross-out|ce:hsp|ce:vsp|ce:inline-figure|mml:math|ce:math|ce:cross-ref|ce:intra-ref|ce:cross-refs|ce:intra-refs|ce:inter-ref|ce:inter-refs|ce:float-anchor|ce:display|ce:displayed-quote|ce:enunciation|ce:def-list|ce:list|ce:footnote|ce:anchor|ce:grant-sponsor|ce:grant-number|ce:associated-resource)\".",
    "error_position": "385:20",
    "error_id": "parser",
    "folder_name": "YMDR1409"
  },
  {
    "input": "<ce:bib-reference xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"bib0001\">\n<ce:label>1</ce:label>\n<sb:reference id=\"sbref0001\">\n<sb:contribution>\n<sb:authors>\n<sb:collaboration>Global Burden of Disease Study 2013 Collaborators</sb:collaboration>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Lancet</sb:maintitle>\n</sb:title>\n<sb:volume-nr>386</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>9995</sb:issue-nr>\n<sb:date>20132015</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>743</sb:first-page>\n<sb:last-page>800</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0001\">Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743-800.</ce:source-text>\n</ce:bib-reference>",
    "output": "<ce:bib-reference xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"bib0001\">\n<ce:label>1</ce:label>\n<sb:reference id=\"sbref0001\">\n<sb:contribution>\n<sb:authors>\n<sb:collaboration>Global Burden of Disease Study 2013 Collaborators</sb:collaboration>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Lancet</sb:maintitle>\n</sb:title>\n<sb:volume-nr>386</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>9995</sb:issue-nr>\n<sb:date>20132015</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>743</sb:first-page>\n<sb:last-page>800</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0001\">Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743-800.</ce:source-text>\n</ce:bib-reference>",
    "error_message": "The 'sb:date' element (\"20132015\") should contain a year, but not a year immediately followed by a letter.",
    "error_position": "953:10",
    "error_id": "DTS504",
    "folder_name": "AMGP2541"
  },
  {
    "input": "<ce:bibliography-sec xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"cebibsec1\">\n<?att type=\"article\"?><ce:bib-reference id=\"bib0001\">\n<ce:label>1</ce:label>\n<sb:reference id=\"sbref0001\">\n<sb:contribution>\n<sb:authors>\n<sb:collaboration>Global Burden of Disease Study 2013 Collaborators</sb:collaboration>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Lancet</sb:maintitle>\n</sb:title>\n<sb:volume-nr>386</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>9995</sb:issue-nr>\n<sb:date>20132015</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>743</sb:first-page>\n<sb:last-page>800</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0001\">Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743-800.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0002\">\n<ce:label>2</ce:label>\n<sb:reference id=\"sbref0002\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Maj</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.J.</ce:given-name>\n<ce:surname>Stein</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Parker</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The clinical characterization of the adult patient with depression aimed at personalization of management</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>19</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>269</sb:first-page>\n<sb:last-page>293</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0002\">Maj M, Stein DJ, Parker G, et al. The clinical characterization of the adult patient with depression aimed at personalization of management. World Psychiatry. 2020;19(3):269-293.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0003\">\n<ce:label>3</ce:label>\n<sb:reference id=\"sbref0003\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>CF 3rd</ce:given-name>\n<ce:surname>Reynolds</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.V.</ce:given-name>\n<ce:surname>Jeste</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.S.</ce:given-name>\n<ce:surname>Sachdev</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.G.</ce:given-name>\n<ce:surname>Blazer</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Mental health care for older adults: recent advances and new directions in clinical practice and research</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>21</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>336</sb:first-page>\n<sb:last-page>363</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0003\">Reynolds CF 3rd, Jeste DV, Sachdev PS, Blazer DG. Mental health care for older adults: recent advances and new directions in clinical practice and research. World Psychiatry. 2022;21(3):336-363.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0004\">\n<ce:label>4</ce:label>\n<sb:reference id=\"sbref0004\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zenebe</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Akele</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>W/Selassie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Necho</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Prevalence and determinants of depression among old age: a systematic review and meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Ann Gen Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>20</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>55</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0004\">Zenebe Y, Akele B, W/Selassie M, Necho M. Prevalence and determinants of depression among old age: a systematic review and meta-analysis. Ann Gen Psychiatry. 2021;20(1):55.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0005\">\n<ce:label>5</ce:label>\n<sb:reference id=\"sbref0005\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.S.</ce:given-name>\n<ce:surname>Hasin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.L.</ce:given-name>\n<ce:surname>Sarvet</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.L.</ce:given-name>\n<ce:surname>Meyers</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>JAMA Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>75</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>336</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0005\">Hasin DS, Sarvet AL, Meyers JL, et al. Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiatry. 2018;75(4):336.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0006\">\n<ce:label>6</ce:label>\n<sb:reference id=\"sbref0006\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.R.</ce:given-name>\n<ce:surname>Azar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.P.</ce:given-name>\n<ce:surname>Chopra</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.Y.</ce:given-name>\n<ce:surname>Cho</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Coakley</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>JL.</ce:given-name>\n<ce:surname>Rudolph</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Remission in major depression: results from a geriatric primary care population</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>26</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2011</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>48</sb:first-page>\n<sb:last-page>55</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0006\">Azar AR, Chopra MP, Cho LY, Coakley E, Rudolph JL. Remission in major depression: results from a geriatric primary care population. Int J Geriatr Psychiatry. 2011;26(1):48-55.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0007\">\n<ce:label>7</ce:label>\n<sb:reference id=\"sbref0007\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>U.</ce:given-name>\n<ce:surname>Klotz</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pharmacokinetics and drug metabolism in the elderly</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Drug Metab Rev</sb:maintitle>\n</sb:title>\n<sb:volume-nr>41</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2009</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>67</sb:first-page>\n<sb:last-page>76</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0007\">Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev. 2009;41(2):67-76.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0008\">\n<ce:label>8</ce:label>\n<sb:reference id=\"sbref0008\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Canadian Coalition for Seniors’ Mental</ce:given-name>\n<ce:surname>Health</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Canadian Guidelines on Prevention, Assessment and Treatment of Depression Among Older Adults</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>CCSMH; 2021</sb:maintitle>\n</sb:title>\n</sb:series>\n<sb:date>June 2021</sb:date>\n</sb:issue>\n</sb:host>\n<sb:comment>Updated</sb:comment>\n<sb:host>\n<sb:e-host>\n<ce:inter-ref id=\"interref0001\" xlink:href=\"https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf\">https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf</ce:inter-ref>\n</sb:e-host>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0008\">Canadian Coalition for Seniors’ Mental Health. Canadian Guidelines on Prevention, Assessment and Treatment of Depression Among Older Adults. CCSMH; 2021. Updated June 2021. https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0009\">\n<ce:label>9</ce:label>\n<sb:reference id=\"sbref0009\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Avasthi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Grover</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Clinical practice guidelines for management of depression in elderly</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Indian J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>60</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>Suppl 3</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>S341</sb:first-page>\n<sb:last-page>S362</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0009\">Avasthi A, Grover S. Clinical practice guidelines for management of depression in elderly. Indian J Psychiatry. 2018;60(Suppl 3):S341-S362.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0010\">\n<ce:label>10</ce:label>\n<sb:reference id=\"sbref0010\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Baba</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Kito</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Nukariya</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Guidelines for diagnosis and treatment of depression in older adults: A report from the Japanese Society of mood disorders</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Psychiatry Clin Neurosci</sb:maintitle>\n</sb:title>\n<sb:volume-nr>76</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>222</sb:first-page>\n<sb:last-page>234</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0010\">Baba H, Kito S, Nukariya K, et al. Guidelines for diagnosis and treatment of depression in older adults: A report from the Japanese Society of mood disorders. Psychiatry Clin Neurosci. 2022;76(6):222-234.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0011\">\n<ce:label>11</ce:label>\n<sb:reference id=\"sbref0011\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Rosenblat</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.B.</ce:given-name>\n<ce:surname>Nemeroff</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>178</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>383</sb:first-page>\n<sb:last-page>399</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0011\">McIntyre RS, Rosenblat JD, Nemeroff CB, et al. Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation. Am J Psychiatry. 2021;178(5):383-399.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0012\">\n<ce:label>12</ce:label>\n<sb:reference id=\"sbref0012\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.C.H.</ce:given-name>\n<ce:surname>Cheng</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.E.</ce:given-name>\n<ce:surname>Dri</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Ballum</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effects of ketamine and esketamine on measures of quality of life in major depressive disorder and treatment-resistant depression: A systematic review</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>382</sb:volume-nr>\n</sb:series>\n<sb:date>2025</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>438</sb:first-page>\n<sb:last-page>442</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0012\">Cheng MCH, Dri CE, Ballum H, et al. The effects of ketamine and esketamine on measures of quality of life in major depressive disorder and treatment-resistant depression: A systematic review. J Affect Disord. 2025;382:438-442.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0013\">\n<ce:label>13</ce:label>\n<sb:reference id=\"sbref0013\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Di Vincenzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.B.</ce:given-name>\n<ce:surname>Rodrigues</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Safety, tolerability, and real-world effectiveness of intravenous ketamine in older adults with treatment-resistant depression: A case series</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>29</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>9</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>899</sb:first-page>\n<sb:last-page>913</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0013\">Lipsitz O, Di Vincenzo JD, Rodrigues NB, et al. Safety, tolerability, and real-world effectiveness of intravenous ketamine in older adults with treatment-resistant depression: A case series. Am J Geriatr Psychiatry. 2021;29(9):899-913.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0014\">\n<ce:label>14</ce:label>\n<sb:reference id=\"sbref0014\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>I.P.</ce:given-name>\n<ce:surname>Carvalho</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.M.W.</ce:given-name>\n<ce:surname>Lui</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>276</sb:volume-nr>\n</sb:series>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>576</sb:first-page>\n<sb:last-page>584</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0014\">McIntyre RS, Carvalho IP, Lui LMW, et al. The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis. J Affect Disord. 2020;276:576-584.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0015\">\n<ce:label>15</ce:label>\n<sb:reference id=\"sbref0015\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Lee</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Syeda</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.A.</ce:given-name>\n<ce:surname>Maruschak</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>A new perspective on the anti-suicide effects with ketamine treatment: A procognitive effect</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Clin Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>36</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2016</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>50</sb:first-page>\n<sb:last-page>56</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0015\">Lee Y, Syeda K, Maruschak NA, et al. A new perspective on the anti-suicide effects with ketamine treatment: A procognitive effect. J Clin Psychopharmacol. 2016;36(1):50-56.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0016\">\n<ce:label>16</ce:label>\n<sb:reference id=\"sbref0016\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Xiong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Chen-Li</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>134</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>57</sb:first-page>\n<sb:last-page>68</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0016\">Xiong J, Lipsitz O, Chen-Li D, et al. The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis. J Psychiatr Res. 2021;134:57-68.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0017\">\n<ce:label>17</ce:label>\n<sb:reference id=\"sbref0017\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Gupta</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Dhar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Patadia</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>A systematic review of ketamine for the treatment of depression among older adults</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int Psychogeriatr</sb:maintitle>\n</sb:title>\n<sb:volume-nr>33</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>179</sb:first-page>\n<sb:last-page>191</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0017\">Gupta A, Dhar R, Patadia P, et al. A systematic review of ketamine for the treatment of depression among older adults. Int Psychogeriatr. 2021;33(2):179-191.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0018\">\n<ce:label>18</ce:label>\n<sb:reference id=\"sbref0018\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Di Vincenzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Siegel</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>137</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>232</sb:first-page>\n<sb:last-page>241</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0018\">Di Vincenzo JD, Siegel A, Lipsitz O, et al. The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review. J Psychiatr Res. 2021;137:232-241.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0019\">\n<ce:label>19</ce:label>\n<sb:reference id=\"sbref0019\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Page</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.E.</ce:given-name>\n<ce:surname>McKenzie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.M.</ce:given-name>\n<ce:surname>Bossuyt</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The PRISMA 2020 statement: an updated guideline for reporting systematic reviews</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>BMJ</sb:maintitle>\n</sb:title>\n<sb:volume-nr>372</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>n71</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0019\">Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0020\">\n<ce:label>20</ce:label>\n<sb:reference id=\"sbref0020\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.A.C.</ce:given-name>\n<ce:surname>Sterne</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Savović</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Page</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>RoB 2: a revised tool for assessing risk of bias in randomised trials</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>BMJ</sb:maintitle>\n</sb:title>\n<sb:volume-nr>366</sb:volume-nr>\n</sb:series>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>l4898</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0020\">Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0021\">\n<ce:label>21</ce:label>\n<sb:reference id=\"sbref0021\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>T.H.</ce:given-name>\n<ce:surname>Barker</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Habibi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Aromataris</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>JBI Evid Synth</sb:maintitle>\n</sb:title>\n<sb:volume-nr>22</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>378</sb:first-page>\n<sb:last-page>388</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0021\">Barker TH, Habibi N, Aromataris E, et al. The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies. JBI Evid Synth. 2024;22(3):378-388.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0022\">\n<ce:label>22</ce:label>\n<sb:reference id=\"sbref0022\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Gálvez</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Huggins</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>32</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>397</sb:first-page>\n<sb:last-page>407</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0022\">Gálvez V, Li A, Huggins C, et al. Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial. J Psychopharmacol. 2018;32(4):397-407.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0023\">\n<ce:label>23</ce:label>\n<sb:reference id=\"sbref0023\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Ochs-Ross</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zhang</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression-TRANSFORM-3</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>28</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>121</sb:first-page>\n<sb:last-page>141</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0023\">Ochs-Ross R, Daly EJ, Zhang Y, et al. Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression-TRANSFORM-3. Am J Geriatr Psychiatry. 2020;28(2):121-141.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0024\">\n<ce:label>24</ce:label>\n<sb:reference id=\"sbref0024\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Lai</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Katalinic</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Glue</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pilot dose-response trial of i.v. ketamine in treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World J Biol Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>15</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>579</sb:first-page>\n<sb:last-page>584</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0024\">Lai R, Katalinic N, Glue P, et al. Pilot dose-response trial of i.v. ketamine in treatment-resistant depression. World J Biol Psychiatry. 2014;15(7):579-584.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0025\">\n<ce:label>25</ce:label>\n<sb:reference id=\"sbref0025\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Glue</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Loo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Fam</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Nat Med</sb:maintitle>\n</sb:title>\n<sb:volume-nr>30</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>2004</sb:first-page>\n<sb:last-page>2009</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0025\">Glue P, Loo C, Fam J, et al. Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial. Nat Med. 2024;30(7):2004-2009.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0026\">\n<ce:label>26</ce:label>\n<sb:reference id=\"sbref0026\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Fernie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Currie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.S.</ce:given-name>\n<ce:surname>Perrin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Br J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>210</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>422</sb:first-page>\n<sb:last-page>428</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0026\">Fernie G, Currie J, Perrin JS, et al. Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial. Br J Psychiatry. 2017;210(6):422-428.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0027\">\n<ce:label>27</ce:label>\n<sb:reference id=\"sbref0027\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Zou</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Min</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Q.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Ren</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-A randomized, double-blind, controlled clinical study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Brain Behav</sb:maintitle>\n</sb:title>\n<sb:volume-nr>11</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:article-number>e01775</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0027\">Zou L, Min S, Chen Q, Li X, Ren L. Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-A randomized, double-blind, controlled clinical study. Brain Behav. 2021;11(1):e01775.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0028\">\n<ce:label>28</ce:label>\n<sb:reference id=\"sbref0028\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>George</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Gálvez</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>25</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>11</sb:issue-nr>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1199</sb:first-page>\n<sb:last-page>1209</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0028\">George D, Gálvez V, Martin D, et al. Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression. Am J Geriatr Psychiatry. 2017;25(11):1199-1209.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0029\">\n<ce:label>29</ce:label>\n<sb:reference id=\"sbref0029\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Wajs</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Aluisio</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Holder</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: Assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2)</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Clin Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>81</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<ce:doi>10.4088/JCP.19m12891</ce:doi>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0029\">Wajs E, Aluisio L, Holder R, et al. Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: Assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2). J Clin Psychiatry. 2020;81(3). doi:10.4088/JCP.19m12891</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0030\">\n<ce:label>30</ce:label>\n<sb:reference id=\"sbref0030\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.A.</ce:given-name>\n<ce:surname>Oughli</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.A.</ce:given-name>\n<ce:surname>Gebara</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Ciarleglio</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Intravenous ketamine for late-life treatment-resistant depression: A pilot study of tolerability, safety, clinical benefits, and effect on cognition</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>31</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>210</sb:first-page>\n<sb:last-page>221</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0030\">Oughli HA, Gebara MA, Ciarleglio A, et al. Intravenous ketamine for late-life treatment-resistant depression: A pilot study of tolerability, safety, clinical benefits, and effect on cognition. Am J Geriatr Psychiatry. 2023;31(3):210-221.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0031\">\n<ce:label>31</ce:label>\n<sb:reference id=\"sbref0031\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Zaki</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.N.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Lane</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Neuropsychopharmacology</sb:maintitle>\n</sb:title>\n<sb:volume-nr>48</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>8</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1225</sb:first-page>\n<sb:last-page>1233</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0031\">Zaki N, Chen LN, Lane R, et al. Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study. Neuropsychopharmacology. 2023;48(8):1225-1233.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0032\">\n<ce:label>32</ce:label>\n<sb:reference id=\"sbref0032\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>K.G.</ce:given-name>\n<ce:surname>Rasmussen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.W.</ce:given-name>\n<ce:surname>Lineberry</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.W.</ce:given-name>\n<ce:surname>Galardy</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Serial infusions of low-dose ketamine for major depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>27</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2013</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>444</sb:first-page>\n<sb:last-page>450</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0032\">Rasmussen KG, Lineberry TW, Galardy CW, et al. Serial infusions of low-dose ketamine for major depression. J Psychopharmacol. 2013;27(5):444-450.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0033\">\n<ce:label>33</ce:label>\n<sb:reference id=\"sbref0033\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Vanderschelden</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.A.</ce:given-name>\n<ce:surname>Gebara</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.A.</ce:given-name>\n<ce:surname>Oughli</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Change in patient-centered outcomes of psychological well-being, sleep, and suicidality following treatment with intravenous ketamine for late-life treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>38</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>e5964</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0033\">Vanderschelden B, Gebara MA, Oughli HA, et al. Change in patient-centered outcomes of psychological well-being, sleep, and suicidality following treatment with intravenous ketamine for late-life treatment-resistant depression. Int J Geriatr Psychiatry. 2023;38(7):e5964.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0034\">\n<ce:label>34</ce:label>\n<sb:reference id=\"sbref0034\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Ochs-Ross</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Wajs</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Comparison of long-term efficacy and safety of esketamine nasal spray plus oral antidepressant in younger versus older patients with treatment-resistant depression: Post-hoc analysis of SUSTAIN-2, a long-term open-label phase 3 safety and efficacy study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>30</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>541</sb:first-page>\n<sb:last-page>556</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0034\">Ochs-Ross R, Wajs E, Daly EJ, et al. Comparison of long-term efficacy and safety of esketamine nasal spray plus oral antidepressant in younger versus older patients with treatment-resistant depression: Post-hoc analysis of SUSTAIN-2, a long-term open-label phase 3 safety and efficacy study. Am J Geriatr Psychiatry. 2022;30(5):541-556.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0035\">\n<ce:label>35</ce:label>\n<sb:reference id=\"sbref0035\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Filteau</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>156</sb:volume-nr>\n</sb:series>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1</sb:first-page>\n<sb:last-page>7</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0035\">McIntyre RS, Filteau MJ, Martin L, et al. Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach. J Affect Disord. 2014;156:1-7.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0036\">\n<ce:label>36</ce:label>\n<sb:reference id=\"sbref0036\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.R.</ce:given-name>\n<ce:surname>Strawn</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.A.</ce:given-name>\n<ce:surname>Mills</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Suresh</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorder</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>159</sb:volume-nr>\n</sb:series>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>266</sb:first-page>\n<sb:last-page>273</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0036\">Strawn JR, Mills JA, Suresh V, et al. The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorder. J Psychiatr Res. 2023;159:266-273.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0037\">\n<ce:label>37</ce:label>\n<sb:reference id=\"sbref0037\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Popova</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Trivedi</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>176</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>428</sb:first-page>\n<sb:last-page>438</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0037\">Popova V, Daly EJ, Trivedi M, et al. Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study. Am J Psychiatry. 2019;176(6):428-438.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0038\">\n<ce:label>38</ce:label>\n<sb:reference id=\"sbref0038\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.F.</ce:given-name>\n<ce:surname>Grunebaum</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.C.</ce:given-name>\n<ce:surname>Galfalvy</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.H.</ce:given-name>\n<ce:surname>Choo</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine for rapid reduction of suicidal thoughts in major depression: A midazolam-controlled randomized clinical trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>175</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>327</sb:first-page>\n<sb:last-page>335</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0038\">Grunebaum MF, Galfalvy HC, Choo TH, et al. Ketamine for rapid reduction of suicidal thoughts in major depression: A midazolam-controlled randomized clinical trial. Am J Psychiatry. 2018;175(4):327-335.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0039\">\n<ce:label>39</ce:label>\n<sb:reference id=\"sbref0039\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.T.</ce:given-name>\n<ce:surname>Wilkinson</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Farmer</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.D.</ce:given-name>\n<ce:surname>Ballard</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Neuropsychopharmacology</sb:maintitle>\n</sb:title>\n<sb:volume-nr>44</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1233</sb:first-page>\n<sb:last-page>1238</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0039\">Wilkinson ST, Farmer C, Ballard ED, et al. Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant. Neuropsychopharmacology. 2019;44(7):1233-1238.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0040\">\n<ce:label>40</ce:label>\n<sb:reference id=\"sbref0040\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.L.</ce:given-name>\n<ce:surname>Naismith</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.M.</ce:given-name>\n<ce:surname>Norrie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Mowszowski</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>IB.</ce:given-name>\n<ce:surname>Hickie</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The neurobiology of depression in later-life: Clinical, neuropsychological, neuroimaging and pathophysiological features</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Prog Neurobiol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>98</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2012</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>99</sb:first-page>\n<sb:last-page>143</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0040\">Naismith SL, Norrie LM, Mowszowski L, Hickie IB. The neurobiology of depression in later-life: Clinical, neuropsychological, neuroimaging and pathophysiological features. Prog Neurobiol. 2012;98(1):99-143.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0041\">\n<ce:label>41</ce:label>\n<sb:reference id=\"sbref0041\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Bayes</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Dong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Alonzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Kabourakis</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Loo</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine treatment for depression: A model of care</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Aust N Z J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>55</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>12</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1134</sb:first-page>\n<sb:last-page>1143</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0041\">Bayes A, Dong V, Martin D, Alonzo A, Kabourakis M, Loo C. Ketamine treatment for depression: A model of care. Aust N Z J Psychiatry. 2021;55(12):1134-1143.</ce:source-text>\n</ce:bib-reference>\n</ce:bibliography-sec>",
    "output": "<ce:bibliography-sec xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"cebibsec1\">\n<?att type=\"article\"?><ce:bib-reference id=\"bib0001\">\n<ce:label>1</ce:label>\n<sb:reference id=\"sbref0001\">\n<sb:contribution>\n<sb:authors>\n<sb:collaboration>Global Burden of Disease Study 2013 Collaborators</sb:collaboration>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Lancet</sb:maintitle>\n</sb:title>\n<sb:volume-nr>386</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>9995</sb:issue-nr>\n<sb:date>20132015</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>743</sb:first-page>\n<sb:last-page>800</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0001\">Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743-800.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0002\">\n<ce:label>2</ce:label>\n<sb:reference id=\"sbref0002\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Maj</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.J.</ce:given-name>\n<ce:surname>Stein</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Parker</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The clinical characterization of the adult patient with depression aimed at personalization of management</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>19</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>269</sb:first-page>\n<sb:last-page>293</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0002\">Maj M, Stein DJ, Parker G, et al. The clinical characterization of the adult patient with depression aimed at personalization of management. World Psychiatry. 2020;19(3):269-293.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0003\">\n<ce:label>3</ce:label>\n<sb:reference id=\"sbref0003\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>CF 3rd</ce:given-name>\n<ce:surname>Reynolds</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.V.</ce:given-name>\n<ce:surname>Jeste</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.S.</ce:given-name>\n<ce:surname>Sachdev</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.G.</ce:given-name>\n<ce:surname>Blazer</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Mental health care for older adults: recent advances and new directions in clinical practice and research</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>21</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>336</sb:first-page>\n<sb:last-page>363</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0003\">Reynolds CF 3rd, Jeste DV, Sachdev PS, Blazer DG. Mental health care for older adults: recent advances and new directions in clinical practice and research. World Psychiatry. 2022;21(3):336-363.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0004\">\n<ce:label>4</ce:label>\n<sb:reference id=\"sbref0004\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zenebe</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Akele</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>W/Selassie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Necho</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Prevalence and determinants of depression among old age: a systematic review and meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Ann Gen Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>20</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>55</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0004\">Zenebe Y, Akele B, W/Selassie M, Necho M. Prevalence and determinants of depression among old age: a systematic review and meta-analysis. Ann Gen Psychiatry. 2021;20(1):55.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0005\">\n<ce:label>5</ce:label>\n<sb:reference id=\"sbref0005\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.S.</ce:given-name>\n<ce:surname>Hasin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.L.</ce:given-name>\n<ce:surname>Sarvet</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.L.</ce:given-name>\n<ce:surname>Meyers</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>JAMA Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>75</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>336</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0005\">Hasin DS, Sarvet AL, Meyers JL, et al. Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiatry. 2018;75(4):336.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0006\">\n<ce:label>6</ce:label>\n<sb:reference id=\"sbref0006\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.R.</ce:given-name>\n<ce:surname>Azar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.P.</ce:given-name>\n<ce:surname>Chopra</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.Y.</ce:given-name>\n<ce:surname>Cho</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Coakley</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>JL.</ce:given-name>\n<ce:surname>Rudolph</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Remission in major depression: results from a geriatric primary care population</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>26</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2011</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>48</sb:first-page>\n<sb:last-page>55</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0006\">Azar AR, Chopra MP, Cho LY, Coakley E, Rudolph JL. Remission in major depression: results from a geriatric primary care population. Int J Geriatr Psychiatry. 2011;26(1):48-55.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0007\">\n<ce:label>7</ce:label>\n<sb:reference id=\"sbref0007\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>U.</ce:given-name>\n<ce:surname>Klotz</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pharmacokinetics and drug metabolism in the elderly</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Drug Metab Rev</sb:maintitle>\n</sb:title>\n<sb:volume-nr>41</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2009</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>67</sb:first-page>\n<sb:last-page>76</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0007\">Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev. 2009;41(2):67-76.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0008\">\n<ce:label>8</ce:label>\n<sb:reference id=\"sbref0008\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Canadian Coalition for Seniors’ Mental</ce:given-name>\n<ce:surname>Health</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Canadian Guidelines on Prevention, Assessment and Treatment of Depression Among Older Adults</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>CCSMH; 2021</sb:maintitle>\n</sb:title>\n</sb:series>\n<sb:date>June 2021</sb:date>\n</sb:issue>\n</sb:host>\n<sb:comment>Updated</sb:comment>\n<sb:host>\n<sb:e-host>\n<ce:inter-ref id=\"interref0001\" xlink:href=\"https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf\">https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf</ce:inter-ref>\n</sb:e-host>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0008\">Canadian Coalition for Seniors’ Mental Health. Canadian Guidelines on Prevention, Assessment and Treatment of Depression Among Older Adults. CCSMH; 2021. Updated June 2021. https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0009\">\n<ce:label>9</ce:label>\n<sb:reference id=\"sbref0009\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Avasthi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Grover</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Clinical practice guidelines for management of depression in elderly</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Indian J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>60</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>Suppl 3</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>S341</sb:first-page>\n<sb:last-page>S362</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0009\">Avasthi A, Grover S. Clinical practice guidelines for management of depression in elderly. Indian J Psychiatry. 2018;60(Suppl 3):S341-S362.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0010\">\n<ce:label>10</ce:label>\n<sb:reference id=\"sbref0010\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Baba</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Kito</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Nukariya</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Guidelines for diagnosis and treatment of depression in older adults: A report from the Japanese Society of mood disorders</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Psychiatry Clin Neurosci</sb:maintitle>\n</sb:title>\n<sb:volume-nr>76</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>222</sb:first-page>\n<sb:last-page>234</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0010\">Baba H, Kito S, Nukariya K, et al. Guidelines for diagnosis and treatment of depression in older adults: A report from the Japanese Society of mood disorders. Psychiatry Clin Neurosci. 2022;76(6):222-234.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0011\">\n<ce:label>11</ce:label>\n<sb:reference id=\"sbref0011\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Rosenblat</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.B.</ce:given-name>\n<ce:surname>Nemeroff</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>178</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>383</sb:first-page>\n<sb:last-page>399</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0011\">McIntyre RS, Rosenblat JD, Nemeroff CB, et al. Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation. Am J Psychiatry. 2021;178(5):383-399.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0012\">\n<ce:label>12</ce:label>\n<sb:reference id=\"sbref0012\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.C.H.</ce:given-name>\n<ce:surname>Cheng</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.E.</ce:given-name>\n<ce:surname>Dri</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Ballum</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effects of ketamine and esketamine on measures of quality of life in major depressive disorder and treatment-resistant depression: A systematic review</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>382</sb:volume-nr>\n</sb:series>\n<sb:date>2025</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>438</sb:first-page>\n<sb:last-page>442</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0012\">Cheng MCH, Dri CE, Ballum H, et al. The effects of ketamine and esketamine on measures of quality of life in major depressive disorder and treatment-resistant depression: A systematic review. J Affect Disord. 2025;382:438-442.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0013\">\n<ce:label>13</ce:label>\n<sb:reference id=\"sbref0013\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Di Vincenzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.B.</ce:given-name>\n<ce:surname>Rodrigues</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Safety, tolerability, and real-world effectiveness of intravenous ketamine in older adults with treatment-resistant depression: A case series</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>29</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>9</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>899</sb:first-page>\n<sb:last-page>913</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0013\">Lipsitz O, Di Vincenzo JD, Rodrigues NB, et al. Safety, tolerability, and real-world effectiveness of intravenous ketamine in older adults with treatment-resistant depression: A case series. Am J Geriatr Psychiatry. 2021;29(9):899-913.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0014\">\n<ce:label>14</ce:label>\n<sb:reference id=\"sbref0014\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>I.P.</ce:given-name>\n<ce:surname>Carvalho</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.M.W.</ce:given-name>\n<ce:surname>Lui</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>276</sb:volume-nr>\n</sb:series>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>576</sb:first-page>\n<sb:last-page>584</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0014\">McIntyre RS, Carvalho IP, Lui LMW, et al. The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis. J Affect Disord. 2020;276:576-584.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0015\">\n<ce:label>15</ce:label>\n<sb:reference id=\"sbref0015\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Lee</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Syeda</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.A.</ce:given-name>\n<ce:surname>Maruschak</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>A new perspective on the anti-suicide effects with ketamine treatment: A procognitive effect</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Clin Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>36</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2016</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>50</sb:first-page>\n<sb:last-page>56</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0015\">Lee Y, Syeda K, Maruschak NA, et al. A new perspective on the anti-suicide effects with ketamine treatment: A procognitive effect. J Clin Psychopharmacol. 2016;36(1):50-56.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0016\">\n<ce:label>16</ce:label>\n<sb:reference id=\"sbref0016\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Xiong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Chen-Li</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>134</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>57</sb:first-page>\n<sb:last-page>68</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0016\">Xiong J, Lipsitz O, Chen-Li D, et al. The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis. J Psychiatr Res. 2021;134:57-68.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0017\">\n<ce:label>17</ce:label>\n<sb:reference id=\"sbref0017\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Gupta</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Dhar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Patadia</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>A systematic review of ketamine for the treatment of depression among older adults</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int Psychogeriatr</sb:maintitle>\n</sb:title>\n<sb:volume-nr>33</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>179</sb:first-page>\n<sb:last-page>191</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0017\">Gupta A, Dhar R, Patadia P, et al. A systematic review of ketamine for the treatment of depression among older adults. Int Psychogeriatr. 2021;33(2):179-191.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0018\">\n<ce:label>18</ce:label>\n<sb:reference id=\"sbref0018\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Di Vincenzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Siegel</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>137</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>232</sb:first-page>\n<sb:last-page>241</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0018\">Di Vincenzo JD, Siegel A, Lipsitz O, et al. The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review. J Psychiatr Res. 2021;137:232-241.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0019\">\n<ce:label>19</ce:label>\n<sb:reference id=\"sbref0019\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Page</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.E.</ce:given-name>\n<ce:surname>McKenzie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.M.</ce:given-name>\n<ce:surname>Bossuyt</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The PRISMA 2020 statement: an updated guideline for reporting systematic reviews</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>BMJ</sb:maintitle>\n</sb:title>\n<sb:volume-nr>372</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>n71</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0019\">Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0020\">\n<ce:label>20</ce:label>\n<sb:reference id=\"sbref0020\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.A.C.</ce:given-name>\n<ce:surname>Sterne</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Savović</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Page</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>RoB 2: a revised tool for assessing risk of bias in randomised trials</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>BMJ</sb:maintitle>\n</sb:title>\n<sb:volume-nr>366</sb:volume-nr>\n</sb:series>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>l4898</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0020\">Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0021\">\n<ce:label>21</ce:label>\n<sb:reference id=\"sbref0021\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>T.H.</ce:given-name>\n<ce:surname>Barker</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Habibi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Aromataris</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>JBI Evid Synth</sb:maintitle>\n</sb:title>\n<sb:volume-nr>22</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>378</sb:first-page>\n<sb:last-page>388</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0021\">Barker TH, Habibi N, Aromataris E, et al. The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies. JBI Evid Synth. 2024;22(3):378-388.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0022\">\n<ce:label>22</ce:label>\n<sb:reference id=\"sbref0022\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Gálvez</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Huggins</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>32</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>397</sb:first-page>\n<sb:last-page>407</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0022\">Gálvez V, Li A, Huggins C, et al. Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial. J Psychopharmacol. 2018;32(4):397-407.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0023\">\n<ce:label>23</ce:label>\n<sb:reference id=\"sbref0023\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Ochs-Ross</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zhang</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression-TRANSFORM-3</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>28</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>121</sb:first-page>\n<sb:last-page>141</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0023\">Ochs-Ross R, Daly EJ, Zhang Y, et al. Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression-TRANSFORM-3. Am J Geriatr Psychiatry. 2020;28(2):121-141.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0024\">\n<ce:label>24</ce:label>\n<sb:reference id=\"sbref0024\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Lai</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Katalinic</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Glue</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pilot dose-response trial of i.v. ketamine in treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World J Biol Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>15</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>579</sb:first-page>\n<sb:last-page>584</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0024\">Lai R, Katalinic N, Glue P, et al. Pilot dose-response trial of i.v. ketamine in treatment-resistant depression. World J Biol Psychiatry. 2014;15(7):579-584.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0025\">\n<ce:label>25</ce:label>\n<sb:reference id=\"sbref0025\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Glue</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Loo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Fam</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Nat Med</sb:maintitle>\n</sb:title>\n<sb:volume-nr>30</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>2004</sb:first-page>\n<sb:last-page>2009</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0025\">Glue P, Loo C, Fam J, et al. Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial. Nat Med. 2024;30(7):2004-2009.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0026\">\n<ce:label>26</ce:label>\n<sb:reference id=\"sbref0026\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Fernie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Currie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.S.</ce:given-name>\n<ce:surname>Perrin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Br J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>210</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>422</sb:first-page>\n<sb:last-page>428</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0026\">Fernie G, Currie J, Perrin JS, et al. Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial. Br J Psychiatry. 2017;210(6):422-428.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0027\">\n<ce:label>27</ce:label>\n<sb:reference id=\"sbref0027\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Zou</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Min</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Q.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Ren</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-A randomized, double-blind, controlled clinical study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Brain Behav</sb:maintitle>\n</sb:title>\n<sb:volume-nr>11</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:article-number>e01775</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0027\">Zou L, Min S, Chen Q, Li X, Ren L. Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-A randomized, double-blind, controlled clinical study. Brain Behav. 2021;11(1):e01775.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0028\">\n<ce:label>28</ce:label>\n<sb:reference id=\"sbref0028\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>George</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Gálvez</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>25</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>11</sb:issue-nr>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1199</sb:first-page>\n<sb:last-page>1209</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0028\">George D, Gálvez V, Martin D, et al. Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression. Am J Geriatr Psychiatry. 2017;25(11):1199-1209.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0029\">\n<ce:label>29</ce:label>\n<sb:reference id=\"sbref0029\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Wajs</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Aluisio</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Holder</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: Assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2)</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Clin Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>81</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<ce:doi>10.4088/JCP.19m12891</ce:doi>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0029\">Wajs E, Aluisio L, Holder R, et al. Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: Assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2). J Clin Psychiatry. 2020;81(3). doi:10.4088/JCP.19m12891</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0030\">\n<ce:label>30</ce:label>\n<sb:reference id=\"sbref0030\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.A.</ce:given-name>\n<ce:surname>Oughli</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.A.</ce:given-name>\n<ce:surname>Gebara</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Ciarleglio</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Intravenous ketamine for late-life treatment-resistant depression: A pilot study of tolerability, safety, clinical benefits, and effect on cognition</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>31</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>210</sb:first-page>\n<sb:last-page>221</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0030\">Oughli HA, Gebara MA, Ciarleglio A, et al. Intravenous ketamine for late-life treatment-resistant depression: A pilot study of tolerability, safety, clinical benefits, and effect on cognition. Am J Geriatr Psychiatry. 2023;31(3):210-221.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0031\">\n<ce:label>31</ce:label>\n<sb:reference id=\"sbref0031\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Zaki</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.N.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Lane</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Neuropsychopharmacology</sb:maintitle>\n</sb:title>\n<sb:volume-nr>48</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>8</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1225</sb:first-page>\n<sb:last-page>1233</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0031\">Zaki N, Chen LN, Lane R, et al. Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study. Neuropsychopharmacology. 2023;48(8):1225-1233.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0032\">\n<ce:label>32</ce:label>\n<sb:reference id=\"sbref0032\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>K.G.</ce:given-name>\n<ce:surname>Rasmussen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.W.</ce:given-name>\n<ce:surname>Lineberry</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.W.</ce:given-name>\n<ce:surname>Galardy</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Serial infusions of low-dose ketamine for major depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>27</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2013</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>444</sb:first-page>\n<sb:last-page>450</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0032\">Rasmussen KG, Lineberry TW, Galardy CW, et al. Serial infusions of low-dose ketamine for major depression. J Psychopharmacol. 2013;27(5):444-450.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0033\">\n<ce:label>33</ce:label>\n<sb:reference id=\"sbref0033\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Vanderschelden</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.A.</ce:given-name>\n<ce:surname>Gebara</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.A.</ce:given-name>\n<ce:surname>Oughli</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Change in patient-centered outcomes of psychological well-being, sleep, and suicidality following treatment with intravenous ketamine for late-life treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>38</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>e5964</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0033\">Vanderschelden B, Gebara MA, Oughli HA, et al. Change in patient-centered outcomes of psychological well-being, sleep, and suicidality following treatment with intravenous ketamine for late-life treatment-resistant depression. Int J Geriatr Psychiatry. 2023;38(7):e5964.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0034\">\n<ce:label>34</ce:label>\n<sb:reference id=\"sbref0034\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Ochs-Ross</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Wajs</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Comparison of long-term efficacy and safety of esketamine nasal spray plus oral antidepressant in younger versus older patients with treatment-resistant depression: Post-hoc analysis of SUSTAIN-2, a long-term open-label phase 3 safety and efficacy study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>30</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>541</sb:first-page>\n<sb:last-page>556</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0034\">Ochs-Ross R, Wajs E, Daly EJ, et al. Comparison of long-term efficacy and safety of esketamine nasal spray plus oral antidepressant in younger versus older patients with treatment-resistant depression: Post-hoc analysis of SUSTAIN-2, a long-term open-label phase 3 safety and efficacy study. Am J Geriatr Psychiatry. 2022;30(5):541-556.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0035\">\n<ce:label>35</ce:label>\n<sb:reference id=\"sbref0035\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Filteau</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>156</sb:volume-nr>\n</sb:series>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1</sb:first-page>\n<sb:last-page>7</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0035\">McIntyre RS, Filteau MJ, Martin L, et al. Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach. J Affect Disord. 2014;156:1-7.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0036\">\n<ce:label>36</ce:label>\n<sb:reference id=\"sbref0036\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.R.</ce:given-name>\n<ce:surname>Strawn</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.A.</ce:given-name>\n<ce:surname>Mills</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Suresh</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorder</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>159</sb:volume-nr>\n</sb:series>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>266</sb:first-page>\n<sb:last-page>273</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0036\">Strawn JR, Mills JA, Suresh V, et al. The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorder. J Psychiatr Res. 2023;159:266-273.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0037\">\n<ce:label>37</ce:label>\n<sb:reference id=\"sbref0037\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Popova</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Trivedi</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>176</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>428</sb:first-page>\n<sb:last-page>438</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0037\">Popova V, Daly EJ, Trivedi M, et al. Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study. Am J Psychiatry. 2019;176(6):428-438.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0038\">\n<ce:label>38</ce:label>\n<sb:reference id=\"sbref0038\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.F.</ce:given-name>\n<ce:surname>Grunebaum</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.C.</ce:given-name>\n<ce:surname>Galfalvy</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.H.</ce:given-name>\n<ce:surname>Choo</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine for rapid reduction of suicidal thoughts in major depression: A midazolam-controlled randomized clinical trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>175</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>327</sb:first-page>\n<sb:last-page>335</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0038\">Grunebaum MF, Galfalvy HC, Choo TH, et al. Ketamine for rapid reduction of suicidal thoughts in major depression: A midazolam-controlled randomized clinical trial. Am J Psychiatry. 2018;175(4):327-335.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0039\">\n<ce:label>39</ce:label>\n<sb:reference id=\"sbref0039\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.T.</ce:given-name>\n<ce:surname>Wilkinson</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Farmer</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.D.</ce:given-name>\n<ce:surname>Ballard</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Neuropsychopharmacology</sb:maintitle>\n</sb:title>\n<sb:volume-nr>44</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1233</sb:first-page>\n<sb:last-page>1238</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0039\">Wilkinson ST, Farmer C, Ballard ED, et al. Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant. Neuropsychopharmacology. 2019;44(7):1233-1238.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0040\">\n<ce:label>40</ce:label>\n<sb:reference id=\"sbref0040\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.L.</ce:given-name>\n<ce:surname>Naismith</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.M.</ce:given-name>\n<ce:surname>Norrie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Mowszowski</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>IB.</ce:given-name>\n<ce:surname>Hickie</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The neurobiology of depression in later-life: Clinical, neuropsychological, neuroimaging and pathophysiological features</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Prog Neurobiol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>98</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2012</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>99</sb:first-page>\n<sb:last-page>143</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0040\">Naismith SL, Norrie LM, Mowszowski L, Hickie IB. The neurobiology of depression in later-life: Clinical, neuropsychological, neuroimaging and pathophysiological features. Prog Neurobiol. 2012;98(1):99-143.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0041\">\n<ce:label>41</ce:label>\n<sb:reference id=\"sbref0041\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Bayes</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Dong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Alonzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Kabourakis</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Loo</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine treatment for depression: A model of care</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Aust N Z J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>55</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>12</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1134</sb:first-page>\n<sb:last-page>1143</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0041\">Bayes A, Dong V, Martin D, Alonzo A, Kabourakis M, Loo C. Ketamine treatment for depression: A model of care. Aust N Z J Psychiatry. 2021;55(12):1134-1143.</ce:source-text>\n</ce:bib-reference>\n</ce:bibliography-sec>",
    "error_message": "All bibliographic references within 'ce:bibliography' must be referred to.",
    "error_position": "933:63",
    "error_id": "IDS503a",
    "folder_name": "AMGP2541"
  },
  {
    "input": "<ce:bibliography-sec xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"cebibsec1\">\n<?att type=\"article\"?><ce:bib-reference id=\"bib0001\">\n<ce:label>1</ce:label>\n<sb:reference id=\"sbref0001\">\n<sb:contribution>\n<sb:authors>\n<sb:collaboration>Global Burden of Disease Study 2013 Collaborators</sb:collaboration>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Lancet</sb:maintitle>\n</sb:title>\n<sb:volume-nr>386</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>9995</sb:issue-nr>\n<sb:date>20132015</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>743</sb:first-page>\n<sb:last-page>800</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0001\">Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743-800.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0002\">\n<ce:label>2</ce:label>\n<sb:reference id=\"sbref0002\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Maj</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.J.</ce:given-name>\n<ce:surname>Stein</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Parker</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The clinical characterization of the adult patient with depression aimed at personalization of management</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>19</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>269</sb:first-page>\n<sb:last-page>293</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0002\">Maj M, Stein DJ, Parker G, et al. The clinical characterization of the adult patient with depression aimed at personalization of management. World Psychiatry. 2020;19(3):269-293.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0003\">\n<ce:label>3</ce:label>\n<sb:reference id=\"sbref0003\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>CF 3rd</ce:given-name>\n<ce:surname>Reynolds</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.V.</ce:given-name>\n<ce:surname>Jeste</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.S.</ce:given-name>\n<ce:surname>Sachdev</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.G.</ce:given-name>\n<ce:surname>Blazer</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Mental health care for older adults: recent advances and new directions in clinical practice and research</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>21</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>336</sb:first-page>\n<sb:last-page>363</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0003\">Reynolds CF 3rd, Jeste DV, Sachdev PS, Blazer DG. Mental health care for older adults: recent advances and new directions in clinical practice and research. World Psychiatry. 2022;21(3):336-363.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0004\">\n<ce:label>4</ce:label>\n<sb:reference id=\"sbref0004\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zenebe</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Akele</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>W/Selassie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Necho</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Prevalence and determinants of depression among old age: a systematic review and meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Ann Gen Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>20</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>55</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0004\">Zenebe Y, Akele B, W/Selassie M, Necho M. Prevalence and determinants of depression among old age: a systematic review and meta-analysis. Ann Gen Psychiatry. 2021;20(1):55.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0005\">\n<ce:label>5</ce:label>\n<sb:reference id=\"sbref0005\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.S.</ce:given-name>\n<ce:surname>Hasin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.L.</ce:given-name>\n<ce:surname>Sarvet</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.L.</ce:given-name>\n<ce:surname>Meyers</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>JAMA Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>75</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>336</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0005\">Hasin DS, Sarvet AL, Meyers JL, et al. Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiatry. 2018;75(4):336.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0006\">\n<ce:label>6</ce:label>\n<sb:reference id=\"sbref0006\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.R.</ce:given-name>\n<ce:surname>Azar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.P.</ce:given-name>\n<ce:surname>Chopra</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.Y.</ce:given-name>\n<ce:surname>Cho</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Coakley</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>JL.</ce:given-name>\n<ce:surname>Rudolph</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Remission in major depression: results from a geriatric primary care population</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>26</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2011</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>48</sb:first-page>\n<sb:last-page>55</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0006\">Azar AR, Chopra MP, Cho LY, Coakley E, Rudolph JL. Remission in major depression: results from a geriatric primary care population. Int J Geriatr Psychiatry. 2011;26(1):48-55.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0007\">\n<ce:label>7</ce:label>\n<sb:reference id=\"sbref0007\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>U.</ce:given-name>\n<ce:surname>Klotz</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pharmacokinetics and drug metabolism in the elderly</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Drug Metab Rev</sb:maintitle>\n</sb:title>\n<sb:volume-nr>41</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2009</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>67</sb:first-page>\n<sb:last-page>76</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0007\">Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev. 2009;41(2):67-76.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0008\">\n<ce:label>8</ce:label>\n<sb:reference id=\"sbref0008\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Canadian Coalition for Seniors’ Mental</ce:given-name>\n<ce:surname>Health</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Canadian Guidelines on Prevention, Assessment and Treatment of Depression Among Older Adults</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>CCSMH; 2021</sb:maintitle>\n</sb:title>\n</sb:series>\n<sb:date>June 2021</sb:date>\n</sb:issue>\n</sb:host>\n<sb:comment>Updated</sb:comment>\n<sb:host>\n<sb:e-host>\n<ce:inter-ref id=\"interref0001\" xlink:href=\"https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf\">https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf</ce:inter-ref>\n</sb:e-host>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0008\">Canadian Coalition for Seniors’ Mental Health. Canadian Guidelines on Prevention, Assessment and Treatment of Depression Among Older Adults. CCSMH; 2021. Updated June 2021. https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0009\">\n<ce:label>9</ce:label>\n<sb:reference id=\"sbref0009\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Avasthi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Grover</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Clinical practice guidelines for management of depression in elderly</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Indian J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>60</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>Suppl 3</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>S341</sb:first-page>\n<sb:last-page>S362</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0009\">Avasthi A, Grover S. Clinical practice guidelines for management of depression in elderly. Indian J Psychiatry. 2018;60(Suppl 3):S341-S362.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0010\">\n<ce:label>10</ce:label>\n<sb:reference id=\"sbref0010\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Baba</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Kito</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Nukariya</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Guidelines for diagnosis and treatment of depression in older adults: A report from the Japanese Society of mood disorders</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Psychiatry Clin Neurosci</sb:maintitle>\n</sb:title>\n<sb:volume-nr>76</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>222</sb:first-page>\n<sb:last-page>234</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0010\">Baba H, Kito S, Nukariya K, et al. Guidelines for diagnosis and treatment of depression in older adults: A report from the Japanese Society of mood disorders. Psychiatry Clin Neurosci. 2022;76(6):222-234.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0011\">\n<ce:label>11</ce:label>\n<sb:reference id=\"sbref0011\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Rosenblat</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.B.</ce:given-name>\n<ce:surname>Nemeroff</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>178</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>383</sb:first-page>\n<sb:last-page>399</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0011\">McIntyre RS, Rosenblat JD, Nemeroff CB, et al. Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation. Am J Psychiatry. 2021;178(5):383-399.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0012\">\n<ce:label>12</ce:label>\n<sb:reference id=\"sbref0012\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.C.H.</ce:given-name>\n<ce:surname>Cheng</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.E.</ce:given-name>\n<ce:surname>Dri</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Ballum</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effects of ketamine and esketamine on measures of quality of life in major depressive disorder and treatment-resistant depression: A systematic review</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>382</sb:volume-nr>\n</sb:series>\n<sb:date>2025</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>438</sb:first-page>\n<sb:last-page>442</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0012\">Cheng MCH, Dri CE, Ballum H, et al. The effects of ketamine and esketamine on measures of quality of life in major depressive disorder and treatment-resistant depression: A systematic review. J Affect Disord. 2025;382:438-442.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0013\">\n<ce:label>13</ce:label>\n<sb:reference id=\"sbref0013\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Di Vincenzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.B.</ce:given-name>\n<ce:surname>Rodrigues</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Safety, tolerability, and real-world effectiveness of intravenous ketamine in older adults with treatment-resistant depression: A case series</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>29</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>9</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>899</sb:first-page>\n<sb:last-page>913</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0013\">Lipsitz O, Di Vincenzo JD, Rodrigues NB, et al. Safety, tolerability, and real-world effectiveness of intravenous ketamine in older adults with treatment-resistant depression: A case series. Am J Geriatr Psychiatry. 2021;29(9):899-913.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0014\">\n<ce:label>14</ce:label>\n<sb:reference id=\"sbref0014\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>I.P.</ce:given-name>\n<ce:surname>Carvalho</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.M.W.</ce:given-name>\n<ce:surname>Lui</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>276</sb:volume-nr>\n</sb:series>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>576</sb:first-page>\n<sb:last-page>584</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0014\">McIntyre RS, Carvalho IP, Lui LMW, et al. The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis. J Affect Disord. 2020;276:576-584.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0015\">\n<ce:label>15</ce:label>\n<sb:reference id=\"sbref0015\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Lee</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Syeda</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.A.</ce:given-name>\n<ce:surname>Maruschak</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>A new perspective on the anti-suicide effects with ketamine treatment: A procognitive effect</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Clin Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>36</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2016</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>50</sb:first-page>\n<sb:last-page>56</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0015\">Lee Y, Syeda K, Maruschak NA, et al. A new perspective on the anti-suicide effects with ketamine treatment: A procognitive effect. J Clin Psychopharmacol. 2016;36(1):50-56.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0016\">\n<ce:label>16</ce:label>\n<sb:reference id=\"sbref0016\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Xiong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Chen-Li</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>134</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>57</sb:first-page>\n<sb:last-page>68</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0016\">Xiong J, Lipsitz O, Chen-Li D, et al. The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis. J Psychiatr Res. 2021;134:57-68.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0017\">\n<ce:label>17</ce:label>\n<sb:reference id=\"sbref0017\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Gupta</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Dhar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Patadia</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>A systematic review of ketamine for the treatment of depression among older adults</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int Psychogeriatr</sb:maintitle>\n</sb:title>\n<sb:volume-nr>33</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>179</sb:first-page>\n<sb:last-page>191</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0017\">Gupta A, Dhar R, Patadia P, et al. A systematic review of ketamine for the treatment of depression among older adults. Int Psychogeriatr. 2021;33(2):179-191.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0018\">\n<ce:label>18</ce:label>\n<sb:reference id=\"sbref0018\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Di Vincenzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Siegel</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>137</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>232</sb:first-page>\n<sb:last-page>241</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0018\">Di Vincenzo JD, Siegel A, Lipsitz O, et al. The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review. J Psychiatr Res. 2021;137:232-241.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0019\">\n<ce:label>19</ce:label>\n<sb:reference id=\"sbref0019\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Page</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.E.</ce:given-name>\n<ce:surname>McKenzie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.M.</ce:given-name>\n<ce:surname>Bossuyt</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The PRISMA 2020 statement: an updated guideline for reporting systematic reviews</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>BMJ</sb:maintitle>\n</sb:title>\n<sb:volume-nr>372</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>n71</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0019\">Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0020\">\n<ce:label>20</ce:label>\n<sb:reference id=\"sbref0020\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.A.C.</ce:given-name>\n<ce:surname>Sterne</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Savović</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Page</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>RoB 2: a revised tool for assessing risk of bias in randomised trials</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>BMJ</sb:maintitle>\n</sb:title>\n<sb:volume-nr>366</sb:volume-nr>\n</sb:series>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>l4898</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0020\">Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0021\">\n<ce:label>21</ce:label>\n<sb:reference id=\"sbref0021\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>T.H.</ce:given-name>\n<ce:surname>Barker</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Habibi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Aromataris</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>JBI Evid Synth</sb:maintitle>\n</sb:title>\n<sb:volume-nr>22</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>378</sb:first-page>\n<sb:last-page>388</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0021\">Barker TH, Habibi N, Aromataris E, et al. The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies. JBI Evid Synth. 2024;22(3):378-388.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0022\">\n<ce:label>22</ce:label>\n<sb:reference id=\"sbref0022\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Gálvez</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Huggins</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>32</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>397</sb:first-page>\n<sb:last-page>407</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0022\">Gálvez V, Li A, Huggins C, et al. Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial. J Psychopharmacol. 2018;32(4):397-407.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0023\">\n<ce:label>23</ce:label>\n<sb:reference id=\"sbref0023\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Ochs-Ross</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zhang</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression-TRANSFORM-3</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>28</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>121</sb:first-page>\n<sb:last-page>141</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0023\">Ochs-Ross R, Daly EJ, Zhang Y, et al. Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression-TRANSFORM-3. Am J Geriatr Psychiatry. 2020;28(2):121-141.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0024\">\n<ce:label>24</ce:label>\n<sb:reference id=\"sbref0024\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Lai</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Katalinic</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Glue</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pilot dose-response trial of i.v. ketamine in treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World J Biol Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>15</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>579</sb:first-page>\n<sb:last-page>584</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0024\">Lai R, Katalinic N, Glue P, et al. Pilot dose-response trial of i.v. ketamine in treatment-resistant depression. World J Biol Psychiatry. 2014;15(7):579-584.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0025\">\n<ce:label>25</ce:label>\n<sb:reference id=\"sbref0025\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Glue</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Loo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Fam</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Nat Med</sb:maintitle>\n</sb:title>\n<sb:volume-nr>30</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>2004</sb:first-page>\n<sb:last-page>2009</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0025\">Glue P, Loo C, Fam J, et al. Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial. Nat Med. 2024;30(7):2004-2009.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0026\">\n<ce:label>26</ce:label>\n<sb:reference id=\"sbref0026\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Fernie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Currie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.S.</ce:given-name>\n<ce:surname>Perrin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Br J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>210</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>422</sb:first-page>\n<sb:last-page>428</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0026\">Fernie G, Currie J, Perrin JS, et al. Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial. Br J Psychiatry. 2017;210(6):422-428.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0027\">\n<ce:label>27</ce:label>\n<sb:reference id=\"sbref0027\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Zou</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Min</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Q.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Ren</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-A randomized, double-blind, controlled clinical study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Brain Behav</sb:maintitle>\n</sb:title>\n<sb:volume-nr>11</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:article-number>e01775</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0027\">Zou L, Min S, Chen Q, Li X, Ren L. Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-A randomized, double-blind, controlled clinical study. Brain Behav. 2021;11(1):e01775.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0028\">\n<ce:label>28</ce:label>\n<sb:reference id=\"sbref0028\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>George</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Gálvez</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>25</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>11</sb:issue-nr>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1199</sb:first-page>\n<sb:last-page>1209</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0028\">George D, Gálvez V, Martin D, et al. Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression. Am J Geriatr Psychiatry. 2017;25(11):1199-1209.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0029\">\n<ce:label>29</ce:label>\n<sb:reference id=\"sbref0029\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Wajs</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Aluisio</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Holder</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: Assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2)</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Clin Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>81</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<ce:doi>10.4088/JCP.19m12891</ce:doi>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0029\">Wajs E, Aluisio L, Holder R, et al. Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: Assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2). J Clin Psychiatry. 2020;81(3). doi:10.4088/JCP.19m12891</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0030\">\n<ce:label>30</ce:label>\n<sb:reference id=\"sbref0030\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.A.</ce:given-name>\n<ce:surname>Oughli</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.A.</ce:given-name>\n<ce:surname>Gebara</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Ciarleglio</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Intravenous ketamine for late-life treatment-resistant depression: A pilot study of tolerability, safety, clinical benefits, and effect on cognition</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>31</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>210</sb:first-page>\n<sb:last-page>221</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0030\">Oughli HA, Gebara MA, Ciarleglio A, et al. Intravenous ketamine for late-life treatment-resistant depression: A pilot study of tolerability, safety, clinical benefits, and effect on cognition. Am J Geriatr Psychiatry. 2023;31(3):210-221.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0031\">\n<ce:label>31</ce:label>\n<sb:reference id=\"sbref0031\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Zaki</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.N.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Lane</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Neuropsychopharmacology</sb:maintitle>\n</sb:title>\n<sb:volume-nr>48</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>8</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1225</sb:first-page>\n<sb:last-page>1233</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0031\">Zaki N, Chen LN, Lane R, et al. Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study. Neuropsychopharmacology. 2023;48(8):1225-1233.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0032\">\n<ce:label>32</ce:label>\n<sb:reference id=\"sbref0032\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>K.G.</ce:given-name>\n<ce:surname>Rasmussen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.W.</ce:given-name>\n<ce:surname>Lineberry</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.W.</ce:given-name>\n<ce:surname>Galardy</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Serial infusions of low-dose ketamine for major depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>27</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2013</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>444</sb:first-page>\n<sb:last-page>450</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0032\">Rasmussen KG, Lineberry TW, Galardy CW, et al. Serial infusions of low-dose ketamine for major depression. J Psychopharmacol. 2013;27(5):444-450.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0033\">\n<ce:label>33</ce:label>\n<sb:reference id=\"sbref0033\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Vanderschelden</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.A.</ce:given-name>\n<ce:surname>Gebara</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.A.</ce:given-name>\n<ce:surname>Oughli</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Change in patient-centered outcomes of psychological well-being, sleep, and suicidality following treatment with intravenous ketamine for late-life treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>38</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>e5964</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0033\">Vanderschelden B, Gebara MA, Oughli HA, et al. Change in patient-centered outcomes of psychological well-being, sleep, and suicidality following treatment with intravenous ketamine for late-life treatment-resistant depression. Int J Geriatr Psychiatry. 2023;38(7):e5964.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0034\">\n<ce:label>34</ce:label>\n<sb:reference id=\"sbref0034\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Ochs-Ross</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Wajs</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Comparison of long-term efficacy and safety of esketamine nasal spray plus oral antidepressant in younger versus older patients with treatment-resistant depression: Post-hoc analysis of SUSTAIN-2, a long-term open-label phase 3 safety and efficacy study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>30</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>541</sb:first-page>\n<sb:last-page>556</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0034\">Ochs-Ross R, Wajs E, Daly EJ, et al. Comparison of long-term efficacy and safety of esketamine nasal spray plus oral antidepressant in younger versus older patients with treatment-resistant depression: Post-hoc analysis of SUSTAIN-2, a long-term open-label phase 3 safety and efficacy study. Am J Geriatr Psychiatry. 2022;30(5):541-556.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0035\">\n<ce:label>35</ce:label>\n<sb:reference id=\"sbref0035\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Filteau</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>156</sb:volume-nr>\n</sb:series>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1</sb:first-page>\n<sb:last-page>7</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0035\">McIntyre RS, Filteau MJ, Martin L, et al. Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach. J Affect Disord. 2014;156:1-7.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0036\">\n<ce:label>36</ce:label>\n<sb:reference id=\"sbref0036\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.R.</ce:given-name>\n<ce:surname>Strawn</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.A.</ce:given-name>\n<ce:surname>Mills</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Suresh</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorder</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>159</sb:volume-nr>\n</sb:series>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>266</sb:first-page>\n<sb:last-page>273</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0036\">Strawn JR, Mills JA, Suresh V, et al. The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorder. J Psychiatr Res. 2023;159:266-273.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0037\">\n<ce:label>37</ce:label>\n<sb:reference id=\"sbref0037\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Popova</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Trivedi</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>176</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>428</sb:first-page>\n<sb:last-page>438</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0037\">Popova V, Daly EJ, Trivedi M, et al. Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study. Am J Psychiatry. 2019;176(6):428-438.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0038\">\n<ce:label>38</ce:label>\n<sb:reference id=\"sbref0038\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.F.</ce:given-name>\n<ce:surname>Grunebaum</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.C.</ce:given-name>\n<ce:surname>Galfalvy</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.H.</ce:given-name>\n<ce:surname>Choo</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine for rapid reduction of suicidal thoughts in major depression: A midazolam-controlled randomized clinical trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>175</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>327</sb:first-page>\n<sb:last-page>335</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0038\">Grunebaum MF, Galfalvy HC, Choo TH, et al. Ketamine for rapid reduction of suicidal thoughts in major depression: A midazolam-controlled randomized clinical trial. Am J Psychiatry. 2018;175(4):327-335.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0039\">\n<ce:label>39</ce:label>\n<sb:reference id=\"sbref0039\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.T.</ce:given-name>\n<ce:surname>Wilkinson</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Farmer</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.D.</ce:given-name>\n<ce:surname>Ballard</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Neuropsychopharmacology</sb:maintitle>\n</sb:title>\n<sb:volume-nr>44</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1233</sb:first-page>\n<sb:last-page>1238</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0039\">Wilkinson ST, Farmer C, Ballard ED, et al. Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant. Neuropsychopharmacology. 2019;44(7):1233-1238.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0040\">\n<ce:label>40</ce:label>\n<sb:reference id=\"sbref0040\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.L.</ce:given-name>\n<ce:surname>Naismith</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.M.</ce:given-name>\n<ce:surname>Norrie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Mowszowski</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>IB.</ce:given-name>\n<ce:surname>Hickie</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The neurobiology of depression in later-life: Clinical, neuropsychological, neuroimaging and pathophysiological features</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Prog Neurobiol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>98</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2012</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>99</sb:first-page>\n<sb:last-page>143</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0040\">Naismith SL, Norrie LM, Mowszowski L, Hickie IB. The neurobiology of depression in later-life: Clinical, neuropsychological, neuroimaging and pathophysiological features. Prog Neurobiol. 2012;98(1):99-143.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0041\">\n<ce:label>41</ce:label>\n<sb:reference id=\"sbref0041\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Bayes</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Dong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Alonzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Kabourakis</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Loo</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine treatment for depression: A model of care</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Aust N Z J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>55</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>12</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1134</sb:first-page>\n<sb:last-page>1143</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0041\">Bayes A, Dong V, Martin D, Alonzo A, Kabourakis M, Loo C. Ketamine treatment for depression: A model of care. Aust N Z J Psychiatry. 2021;55(12):1134-1143.</ce:source-text>\n</ce:bib-reference>\n</ce:bibliography-sec>",
    "output": "<ce:bibliography-sec xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"cebibsec1\">\n<?att type=\"article\"?><ce:bib-reference id=\"bib0001\">\n<ce:label>1</ce:label>\n<sb:reference id=\"sbref0001\">\n<sb:contribution>\n<sb:authors>\n<sb:collaboration>Global Burden of Disease Study 2013 Collaborators</sb:collaboration>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Lancet</sb:maintitle>\n</sb:title>\n<sb:volume-nr>386</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>9995</sb:issue-nr>\n<sb:date>20132015</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>743</sb:first-page>\n<sb:last-page>800</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0001\">Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743-800.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0002\">\n<ce:label>2</ce:label>\n<sb:reference id=\"sbref0002\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Maj</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.J.</ce:given-name>\n<ce:surname>Stein</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Parker</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The clinical characterization of the adult patient with depression aimed at personalization of management</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>19</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>269</sb:first-page>\n<sb:last-page>293</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0002\">Maj M, Stein DJ, Parker G, et al. The clinical characterization of the adult patient with depression aimed at personalization of management. World Psychiatry. 2020;19(3):269-293.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0003\">\n<ce:label>3</ce:label>\n<sb:reference id=\"sbref0003\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>CF 3rd</ce:given-name>\n<ce:surname>Reynolds</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.V.</ce:given-name>\n<ce:surname>Jeste</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.S.</ce:given-name>\n<ce:surname>Sachdev</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.G.</ce:given-name>\n<ce:surname>Blazer</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Mental health care for older adults: recent advances and new directions in clinical practice and research</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>21</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>336</sb:first-page>\n<sb:last-page>363</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0003\">Reynolds CF 3rd, Jeste DV, Sachdev PS, Blazer DG. Mental health care for older adults: recent advances and new directions in clinical practice and research. World Psychiatry. 2022;21(3):336-363.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0004\">\n<ce:label>4</ce:label>\n<sb:reference id=\"sbref0004\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zenebe</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Akele</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>W/Selassie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Necho</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Prevalence and determinants of depression among old age: a systematic review and meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Ann Gen Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>20</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>55</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0004\">Zenebe Y, Akele B, W/Selassie M, Necho M. Prevalence and determinants of depression among old age: a systematic review and meta-analysis. Ann Gen Psychiatry. 2021;20(1):55.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0005\">\n<ce:label>5</ce:label>\n<sb:reference id=\"sbref0005\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.S.</ce:given-name>\n<ce:surname>Hasin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.L.</ce:given-name>\n<ce:surname>Sarvet</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.L.</ce:given-name>\n<ce:surname>Meyers</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>JAMA Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>75</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>336</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0005\">Hasin DS, Sarvet AL, Meyers JL, et al. Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiatry. 2018;75(4):336.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0006\">\n<ce:label>6</ce:label>\n<sb:reference id=\"sbref0006\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.R.</ce:given-name>\n<ce:surname>Azar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.P.</ce:given-name>\n<ce:surname>Chopra</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.Y.</ce:given-name>\n<ce:surname>Cho</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Coakley</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>JL.</ce:given-name>\n<ce:surname>Rudolph</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Remission in major depression: results from a geriatric primary care population</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>26</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2011</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>48</sb:first-page>\n<sb:last-page>55</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0006\">Azar AR, Chopra MP, Cho LY, Coakley E, Rudolph JL. Remission in major depression: results from a geriatric primary care population. Int J Geriatr Psychiatry. 2011;26(1):48-55.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0007\">\n<ce:label>7</ce:label>\n<sb:reference id=\"sbref0007\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>U.</ce:given-name>\n<ce:surname>Klotz</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pharmacokinetics and drug metabolism in the elderly</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Drug Metab Rev</sb:maintitle>\n</sb:title>\n<sb:volume-nr>41</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2009</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>67</sb:first-page>\n<sb:last-page>76</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0007\">Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev. 2009;41(2):67-76.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0008\">\n<ce:label>8</ce:label>\n<sb:reference id=\"sbref0008\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Canadian Coalition for Seniors’ Mental</ce:given-name>\n<ce:surname>Health</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Canadian Guidelines on Prevention, Assessment and Treatment of Depression Among Older Adults</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>CCSMH; 2021</sb:maintitle>\n</sb:title>\n</sb:series>\n<sb:date>June 2021</sb:date>\n</sb:issue>\n</sb:host>\n<sb:comment>Updated</sb:comment>\n<sb:host>\n<sb:e-host>\n<ce:inter-ref id=\"interref0001\" xlink:href=\"https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf\">https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf</ce:inter-ref>\n</sb:e-host>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0008\">Canadian Coalition for Seniors’ Mental Health. Canadian Guidelines on Prevention, Assessment and Treatment of Depression Among Older Adults. CCSMH; 2021. Updated June 2021. https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0009\">\n<ce:label>9</ce:label>\n<sb:reference id=\"sbref0009\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Avasthi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Grover</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Clinical practice guidelines for management of depression in elderly</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Indian J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>60</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>Suppl 3</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>S341</sb:first-page>\n<sb:last-page>S362</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0009\">Avasthi A, Grover S. Clinical practice guidelines for management of depression in elderly. Indian J Psychiatry. 2018;60(Suppl 3):S341-S362.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0010\">\n<ce:label>10</ce:label>\n<sb:reference id=\"sbref0010\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Baba</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Kito</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Nukariya</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Guidelines for diagnosis and treatment of depression in older adults: A report from the Japanese Society of mood disorders</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Psychiatry Clin Neurosci</sb:maintitle>\n</sb:title>\n<sb:volume-nr>76</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>222</sb:first-page>\n<sb:last-page>234</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0010\">Baba H, Kito S, Nukariya K, et al. Guidelines for diagnosis and treatment of depression in older adults: A report from the Japanese Society of mood disorders. Psychiatry Clin Neurosci. 2022;76(6):222-234.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0011\">\n<ce:label>11</ce:label>\n<sb:reference id=\"sbref0011\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Rosenblat</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.B.</ce:given-name>\n<ce:surname>Nemeroff</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>178</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>383</sb:first-page>\n<sb:last-page>399</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0011\">McIntyre RS, Rosenblat JD, Nemeroff CB, et al. Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation. Am J Psychiatry. 2021;178(5):383-399.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0012\">\n<ce:label>12</ce:label>\n<sb:reference id=\"sbref0012\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.C.H.</ce:given-name>\n<ce:surname>Cheng</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.E.</ce:given-name>\n<ce:surname>Dri</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Ballum</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effects of ketamine and esketamine on measures of quality of life in major depressive disorder and treatment-resistant depression: A systematic review</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>382</sb:volume-nr>\n</sb:series>\n<sb:date>2025</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>438</sb:first-page>\n<sb:last-page>442</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0012\">Cheng MCH, Dri CE, Ballum H, et al. The effects of ketamine and esketamine on measures of quality of life in major depressive disorder and treatment-resistant depression: A systematic review. J Affect Disord. 2025;382:438-442.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0013\">\n<ce:label>13</ce:label>\n<sb:reference id=\"sbref0013\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Di Vincenzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.B.</ce:given-name>\n<ce:surname>Rodrigues</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Safety, tolerability, and real-world effectiveness of intravenous ketamine in older adults with treatment-resistant depression: A case series</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>29</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>9</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>899</sb:first-page>\n<sb:last-page>913</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0013\">Lipsitz O, Di Vincenzo JD, Rodrigues NB, et al. Safety, tolerability, and real-world effectiveness of intravenous ketamine in older adults with treatment-resistant depression: A case series. Am J Geriatr Psychiatry. 2021;29(9):899-913.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0014\">\n<ce:label>14</ce:label>\n<sb:reference id=\"sbref0014\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>I.P.</ce:given-name>\n<ce:surname>Carvalho</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.M.W.</ce:given-name>\n<ce:surname>Lui</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>276</sb:volume-nr>\n</sb:series>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>576</sb:first-page>\n<sb:last-page>584</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0014\">McIntyre RS, Carvalho IP, Lui LMW, et al. The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis. J Affect Disord. 2020;276:576-584.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0015\">\n<ce:label>15</ce:label>\n<sb:reference id=\"sbref0015\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Lee</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Syeda</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.A.</ce:given-name>\n<ce:surname>Maruschak</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>A new perspective on the anti-suicide effects with ketamine treatment: A procognitive effect</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Clin Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>36</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2016</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>50</sb:first-page>\n<sb:last-page>56</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0015\">Lee Y, Syeda K, Maruschak NA, et al. A new perspective on the anti-suicide effects with ketamine treatment: A procognitive effect. J Clin Psychopharmacol. 2016;36(1):50-56.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0016\">\n<ce:label>16</ce:label>\n<sb:reference id=\"sbref0016\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Xiong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Chen-Li</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>134</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>57</sb:first-page>\n<sb:last-page>68</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0016\">Xiong J, Lipsitz O, Chen-Li D, et al. The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis. J Psychiatr Res. 2021;134:57-68.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0017\">\n<ce:label>17</ce:label>\n<sb:reference id=\"sbref0017\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Gupta</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Dhar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Patadia</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>A systematic review of ketamine for the treatment of depression among older adults</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int Psychogeriatr</sb:maintitle>\n</sb:title>\n<sb:volume-nr>33</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>179</sb:first-page>\n<sb:last-page>191</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0017\">Gupta A, Dhar R, Patadia P, et al. A systematic review of ketamine for the treatment of depression among older adults. Int Psychogeriatr. 2021;33(2):179-191.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0018\">\n<ce:label>18</ce:label>\n<sb:reference id=\"sbref0018\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Di Vincenzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Siegel</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>137</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>232</sb:first-page>\n<sb:last-page>241</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0018\">Di Vincenzo JD, Siegel A, Lipsitz O, et al. The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review. J Psychiatr Res. 2021;137:232-241.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0019\">\n<ce:label>19</ce:label>\n<sb:reference id=\"sbref0019\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Page</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.E.</ce:given-name>\n<ce:surname>McKenzie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.M.</ce:given-name>\n<ce:surname>Bossuyt</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The PRISMA 2020 statement: an updated guideline for reporting systematic reviews</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>BMJ</sb:maintitle>\n</sb:title>\n<sb:volume-nr>372</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>n71</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0019\">Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0020\">\n<ce:label>20</ce:label>\n<sb:reference id=\"sbref0020\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.A.C.</ce:given-name>\n<ce:surname>Sterne</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Savović</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Page</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>RoB 2: a revised tool for assessing risk of bias in randomised trials</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>BMJ</sb:maintitle>\n</sb:title>\n<sb:volume-nr>366</sb:volume-nr>\n</sb:series>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>l4898</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0020\">Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0021\">\n<ce:label>21</ce:label>\n<sb:reference id=\"sbref0021\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>T.H.</ce:given-name>\n<ce:surname>Barker</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Habibi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Aromataris</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>JBI Evid Synth</sb:maintitle>\n</sb:title>\n<sb:volume-nr>22</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>378</sb:first-page>\n<sb:last-page>388</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0021\">Barker TH, Habibi N, Aromataris E, et al. The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies. JBI Evid Synth. 2024;22(3):378-388.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0022\">\n<ce:label>22</ce:label>\n<sb:reference id=\"sbref0022\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Gálvez</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Huggins</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>32</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>397</sb:first-page>\n<sb:last-page>407</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0022\">Gálvez V, Li A, Huggins C, et al. Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial. J Psychopharmacol. 2018;32(4):397-407.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0023\">\n<ce:label>23</ce:label>\n<sb:reference id=\"sbref0023\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Ochs-Ross</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zhang</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression-TRANSFORM-3</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>28</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>121</sb:first-page>\n<sb:last-page>141</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0023\">Ochs-Ross R, Daly EJ, Zhang Y, et al. Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression-TRANSFORM-3. Am J Geriatr Psychiatry. 2020;28(2):121-141.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0024\">\n<ce:label>24</ce:label>\n<sb:reference id=\"sbref0024\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Lai</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Katalinic</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Glue</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pilot dose-response trial of i.v. ketamine in treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World J Biol Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>15</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>579</sb:first-page>\n<sb:last-page>584</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0024\">Lai R, Katalinic N, Glue P, et al. Pilot dose-response trial of i.v. ketamine in treatment-resistant depression. World J Biol Psychiatry. 2014;15(7):579-584.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0025\">\n<ce:label>25</ce:label>\n<sb:reference id=\"sbref0025\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Glue</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Loo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Fam</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Nat Med</sb:maintitle>\n</sb:title>\n<sb:volume-nr>30</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>2004</sb:first-page>\n<sb:last-page>2009</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0025\">Glue P, Loo C, Fam J, et al. Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial. Nat Med. 2024;30(7):2004-2009.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0026\">\n<ce:label>26</ce:label>\n<sb:reference id=\"sbref0026\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Fernie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Currie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.S.</ce:given-name>\n<ce:surname>Perrin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Br J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>210</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>422</sb:first-page>\n<sb:last-page>428</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0026\">Fernie G, Currie J, Perrin JS, et al. Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial. Br J Psychiatry. 2017;210(6):422-428.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0027\">\n<ce:label>27</ce:label>\n<sb:reference id=\"sbref0027\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Zou</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Min</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Q.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Ren</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-A randomized, double-blind, controlled clinical study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Brain Behav</sb:maintitle>\n</sb:title>\n<sb:volume-nr>11</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:article-number>e01775</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0027\">Zou L, Min S, Chen Q, Li X, Ren L. Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-A randomized, double-blind, controlled clinical study. Brain Behav. 2021;11(1):e01775.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0028\">\n<ce:label>28</ce:label>\n<sb:reference id=\"sbref0028\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>George</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Gálvez</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>25</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>11</sb:issue-nr>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1199</sb:first-page>\n<sb:last-page>1209</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0028\">George D, Gálvez V, Martin D, et al. Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression. Am J Geriatr Psychiatry. 2017;25(11):1199-1209.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0029\">\n<ce:label>29</ce:label>\n<sb:reference id=\"sbref0029\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Wajs</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Aluisio</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Holder</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: Assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2)</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Clin Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>81</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<ce:doi>10.4088/JCP.19m12891</ce:doi>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0029\">Wajs E, Aluisio L, Holder R, et al. Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: Assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2). J Clin Psychiatry. 2020;81(3). doi:10.4088/JCP.19m12891</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0030\">\n<ce:label>30</ce:label>\n<sb:reference id=\"sbref0030\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.A.</ce:given-name>\n<ce:surname>Oughli</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.A.</ce:given-name>\n<ce:surname>Gebara</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Ciarleglio</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Intravenous ketamine for late-life treatment-resistant depression: A pilot study of tolerability, safety, clinical benefits, and effect on cognition</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>31</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>210</sb:first-page>\n<sb:last-page>221</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0030\">Oughli HA, Gebara MA, Ciarleglio A, et al. Intravenous ketamine for late-life treatment-resistant depression: A pilot study of tolerability, safety, clinical benefits, and effect on cognition. Am J Geriatr Psychiatry. 2023;31(3):210-221.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0031\">\n<ce:label>31</ce:label>\n<sb:reference id=\"sbref0031\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Zaki</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.N.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Lane</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Neuropsychopharmacology</sb:maintitle>\n</sb:title>\n<sb:volume-nr>48</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>8</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1225</sb:first-page>\n<sb:last-page>1233</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0031\">Zaki N, Chen LN, Lane R, et al. Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study. Neuropsychopharmacology. 2023;48(8):1225-1233.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0032\">\n<ce:label>32</ce:label>\n<sb:reference id=\"sbref0032\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>K.G.</ce:given-name>\n<ce:surname>Rasmussen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.W.</ce:given-name>\n<ce:surname>Lineberry</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.W.</ce:given-name>\n<ce:surname>Galardy</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Serial infusions of low-dose ketamine for major depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>27</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2013</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>444</sb:first-page>\n<sb:last-page>450</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0032\">Rasmussen KG, Lineberry TW, Galardy CW, et al. Serial infusions of low-dose ketamine for major depression. J Psychopharmacol. 2013;27(5):444-450.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0033\">\n<ce:label>33</ce:label>\n<sb:reference id=\"sbref0033\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Vanderschelden</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.A.</ce:given-name>\n<ce:surname>Gebara</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.A.</ce:given-name>\n<ce:surname>Oughli</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Change in patient-centered outcomes of psychological well-being, sleep, and suicidality following treatment with intravenous ketamine for late-life treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>38</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>e5964</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0033\">Vanderschelden B, Gebara MA, Oughli HA, et al. Change in patient-centered outcomes of psychological well-being, sleep, and suicidality following treatment with intravenous ketamine for late-life treatment-resistant depression. Int J Geriatr Psychiatry. 2023;38(7):e5964.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0034\">\n<ce:label>34</ce:label>\n<sb:reference id=\"sbref0034\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Ochs-Ross</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Wajs</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Comparison of long-term efficacy and safety of esketamine nasal spray plus oral antidepressant in younger versus older patients with treatment-resistant depression: Post-hoc analysis of SUSTAIN-2, a long-term open-label phase 3 safety and efficacy study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>30</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>541</sb:first-page>\n<sb:last-page>556</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0034\">Ochs-Ross R, Wajs E, Daly EJ, et al. Comparison of long-term efficacy and safety of esketamine nasal spray plus oral antidepressant in younger versus older patients with treatment-resistant depression: Post-hoc analysis of SUSTAIN-2, a long-term open-label phase 3 safety and efficacy study. Am J Geriatr Psychiatry. 2022;30(5):541-556.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0035\">\n<ce:label>35</ce:label>\n<sb:reference id=\"sbref0035\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Filteau</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>156</sb:volume-nr>\n</sb:series>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1</sb:first-page>\n<sb:last-page>7</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0035\">McIntyre RS, Filteau MJ, Martin L, et al. Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach. J Affect Disord. 2014;156:1-7.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0036\">\n<ce:label>36</ce:label>\n<sb:reference id=\"sbref0036\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.R.</ce:given-name>\n<ce:surname>Strawn</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.A.</ce:given-name>\n<ce:surname>Mills</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Suresh</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorder</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>159</sb:volume-nr>\n</sb:series>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>266</sb:first-page>\n<sb:last-page>273</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0036\">Strawn JR, Mills JA, Suresh V, et al. The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorder. J Psychiatr Res. 2023;159:266-273.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0037\">\n<ce:label>37</ce:label>\n<sb:reference id=\"sbref0037\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Popova</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Trivedi</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>176</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>428</sb:first-page>\n<sb:last-page>438</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0037\">Popova V, Daly EJ, Trivedi M, et al. Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study. Am J Psychiatry. 2019;176(6):428-438.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0038\">\n<ce:label>38</ce:label>\n<sb:reference id=\"sbref0038\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.F.</ce:given-name>\n<ce:surname>Grunebaum</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.C.</ce:given-name>\n<ce:surname>Galfalvy</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.H.</ce:given-name>\n<ce:surname>Choo</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine for rapid reduction of suicidal thoughts in major depression: A midazolam-controlled randomized clinical trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>175</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>327</sb:first-page>\n<sb:last-page>335</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0038\">Grunebaum MF, Galfalvy HC, Choo TH, et al. Ketamine for rapid reduction of suicidal thoughts in major depression: A midazolam-controlled randomized clinical trial. Am J Psychiatry. 2018;175(4):327-335.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0039\">\n<ce:label>39</ce:label>\n<sb:reference id=\"sbref0039\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.T.</ce:given-name>\n<ce:surname>Wilkinson</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Farmer</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.D.</ce:given-name>\n<ce:surname>Ballard</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Neuropsychopharmacology</sb:maintitle>\n</sb:title>\n<sb:volume-nr>44</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1233</sb:first-page>\n<sb:last-page>1238</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0039\">Wilkinson ST, Farmer C, Ballard ED, et al. Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant. Neuropsychopharmacology. 2019;44(7):1233-1238.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0040\">\n<ce:label>40</ce:label>\n<sb:reference id=\"sbref0040\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.L.</ce:given-name>\n<ce:surname>Naismith</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.M.</ce:given-name>\n<ce:surname>Norrie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Mowszowski</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>IB.</ce:given-name>\n<ce:surname>Hickie</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The neurobiology of depression in later-life: Clinical, neuropsychological, neuroimaging and pathophysiological features</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Prog Neurobiol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>98</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2012</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>99</sb:first-page>\n<sb:last-page>143</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0040\">Naismith SL, Norrie LM, Mowszowski L, Hickie IB. The neurobiology of depression in later-life: Clinical, neuropsychological, neuroimaging and pathophysiological features. Prog Neurobiol. 2012;98(1):99-143.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0041\">\n<ce:label>41</ce:label>\n<sb:reference id=\"sbref0041\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Bayes</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Dong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Alonzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Kabourakis</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Loo</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine treatment for depression: A model of care</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Aust N Z J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>55</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>12</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1134</sb:first-page>\n<sb:last-page>1143</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0041\">Bayes A, Dong V, Martin D, Alonzo A, Kabourakis M, Loo C. Ketamine treatment for depression: A model of care. Aust N Z J Psychiatry. 2021;55(12):1134-1143.</ce:source-text>\n</ce:bib-reference>\n</ce:bibliography-sec>",
    "error_message": "All bibliographic references within 'ce:bibliography' must be referred to.",
    "error_position": "963:63",
    "error_id": "IDS503a",
    "folder_name": "AMGP2541"
  },
  {
    "input": "<ce:bibliography-sec xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"cebibsec1\">\n<?att type=\"article\"?><ce:bib-reference id=\"bib0001\">\n<ce:label>1</ce:label>\n<sb:reference id=\"sbref0001\">\n<sb:contribution>\n<sb:authors>\n<sb:collaboration>Global Burden of Disease Study 2013 Collaborators</sb:collaboration>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Lancet</sb:maintitle>\n</sb:title>\n<sb:volume-nr>386</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>9995</sb:issue-nr>\n<sb:date>20132015</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>743</sb:first-page>\n<sb:last-page>800</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0001\">Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743-800.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0002\">\n<ce:label>2</ce:label>\n<sb:reference id=\"sbref0002\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Maj</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.J.</ce:given-name>\n<ce:surname>Stein</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Parker</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The clinical characterization of the adult patient with depression aimed at personalization of management</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>19</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>269</sb:first-page>\n<sb:last-page>293</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0002\">Maj M, Stein DJ, Parker G, et al. The clinical characterization of the adult patient with depression aimed at personalization of management. World Psychiatry. 2020;19(3):269-293.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0003\">\n<ce:label>3</ce:label>\n<sb:reference id=\"sbref0003\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>CF 3rd</ce:given-name>\n<ce:surname>Reynolds</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.V.</ce:given-name>\n<ce:surname>Jeste</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.S.</ce:given-name>\n<ce:surname>Sachdev</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.G.</ce:given-name>\n<ce:surname>Blazer</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Mental health care for older adults: recent advances and new directions in clinical practice and research</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>21</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>336</sb:first-page>\n<sb:last-page>363</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0003\">Reynolds CF 3rd, Jeste DV, Sachdev PS, Blazer DG. Mental health care for older adults: recent advances and new directions in clinical practice and research. World Psychiatry. 2022;21(3):336-363.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0004\">\n<ce:label>4</ce:label>\n<sb:reference id=\"sbref0004\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zenebe</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Akele</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>W/Selassie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Necho</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Prevalence and determinants of depression among old age: a systematic review and meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Ann Gen Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>20</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>55</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0004\">Zenebe Y, Akele B, W/Selassie M, Necho M. Prevalence and determinants of depression among old age: a systematic review and meta-analysis. Ann Gen Psychiatry. 2021;20(1):55.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0005\">\n<ce:label>5</ce:label>\n<sb:reference id=\"sbref0005\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.S.</ce:given-name>\n<ce:surname>Hasin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.L.</ce:given-name>\n<ce:surname>Sarvet</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.L.</ce:given-name>\n<ce:surname>Meyers</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>JAMA Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>75</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>336</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0005\">Hasin DS, Sarvet AL, Meyers JL, et al. Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiatry. 2018;75(4):336.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0006\">\n<ce:label>6</ce:label>\n<sb:reference id=\"sbref0006\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.R.</ce:given-name>\n<ce:surname>Azar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.P.</ce:given-name>\n<ce:surname>Chopra</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.Y.</ce:given-name>\n<ce:surname>Cho</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Coakley</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>JL.</ce:given-name>\n<ce:surname>Rudolph</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Remission in major depression: results from a geriatric primary care population</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>26</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2011</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>48</sb:first-page>\n<sb:last-page>55</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0006\">Azar AR, Chopra MP, Cho LY, Coakley E, Rudolph JL. Remission in major depression: results from a geriatric primary care population. Int J Geriatr Psychiatry. 2011;26(1):48-55.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0007\">\n<ce:label>7</ce:label>\n<sb:reference id=\"sbref0007\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>U.</ce:given-name>\n<ce:surname>Klotz</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pharmacokinetics and drug metabolism in the elderly</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Drug Metab Rev</sb:maintitle>\n</sb:title>\n<sb:volume-nr>41</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2009</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>67</sb:first-page>\n<sb:last-page>76</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0007\">Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev. 2009;41(2):67-76.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0008\">\n<ce:label>8</ce:label>\n<sb:reference id=\"sbref0008\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Canadian Coalition for Seniors’ Mental</ce:given-name>\n<ce:surname>Health</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Canadian Guidelines on Prevention, Assessment and Treatment of Depression Among Older Adults</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>CCSMH; 2021</sb:maintitle>\n</sb:title>\n</sb:series>\n<sb:date>June 2021</sb:date>\n</sb:issue>\n</sb:host>\n<sb:comment>Updated</sb:comment>\n<sb:host>\n<sb:e-host>\n<ce:inter-ref id=\"interref0001\" xlink:href=\"https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf\">https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf</ce:inter-ref>\n</sb:e-host>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0008\">Canadian Coalition for Seniors’ Mental Health. Canadian Guidelines on Prevention, Assessment and Treatment of Depression Among Older Adults. CCSMH; 2021. Updated June 2021. https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0009\">\n<ce:label>9</ce:label>\n<sb:reference id=\"sbref0009\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Avasthi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Grover</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Clinical practice guidelines for management of depression in elderly</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Indian J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>60</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>Suppl 3</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>S341</sb:first-page>\n<sb:last-page>S362</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0009\">Avasthi A, Grover S. Clinical practice guidelines for management of depression in elderly. Indian J Psychiatry. 2018;60(Suppl 3):S341-S362.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0010\">\n<ce:label>10</ce:label>\n<sb:reference id=\"sbref0010\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Baba</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Kito</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Nukariya</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Guidelines for diagnosis and treatment of depression in older adults: A report from the Japanese Society of mood disorders</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Psychiatry Clin Neurosci</sb:maintitle>\n</sb:title>\n<sb:volume-nr>76</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>222</sb:first-page>\n<sb:last-page>234</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0010\">Baba H, Kito S, Nukariya K, et al. Guidelines for diagnosis and treatment of depression in older adults: A report from the Japanese Society of mood disorders. Psychiatry Clin Neurosci. 2022;76(6):222-234.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0011\">\n<ce:label>11</ce:label>\n<sb:reference id=\"sbref0011\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Rosenblat</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.B.</ce:given-name>\n<ce:surname>Nemeroff</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>178</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>383</sb:first-page>\n<sb:last-page>399</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0011\">McIntyre RS, Rosenblat JD, Nemeroff CB, et al. Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation. Am J Psychiatry. 2021;178(5):383-399.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0012\">\n<ce:label>12</ce:label>\n<sb:reference id=\"sbref0012\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.C.H.</ce:given-name>\n<ce:surname>Cheng</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.E.</ce:given-name>\n<ce:surname>Dri</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Ballum</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effects of ketamine and esketamine on measures of quality of life in major depressive disorder and treatment-resistant depression: A systematic review</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>382</sb:volume-nr>\n</sb:series>\n<sb:date>2025</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>438</sb:first-page>\n<sb:last-page>442</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0012\">Cheng MCH, Dri CE, Ballum H, et al. The effects of ketamine and esketamine on measures of quality of life in major depressive disorder and treatment-resistant depression: A systematic review. J Affect Disord. 2025;382:438-442.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0013\">\n<ce:label>13</ce:label>\n<sb:reference id=\"sbref0013\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Di Vincenzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.B.</ce:given-name>\n<ce:surname>Rodrigues</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Safety, tolerability, and real-world effectiveness of intravenous ketamine in older adults with treatment-resistant depression: A case series</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>29</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>9</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>899</sb:first-page>\n<sb:last-page>913</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0013\">Lipsitz O, Di Vincenzo JD, Rodrigues NB, et al. Safety, tolerability, and real-world effectiveness of intravenous ketamine in older adults with treatment-resistant depression: A case series. Am J Geriatr Psychiatry. 2021;29(9):899-913.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0014\">\n<ce:label>14</ce:label>\n<sb:reference id=\"sbref0014\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>I.P.</ce:given-name>\n<ce:surname>Carvalho</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.M.W.</ce:given-name>\n<ce:surname>Lui</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>276</sb:volume-nr>\n</sb:series>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>576</sb:first-page>\n<sb:last-page>584</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0014\">McIntyre RS, Carvalho IP, Lui LMW, et al. The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis. J Affect Disord. 2020;276:576-584.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0015\">\n<ce:label>15</ce:label>\n<sb:reference id=\"sbref0015\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Lee</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Syeda</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.A.</ce:given-name>\n<ce:surname>Maruschak</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>A new perspective on the anti-suicide effects with ketamine treatment: A procognitive effect</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Clin Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>36</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2016</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>50</sb:first-page>\n<sb:last-page>56</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0015\">Lee Y, Syeda K, Maruschak NA, et al. A new perspective on the anti-suicide effects with ketamine treatment: A procognitive effect. J Clin Psychopharmacol. 2016;36(1):50-56.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0016\">\n<ce:label>16</ce:label>\n<sb:reference id=\"sbref0016\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Xiong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Chen-Li</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>134</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>57</sb:first-page>\n<sb:last-page>68</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0016\">Xiong J, Lipsitz O, Chen-Li D, et al. The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis. J Psychiatr Res. 2021;134:57-68.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0017\">\n<ce:label>17</ce:label>\n<sb:reference id=\"sbref0017\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Gupta</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Dhar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Patadia</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>A systematic review of ketamine for the treatment of depression among older adults</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int Psychogeriatr</sb:maintitle>\n</sb:title>\n<sb:volume-nr>33</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>179</sb:first-page>\n<sb:last-page>191</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0017\">Gupta A, Dhar R, Patadia P, et al. A systematic review of ketamine for the treatment of depression among older adults. Int Psychogeriatr. 2021;33(2):179-191.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0018\">\n<ce:label>18</ce:label>\n<sb:reference id=\"sbref0018\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Di Vincenzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Siegel</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>137</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>232</sb:first-page>\n<sb:last-page>241</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0018\">Di Vincenzo JD, Siegel A, Lipsitz O, et al. The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review. J Psychiatr Res. 2021;137:232-241.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0019\">\n<ce:label>19</ce:label>\n<sb:reference id=\"sbref0019\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Page</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.E.</ce:given-name>\n<ce:surname>McKenzie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.M.</ce:given-name>\n<ce:surname>Bossuyt</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The PRISMA 2020 statement: an updated guideline for reporting systematic reviews</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>BMJ</sb:maintitle>\n</sb:title>\n<sb:volume-nr>372</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>n71</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0019\">Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0020\">\n<ce:label>20</ce:label>\n<sb:reference id=\"sbref0020\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.A.C.</ce:given-name>\n<ce:surname>Sterne</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Savović</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Page</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>RoB 2: a revised tool for assessing risk of bias in randomised trials</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>BMJ</sb:maintitle>\n</sb:title>\n<sb:volume-nr>366</sb:volume-nr>\n</sb:series>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>l4898</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0020\">Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0021\">\n<ce:label>21</ce:label>\n<sb:reference id=\"sbref0021\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>T.H.</ce:given-name>\n<ce:surname>Barker</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Habibi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Aromataris</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>JBI Evid Synth</sb:maintitle>\n</sb:title>\n<sb:volume-nr>22</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>378</sb:first-page>\n<sb:last-page>388</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0021\">Barker TH, Habibi N, Aromataris E, et al. The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies. JBI Evid Synth. 2024;22(3):378-388.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0022\">\n<ce:label>22</ce:label>\n<sb:reference id=\"sbref0022\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Gálvez</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Huggins</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>32</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>397</sb:first-page>\n<sb:last-page>407</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0022\">Gálvez V, Li A, Huggins C, et al. Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial. J Psychopharmacol. 2018;32(4):397-407.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0023\">\n<ce:label>23</ce:label>\n<sb:reference id=\"sbref0023\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Ochs-Ross</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zhang</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression-TRANSFORM-3</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>28</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>121</sb:first-page>\n<sb:last-page>141</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0023\">Ochs-Ross R, Daly EJ, Zhang Y, et al. Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression-TRANSFORM-3. Am J Geriatr Psychiatry. 2020;28(2):121-141.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0024\">\n<ce:label>24</ce:label>\n<sb:reference id=\"sbref0024\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Lai</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Katalinic</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Glue</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pilot dose-response trial of i.v. ketamine in treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World J Biol Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>15</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>579</sb:first-page>\n<sb:last-page>584</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0024\">Lai R, Katalinic N, Glue P, et al. Pilot dose-response trial of i.v. ketamine in treatment-resistant depression. World J Biol Psychiatry. 2014;15(7):579-584.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0025\">\n<ce:label>25</ce:label>\n<sb:reference id=\"sbref0025\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Glue</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Loo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Fam</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Nat Med</sb:maintitle>\n</sb:title>\n<sb:volume-nr>30</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>2004</sb:first-page>\n<sb:last-page>2009</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0025\">Glue P, Loo C, Fam J, et al. Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial. Nat Med. 2024;30(7):2004-2009.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0026\">\n<ce:label>26</ce:label>\n<sb:reference id=\"sbref0026\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Fernie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Currie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.S.</ce:given-name>\n<ce:surname>Perrin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Br J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>210</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>422</sb:first-page>\n<sb:last-page>428</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0026\">Fernie G, Currie J, Perrin JS, et al. Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial. Br J Psychiatry. 2017;210(6):422-428.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0027\">\n<ce:label>27</ce:label>\n<sb:reference id=\"sbref0027\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Zou</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Min</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Q.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Ren</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-A randomized, double-blind, controlled clinical study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Brain Behav</sb:maintitle>\n</sb:title>\n<sb:volume-nr>11</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:article-number>e01775</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0027\">Zou L, Min S, Chen Q, Li X, Ren L. Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-A randomized, double-blind, controlled clinical study. Brain Behav. 2021;11(1):e01775.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0028\">\n<ce:label>28</ce:label>\n<sb:reference id=\"sbref0028\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>George</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Gálvez</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>25</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>11</sb:issue-nr>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1199</sb:first-page>\n<sb:last-page>1209</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0028\">George D, Gálvez V, Martin D, et al. Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression. Am J Geriatr Psychiatry. 2017;25(11):1199-1209.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0029\">\n<ce:label>29</ce:label>\n<sb:reference id=\"sbref0029\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Wajs</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Aluisio</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Holder</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: Assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2)</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Clin Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>81</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<ce:doi>10.4088/JCP.19m12891</ce:doi>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0029\">Wajs E, Aluisio L, Holder R, et al. Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: Assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2). J Clin Psychiatry. 2020;81(3). doi:10.4088/JCP.19m12891</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0030\">\n<ce:label>30</ce:label>\n<sb:reference id=\"sbref0030\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.A.</ce:given-name>\n<ce:surname>Oughli</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.A.</ce:given-name>\n<ce:surname>Gebara</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Ciarleglio</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Intravenous ketamine for late-life treatment-resistant depression: A pilot study of tolerability, safety, clinical benefits, and effect on cognition</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>31</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>210</sb:first-page>\n<sb:last-page>221</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0030\">Oughli HA, Gebara MA, Ciarleglio A, et al. Intravenous ketamine for late-life treatment-resistant depression: A pilot study of tolerability, safety, clinical benefits, and effect on cognition. Am J Geriatr Psychiatry. 2023;31(3):210-221.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0031\">\n<ce:label>31</ce:label>\n<sb:reference id=\"sbref0031\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Zaki</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.N.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Lane</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Neuropsychopharmacology</sb:maintitle>\n</sb:title>\n<sb:volume-nr>48</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>8</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1225</sb:first-page>\n<sb:last-page>1233</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0031\">Zaki N, Chen LN, Lane R, et al. Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study. Neuropsychopharmacology. 2023;48(8):1225-1233.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0032\">\n<ce:label>32</ce:label>\n<sb:reference id=\"sbref0032\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>K.G.</ce:given-name>\n<ce:surname>Rasmussen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.W.</ce:given-name>\n<ce:surname>Lineberry</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.W.</ce:given-name>\n<ce:surname>Galardy</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Serial infusions of low-dose ketamine for major depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>27</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2013</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>444</sb:first-page>\n<sb:last-page>450</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0032\">Rasmussen KG, Lineberry TW, Galardy CW, et al. Serial infusions of low-dose ketamine for major depression. J Psychopharmacol. 2013;27(5):444-450.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0033\">\n<ce:label>33</ce:label>\n<sb:reference id=\"sbref0033\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Vanderschelden</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.A.</ce:given-name>\n<ce:surname>Gebara</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.A.</ce:given-name>\n<ce:surname>Oughli</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Change in patient-centered outcomes of psychological well-being, sleep, and suicidality following treatment with intravenous ketamine for late-life treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>38</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>e5964</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0033\">Vanderschelden B, Gebara MA, Oughli HA, et al. Change in patient-centered outcomes of psychological well-being, sleep, and suicidality following treatment with intravenous ketamine for late-life treatment-resistant depression. Int J Geriatr Psychiatry. 2023;38(7):e5964.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0034\">\n<ce:label>34</ce:label>\n<sb:reference id=\"sbref0034\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Ochs-Ross</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Wajs</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Comparison of long-term efficacy and safety of esketamine nasal spray plus oral antidepressant in younger versus older patients with treatment-resistant depression: Post-hoc analysis of SUSTAIN-2, a long-term open-label phase 3 safety and efficacy study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>30</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>541</sb:first-page>\n<sb:last-page>556</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0034\">Ochs-Ross R, Wajs E, Daly EJ, et al. Comparison of long-term efficacy and safety of esketamine nasal spray plus oral antidepressant in younger versus older patients with treatment-resistant depression: Post-hoc analysis of SUSTAIN-2, a long-term open-label phase 3 safety and efficacy study. Am J Geriatr Psychiatry. 2022;30(5):541-556.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0035\">\n<ce:label>35</ce:label>\n<sb:reference id=\"sbref0035\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Filteau</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>156</sb:volume-nr>\n</sb:series>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1</sb:first-page>\n<sb:last-page>7</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0035\">McIntyre RS, Filteau MJ, Martin L, et al. Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach. J Affect Disord. 2014;156:1-7.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0036\">\n<ce:label>36</ce:label>\n<sb:reference id=\"sbref0036\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.R.</ce:given-name>\n<ce:surname>Strawn</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.A.</ce:given-name>\n<ce:surname>Mills</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Suresh</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorder</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>159</sb:volume-nr>\n</sb:series>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>266</sb:first-page>\n<sb:last-page>273</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0036\">Strawn JR, Mills JA, Suresh V, et al. The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorder. J Psychiatr Res. 2023;159:266-273.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0037\">\n<ce:label>37</ce:label>\n<sb:reference id=\"sbref0037\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Popova</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Trivedi</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>176</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>428</sb:first-page>\n<sb:last-page>438</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0037\">Popova V, Daly EJ, Trivedi M, et al. Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study. Am J Psychiatry. 2019;176(6):428-438.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0038\">\n<ce:label>38</ce:label>\n<sb:reference id=\"sbref0038\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.F.</ce:given-name>\n<ce:surname>Grunebaum</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.C.</ce:given-name>\n<ce:surname>Galfalvy</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.H.</ce:given-name>\n<ce:surname>Choo</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine for rapid reduction of suicidal thoughts in major depression: A midazolam-controlled randomized clinical trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>175</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>327</sb:first-page>\n<sb:last-page>335</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0038\">Grunebaum MF, Galfalvy HC, Choo TH, et al. Ketamine for rapid reduction of suicidal thoughts in major depression: A midazolam-controlled randomized clinical trial. Am J Psychiatry. 2018;175(4):327-335.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0039\">\n<ce:label>39</ce:label>\n<sb:reference id=\"sbref0039\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.T.</ce:given-name>\n<ce:surname>Wilkinson</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Farmer</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.D.</ce:given-name>\n<ce:surname>Ballard</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Neuropsychopharmacology</sb:maintitle>\n</sb:title>\n<sb:volume-nr>44</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1233</sb:first-page>\n<sb:last-page>1238</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0039\">Wilkinson ST, Farmer C, Ballard ED, et al. Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant. Neuropsychopharmacology. 2019;44(7):1233-1238.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0040\">\n<ce:label>40</ce:label>\n<sb:reference id=\"sbref0040\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.L.</ce:given-name>\n<ce:surname>Naismith</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.M.</ce:given-name>\n<ce:surname>Norrie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Mowszowski</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>IB.</ce:given-name>\n<ce:surname>Hickie</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The neurobiology of depression in later-life: Clinical, neuropsychological, neuroimaging and pathophysiological features</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Prog Neurobiol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>98</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2012</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>99</sb:first-page>\n<sb:last-page>143</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0040\">Naismith SL, Norrie LM, Mowszowski L, Hickie IB. The neurobiology of depression in later-life: Clinical, neuropsychological, neuroimaging and pathophysiological features. Prog Neurobiol. 2012;98(1):99-143.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0041\">\n<ce:label>41</ce:label>\n<sb:reference id=\"sbref0041\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Bayes</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Dong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Alonzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Kabourakis</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Loo</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine treatment for depression: A model of care</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Aust N Z J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>55</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>12</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1134</sb:first-page>\n<sb:last-page>1143</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0041\">Bayes A, Dong V, Martin D, Alonzo A, Kabourakis M, Loo C. Ketamine treatment for depression: A model of care. Aust N Z J Psychiatry. 2021;55(12):1134-1143.</ce:source-text>\n</ce:bib-reference>\n</ce:bibliography-sec>",
    "output": "<ce:bibliography-sec xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"cebibsec1\">\n<?att type=\"article\"?><ce:bib-reference id=\"bib0001\">\n<ce:label>1</ce:label>\n<sb:reference id=\"sbref0001\">\n<sb:contribution>\n<sb:authors>\n<sb:collaboration>Global Burden of Disease Study 2013 Collaborators</sb:collaboration>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Lancet</sb:maintitle>\n</sb:title>\n<sb:volume-nr>386</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>9995</sb:issue-nr>\n<sb:date>20132015</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>743</sb:first-page>\n<sb:last-page>800</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0001\">Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743-800.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0002\">\n<ce:label>2</ce:label>\n<sb:reference id=\"sbref0002\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Maj</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.J.</ce:given-name>\n<ce:surname>Stein</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Parker</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The clinical characterization of the adult patient with depression aimed at personalization of management</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>19</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>269</sb:first-page>\n<sb:last-page>293</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0002\">Maj M, Stein DJ, Parker G, et al. The clinical characterization of the adult patient with depression aimed at personalization of management. World Psychiatry. 2020;19(3):269-293.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0003\">\n<ce:label>3</ce:label>\n<sb:reference id=\"sbref0003\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>CF 3rd</ce:given-name>\n<ce:surname>Reynolds</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.V.</ce:given-name>\n<ce:surname>Jeste</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.S.</ce:given-name>\n<ce:surname>Sachdev</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.G.</ce:given-name>\n<ce:surname>Blazer</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Mental health care for older adults: recent advances and new directions in clinical practice and research</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>21</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>336</sb:first-page>\n<sb:last-page>363</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0003\">Reynolds CF 3rd, Jeste DV, Sachdev PS, Blazer DG. Mental health care for older adults: recent advances and new directions in clinical practice and research. World Psychiatry. 2022;21(3):336-363.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0004\">\n<ce:label>4</ce:label>\n<sb:reference id=\"sbref0004\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zenebe</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Akele</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>W/Selassie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Necho</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Prevalence and determinants of depression among old age: a systematic review and meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Ann Gen Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>20</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>55</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0004\">Zenebe Y, Akele B, W/Selassie M, Necho M. Prevalence and determinants of depression among old age: a systematic review and meta-analysis. Ann Gen Psychiatry. 2021;20(1):55.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0005\">\n<ce:label>5</ce:label>\n<sb:reference id=\"sbref0005\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.S.</ce:given-name>\n<ce:surname>Hasin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.L.</ce:given-name>\n<ce:surname>Sarvet</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.L.</ce:given-name>\n<ce:surname>Meyers</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>JAMA Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>75</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>336</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0005\">Hasin DS, Sarvet AL, Meyers JL, et al. Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiatry. 2018;75(4):336.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0006\">\n<ce:label>6</ce:label>\n<sb:reference id=\"sbref0006\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.R.</ce:given-name>\n<ce:surname>Azar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.P.</ce:given-name>\n<ce:surname>Chopra</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.Y.</ce:given-name>\n<ce:surname>Cho</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Coakley</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>JL.</ce:given-name>\n<ce:surname>Rudolph</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Remission in major depression: results from a geriatric primary care population</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>26</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2011</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>48</sb:first-page>\n<sb:last-page>55</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0006\">Azar AR, Chopra MP, Cho LY, Coakley E, Rudolph JL. Remission in major depression: results from a geriatric primary care population. Int J Geriatr Psychiatry. 2011;26(1):48-55.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0007\">\n<ce:label>7</ce:label>\n<sb:reference id=\"sbref0007\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>U.</ce:given-name>\n<ce:surname>Klotz</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pharmacokinetics and drug metabolism in the elderly</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Drug Metab Rev</sb:maintitle>\n</sb:title>\n<sb:volume-nr>41</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2009</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>67</sb:first-page>\n<sb:last-page>76</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0007\">Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev. 2009;41(2):67-76.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0008\">\n<ce:label>8</ce:label>\n<sb:reference id=\"sbref0008\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Canadian Coalition for Seniors’ Mental</ce:given-name>\n<ce:surname>Health</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Canadian Guidelines on Prevention, Assessment and Treatment of Depression Among Older Adults</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>CCSMH; 2021</sb:maintitle>\n</sb:title>\n</sb:series>\n<sb:date>June 2021</sb:date>\n</sb:issue>\n</sb:host>\n<sb:comment>Updated</sb:comment>\n<sb:host>\n<sb:e-host>\n<ce:inter-ref id=\"interref0001\" xlink:href=\"https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf\">https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf</ce:inter-ref>\n</sb:e-host>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0008\">Canadian Coalition for Seniors’ Mental Health. Canadian Guidelines on Prevention, Assessment and Treatment of Depression Among Older Adults. CCSMH; 2021. Updated June 2021. https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0009\">\n<ce:label>9</ce:label>\n<sb:reference id=\"sbref0009\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Avasthi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Grover</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Clinical practice guidelines for management of depression in elderly</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Indian J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>60</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>Suppl 3</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>S341</sb:first-page>\n<sb:last-page>S362</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0009\">Avasthi A, Grover S. Clinical practice guidelines for management of depression in elderly. Indian J Psychiatry. 2018;60(Suppl 3):S341-S362.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0010\">\n<ce:label>10</ce:label>\n<sb:reference id=\"sbref0010\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Baba</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Kito</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Nukariya</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Guidelines for diagnosis and treatment of depression in older adults: A report from the Japanese Society of mood disorders</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Psychiatry Clin Neurosci</sb:maintitle>\n</sb:title>\n<sb:volume-nr>76</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>222</sb:first-page>\n<sb:last-page>234</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0010\">Baba H, Kito S, Nukariya K, et al. Guidelines for diagnosis and treatment of depression in older adults: A report from the Japanese Society of mood disorders. Psychiatry Clin Neurosci. 2022;76(6):222-234.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0011\">\n<ce:label>11</ce:label>\n<sb:reference id=\"sbref0011\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Rosenblat</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.B.</ce:given-name>\n<ce:surname>Nemeroff</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>178</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>383</sb:first-page>\n<sb:last-page>399</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0011\">McIntyre RS, Rosenblat JD, Nemeroff CB, et al. Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation. Am J Psychiatry. 2021;178(5):383-399.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0012\">\n<ce:label>12</ce:label>\n<sb:reference id=\"sbref0012\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.C.H.</ce:given-name>\n<ce:surname>Cheng</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.E.</ce:given-name>\n<ce:surname>Dri</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Ballum</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effects of ketamine and esketamine on measures of quality of life in major depressive disorder and treatment-resistant depression: A systematic review</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>382</sb:volume-nr>\n</sb:series>\n<sb:date>2025</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>438</sb:first-page>\n<sb:last-page>442</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0012\">Cheng MCH, Dri CE, Ballum H, et al. The effects of ketamine and esketamine on measures of quality of life in major depressive disorder and treatment-resistant depression: A systematic review. J Affect Disord. 2025;382:438-442.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0013\">\n<ce:label>13</ce:label>\n<sb:reference id=\"sbref0013\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Di Vincenzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.B.</ce:given-name>\n<ce:surname>Rodrigues</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Safety, tolerability, and real-world effectiveness of intravenous ketamine in older adults with treatment-resistant depression: A case series</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>29</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>9</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>899</sb:first-page>\n<sb:last-page>913</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0013\">Lipsitz O, Di Vincenzo JD, Rodrigues NB, et al. Safety, tolerability, and real-world effectiveness of intravenous ketamine in older adults with treatment-resistant depression: A case series. Am J Geriatr Psychiatry. 2021;29(9):899-913.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0014\">\n<ce:label>14</ce:label>\n<sb:reference id=\"sbref0014\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>I.P.</ce:given-name>\n<ce:surname>Carvalho</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.M.W.</ce:given-name>\n<ce:surname>Lui</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>276</sb:volume-nr>\n</sb:series>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>576</sb:first-page>\n<sb:last-page>584</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0014\">McIntyre RS, Carvalho IP, Lui LMW, et al. The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis. J Affect Disord. 2020;276:576-584.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0015\">\n<ce:label>15</ce:label>\n<sb:reference id=\"sbref0015\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Lee</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Syeda</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.A.</ce:given-name>\n<ce:surname>Maruschak</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>A new perspective on the anti-suicide effects with ketamine treatment: A procognitive effect</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Clin Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>36</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2016</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>50</sb:first-page>\n<sb:last-page>56</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0015\">Lee Y, Syeda K, Maruschak NA, et al. A new perspective on the anti-suicide effects with ketamine treatment: A procognitive effect. J Clin Psychopharmacol. 2016;36(1):50-56.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0016\">\n<ce:label>16</ce:label>\n<sb:reference id=\"sbref0016\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Xiong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Chen-Li</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>134</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>57</sb:first-page>\n<sb:last-page>68</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0016\">Xiong J, Lipsitz O, Chen-Li D, et al. The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis. J Psychiatr Res. 2021;134:57-68.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0017\">\n<ce:label>17</ce:label>\n<sb:reference id=\"sbref0017\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Gupta</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Dhar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Patadia</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>A systematic review of ketamine for the treatment of depression among older adults</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int Psychogeriatr</sb:maintitle>\n</sb:title>\n<sb:volume-nr>33</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>179</sb:first-page>\n<sb:last-page>191</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0017\">Gupta A, Dhar R, Patadia P, et al. A systematic review of ketamine for the treatment of depression among older adults. Int Psychogeriatr. 2021;33(2):179-191.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0018\">\n<ce:label>18</ce:label>\n<sb:reference id=\"sbref0018\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Di Vincenzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Siegel</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>137</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>232</sb:first-page>\n<sb:last-page>241</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0018\">Di Vincenzo JD, Siegel A, Lipsitz O, et al. The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review. J Psychiatr Res. 2021;137:232-241.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0019\">\n<ce:label>19</ce:label>\n<sb:reference id=\"sbref0019\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Page</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.E.</ce:given-name>\n<ce:surname>McKenzie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.M.</ce:given-name>\n<ce:surname>Bossuyt</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The PRISMA 2020 statement: an updated guideline for reporting systematic reviews</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>BMJ</sb:maintitle>\n</sb:title>\n<sb:volume-nr>372</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>n71</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0019\">Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0020\">\n<ce:label>20</ce:label>\n<sb:reference id=\"sbref0020\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.A.C.</ce:given-name>\n<ce:surname>Sterne</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Savović</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Page</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>RoB 2: a revised tool for assessing risk of bias in randomised trials</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>BMJ</sb:maintitle>\n</sb:title>\n<sb:volume-nr>366</sb:volume-nr>\n</sb:series>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>l4898</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0020\">Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0021\">\n<ce:label>21</ce:label>\n<sb:reference id=\"sbref0021\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>T.H.</ce:given-name>\n<ce:surname>Barker</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Habibi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Aromataris</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>JBI Evid Synth</sb:maintitle>\n</sb:title>\n<sb:volume-nr>22</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>378</sb:first-page>\n<sb:last-page>388</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0021\">Barker TH, Habibi N, Aromataris E, et al. The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies. JBI Evid Synth. 2024;22(3):378-388.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0022\">\n<ce:label>22</ce:label>\n<sb:reference id=\"sbref0022\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Gálvez</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Huggins</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>32</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>397</sb:first-page>\n<sb:last-page>407</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0022\">Gálvez V, Li A, Huggins C, et al. Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial. J Psychopharmacol. 2018;32(4):397-407.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0023\">\n<ce:label>23</ce:label>\n<sb:reference id=\"sbref0023\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Ochs-Ross</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zhang</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression-TRANSFORM-3</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>28</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>121</sb:first-page>\n<sb:last-page>141</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0023\">Ochs-Ross R, Daly EJ, Zhang Y, et al. Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression-TRANSFORM-3. Am J Geriatr Psychiatry. 2020;28(2):121-141.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0024\">\n<ce:label>24</ce:label>\n<sb:reference id=\"sbref0024\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Lai</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Katalinic</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Glue</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pilot dose-response trial of i.v. ketamine in treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World J Biol Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>15</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>579</sb:first-page>\n<sb:last-page>584</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0024\">Lai R, Katalinic N, Glue P, et al. Pilot dose-response trial of i.v. ketamine in treatment-resistant depression. World J Biol Psychiatry. 2014;15(7):579-584.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0025\">\n<ce:label>25</ce:label>\n<sb:reference id=\"sbref0025\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Glue</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Loo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Fam</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Nat Med</sb:maintitle>\n</sb:title>\n<sb:volume-nr>30</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>2004</sb:first-page>\n<sb:last-page>2009</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0025\">Glue P, Loo C, Fam J, et al. Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial. Nat Med. 2024;30(7):2004-2009.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0026\">\n<ce:label>26</ce:label>\n<sb:reference id=\"sbref0026\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Fernie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Currie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.S.</ce:given-name>\n<ce:surname>Perrin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Br J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>210</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>422</sb:first-page>\n<sb:last-page>428</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0026\">Fernie G, Currie J, Perrin JS, et al. Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial. Br J Psychiatry. 2017;210(6):422-428.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0027\">\n<ce:label>27</ce:label>\n<sb:reference id=\"sbref0027\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Zou</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Min</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Q.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Ren</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-A randomized, double-blind, controlled clinical study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Brain Behav</sb:maintitle>\n</sb:title>\n<sb:volume-nr>11</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:article-number>e01775</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0027\">Zou L, Min S, Chen Q, Li X, Ren L. Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-A randomized, double-blind, controlled clinical study. Brain Behav. 2021;11(1):e01775.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0028\">\n<ce:label>28</ce:label>\n<sb:reference id=\"sbref0028\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>George</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Gálvez</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>25</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>11</sb:issue-nr>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1199</sb:first-page>\n<sb:last-page>1209</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0028\">George D, Gálvez V, Martin D, et al. Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression. Am J Geriatr Psychiatry. 2017;25(11):1199-1209.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0029\">\n<ce:label>29</ce:label>\n<sb:reference id=\"sbref0029\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Wajs</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Aluisio</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Holder</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: Assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2)</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Clin Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>81</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<ce:doi>10.4088/JCP.19m12891</ce:doi>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0029\">Wajs E, Aluisio L, Holder R, et al. Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: Assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2). J Clin Psychiatry. 2020;81(3). doi:10.4088/JCP.19m12891</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0030\">\n<ce:label>30</ce:label>\n<sb:reference id=\"sbref0030\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.A.</ce:given-name>\n<ce:surname>Oughli</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.A.</ce:given-name>\n<ce:surname>Gebara</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Ciarleglio</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Intravenous ketamine for late-life treatment-resistant depression: A pilot study of tolerability, safety, clinical benefits, and effect on cognition</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>31</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>210</sb:first-page>\n<sb:last-page>221</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0030\">Oughli HA, Gebara MA, Ciarleglio A, et al. Intravenous ketamine for late-life treatment-resistant depression: A pilot study of tolerability, safety, clinical benefits, and effect on cognition. Am J Geriatr Psychiatry. 2023;31(3):210-221.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0031\">\n<ce:label>31</ce:label>\n<sb:reference id=\"sbref0031\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Zaki</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.N.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Lane</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Neuropsychopharmacology</sb:maintitle>\n</sb:title>\n<sb:volume-nr>48</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>8</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1225</sb:first-page>\n<sb:last-page>1233</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0031\">Zaki N, Chen LN, Lane R, et al. Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study. Neuropsychopharmacology. 2023;48(8):1225-1233.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0032\">\n<ce:label>32</ce:label>\n<sb:reference id=\"sbref0032\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>K.G.</ce:given-name>\n<ce:surname>Rasmussen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.W.</ce:given-name>\n<ce:surname>Lineberry</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.W.</ce:given-name>\n<ce:surname>Galardy</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Serial infusions of low-dose ketamine for major depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>27</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2013</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>444</sb:first-page>\n<sb:last-page>450</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0032\">Rasmussen KG, Lineberry TW, Galardy CW, et al. Serial infusions of low-dose ketamine for major depression. J Psychopharmacol. 2013;27(5):444-450.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0033\">\n<ce:label>33</ce:label>\n<sb:reference id=\"sbref0033\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Vanderschelden</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.A.</ce:given-name>\n<ce:surname>Gebara</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.A.</ce:given-name>\n<ce:surname>Oughli</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Change in patient-centered outcomes of psychological well-being, sleep, and suicidality following treatment with intravenous ketamine for late-life treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>38</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>e5964</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0033\">Vanderschelden B, Gebara MA, Oughli HA, et al. Change in patient-centered outcomes of psychological well-being, sleep, and suicidality following treatment with intravenous ketamine for late-life treatment-resistant depression. Int J Geriatr Psychiatry. 2023;38(7):e5964.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0034\">\n<ce:label>34</ce:label>\n<sb:reference id=\"sbref0034\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Ochs-Ross</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Wajs</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Comparison of long-term efficacy and safety of esketamine nasal spray plus oral antidepressant in younger versus older patients with treatment-resistant depression: Post-hoc analysis of SUSTAIN-2, a long-term open-label phase 3 safety and efficacy study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>30</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>541</sb:first-page>\n<sb:last-page>556</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0034\">Ochs-Ross R, Wajs E, Daly EJ, et al. Comparison of long-term efficacy and safety of esketamine nasal spray plus oral antidepressant in younger versus older patients with treatment-resistant depression: Post-hoc analysis of SUSTAIN-2, a long-term open-label phase 3 safety and efficacy study. Am J Geriatr Psychiatry. 2022;30(5):541-556.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0035\">\n<ce:label>35</ce:label>\n<sb:reference id=\"sbref0035\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Filteau</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>156</sb:volume-nr>\n</sb:series>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1</sb:first-page>\n<sb:last-page>7</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0035\">McIntyre RS, Filteau MJ, Martin L, et al. Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach. J Affect Disord. 2014;156:1-7.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0036\">\n<ce:label>36</ce:label>\n<sb:reference id=\"sbref0036\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.R.</ce:given-name>\n<ce:surname>Strawn</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.A.</ce:given-name>\n<ce:surname>Mills</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Suresh</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorder</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>159</sb:volume-nr>\n</sb:series>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>266</sb:first-page>\n<sb:last-page>273</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0036\">Strawn JR, Mills JA, Suresh V, et al. The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorder. J Psychiatr Res. 2023;159:266-273.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0037\">\n<ce:label>37</ce:label>\n<sb:reference id=\"sbref0037\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Popova</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Trivedi</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>176</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>428</sb:first-page>\n<sb:last-page>438</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0037\">Popova V, Daly EJ, Trivedi M, et al. Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study. Am J Psychiatry. 2019;176(6):428-438.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0038\">\n<ce:label>38</ce:label>\n<sb:reference id=\"sbref0038\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.F.</ce:given-name>\n<ce:surname>Grunebaum</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.C.</ce:given-name>\n<ce:surname>Galfalvy</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.H.</ce:given-name>\n<ce:surname>Choo</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine for rapid reduction of suicidal thoughts in major depression: A midazolam-controlled randomized clinical trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>175</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>327</sb:first-page>\n<sb:last-page>335</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0038\">Grunebaum MF, Galfalvy HC, Choo TH, et al. Ketamine for rapid reduction of suicidal thoughts in major depression: A midazolam-controlled randomized clinical trial. Am J Psychiatry. 2018;175(4):327-335.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0039\">\n<ce:label>39</ce:label>\n<sb:reference id=\"sbref0039\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.T.</ce:given-name>\n<ce:surname>Wilkinson</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Farmer</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.D.</ce:given-name>\n<ce:surname>Ballard</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Neuropsychopharmacology</sb:maintitle>\n</sb:title>\n<sb:volume-nr>44</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1233</sb:first-page>\n<sb:last-page>1238</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0039\">Wilkinson ST, Farmer C, Ballard ED, et al. Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant. Neuropsychopharmacology. 2019;44(7):1233-1238.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0040\">\n<ce:label>40</ce:label>\n<sb:reference id=\"sbref0040\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.L.</ce:given-name>\n<ce:surname>Naismith</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.M.</ce:given-name>\n<ce:surname>Norrie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Mowszowski</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>IB.</ce:given-name>\n<ce:surname>Hickie</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The neurobiology of depression in later-life: Clinical, neuropsychological, neuroimaging and pathophysiological features</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Prog Neurobiol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>98</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2012</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>99</sb:first-page>\n<sb:last-page>143</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0040\">Naismith SL, Norrie LM, Mowszowski L, Hickie IB. The neurobiology of depression in later-life: Clinical, neuropsychological, neuroimaging and pathophysiological features. Prog Neurobiol. 2012;98(1):99-143.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0041\">\n<ce:label>41</ce:label>\n<sb:reference id=\"sbref0041\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Bayes</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Dong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Alonzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Kabourakis</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Loo</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine treatment for depression: A model of care</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Aust N Z J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>55</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>12</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1134</sb:first-page>\n<sb:last-page>1143</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0041\">Bayes A, Dong V, Martin D, Alonzo A, Kabourakis M, Loo C. Ketamine treatment for depression: A model of care. Aust N Z J Psychiatry. 2021;55(12):1134-1143.</ce:source-text>\n</ce:bib-reference>\n</ce:bibliography-sec>",
    "error_message": "All bibliographic references within 'ce:bibliography' must be referred to.",
    "error_position": "1005:63",
    "error_id": "IDS503a",
    "folder_name": "AMGP2541"
  },
  {
    "input": "<ce:bibliography-sec xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"cebibsec1\">\n<?att type=\"article\"?><ce:bib-reference id=\"bib0001\">\n<ce:label>1</ce:label>\n<sb:reference id=\"sbref0001\">\n<sb:contribution>\n<sb:authors>\n<sb:collaboration>Global Burden of Disease Study 2013 Collaborators</sb:collaboration>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Lancet</sb:maintitle>\n</sb:title>\n<sb:volume-nr>386</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>9995</sb:issue-nr>\n<sb:date>20132015</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>743</sb:first-page>\n<sb:last-page>800</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0001\">Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743-800.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0002\">\n<ce:label>2</ce:label>\n<sb:reference id=\"sbref0002\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Maj</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.J.</ce:given-name>\n<ce:surname>Stein</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Parker</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The clinical characterization of the adult patient with depression aimed at personalization of management</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>19</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>269</sb:first-page>\n<sb:last-page>293</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0002\">Maj M, Stein DJ, Parker G, et al. The clinical characterization of the adult patient with depression aimed at personalization of management. World Psychiatry. 2020;19(3):269-293.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0003\">\n<ce:label>3</ce:label>\n<sb:reference id=\"sbref0003\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>CF 3rd</ce:given-name>\n<ce:surname>Reynolds</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.V.</ce:given-name>\n<ce:surname>Jeste</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.S.</ce:given-name>\n<ce:surname>Sachdev</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.G.</ce:given-name>\n<ce:surname>Blazer</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Mental health care for older adults: recent advances and new directions in clinical practice and research</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>21</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>336</sb:first-page>\n<sb:last-page>363</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0003\">Reynolds CF 3rd, Jeste DV, Sachdev PS, Blazer DG. Mental health care for older adults: recent advances and new directions in clinical practice and research. World Psychiatry. 2022;21(3):336-363.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0004\">\n<ce:label>4</ce:label>\n<sb:reference id=\"sbref0004\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zenebe</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Akele</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>W/Selassie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Necho</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Prevalence and determinants of depression among old age: a systematic review and meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Ann Gen Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>20</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>55</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0004\">Zenebe Y, Akele B, W/Selassie M, Necho M. Prevalence and determinants of depression among old age: a systematic review and meta-analysis. Ann Gen Psychiatry. 2021;20(1):55.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0005\">\n<ce:label>5</ce:label>\n<sb:reference id=\"sbref0005\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.S.</ce:given-name>\n<ce:surname>Hasin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.L.</ce:given-name>\n<ce:surname>Sarvet</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.L.</ce:given-name>\n<ce:surname>Meyers</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>JAMA Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>75</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>336</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0005\">Hasin DS, Sarvet AL, Meyers JL, et al. Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiatry. 2018;75(4):336.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0006\">\n<ce:label>6</ce:label>\n<sb:reference id=\"sbref0006\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.R.</ce:given-name>\n<ce:surname>Azar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.P.</ce:given-name>\n<ce:surname>Chopra</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.Y.</ce:given-name>\n<ce:surname>Cho</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Coakley</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>JL.</ce:given-name>\n<ce:surname>Rudolph</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Remission in major depression: results from a geriatric primary care population</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>26</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2011</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>48</sb:first-page>\n<sb:last-page>55</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0006\">Azar AR, Chopra MP, Cho LY, Coakley E, Rudolph JL. Remission in major depression: results from a geriatric primary care population. Int J Geriatr Psychiatry. 2011;26(1):48-55.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0007\">\n<ce:label>7</ce:label>\n<sb:reference id=\"sbref0007\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>U.</ce:given-name>\n<ce:surname>Klotz</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pharmacokinetics and drug metabolism in the elderly</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Drug Metab Rev</sb:maintitle>\n</sb:title>\n<sb:volume-nr>41</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2009</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>67</sb:first-page>\n<sb:last-page>76</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0007\">Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev. 2009;41(2):67-76.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0008\">\n<ce:label>8</ce:label>\n<sb:reference id=\"sbref0008\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Canadian Coalition for Seniors’ Mental</ce:given-name>\n<ce:surname>Health</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Canadian Guidelines on Prevention, Assessment and Treatment of Depression Among Older Adults</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>CCSMH; 2021</sb:maintitle>\n</sb:title>\n</sb:series>\n<sb:date>June 2021</sb:date>\n</sb:issue>\n</sb:host>\n<sb:comment>Updated</sb:comment>\n<sb:host>\n<sb:e-host>\n<ce:inter-ref id=\"interref0001\" xlink:href=\"https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf\">https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf</ce:inter-ref>\n</sb:e-host>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0008\">Canadian Coalition for Seniors’ Mental Health. Canadian Guidelines on Prevention, Assessment and Treatment of Depression Among Older Adults. CCSMH; 2021. Updated June 2021. https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0009\">\n<ce:label>9</ce:label>\n<sb:reference id=\"sbref0009\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Avasthi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Grover</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Clinical practice guidelines for management of depression in elderly</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Indian J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>60</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>Suppl 3</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>S341</sb:first-page>\n<sb:last-page>S362</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0009\">Avasthi A, Grover S. Clinical practice guidelines for management of depression in elderly. Indian J Psychiatry. 2018;60(Suppl 3):S341-S362.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0010\">\n<ce:label>10</ce:label>\n<sb:reference id=\"sbref0010\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Baba</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Kito</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Nukariya</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Guidelines for diagnosis and treatment of depression in older adults: A report from the Japanese Society of mood disorders</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Psychiatry Clin Neurosci</sb:maintitle>\n</sb:title>\n<sb:volume-nr>76</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>222</sb:first-page>\n<sb:last-page>234</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0010\">Baba H, Kito S, Nukariya K, et al. Guidelines for diagnosis and treatment of depression in older adults: A report from the Japanese Society of mood disorders. Psychiatry Clin Neurosci. 2022;76(6):222-234.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0011\">\n<ce:label>11</ce:label>\n<sb:reference id=\"sbref0011\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Rosenblat</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.B.</ce:given-name>\n<ce:surname>Nemeroff</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>178</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>383</sb:first-page>\n<sb:last-page>399</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0011\">McIntyre RS, Rosenblat JD, Nemeroff CB, et al. Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation. Am J Psychiatry. 2021;178(5):383-399.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0012\">\n<ce:label>12</ce:label>\n<sb:reference id=\"sbref0012\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.C.H.</ce:given-name>\n<ce:surname>Cheng</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.E.</ce:given-name>\n<ce:surname>Dri</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Ballum</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effects of ketamine and esketamine on measures of quality of life in major depressive disorder and treatment-resistant depression: A systematic review</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>382</sb:volume-nr>\n</sb:series>\n<sb:date>2025</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>438</sb:first-page>\n<sb:last-page>442</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0012\">Cheng MCH, Dri CE, Ballum H, et al. The effects of ketamine and esketamine on measures of quality of life in major depressive disorder and treatment-resistant depression: A systematic review. J Affect Disord. 2025;382:438-442.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0013\">\n<ce:label>13</ce:label>\n<sb:reference id=\"sbref0013\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Di Vincenzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.B.</ce:given-name>\n<ce:surname>Rodrigues</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Safety, tolerability, and real-world effectiveness of intravenous ketamine in older adults with treatment-resistant depression: A case series</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>29</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>9</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>899</sb:first-page>\n<sb:last-page>913</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0013\">Lipsitz O, Di Vincenzo JD, Rodrigues NB, et al. Safety, tolerability, and real-world effectiveness of intravenous ketamine in older adults with treatment-resistant depression: A case series. Am J Geriatr Psychiatry. 2021;29(9):899-913.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0014\">\n<ce:label>14</ce:label>\n<sb:reference id=\"sbref0014\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>I.P.</ce:given-name>\n<ce:surname>Carvalho</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.M.W.</ce:given-name>\n<ce:surname>Lui</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>276</sb:volume-nr>\n</sb:series>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>576</sb:first-page>\n<sb:last-page>584</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0014\">McIntyre RS, Carvalho IP, Lui LMW, et al. The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis. J Affect Disord. 2020;276:576-584.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0015\">\n<ce:label>15</ce:label>\n<sb:reference id=\"sbref0015\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Lee</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Syeda</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.A.</ce:given-name>\n<ce:surname>Maruschak</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>A new perspective on the anti-suicide effects with ketamine treatment: A procognitive effect</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Clin Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>36</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2016</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>50</sb:first-page>\n<sb:last-page>56</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0015\">Lee Y, Syeda K, Maruschak NA, et al. A new perspective on the anti-suicide effects with ketamine treatment: A procognitive effect. J Clin Psychopharmacol. 2016;36(1):50-56.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0016\">\n<ce:label>16</ce:label>\n<sb:reference id=\"sbref0016\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Xiong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Chen-Li</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>134</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>57</sb:first-page>\n<sb:last-page>68</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0016\">Xiong J, Lipsitz O, Chen-Li D, et al. The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis. J Psychiatr Res. 2021;134:57-68.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0017\">\n<ce:label>17</ce:label>\n<sb:reference id=\"sbref0017\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Gupta</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Dhar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Patadia</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>A systematic review of ketamine for the treatment of depression among older adults</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int Psychogeriatr</sb:maintitle>\n</sb:title>\n<sb:volume-nr>33</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>179</sb:first-page>\n<sb:last-page>191</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0017\">Gupta A, Dhar R, Patadia P, et al. A systematic review of ketamine for the treatment of depression among older adults. Int Psychogeriatr. 2021;33(2):179-191.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0018\">\n<ce:label>18</ce:label>\n<sb:reference id=\"sbref0018\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Di Vincenzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Siegel</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>137</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>232</sb:first-page>\n<sb:last-page>241</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0018\">Di Vincenzo JD, Siegel A, Lipsitz O, et al. The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review. J Psychiatr Res. 2021;137:232-241.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0019\">\n<ce:label>19</ce:label>\n<sb:reference id=\"sbref0019\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Page</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.E.</ce:given-name>\n<ce:surname>McKenzie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.M.</ce:given-name>\n<ce:surname>Bossuyt</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The PRISMA 2020 statement: an updated guideline for reporting systematic reviews</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>BMJ</sb:maintitle>\n</sb:title>\n<sb:volume-nr>372</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>n71</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0019\">Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0020\">\n<ce:label>20</ce:label>\n<sb:reference id=\"sbref0020\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.A.C.</ce:given-name>\n<ce:surname>Sterne</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Savović</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Page</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>RoB 2: a revised tool for assessing risk of bias in randomised trials</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>BMJ</sb:maintitle>\n</sb:title>\n<sb:volume-nr>366</sb:volume-nr>\n</sb:series>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>l4898</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0020\">Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0021\">\n<ce:label>21</ce:label>\n<sb:reference id=\"sbref0021\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>T.H.</ce:given-name>\n<ce:surname>Barker</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Habibi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Aromataris</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>JBI Evid Synth</sb:maintitle>\n</sb:title>\n<sb:volume-nr>22</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>378</sb:first-page>\n<sb:last-page>388</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0021\">Barker TH, Habibi N, Aromataris E, et al. The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies. JBI Evid Synth. 2024;22(3):378-388.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0022\">\n<ce:label>22</ce:label>\n<sb:reference id=\"sbref0022\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Gálvez</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Huggins</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>32</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>397</sb:first-page>\n<sb:last-page>407</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0022\">Gálvez V, Li A, Huggins C, et al. Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial. J Psychopharmacol. 2018;32(4):397-407.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0023\">\n<ce:label>23</ce:label>\n<sb:reference id=\"sbref0023\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Ochs-Ross</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zhang</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression-TRANSFORM-3</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>28</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>121</sb:first-page>\n<sb:last-page>141</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0023\">Ochs-Ross R, Daly EJ, Zhang Y, et al. Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression-TRANSFORM-3. Am J Geriatr Psychiatry. 2020;28(2):121-141.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0024\">\n<ce:label>24</ce:label>\n<sb:reference id=\"sbref0024\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Lai</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Katalinic</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Glue</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pilot dose-response trial of i.v. ketamine in treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World J Biol Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>15</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>579</sb:first-page>\n<sb:last-page>584</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0024\">Lai R, Katalinic N, Glue P, et al. Pilot dose-response trial of i.v. ketamine in treatment-resistant depression. World J Biol Psychiatry. 2014;15(7):579-584.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0025\">\n<ce:label>25</ce:label>\n<sb:reference id=\"sbref0025\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Glue</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Loo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Fam</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Nat Med</sb:maintitle>\n</sb:title>\n<sb:volume-nr>30</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>2004</sb:first-page>\n<sb:last-page>2009</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0025\">Glue P, Loo C, Fam J, et al. Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial. Nat Med. 2024;30(7):2004-2009.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0026\">\n<ce:label>26</ce:label>\n<sb:reference id=\"sbref0026\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Fernie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Currie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.S.</ce:given-name>\n<ce:surname>Perrin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Br J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>210</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>422</sb:first-page>\n<sb:last-page>428</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0026\">Fernie G, Currie J, Perrin JS, et al. Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial. Br J Psychiatry. 2017;210(6):422-428.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0027\">\n<ce:label>27</ce:label>\n<sb:reference id=\"sbref0027\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Zou</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Min</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Q.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Ren</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-A randomized, double-blind, controlled clinical study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Brain Behav</sb:maintitle>\n</sb:title>\n<sb:volume-nr>11</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:article-number>e01775</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0027\">Zou L, Min S, Chen Q, Li X, Ren L. Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-A randomized, double-blind, controlled clinical study. Brain Behav. 2021;11(1):e01775.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0028\">\n<ce:label>28</ce:label>\n<sb:reference id=\"sbref0028\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>George</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Gálvez</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>25</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>11</sb:issue-nr>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1199</sb:first-page>\n<sb:last-page>1209</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0028\">George D, Gálvez V, Martin D, et al. Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression. Am J Geriatr Psychiatry. 2017;25(11):1199-1209.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0029\">\n<ce:label>29</ce:label>\n<sb:reference id=\"sbref0029\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Wajs</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Aluisio</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Holder</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: Assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2)</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Clin Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>81</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<ce:doi>10.4088/JCP.19m12891</ce:doi>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0029\">Wajs E, Aluisio L, Holder R, et al. Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: Assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2). J Clin Psychiatry. 2020;81(3). doi:10.4088/JCP.19m12891</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0030\">\n<ce:label>30</ce:label>\n<sb:reference id=\"sbref0030\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.A.</ce:given-name>\n<ce:surname>Oughli</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.A.</ce:given-name>\n<ce:surname>Gebara</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Ciarleglio</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Intravenous ketamine for late-life treatment-resistant depression: A pilot study of tolerability, safety, clinical benefits, and effect on cognition</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>31</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>210</sb:first-page>\n<sb:last-page>221</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0030\">Oughli HA, Gebara MA, Ciarleglio A, et al. Intravenous ketamine for late-life treatment-resistant depression: A pilot study of tolerability, safety, clinical benefits, and effect on cognition. Am J Geriatr Psychiatry. 2023;31(3):210-221.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0031\">\n<ce:label>31</ce:label>\n<sb:reference id=\"sbref0031\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Zaki</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.N.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Lane</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Neuropsychopharmacology</sb:maintitle>\n</sb:title>\n<sb:volume-nr>48</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>8</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1225</sb:first-page>\n<sb:last-page>1233</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0031\">Zaki N, Chen LN, Lane R, et al. Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study. Neuropsychopharmacology. 2023;48(8):1225-1233.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0032\">\n<ce:label>32</ce:label>\n<sb:reference id=\"sbref0032\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>K.G.</ce:given-name>\n<ce:surname>Rasmussen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.W.</ce:given-name>\n<ce:surname>Lineberry</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.W.</ce:given-name>\n<ce:surname>Galardy</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Serial infusions of low-dose ketamine for major depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>27</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2013</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>444</sb:first-page>\n<sb:last-page>450</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0032\">Rasmussen KG, Lineberry TW, Galardy CW, et al. Serial infusions of low-dose ketamine for major depression. J Psychopharmacol. 2013;27(5):444-450.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0033\">\n<ce:label>33</ce:label>\n<sb:reference id=\"sbref0033\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Vanderschelden</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.A.</ce:given-name>\n<ce:surname>Gebara</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.A.</ce:given-name>\n<ce:surname>Oughli</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Change in patient-centered outcomes of psychological well-being, sleep, and suicidality following treatment with intravenous ketamine for late-life treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>38</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>e5964</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0033\">Vanderschelden B, Gebara MA, Oughli HA, et al. Change in patient-centered outcomes of psychological well-being, sleep, and suicidality following treatment with intravenous ketamine for late-life treatment-resistant depression. Int J Geriatr Psychiatry. 2023;38(7):e5964.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0034\">\n<ce:label>34</ce:label>\n<sb:reference id=\"sbref0034\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Ochs-Ross</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Wajs</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Comparison of long-term efficacy and safety of esketamine nasal spray plus oral antidepressant in younger versus older patients with treatment-resistant depression: Post-hoc analysis of SUSTAIN-2, a long-term open-label phase 3 safety and efficacy study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>30</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>541</sb:first-page>\n<sb:last-page>556</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0034\">Ochs-Ross R, Wajs E, Daly EJ, et al. Comparison of long-term efficacy and safety of esketamine nasal spray plus oral antidepressant in younger versus older patients with treatment-resistant depression: Post-hoc analysis of SUSTAIN-2, a long-term open-label phase 3 safety and efficacy study. Am J Geriatr Psychiatry. 2022;30(5):541-556.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0035\">\n<ce:label>35</ce:label>\n<sb:reference id=\"sbref0035\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Filteau</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>156</sb:volume-nr>\n</sb:series>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1</sb:first-page>\n<sb:last-page>7</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0035\">McIntyre RS, Filteau MJ, Martin L, et al. Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach. J Affect Disord. 2014;156:1-7.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0036\">\n<ce:label>36</ce:label>\n<sb:reference id=\"sbref0036\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.R.</ce:given-name>\n<ce:surname>Strawn</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.A.</ce:given-name>\n<ce:surname>Mills</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Suresh</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorder</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>159</sb:volume-nr>\n</sb:series>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>266</sb:first-page>\n<sb:last-page>273</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0036\">Strawn JR, Mills JA, Suresh V, et al. The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorder. J Psychiatr Res. 2023;159:266-273.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0037\">\n<ce:label>37</ce:label>\n<sb:reference id=\"sbref0037\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Popova</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Trivedi</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>176</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>428</sb:first-page>\n<sb:last-page>438</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0037\">Popova V, Daly EJ, Trivedi M, et al. Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study. Am J Psychiatry. 2019;176(6):428-438.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0038\">\n<ce:label>38</ce:label>\n<sb:reference id=\"sbref0038\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.F.</ce:given-name>\n<ce:surname>Grunebaum</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.C.</ce:given-name>\n<ce:surname>Galfalvy</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.H.</ce:given-name>\n<ce:surname>Choo</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine for rapid reduction of suicidal thoughts in major depression: A midazolam-controlled randomized clinical trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>175</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>327</sb:first-page>\n<sb:last-page>335</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0038\">Grunebaum MF, Galfalvy HC, Choo TH, et al. Ketamine for rapid reduction of suicidal thoughts in major depression: A midazolam-controlled randomized clinical trial. Am J Psychiatry. 2018;175(4):327-335.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0039\">\n<ce:label>39</ce:label>\n<sb:reference id=\"sbref0039\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.T.</ce:given-name>\n<ce:surname>Wilkinson</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Farmer</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.D.</ce:given-name>\n<ce:surname>Ballard</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Neuropsychopharmacology</sb:maintitle>\n</sb:title>\n<sb:volume-nr>44</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1233</sb:first-page>\n<sb:last-page>1238</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0039\">Wilkinson ST, Farmer C, Ballard ED, et al. Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant. Neuropsychopharmacology. 2019;44(7):1233-1238.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0040\">\n<ce:label>40</ce:label>\n<sb:reference id=\"sbref0040\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.L.</ce:given-name>\n<ce:surname>Naismith</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.M.</ce:given-name>\n<ce:surname>Norrie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Mowszowski</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>IB.</ce:given-name>\n<ce:surname>Hickie</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The neurobiology of depression in later-life: Clinical, neuropsychological, neuroimaging and pathophysiological features</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Prog Neurobiol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>98</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2012</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>99</sb:first-page>\n<sb:last-page>143</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0040\">Naismith SL, Norrie LM, Mowszowski L, Hickie IB. The neurobiology of depression in later-life: Clinical, neuropsychological, neuroimaging and pathophysiological features. Prog Neurobiol. 2012;98(1):99-143.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0041\">\n<ce:label>41</ce:label>\n<sb:reference id=\"sbref0041\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Bayes</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Dong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Alonzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Kabourakis</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Loo</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine treatment for depression: A model of care</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Aust N Z J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>55</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>12</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1134</sb:first-page>\n<sb:last-page>1143</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0041\">Bayes A, Dong V, Martin D, Alonzo A, Kabourakis M, Loo C. Ketamine treatment for depression: A model of care. Aust N Z J Psychiatry. 2021;55(12):1134-1143.</ce:source-text>\n</ce:bib-reference>\n</ce:bibliography-sec>",
    "output": "<ce:bibliography-sec xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"cebibsec1\">\n<?att type=\"article\"?><ce:bib-reference id=\"bib0001\">\n<ce:label>1</ce:label>\n<sb:reference id=\"sbref0001\">\n<sb:contribution>\n<sb:authors>\n<sb:collaboration>Global Burden of Disease Study 2013 Collaborators</sb:collaboration>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Lancet</sb:maintitle>\n</sb:title>\n<sb:volume-nr>386</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>9995</sb:issue-nr>\n<sb:date>20132015</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>743</sb:first-page>\n<sb:last-page>800</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0001\">Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743-800.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0002\">\n<ce:label>2</ce:label>\n<sb:reference id=\"sbref0002\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Maj</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.J.</ce:given-name>\n<ce:surname>Stein</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Parker</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The clinical characterization of the adult patient with depression aimed at personalization of management</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>19</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>269</sb:first-page>\n<sb:last-page>293</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0002\">Maj M, Stein DJ, Parker G, et al. The clinical characterization of the adult patient with depression aimed at personalization of management. World Psychiatry. 2020;19(3):269-293.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0003\">\n<ce:label>3</ce:label>\n<sb:reference id=\"sbref0003\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>CF 3rd</ce:given-name>\n<ce:surname>Reynolds</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.V.</ce:given-name>\n<ce:surname>Jeste</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.S.</ce:given-name>\n<ce:surname>Sachdev</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.G.</ce:given-name>\n<ce:surname>Blazer</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Mental health care for older adults: recent advances and new directions in clinical practice and research</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>21</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>336</sb:first-page>\n<sb:last-page>363</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0003\">Reynolds CF 3rd, Jeste DV, Sachdev PS, Blazer DG. Mental health care for older adults: recent advances and new directions in clinical practice and research. World Psychiatry. 2022;21(3):336-363.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0004\">\n<ce:label>4</ce:label>\n<sb:reference id=\"sbref0004\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zenebe</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Akele</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>W/Selassie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Necho</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Prevalence and determinants of depression among old age: a systematic review and meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Ann Gen Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>20</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>55</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0004\">Zenebe Y, Akele B, W/Selassie M, Necho M. Prevalence and determinants of depression among old age: a systematic review and meta-analysis. Ann Gen Psychiatry. 2021;20(1):55.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0005\">\n<ce:label>5</ce:label>\n<sb:reference id=\"sbref0005\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.S.</ce:given-name>\n<ce:surname>Hasin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.L.</ce:given-name>\n<ce:surname>Sarvet</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.L.</ce:given-name>\n<ce:surname>Meyers</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>JAMA Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>75</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>336</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0005\">Hasin DS, Sarvet AL, Meyers JL, et al. Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiatry. 2018;75(4):336.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0006\">\n<ce:label>6</ce:label>\n<sb:reference id=\"sbref0006\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.R.</ce:given-name>\n<ce:surname>Azar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.P.</ce:given-name>\n<ce:surname>Chopra</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.Y.</ce:given-name>\n<ce:surname>Cho</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Coakley</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>JL.</ce:given-name>\n<ce:surname>Rudolph</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Remission in major depression: results from a geriatric primary care population</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>26</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2011</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>48</sb:first-page>\n<sb:last-page>55</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0006\">Azar AR, Chopra MP, Cho LY, Coakley E, Rudolph JL. Remission in major depression: results from a geriatric primary care population. Int J Geriatr Psychiatry. 2011;26(1):48-55.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0007\">\n<ce:label>7</ce:label>\n<sb:reference id=\"sbref0007\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>U.</ce:given-name>\n<ce:surname>Klotz</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pharmacokinetics and drug metabolism in the elderly</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Drug Metab Rev</sb:maintitle>\n</sb:title>\n<sb:volume-nr>41</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2009</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>67</sb:first-page>\n<sb:last-page>76</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0007\">Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev. 2009;41(2):67-76.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0008\">\n<ce:label>8</ce:label>\n<sb:reference id=\"sbref0008\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Canadian Coalition for Seniors’ Mental</ce:given-name>\n<ce:surname>Health</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Canadian Guidelines on Prevention, Assessment and Treatment of Depression Among Older Adults</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>CCSMH; 2021</sb:maintitle>\n</sb:title>\n</sb:series>\n<sb:date>June 2021</sb:date>\n</sb:issue>\n</sb:host>\n<sb:comment>Updated</sb:comment>\n<sb:host>\n<sb:e-host>\n<ce:inter-ref id=\"interref0001\" xlink:href=\"https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf\">https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf</ce:inter-ref>\n</sb:e-host>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0008\">Canadian Coalition for Seniors’ Mental Health. Canadian Guidelines on Prevention, Assessment and Treatment of Depression Among Older Adults. CCSMH; 2021. Updated June 2021. https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0009\">\n<ce:label>9</ce:label>\n<sb:reference id=\"sbref0009\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Avasthi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Grover</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Clinical practice guidelines for management of depression in elderly</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Indian J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>60</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>Suppl 3</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>S341</sb:first-page>\n<sb:last-page>S362</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0009\">Avasthi A, Grover S. Clinical practice guidelines for management of depression in elderly. Indian J Psychiatry. 2018;60(Suppl 3):S341-S362.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0010\">\n<ce:label>10</ce:label>\n<sb:reference id=\"sbref0010\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Baba</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Kito</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Nukariya</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Guidelines for diagnosis and treatment of depression in older adults: A report from the Japanese Society of mood disorders</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Psychiatry Clin Neurosci</sb:maintitle>\n</sb:title>\n<sb:volume-nr>76</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>222</sb:first-page>\n<sb:last-page>234</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0010\">Baba H, Kito S, Nukariya K, et al. Guidelines for diagnosis and treatment of depression in older adults: A report from the Japanese Society of mood disorders. Psychiatry Clin Neurosci. 2022;76(6):222-234.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0011\">\n<ce:label>11</ce:label>\n<sb:reference id=\"sbref0011\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Rosenblat</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.B.</ce:given-name>\n<ce:surname>Nemeroff</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>178</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>383</sb:first-page>\n<sb:last-page>399</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0011\">McIntyre RS, Rosenblat JD, Nemeroff CB, et al. Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation. Am J Psychiatry. 2021;178(5):383-399.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0012\">\n<ce:label>12</ce:label>\n<sb:reference id=\"sbref0012\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.C.H.</ce:given-name>\n<ce:surname>Cheng</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.E.</ce:given-name>\n<ce:surname>Dri</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Ballum</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effects of ketamine and esketamine on measures of quality of life in major depressive disorder and treatment-resistant depression: A systematic review</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>382</sb:volume-nr>\n</sb:series>\n<sb:date>2025</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>438</sb:first-page>\n<sb:last-page>442</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0012\">Cheng MCH, Dri CE, Ballum H, et al. The effects of ketamine and esketamine on measures of quality of life in major depressive disorder and treatment-resistant depression: A systematic review. J Affect Disord. 2025;382:438-442.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0013\">\n<ce:label>13</ce:label>\n<sb:reference id=\"sbref0013\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Di Vincenzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.B.</ce:given-name>\n<ce:surname>Rodrigues</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Safety, tolerability, and real-world effectiveness of intravenous ketamine in older adults with treatment-resistant depression: A case series</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>29</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>9</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>899</sb:first-page>\n<sb:last-page>913</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0013\">Lipsitz O, Di Vincenzo JD, Rodrigues NB, et al. Safety, tolerability, and real-world effectiveness of intravenous ketamine in older adults with treatment-resistant depression: A case series. Am J Geriatr Psychiatry. 2021;29(9):899-913.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0014\">\n<ce:label>14</ce:label>\n<sb:reference id=\"sbref0014\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>I.P.</ce:given-name>\n<ce:surname>Carvalho</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.M.W.</ce:given-name>\n<ce:surname>Lui</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>276</sb:volume-nr>\n</sb:series>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>576</sb:first-page>\n<sb:last-page>584</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0014\">McIntyre RS, Carvalho IP, Lui LMW, et al. The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis. J Affect Disord. 2020;276:576-584.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0015\">\n<ce:label>15</ce:label>\n<sb:reference id=\"sbref0015\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Lee</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Syeda</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.A.</ce:given-name>\n<ce:surname>Maruschak</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>A new perspective on the anti-suicide effects with ketamine treatment: A procognitive effect</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Clin Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>36</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2016</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>50</sb:first-page>\n<sb:last-page>56</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0015\">Lee Y, Syeda K, Maruschak NA, et al. A new perspective on the anti-suicide effects with ketamine treatment: A procognitive effect. J Clin Psychopharmacol. 2016;36(1):50-56.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0016\">\n<ce:label>16</ce:label>\n<sb:reference id=\"sbref0016\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Xiong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Chen-Li</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>134</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>57</sb:first-page>\n<sb:last-page>68</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0016\">Xiong J, Lipsitz O, Chen-Li D, et al. The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis. J Psychiatr Res. 2021;134:57-68.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0017\">\n<ce:label>17</ce:label>\n<sb:reference id=\"sbref0017\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Gupta</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Dhar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Patadia</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>A systematic review of ketamine for the treatment of depression among older adults</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int Psychogeriatr</sb:maintitle>\n</sb:title>\n<sb:volume-nr>33</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>179</sb:first-page>\n<sb:last-page>191</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0017\">Gupta A, Dhar R, Patadia P, et al. A systematic review of ketamine for the treatment of depression among older adults. Int Psychogeriatr. 2021;33(2):179-191.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0018\">\n<ce:label>18</ce:label>\n<sb:reference id=\"sbref0018\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Di Vincenzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Siegel</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>137</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>232</sb:first-page>\n<sb:last-page>241</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0018\">Di Vincenzo JD, Siegel A, Lipsitz O, et al. The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review. J Psychiatr Res. 2021;137:232-241.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0019\">\n<ce:label>19</ce:label>\n<sb:reference id=\"sbref0019\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Page</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.E.</ce:given-name>\n<ce:surname>McKenzie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.M.</ce:given-name>\n<ce:surname>Bossuyt</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The PRISMA 2020 statement: an updated guideline for reporting systematic reviews</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>BMJ</sb:maintitle>\n</sb:title>\n<sb:volume-nr>372</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>n71</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0019\">Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0020\">\n<ce:label>20</ce:label>\n<sb:reference id=\"sbref0020\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.A.C.</ce:given-name>\n<ce:surname>Sterne</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Savović</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Page</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>RoB 2: a revised tool for assessing risk of bias in randomised trials</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>BMJ</sb:maintitle>\n</sb:title>\n<sb:volume-nr>366</sb:volume-nr>\n</sb:series>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>l4898</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0020\">Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0021\">\n<ce:label>21</ce:label>\n<sb:reference id=\"sbref0021\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>T.H.</ce:given-name>\n<ce:surname>Barker</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Habibi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Aromataris</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>JBI Evid Synth</sb:maintitle>\n</sb:title>\n<sb:volume-nr>22</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>378</sb:first-page>\n<sb:last-page>388</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0021\">Barker TH, Habibi N, Aromataris E, et al. The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies. JBI Evid Synth. 2024;22(3):378-388.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0022\">\n<ce:label>22</ce:label>\n<sb:reference id=\"sbref0022\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Gálvez</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Huggins</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>32</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>397</sb:first-page>\n<sb:last-page>407</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0022\">Gálvez V, Li A, Huggins C, et al. Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial. J Psychopharmacol. 2018;32(4):397-407.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0023\">\n<ce:label>23</ce:label>\n<sb:reference id=\"sbref0023\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Ochs-Ross</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zhang</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression-TRANSFORM-3</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>28</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>121</sb:first-page>\n<sb:last-page>141</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0023\">Ochs-Ross R, Daly EJ, Zhang Y, et al. Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression-TRANSFORM-3. Am J Geriatr Psychiatry. 2020;28(2):121-141.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0024\">\n<ce:label>24</ce:label>\n<sb:reference id=\"sbref0024\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Lai</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Katalinic</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Glue</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pilot dose-response trial of i.v. ketamine in treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World J Biol Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>15</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>579</sb:first-page>\n<sb:last-page>584</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0024\">Lai R, Katalinic N, Glue P, et al. Pilot dose-response trial of i.v. ketamine in treatment-resistant depression. World J Biol Psychiatry. 2014;15(7):579-584.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0025\">\n<ce:label>25</ce:label>\n<sb:reference id=\"sbref0025\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Glue</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Loo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Fam</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Nat Med</sb:maintitle>\n</sb:title>\n<sb:volume-nr>30</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>2004</sb:first-page>\n<sb:last-page>2009</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0025\">Glue P, Loo C, Fam J, et al. Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial. Nat Med. 2024;30(7):2004-2009.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0026\">\n<ce:label>26</ce:label>\n<sb:reference id=\"sbref0026\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Fernie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Currie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.S.</ce:given-name>\n<ce:surname>Perrin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Br J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>210</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>422</sb:first-page>\n<sb:last-page>428</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0026\">Fernie G, Currie J, Perrin JS, et al. Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial. Br J Psychiatry. 2017;210(6):422-428.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0027\">\n<ce:label>27</ce:label>\n<sb:reference id=\"sbref0027\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Zou</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Min</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Q.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Ren</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-A randomized, double-blind, controlled clinical study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Brain Behav</sb:maintitle>\n</sb:title>\n<sb:volume-nr>11</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:article-number>e01775</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0027\">Zou L, Min S, Chen Q, Li X, Ren L. Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-A randomized, double-blind, controlled clinical study. Brain Behav. 2021;11(1):e01775.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0028\">\n<ce:label>28</ce:label>\n<sb:reference id=\"sbref0028\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>George</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Gálvez</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>25</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>11</sb:issue-nr>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1199</sb:first-page>\n<sb:last-page>1209</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0028\">George D, Gálvez V, Martin D, et al. Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression. Am J Geriatr Psychiatry. 2017;25(11):1199-1209.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0029\">\n<ce:label>29</ce:label>\n<sb:reference id=\"sbref0029\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Wajs</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Aluisio</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Holder</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: Assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2)</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Clin Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>81</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<ce:doi>10.4088/JCP.19m12891</ce:doi>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0029\">Wajs E, Aluisio L, Holder R, et al. Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: Assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2). J Clin Psychiatry. 2020;81(3). doi:10.4088/JCP.19m12891</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0030\">\n<ce:label>30</ce:label>\n<sb:reference id=\"sbref0030\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.A.</ce:given-name>\n<ce:surname>Oughli</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.A.</ce:given-name>\n<ce:surname>Gebara</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Ciarleglio</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Intravenous ketamine for late-life treatment-resistant depression: A pilot study of tolerability, safety, clinical benefits, and effect on cognition</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>31</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>210</sb:first-page>\n<sb:last-page>221</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0030\">Oughli HA, Gebara MA, Ciarleglio A, et al. Intravenous ketamine for late-life treatment-resistant depression: A pilot study of tolerability, safety, clinical benefits, and effect on cognition. Am J Geriatr Psychiatry. 2023;31(3):210-221.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0031\">\n<ce:label>31</ce:label>\n<sb:reference id=\"sbref0031\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Zaki</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.N.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Lane</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Neuropsychopharmacology</sb:maintitle>\n</sb:title>\n<sb:volume-nr>48</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>8</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1225</sb:first-page>\n<sb:last-page>1233</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0031\">Zaki N, Chen LN, Lane R, et al. Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study. Neuropsychopharmacology. 2023;48(8):1225-1233.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0032\">\n<ce:label>32</ce:label>\n<sb:reference id=\"sbref0032\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>K.G.</ce:given-name>\n<ce:surname>Rasmussen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.W.</ce:given-name>\n<ce:surname>Lineberry</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.W.</ce:given-name>\n<ce:surname>Galardy</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Serial infusions of low-dose ketamine for major depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>27</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2013</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>444</sb:first-page>\n<sb:last-page>450</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0032\">Rasmussen KG, Lineberry TW, Galardy CW, et al. Serial infusions of low-dose ketamine for major depression. J Psychopharmacol. 2013;27(5):444-450.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0033\">\n<ce:label>33</ce:label>\n<sb:reference id=\"sbref0033\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Vanderschelden</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.A.</ce:given-name>\n<ce:surname>Gebara</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.A.</ce:given-name>\n<ce:surname>Oughli</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Change in patient-centered outcomes of psychological well-being, sleep, and suicidality following treatment with intravenous ketamine for late-life treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>38</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>e5964</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0033\">Vanderschelden B, Gebara MA, Oughli HA, et al. Change in patient-centered outcomes of psychological well-being, sleep, and suicidality following treatment with intravenous ketamine for late-life treatment-resistant depression. Int J Geriatr Psychiatry. 2023;38(7):e5964.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0034\">\n<ce:label>34</ce:label>\n<sb:reference id=\"sbref0034\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Ochs-Ross</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Wajs</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Comparison of long-term efficacy and safety of esketamine nasal spray plus oral antidepressant in younger versus older patients with treatment-resistant depression: Post-hoc analysis of SUSTAIN-2, a long-term open-label phase 3 safety and efficacy study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>30</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>541</sb:first-page>\n<sb:last-page>556</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0034\">Ochs-Ross R, Wajs E, Daly EJ, et al. Comparison of long-term efficacy and safety of esketamine nasal spray plus oral antidepressant in younger versus older patients with treatment-resistant depression: Post-hoc analysis of SUSTAIN-2, a long-term open-label phase 3 safety and efficacy study. Am J Geriatr Psychiatry. 2022;30(5):541-556.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0035\">\n<ce:label>35</ce:label>\n<sb:reference id=\"sbref0035\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Filteau</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>156</sb:volume-nr>\n</sb:series>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1</sb:first-page>\n<sb:last-page>7</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0035\">McIntyre RS, Filteau MJ, Martin L, et al. Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach. J Affect Disord. 2014;156:1-7.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0036\">\n<ce:label>36</ce:label>\n<sb:reference id=\"sbref0036\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.R.</ce:given-name>\n<ce:surname>Strawn</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.A.</ce:given-name>\n<ce:surname>Mills</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Suresh</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorder</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>159</sb:volume-nr>\n</sb:series>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>266</sb:first-page>\n<sb:last-page>273</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0036\">Strawn JR, Mills JA, Suresh V, et al. The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorder. J Psychiatr Res. 2023;159:266-273.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0037\">\n<ce:label>37</ce:label>\n<sb:reference id=\"sbref0037\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Popova</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Trivedi</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>176</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>428</sb:first-page>\n<sb:last-page>438</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0037\">Popova V, Daly EJ, Trivedi M, et al. Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study. Am J Psychiatry. 2019;176(6):428-438.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0038\">\n<ce:label>38</ce:label>\n<sb:reference id=\"sbref0038\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.F.</ce:given-name>\n<ce:surname>Grunebaum</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.C.</ce:given-name>\n<ce:surname>Galfalvy</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.H.</ce:given-name>\n<ce:surname>Choo</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine for rapid reduction of suicidal thoughts in major depression: A midazolam-controlled randomized clinical trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>175</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>327</sb:first-page>\n<sb:last-page>335</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0038\">Grunebaum MF, Galfalvy HC, Choo TH, et al. Ketamine for rapid reduction of suicidal thoughts in major depression: A midazolam-controlled randomized clinical trial. Am J Psychiatry. 2018;175(4):327-335.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0039\">\n<ce:label>39</ce:label>\n<sb:reference id=\"sbref0039\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.T.</ce:given-name>\n<ce:surname>Wilkinson</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Farmer</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.D.</ce:given-name>\n<ce:surname>Ballard</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Neuropsychopharmacology</sb:maintitle>\n</sb:title>\n<sb:volume-nr>44</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1233</sb:first-page>\n<sb:last-page>1238</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0039\">Wilkinson ST, Farmer C, Ballard ED, et al. Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant. Neuropsychopharmacology. 2019;44(7):1233-1238.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0040\">\n<ce:label>40</ce:label>\n<sb:reference id=\"sbref0040\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.L.</ce:given-name>\n<ce:surname>Naismith</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.M.</ce:given-name>\n<ce:surname>Norrie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Mowszowski</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>IB.</ce:given-name>\n<ce:surname>Hickie</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The neurobiology of depression in later-life: Clinical, neuropsychological, neuroimaging and pathophysiological features</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Prog Neurobiol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>98</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2012</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>99</sb:first-page>\n<sb:last-page>143</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0040\">Naismith SL, Norrie LM, Mowszowski L, Hickie IB. The neurobiology of depression in later-life: Clinical, neuropsychological, neuroimaging and pathophysiological features. Prog Neurobiol. 2012;98(1):99-143.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0041\">\n<ce:label>41</ce:label>\n<sb:reference id=\"sbref0041\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Bayes</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Dong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Alonzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Kabourakis</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Loo</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine treatment for depression: A model of care</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Aust N Z J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>55</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>12</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1134</sb:first-page>\n<sb:last-page>1143</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0041\">Bayes A, Dong V, Martin D, Alonzo A, Kabourakis M, Loo C. Ketamine treatment for depression: A model of care. Aust N Z J Psychiatry. 2021;55(12):1134-1143.</ce:source-text>\n</ce:bib-reference>\n</ce:bibliography-sec>",
    "error_message": "All bibliographic references within 'ce:bibliography' must be referred to.",
    "error_position": "1050:63",
    "error_id": "IDS503a",
    "folder_name": "AMGP2541"
  },
  {
    "input": "<ce:bibliography-sec xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"cebibsec1\">\n<?att type=\"article\"?><ce:bib-reference id=\"bib0001\">\n<ce:label>1</ce:label>\n<sb:reference id=\"sbref0001\">\n<sb:contribution>\n<sb:authors>\n<sb:collaboration>Global Burden of Disease Study 2013 Collaborators</sb:collaboration>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Lancet</sb:maintitle>\n</sb:title>\n<sb:volume-nr>386</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>9995</sb:issue-nr>\n<sb:date>20132015</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>743</sb:first-page>\n<sb:last-page>800</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0001\">Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743-800.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0002\">\n<ce:label>2</ce:label>\n<sb:reference id=\"sbref0002\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Maj</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.J.</ce:given-name>\n<ce:surname>Stein</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Parker</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The clinical characterization of the adult patient with depression aimed at personalization of management</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>19</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>269</sb:first-page>\n<sb:last-page>293</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0002\">Maj M, Stein DJ, Parker G, et al. The clinical characterization of the adult patient with depression aimed at personalization of management. World Psychiatry. 2020;19(3):269-293.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0003\">\n<ce:label>3</ce:label>\n<sb:reference id=\"sbref0003\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>CF 3rd</ce:given-name>\n<ce:surname>Reynolds</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.V.</ce:given-name>\n<ce:surname>Jeste</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.S.</ce:given-name>\n<ce:surname>Sachdev</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.G.</ce:given-name>\n<ce:surname>Blazer</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Mental health care for older adults: recent advances and new directions in clinical practice and research</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>21</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>336</sb:first-page>\n<sb:last-page>363</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0003\">Reynolds CF 3rd, Jeste DV, Sachdev PS, Blazer DG. Mental health care for older adults: recent advances and new directions in clinical practice and research. World Psychiatry. 2022;21(3):336-363.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0004\">\n<ce:label>4</ce:label>\n<sb:reference id=\"sbref0004\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zenebe</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Akele</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>W/Selassie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Necho</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Prevalence and determinants of depression among old age: a systematic review and meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Ann Gen Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>20</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>55</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0004\">Zenebe Y, Akele B, W/Selassie M, Necho M. Prevalence and determinants of depression among old age: a systematic review and meta-analysis. Ann Gen Psychiatry. 2021;20(1):55.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0005\">\n<ce:label>5</ce:label>\n<sb:reference id=\"sbref0005\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.S.</ce:given-name>\n<ce:surname>Hasin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.L.</ce:given-name>\n<ce:surname>Sarvet</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.L.</ce:given-name>\n<ce:surname>Meyers</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>JAMA Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>75</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>336</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0005\">Hasin DS, Sarvet AL, Meyers JL, et al. Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiatry. 2018;75(4):336.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0006\">\n<ce:label>6</ce:label>\n<sb:reference id=\"sbref0006\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.R.</ce:given-name>\n<ce:surname>Azar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.P.</ce:given-name>\n<ce:surname>Chopra</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.Y.</ce:given-name>\n<ce:surname>Cho</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Coakley</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>JL.</ce:given-name>\n<ce:surname>Rudolph</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Remission in major depression: results from a geriatric primary care population</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>26</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2011</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>48</sb:first-page>\n<sb:last-page>55</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0006\">Azar AR, Chopra MP, Cho LY, Coakley E, Rudolph JL. Remission in major depression: results from a geriatric primary care population. Int J Geriatr Psychiatry. 2011;26(1):48-55.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0007\">\n<ce:label>7</ce:label>\n<sb:reference id=\"sbref0007\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>U.</ce:given-name>\n<ce:surname>Klotz</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pharmacokinetics and drug metabolism in the elderly</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Drug Metab Rev</sb:maintitle>\n</sb:title>\n<sb:volume-nr>41</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2009</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>67</sb:first-page>\n<sb:last-page>76</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0007\">Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev. 2009;41(2):67-76.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0008\">\n<ce:label>8</ce:label>\n<sb:reference id=\"sbref0008\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Canadian Coalition for Seniors’ Mental</ce:given-name>\n<ce:surname>Health</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Canadian Guidelines on Prevention, Assessment and Treatment of Depression Among Older Adults</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>CCSMH; 2021</sb:maintitle>\n</sb:title>\n</sb:series>\n<sb:date>June 2021</sb:date>\n</sb:issue>\n</sb:host>\n<sb:comment>Updated</sb:comment>\n<sb:host>\n<sb:e-host>\n<ce:inter-ref id=\"interref0001\" xlink:href=\"https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf\">https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf</ce:inter-ref>\n</sb:e-host>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0008\">Canadian Coalition for Seniors’ Mental Health. Canadian Guidelines on Prevention, Assessment and Treatment of Depression Among Older Adults. CCSMH; 2021. Updated June 2021. https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0009\">\n<ce:label>9</ce:label>\n<sb:reference id=\"sbref0009\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Avasthi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Grover</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Clinical practice guidelines for management of depression in elderly</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Indian J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>60</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>Suppl 3</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>S341</sb:first-page>\n<sb:last-page>S362</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0009\">Avasthi A, Grover S. Clinical practice guidelines for management of depression in elderly. Indian J Psychiatry. 2018;60(Suppl 3):S341-S362.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0010\">\n<ce:label>10</ce:label>\n<sb:reference id=\"sbref0010\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Baba</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Kito</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Nukariya</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Guidelines for diagnosis and treatment of depression in older adults: A report from the Japanese Society of mood disorders</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Psychiatry Clin Neurosci</sb:maintitle>\n</sb:title>\n<sb:volume-nr>76</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>222</sb:first-page>\n<sb:last-page>234</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0010\">Baba H, Kito S, Nukariya K, et al. Guidelines for diagnosis and treatment of depression in older adults: A report from the Japanese Society of mood disorders. Psychiatry Clin Neurosci. 2022;76(6):222-234.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0011\">\n<ce:label>11</ce:label>\n<sb:reference id=\"sbref0011\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Rosenblat</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.B.</ce:given-name>\n<ce:surname>Nemeroff</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>178</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>383</sb:first-page>\n<sb:last-page>399</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0011\">McIntyre RS, Rosenblat JD, Nemeroff CB, et al. Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation. Am J Psychiatry. 2021;178(5):383-399.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0012\">\n<ce:label>12</ce:label>\n<sb:reference id=\"sbref0012\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.C.H.</ce:given-name>\n<ce:surname>Cheng</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.E.</ce:given-name>\n<ce:surname>Dri</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Ballum</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effects of ketamine and esketamine on measures of quality of life in major depressive disorder and treatment-resistant depression: A systematic review</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>382</sb:volume-nr>\n</sb:series>\n<sb:date>2025</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>438</sb:first-page>\n<sb:last-page>442</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0012\">Cheng MCH, Dri CE, Ballum H, et al. The effects of ketamine and esketamine on measures of quality of life in major depressive disorder and treatment-resistant depression: A systematic review. J Affect Disord. 2025;382:438-442.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0013\">\n<ce:label>13</ce:label>\n<sb:reference id=\"sbref0013\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Di Vincenzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.B.</ce:given-name>\n<ce:surname>Rodrigues</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Safety, tolerability, and real-world effectiveness of intravenous ketamine in older adults with treatment-resistant depression: A case series</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>29</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>9</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>899</sb:first-page>\n<sb:last-page>913</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0013\">Lipsitz O, Di Vincenzo JD, Rodrigues NB, et al. Safety, tolerability, and real-world effectiveness of intravenous ketamine in older adults with treatment-resistant depression: A case series. Am J Geriatr Psychiatry. 2021;29(9):899-913.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0014\">\n<ce:label>14</ce:label>\n<sb:reference id=\"sbref0014\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>I.P.</ce:given-name>\n<ce:surname>Carvalho</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.M.W.</ce:given-name>\n<ce:surname>Lui</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>276</sb:volume-nr>\n</sb:series>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>576</sb:first-page>\n<sb:last-page>584</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0014\">McIntyre RS, Carvalho IP, Lui LMW, et al. The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis. J Affect Disord. 2020;276:576-584.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0015\">\n<ce:label>15</ce:label>\n<sb:reference id=\"sbref0015\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Lee</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Syeda</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.A.</ce:given-name>\n<ce:surname>Maruschak</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>A new perspective on the anti-suicide effects with ketamine treatment: A procognitive effect</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Clin Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>36</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2016</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>50</sb:first-page>\n<sb:last-page>56</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0015\">Lee Y, Syeda K, Maruschak NA, et al. A new perspective on the anti-suicide effects with ketamine treatment: A procognitive effect. J Clin Psychopharmacol. 2016;36(1):50-56.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0016\">\n<ce:label>16</ce:label>\n<sb:reference id=\"sbref0016\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Xiong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Chen-Li</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>134</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>57</sb:first-page>\n<sb:last-page>68</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0016\">Xiong J, Lipsitz O, Chen-Li D, et al. The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis. J Psychiatr Res. 2021;134:57-68.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0017\">\n<ce:label>17</ce:label>\n<sb:reference id=\"sbref0017\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Gupta</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Dhar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Patadia</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>A systematic review of ketamine for the treatment of depression among older adults</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int Psychogeriatr</sb:maintitle>\n</sb:title>\n<sb:volume-nr>33</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>179</sb:first-page>\n<sb:last-page>191</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0017\">Gupta A, Dhar R, Patadia P, et al. A systematic review of ketamine for the treatment of depression among older adults. Int Psychogeriatr. 2021;33(2):179-191.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0018\">\n<ce:label>18</ce:label>\n<sb:reference id=\"sbref0018\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Di Vincenzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Siegel</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>137</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>232</sb:first-page>\n<sb:last-page>241</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0018\">Di Vincenzo JD, Siegel A, Lipsitz O, et al. The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review. J Psychiatr Res. 2021;137:232-241.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0019\">\n<ce:label>19</ce:label>\n<sb:reference id=\"sbref0019\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Page</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.E.</ce:given-name>\n<ce:surname>McKenzie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.M.</ce:given-name>\n<ce:surname>Bossuyt</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The PRISMA 2020 statement: an updated guideline for reporting systematic reviews</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>BMJ</sb:maintitle>\n</sb:title>\n<sb:volume-nr>372</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>n71</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0019\">Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0020\">\n<ce:label>20</ce:label>\n<sb:reference id=\"sbref0020\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.A.C.</ce:given-name>\n<ce:surname>Sterne</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Savović</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Page</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>RoB 2: a revised tool for assessing risk of bias in randomised trials</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>BMJ</sb:maintitle>\n</sb:title>\n<sb:volume-nr>366</sb:volume-nr>\n</sb:series>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>l4898</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0020\">Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0021\">\n<ce:label>21</ce:label>\n<sb:reference id=\"sbref0021\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>T.H.</ce:given-name>\n<ce:surname>Barker</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Habibi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Aromataris</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>JBI Evid Synth</sb:maintitle>\n</sb:title>\n<sb:volume-nr>22</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>378</sb:first-page>\n<sb:last-page>388</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0021\">Barker TH, Habibi N, Aromataris E, et al. The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies. JBI Evid Synth. 2024;22(3):378-388.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0022\">\n<ce:label>22</ce:label>\n<sb:reference id=\"sbref0022\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Gálvez</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Huggins</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>32</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>397</sb:first-page>\n<sb:last-page>407</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0022\">Gálvez V, Li A, Huggins C, et al. Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial. J Psychopharmacol. 2018;32(4):397-407.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0023\">\n<ce:label>23</ce:label>\n<sb:reference id=\"sbref0023\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Ochs-Ross</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zhang</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression-TRANSFORM-3</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>28</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>121</sb:first-page>\n<sb:last-page>141</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0023\">Ochs-Ross R, Daly EJ, Zhang Y, et al. Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression-TRANSFORM-3. Am J Geriatr Psychiatry. 2020;28(2):121-141.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0024\">\n<ce:label>24</ce:label>\n<sb:reference id=\"sbref0024\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Lai</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Katalinic</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Glue</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pilot dose-response trial of i.v. ketamine in treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World J Biol Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>15</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>579</sb:first-page>\n<sb:last-page>584</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0024\">Lai R, Katalinic N, Glue P, et al. Pilot dose-response trial of i.v. ketamine in treatment-resistant depression. World J Biol Psychiatry. 2014;15(7):579-584.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0025\">\n<ce:label>25</ce:label>\n<sb:reference id=\"sbref0025\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Glue</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Loo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Fam</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Nat Med</sb:maintitle>\n</sb:title>\n<sb:volume-nr>30</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>2004</sb:first-page>\n<sb:last-page>2009</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0025\">Glue P, Loo C, Fam J, et al. Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial. Nat Med. 2024;30(7):2004-2009.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0026\">\n<ce:label>26</ce:label>\n<sb:reference id=\"sbref0026\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Fernie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Currie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.S.</ce:given-name>\n<ce:surname>Perrin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Br J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>210</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>422</sb:first-page>\n<sb:last-page>428</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0026\">Fernie G, Currie J, Perrin JS, et al. Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial. Br J Psychiatry. 2017;210(6):422-428.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0027\">\n<ce:label>27</ce:label>\n<sb:reference id=\"sbref0027\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Zou</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Min</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Q.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Ren</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-A randomized, double-blind, controlled clinical study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Brain Behav</sb:maintitle>\n</sb:title>\n<sb:volume-nr>11</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:article-number>e01775</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0027\">Zou L, Min S, Chen Q, Li X, Ren L. Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-A randomized, double-blind, controlled clinical study. Brain Behav. 2021;11(1):e01775.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0028\">\n<ce:label>28</ce:label>\n<sb:reference id=\"sbref0028\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>George</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Gálvez</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>25</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>11</sb:issue-nr>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1199</sb:first-page>\n<sb:last-page>1209</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0028\">George D, Gálvez V, Martin D, et al. Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression. Am J Geriatr Psychiatry. 2017;25(11):1199-1209.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0029\">\n<ce:label>29</ce:label>\n<sb:reference id=\"sbref0029\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Wajs</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Aluisio</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Holder</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: Assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2)</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Clin Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>81</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<ce:doi>10.4088/JCP.19m12891</ce:doi>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0029\">Wajs E, Aluisio L, Holder R, et al. Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: Assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2). J Clin Psychiatry. 2020;81(3). doi:10.4088/JCP.19m12891</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0030\">\n<ce:label>30</ce:label>\n<sb:reference id=\"sbref0030\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.A.</ce:given-name>\n<ce:surname>Oughli</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.A.</ce:given-name>\n<ce:surname>Gebara</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Ciarleglio</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Intravenous ketamine for late-life treatment-resistant depression: A pilot study of tolerability, safety, clinical benefits, and effect on cognition</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>31</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>210</sb:first-page>\n<sb:last-page>221</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0030\">Oughli HA, Gebara MA, Ciarleglio A, et al. Intravenous ketamine for late-life treatment-resistant depression: A pilot study of tolerability, safety, clinical benefits, and effect on cognition. Am J Geriatr Psychiatry. 2023;31(3):210-221.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0031\">\n<ce:label>31</ce:label>\n<sb:reference id=\"sbref0031\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Zaki</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.N.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Lane</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Neuropsychopharmacology</sb:maintitle>\n</sb:title>\n<sb:volume-nr>48</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>8</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1225</sb:first-page>\n<sb:last-page>1233</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0031\">Zaki N, Chen LN, Lane R, et al. Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study. Neuropsychopharmacology. 2023;48(8):1225-1233.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0032\">\n<ce:label>32</ce:label>\n<sb:reference id=\"sbref0032\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>K.G.</ce:given-name>\n<ce:surname>Rasmussen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.W.</ce:given-name>\n<ce:surname>Lineberry</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.W.</ce:given-name>\n<ce:surname>Galardy</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Serial infusions of low-dose ketamine for major depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>27</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2013</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>444</sb:first-page>\n<sb:last-page>450</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0032\">Rasmussen KG, Lineberry TW, Galardy CW, et al. Serial infusions of low-dose ketamine for major depression. J Psychopharmacol. 2013;27(5):444-450.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0033\">\n<ce:label>33</ce:label>\n<sb:reference id=\"sbref0033\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Vanderschelden</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.A.</ce:given-name>\n<ce:surname>Gebara</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.A.</ce:given-name>\n<ce:surname>Oughli</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Change in patient-centered outcomes of psychological well-being, sleep, and suicidality following treatment with intravenous ketamine for late-life treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>38</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>e5964</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0033\">Vanderschelden B, Gebara MA, Oughli HA, et al. Change in patient-centered outcomes of psychological well-being, sleep, and suicidality following treatment with intravenous ketamine for late-life treatment-resistant depression. Int J Geriatr Psychiatry. 2023;38(7):e5964.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0034\">\n<ce:label>34</ce:label>\n<sb:reference id=\"sbref0034\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Ochs-Ross</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Wajs</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Comparison of long-term efficacy and safety of esketamine nasal spray plus oral antidepressant in younger versus older patients with treatment-resistant depression: Post-hoc analysis of SUSTAIN-2, a long-term open-label phase 3 safety and efficacy study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>30</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>541</sb:first-page>\n<sb:last-page>556</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0034\">Ochs-Ross R, Wajs E, Daly EJ, et al. Comparison of long-term efficacy and safety of esketamine nasal spray plus oral antidepressant in younger versus older patients with treatment-resistant depression: Post-hoc analysis of SUSTAIN-2, a long-term open-label phase 3 safety and efficacy study. Am J Geriatr Psychiatry. 2022;30(5):541-556.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0035\">\n<ce:label>35</ce:label>\n<sb:reference id=\"sbref0035\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Filteau</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>156</sb:volume-nr>\n</sb:series>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1</sb:first-page>\n<sb:last-page>7</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0035\">McIntyre RS, Filteau MJ, Martin L, et al. Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach. J Affect Disord. 2014;156:1-7.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0036\">\n<ce:label>36</ce:label>\n<sb:reference id=\"sbref0036\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.R.</ce:given-name>\n<ce:surname>Strawn</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.A.</ce:given-name>\n<ce:surname>Mills</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Suresh</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorder</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>159</sb:volume-nr>\n</sb:series>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>266</sb:first-page>\n<sb:last-page>273</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0036\">Strawn JR, Mills JA, Suresh V, et al. The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorder. J Psychiatr Res. 2023;159:266-273.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0037\">\n<ce:label>37</ce:label>\n<sb:reference id=\"sbref0037\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Popova</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Trivedi</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>176</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>428</sb:first-page>\n<sb:last-page>438</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0037\">Popova V, Daly EJ, Trivedi M, et al. Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study. Am J Psychiatry. 2019;176(6):428-438.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0038\">\n<ce:label>38</ce:label>\n<sb:reference id=\"sbref0038\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.F.</ce:given-name>\n<ce:surname>Grunebaum</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.C.</ce:given-name>\n<ce:surname>Galfalvy</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.H.</ce:given-name>\n<ce:surname>Choo</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine for rapid reduction of suicidal thoughts in major depression: A midazolam-controlled randomized clinical trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>175</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>327</sb:first-page>\n<sb:last-page>335</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0038\">Grunebaum MF, Galfalvy HC, Choo TH, et al. Ketamine for rapid reduction of suicidal thoughts in major depression: A midazolam-controlled randomized clinical trial. Am J Psychiatry. 2018;175(4):327-335.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0039\">\n<ce:label>39</ce:label>\n<sb:reference id=\"sbref0039\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.T.</ce:given-name>\n<ce:surname>Wilkinson</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Farmer</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.D.</ce:given-name>\n<ce:surname>Ballard</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Neuropsychopharmacology</sb:maintitle>\n</sb:title>\n<sb:volume-nr>44</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1233</sb:first-page>\n<sb:last-page>1238</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0039\">Wilkinson ST, Farmer C, Ballard ED, et al. Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant. Neuropsychopharmacology. 2019;44(7):1233-1238.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0040\">\n<ce:label>40</ce:label>\n<sb:reference id=\"sbref0040\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.L.</ce:given-name>\n<ce:surname>Naismith</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.M.</ce:given-name>\n<ce:surname>Norrie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Mowszowski</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>IB.</ce:given-name>\n<ce:surname>Hickie</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The neurobiology of depression in later-life: Clinical, neuropsychological, neuroimaging and pathophysiological features</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Prog Neurobiol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>98</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2012</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>99</sb:first-page>\n<sb:last-page>143</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0040\">Naismith SL, Norrie LM, Mowszowski L, Hickie IB. The neurobiology of depression in later-life: Clinical, neuropsychological, neuroimaging and pathophysiological features. Prog Neurobiol. 2012;98(1):99-143.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0041\">\n<ce:label>41</ce:label>\n<sb:reference id=\"sbref0041\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Bayes</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Dong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Alonzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Kabourakis</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Loo</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine treatment for depression: A model of care</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Aust N Z J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>55</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>12</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1134</sb:first-page>\n<sb:last-page>1143</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0041\">Bayes A, Dong V, Martin D, Alonzo A, Kabourakis M, Loo C. Ketamine treatment for depression: A model of care. Aust N Z J Psychiatry. 2021;55(12):1134-1143.</ce:source-text>\n</ce:bib-reference>\n</ce:bibliography-sec>",
    "output": "<ce:bibliography-sec xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"cebibsec1\">\n<?att type=\"article\"?><ce:bib-reference id=\"bib0001\">\n<ce:label>1</ce:label>\n<sb:reference id=\"sbref0001\">\n<sb:contribution>\n<sb:authors>\n<sb:collaboration>Global Burden of Disease Study 2013 Collaborators</sb:collaboration>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Lancet</sb:maintitle>\n</sb:title>\n<sb:volume-nr>386</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>9995</sb:issue-nr>\n<sb:date>20132015</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>743</sb:first-page>\n<sb:last-page>800</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0001\">Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743-800.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0002\">\n<ce:label>2</ce:label>\n<sb:reference id=\"sbref0002\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Maj</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.J.</ce:given-name>\n<ce:surname>Stein</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Parker</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The clinical characterization of the adult patient with depression aimed at personalization of management</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>19</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>269</sb:first-page>\n<sb:last-page>293</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0002\">Maj M, Stein DJ, Parker G, et al. The clinical characterization of the adult patient with depression aimed at personalization of management. World Psychiatry. 2020;19(3):269-293.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0003\">\n<ce:label>3</ce:label>\n<sb:reference id=\"sbref0003\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>CF 3rd</ce:given-name>\n<ce:surname>Reynolds</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.V.</ce:given-name>\n<ce:surname>Jeste</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.S.</ce:given-name>\n<ce:surname>Sachdev</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.G.</ce:given-name>\n<ce:surname>Blazer</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Mental health care for older adults: recent advances and new directions in clinical practice and research</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>21</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>336</sb:first-page>\n<sb:last-page>363</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0003\">Reynolds CF 3rd, Jeste DV, Sachdev PS, Blazer DG. Mental health care for older adults: recent advances and new directions in clinical practice and research. World Psychiatry. 2022;21(3):336-363.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0004\">\n<ce:label>4</ce:label>\n<sb:reference id=\"sbref0004\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zenebe</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Akele</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>W/Selassie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Necho</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Prevalence and determinants of depression among old age: a systematic review and meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Ann Gen Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>20</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>55</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0004\">Zenebe Y, Akele B, W/Selassie M, Necho M. Prevalence and determinants of depression among old age: a systematic review and meta-analysis. Ann Gen Psychiatry. 2021;20(1):55.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0005\">\n<ce:label>5</ce:label>\n<sb:reference id=\"sbref0005\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.S.</ce:given-name>\n<ce:surname>Hasin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.L.</ce:given-name>\n<ce:surname>Sarvet</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.L.</ce:given-name>\n<ce:surname>Meyers</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>JAMA Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>75</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>336</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0005\">Hasin DS, Sarvet AL, Meyers JL, et al. Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiatry. 2018;75(4):336.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0006\">\n<ce:label>6</ce:label>\n<sb:reference id=\"sbref0006\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.R.</ce:given-name>\n<ce:surname>Azar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.P.</ce:given-name>\n<ce:surname>Chopra</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.Y.</ce:given-name>\n<ce:surname>Cho</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Coakley</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>JL.</ce:given-name>\n<ce:surname>Rudolph</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Remission in major depression: results from a geriatric primary care population</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>26</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2011</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>48</sb:first-page>\n<sb:last-page>55</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0006\">Azar AR, Chopra MP, Cho LY, Coakley E, Rudolph JL. Remission in major depression: results from a geriatric primary care population. Int J Geriatr Psychiatry. 2011;26(1):48-55.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0007\">\n<ce:label>7</ce:label>\n<sb:reference id=\"sbref0007\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>U.</ce:given-name>\n<ce:surname>Klotz</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pharmacokinetics and drug metabolism in the elderly</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Drug Metab Rev</sb:maintitle>\n</sb:title>\n<sb:volume-nr>41</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2009</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>67</sb:first-page>\n<sb:last-page>76</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0007\">Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev. 2009;41(2):67-76.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0008\">\n<ce:label>8</ce:label>\n<sb:reference id=\"sbref0008\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Canadian Coalition for Seniors’ Mental</ce:given-name>\n<ce:surname>Health</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Canadian Guidelines on Prevention, Assessment and Treatment of Depression Among Older Adults</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>CCSMH; 2021</sb:maintitle>\n</sb:title>\n</sb:series>\n<sb:date>June 2021</sb:date>\n</sb:issue>\n</sb:host>\n<sb:comment>Updated</sb:comment>\n<sb:host>\n<sb:e-host>\n<ce:inter-ref id=\"interref0001\" xlink:href=\"https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf\">https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf</ce:inter-ref>\n</sb:e-host>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0008\">Canadian Coalition for Seniors’ Mental Health. Canadian Guidelines on Prevention, Assessment and Treatment of Depression Among Older Adults. CCSMH; 2021. Updated June 2021. https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0009\">\n<ce:label>9</ce:label>\n<sb:reference id=\"sbref0009\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Avasthi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Grover</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Clinical practice guidelines for management of depression in elderly</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Indian J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>60</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>Suppl 3</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>S341</sb:first-page>\n<sb:last-page>S362</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0009\">Avasthi A, Grover S. Clinical practice guidelines for management of depression in elderly. Indian J Psychiatry. 2018;60(Suppl 3):S341-S362.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0010\">\n<ce:label>10</ce:label>\n<sb:reference id=\"sbref0010\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Baba</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Kito</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Nukariya</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Guidelines for diagnosis and treatment of depression in older adults: A report from the Japanese Society of mood disorders</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Psychiatry Clin Neurosci</sb:maintitle>\n</sb:title>\n<sb:volume-nr>76</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>222</sb:first-page>\n<sb:last-page>234</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0010\">Baba H, Kito S, Nukariya K, et al. Guidelines for diagnosis and treatment of depression in older adults: A report from the Japanese Society of mood disorders. Psychiatry Clin Neurosci. 2022;76(6):222-234.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0011\">\n<ce:label>11</ce:label>\n<sb:reference id=\"sbref0011\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Rosenblat</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.B.</ce:given-name>\n<ce:surname>Nemeroff</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>178</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>383</sb:first-page>\n<sb:last-page>399</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0011\">McIntyre RS, Rosenblat JD, Nemeroff CB, et al. Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation. Am J Psychiatry. 2021;178(5):383-399.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0012\">\n<ce:label>12</ce:label>\n<sb:reference id=\"sbref0012\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.C.H.</ce:given-name>\n<ce:surname>Cheng</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.E.</ce:given-name>\n<ce:surname>Dri</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Ballum</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effects of ketamine and esketamine on measures of quality of life in major depressive disorder and treatment-resistant depression: A systematic review</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>382</sb:volume-nr>\n</sb:series>\n<sb:date>2025</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>438</sb:first-page>\n<sb:last-page>442</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0012\">Cheng MCH, Dri CE, Ballum H, et al. The effects of ketamine and esketamine on measures of quality of life in major depressive disorder and treatment-resistant depression: A systematic review. J Affect Disord. 2025;382:438-442.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0013\">\n<ce:label>13</ce:label>\n<sb:reference id=\"sbref0013\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Di Vincenzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.B.</ce:given-name>\n<ce:surname>Rodrigues</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Safety, tolerability, and real-world effectiveness of intravenous ketamine in older adults with treatment-resistant depression: A case series</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>29</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>9</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>899</sb:first-page>\n<sb:last-page>913</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0013\">Lipsitz O, Di Vincenzo JD, Rodrigues NB, et al. Safety, tolerability, and real-world effectiveness of intravenous ketamine in older adults with treatment-resistant depression: A case series. Am J Geriatr Psychiatry. 2021;29(9):899-913.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0014\">\n<ce:label>14</ce:label>\n<sb:reference id=\"sbref0014\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>I.P.</ce:given-name>\n<ce:surname>Carvalho</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.M.W.</ce:given-name>\n<ce:surname>Lui</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>276</sb:volume-nr>\n</sb:series>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>576</sb:first-page>\n<sb:last-page>584</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0014\">McIntyre RS, Carvalho IP, Lui LMW, et al. The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis. J Affect Disord. 2020;276:576-584.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0015\">\n<ce:label>15</ce:label>\n<sb:reference id=\"sbref0015\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Lee</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Syeda</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.A.</ce:given-name>\n<ce:surname>Maruschak</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>A new perspective on the anti-suicide effects with ketamine treatment: A procognitive effect</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Clin Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>36</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2016</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>50</sb:first-page>\n<sb:last-page>56</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0015\">Lee Y, Syeda K, Maruschak NA, et al. A new perspective on the anti-suicide effects with ketamine treatment: A procognitive effect. J Clin Psychopharmacol. 2016;36(1):50-56.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0016\">\n<ce:label>16</ce:label>\n<sb:reference id=\"sbref0016\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Xiong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Chen-Li</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>134</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>57</sb:first-page>\n<sb:last-page>68</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0016\">Xiong J, Lipsitz O, Chen-Li D, et al. The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis. J Psychiatr Res. 2021;134:57-68.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0017\">\n<ce:label>17</ce:label>\n<sb:reference id=\"sbref0017\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Gupta</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Dhar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Patadia</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>A systematic review of ketamine for the treatment of depression among older adults</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int Psychogeriatr</sb:maintitle>\n</sb:title>\n<sb:volume-nr>33</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>179</sb:first-page>\n<sb:last-page>191</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0017\">Gupta A, Dhar R, Patadia P, et al. A systematic review of ketamine for the treatment of depression among older adults. Int Psychogeriatr. 2021;33(2):179-191.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0018\">\n<ce:label>18</ce:label>\n<sb:reference id=\"sbref0018\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Di Vincenzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Siegel</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>137</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>232</sb:first-page>\n<sb:last-page>241</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0018\">Di Vincenzo JD, Siegel A, Lipsitz O, et al. The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review. J Psychiatr Res. 2021;137:232-241.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0019\">\n<ce:label>19</ce:label>\n<sb:reference id=\"sbref0019\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Page</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.E.</ce:given-name>\n<ce:surname>McKenzie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.M.</ce:given-name>\n<ce:surname>Bossuyt</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The PRISMA 2020 statement: an updated guideline for reporting systematic reviews</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>BMJ</sb:maintitle>\n</sb:title>\n<sb:volume-nr>372</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>n71</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0019\">Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0020\">\n<ce:label>20</ce:label>\n<sb:reference id=\"sbref0020\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.A.C.</ce:given-name>\n<ce:surname>Sterne</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Savović</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Page</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>RoB 2: a revised tool for assessing risk of bias in randomised trials</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>BMJ</sb:maintitle>\n</sb:title>\n<sb:volume-nr>366</sb:volume-nr>\n</sb:series>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>l4898</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0020\">Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0021\">\n<ce:label>21</ce:label>\n<sb:reference id=\"sbref0021\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>T.H.</ce:given-name>\n<ce:surname>Barker</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Habibi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Aromataris</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>JBI Evid Synth</sb:maintitle>\n</sb:title>\n<sb:volume-nr>22</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>378</sb:first-page>\n<sb:last-page>388</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0021\">Barker TH, Habibi N, Aromataris E, et al. The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies. JBI Evid Synth. 2024;22(3):378-388.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0022\">\n<ce:label>22</ce:label>\n<sb:reference id=\"sbref0022\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Gálvez</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Huggins</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>32</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>397</sb:first-page>\n<sb:last-page>407</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0022\">Gálvez V, Li A, Huggins C, et al. Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial. J Psychopharmacol. 2018;32(4):397-407.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0023\">\n<ce:label>23</ce:label>\n<sb:reference id=\"sbref0023\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Ochs-Ross</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zhang</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression-TRANSFORM-3</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>28</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>121</sb:first-page>\n<sb:last-page>141</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0023\">Ochs-Ross R, Daly EJ, Zhang Y, et al. Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression-TRANSFORM-3. Am J Geriatr Psychiatry. 2020;28(2):121-141.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0024\">\n<ce:label>24</ce:label>\n<sb:reference id=\"sbref0024\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Lai</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Katalinic</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Glue</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pilot dose-response trial of i.v. ketamine in treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World J Biol Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>15</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>579</sb:first-page>\n<sb:last-page>584</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0024\">Lai R, Katalinic N, Glue P, et al. Pilot dose-response trial of i.v. ketamine in treatment-resistant depression. World J Biol Psychiatry. 2014;15(7):579-584.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0025\">\n<ce:label>25</ce:label>\n<sb:reference id=\"sbref0025\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Glue</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Loo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Fam</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Nat Med</sb:maintitle>\n</sb:title>\n<sb:volume-nr>30</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>2004</sb:first-page>\n<sb:last-page>2009</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0025\">Glue P, Loo C, Fam J, et al. Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial. Nat Med. 2024;30(7):2004-2009.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0026\">\n<ce:label>26</ce:label>\n<sb:reference id=\"sbref0026\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Fernie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Currie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.S.</ce:given-name>\n<ce:surname>Perrin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Br J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>210</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>422</sb:first-page>\n<sb:last-page>428</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0026\">Fernie G, Currie J, Perrin JS, et al. Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial. Br J Psychiatry. 2017;210(6):422-428.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0027\">\n<ce:label>27</ce:label>\n<sb:reference id=\"sbref0027\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Zou</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Min</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Q.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Ren</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-A randomized, double-blind, controlled clinical study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Brain Behav</sb:maintitle>\n</sb:title>\n<sb:volume-nr>11</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:article-number>e01775</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0027\">Zou L, Min S, Chen Q, Li X, Ren L. Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-A randomized, double-blind, controlled clinical study. Brain Behav. 2021;11(1):e01775.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0028\">\n<ce:label>28</ce:label>\n<sb:reference id=\"sbref0028\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>George</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Gálvez</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>25</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>11</sb:issue-nr>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1199</sb:first-page>\n<sb:last-page>1209</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0028\">George D, Gálvez V, Martin D, et al. Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression. Am J Geriatr Psychiatry. 2017;25(11):1199-1209.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0029\">\n<ce:label>29</ce:label>\n<sb:reference id=\"sbref0029\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Wajs</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Aluisio</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Holder</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: Assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2)</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Clin Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>81</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<ce:doi>10.4088/JCP.19m12891</ce:doi>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0029\">Wajs E, Aluisio L, Holder R, et al. Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: Assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2). J Clin Psychiatry. 2020;81(3). doi:10.4088/JCP.19m12891</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0030\">\n<ce:label>30</ce:label>\n<sb:reference id=\"sbref0030\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.A.</ce:given-name>\n<ce:surname>Oughli</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.A.</ce:given-name>\n<ce:surname>Gebara</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Ciarleglio</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Intravenous ketamine for late-life treatment-resistant depression: A pilot study of tolerability, safety, clinical benefits, and effect on cognition</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>31</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>210</sb:first-page>\n<sb:last-page>221</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0030\">Oughli HA, Gebara MA, Ciarleglio A, et al. Intravenous ketamine for late-life treatment-resistant depression: A pilot study of tolerability, safety, clinical benefits, and effect on cognition. Am J Geriatr Psychiatry. 2023;31(3):210-221.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0031\">\n<ce:label>31</ce:label>\n<sb:reference id=\"sbref0031\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Zaki</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.N.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Lane</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Neuropsychopharmacology</sb:maintitle>\n</sb:title>\n<sb:volume-nr>48</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>8</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1225</sb:first-page>\n<sb:last-page>1233</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0031\">Zaki N, Chen LN, Lane R, et al. Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study. Neuropsychopharmacology. 2023;48(8):1225-1233.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0032\">\n<ce:label>32</ce:label>\n<sb:reference id=\"sbref0032\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>K.G.</ce:given-name>\n<ce:surname>Rasmussen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.W.</ce:given-name>\n<ce:surname>Lineberry</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.W.</ce:given-name>\n<ce:surname>Galardy</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Serial infusions of low-dose ketamine for major depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>27</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2013</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>444</sb:first-page>\n<sb:last-page>450</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0032\">Rasmussen KG, Lineberry TW, Galardy CW, et al. Serial infusions of low-dose ketamine for major depression. J Psychopharmacol. 2013;27(5):444-450.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0033\">\n<ce:label>33</ce:label>\n<sb:reference id=\"sbref0033\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Vanderschelden</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.A.</ce:given-name>\n<ce:surname>Gebara</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.A.</ce:given-name>\n<ce:surname>Oughli</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Change in patient-centered outcomes of psychological well-being, sleep, and suicidality following treatment with intravenous ketamine for late-life treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>38</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>e5964</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0033\">Vanderschelden B, Gebara MA, Oughli HA, et al. Change in patient-centered outcomes of psychological well-being, sleep, and suicidality following treatment with intravenous ketamine for late-life treatment-resistant depression. Int J Geriatr Psychiatry. 2023;38(7):e5964.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0034\">\n<ce:label>34</ce:label>\n<sb:reference id=\"sbref0034\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Ochs-Ross</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Wajs</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Comparison of long-term efficacy and safety of esketamine nasal spray plus oral antidepressant in younger versus older patients with treatment-resistant depression: Post-hoc analysis of SUSTAIN-2, a long-term open-label phase 3 safety and efficacy study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>30</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>541</sb:first-page>\n<sb:last-page>556</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0034\">Ochs-Ross R, Wajs E, Daly EJ, et al. Comparison of long-term efficacy and safety of esketamine nasal spray plus oral antidepressant in younger versus older patients with treatment-resistant depression: Post-hoc analysis of SUSTAIN-2, a long-term open-label phase 3 safety and efficacy study. Am J Geriatr Psychiatry. 2022;30(5):541-556.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0035\">\n<ce:label>35</ce:label>\n<sb:reference id=\"sbref0035\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Filteau</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>156</sb:volume-nr>\n</sb:series>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1</sb:first-page>\n<sb:last-page>7</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0035\">McIntyre RS, Filteau MJ, Martin L, et al. Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach. J Affect Disord. 2014;156:1-7.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0036\">\n<ce:label>36</ce:label>\n<sb:reference id=\"sbref0036\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.R.</ce:given-name>\n<ce:surname>Strawn</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.A.</ce:given-name>\n<ce:surname>Mills</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Suresh</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorder</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>159</sb:volume-nr>\n</sb:series>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>266</sb:first-page>\n<sb:last-page>273</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0036\">Strawn JR, Mills JA, Suresh V, et al. The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorder. J Psychiatr Res. 2023;159:266-273.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0037\">\n<ce:label>37</ce:label>\n<sb:reference id=\"sbref0037\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Popova</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Trivedi</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>176</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>428</sb:first-page>\n<sb:last-page>438</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0037\">Popova V, Daly EJ, Trivedi M, et al. Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study. Am J Psychiatry. 2019;176(6):428-438.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0038\">\n<ce:label>38</ce:label>\n<sb:reference id=\"sbref0038\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.F.</ce:given-name>\n<ce:surname>Grunebaum</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.C.</ce:given-name>\n<ce:surname>Galfalvy</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.H.</ce:given-name>\n<ce:surname>Choo</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine for rapid reduction of suicidal thoughts in major depression: A midazolam-controlled randomized clinical trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>175</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>327</sb:first-page>\n<sb:last-page>335</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0038\">Grunebaum MF, Galfalvy HC, Choo TH, et al. Ketamine for rapid reduction of suicidal thoughts in major depression: A midazolam-controlled randomized clinical trial. Am J Psychiatry. 2018;175(4):327-335.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0039\">\n<ce:label>39</ce:label>\n<sb:reference id=\"sbref0039\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.T.</ce:given-name>\n<ce:surname>Wilkinson</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Farmer</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.D.</ce:given-name>\n<ce:surname>Ballard</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Neuropsychopharmacology</sb:maintitle>\n</sb:title>\n<sb:volume-nr>44</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1233</sb:first-page>\n<sb:last-page>1238</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0039\">Wilkinson ST, Farmer C, Ballard ED, et al. Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant. Neuropsychopharmacology. 2019;44(7):1233-1238.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0040\">\n<ce:label>40</ce:label>\n<sb:reference id=\"sbref0040\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.L.</ce:given-name>\n<ce:surname>Naismith</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.M.</ce:given-name>\n<ce:surname>Norrie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Mowszowski</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>IB.</ce:given-name>\n<ce:surname>Hickie</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The neurobiology of depression in later-life: Clinical, neuropsychological, neuroimaging and pathophysiological features</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Prog Neurobiol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>98</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2012</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>99</sb:first-page>\n<sb:last-page>143</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0040\">Naismith SL, Norrie LM, Mowszowski L, Hickie IB. The neurobiology of depression in later-life: Clinical, neuropsychological, neuroimaging and pathophysiological features. Prog Neurobiol. 2012;98(1):99-143.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0041\">\n<ce:label>41</ce:label>\n<sb:reference id=\"sbref0041\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Bayes</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Dong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Alonzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Kabourakis</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Loo</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine treatment for depression: A model of care</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Aust N Z J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>55</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>12</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1134</sb:first-page>\n<sb:last-page>1143</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0041\">Bayes A, Dong V, Martin D, Alonzo A, Kabourakis M, Loo C. Ketamine treatment for depression: A model of care. Aust N Z J Psychiatry. 2021;55(12):1134-1143.</ce:source-text>\n</ce:bib-reference>\n</ce:bibliography-sec>",
    "error_message": "All bibliographic references within 'ce:bibliography' must be referred to.",
    "error_position": "1094:63",
    "error_id": "IDS503a",
    "folder_name": "AMGP2541"
  },
  {
    "input": "<ce:bibliography-sec xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"cebibsec1\">\n<?att type=\"article\"?><ce:bib-reference id=\"bib0001\">\n<ce:label>1</ce:label>\n<sb:reference id=\"sbref0001\">\n<sb:contribution>\n<sb:authors>\n<sb:collaboration>Global Burden of Disease Study 2013 Collaborators</sb:collaboration>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Lancet</sb:maintitle>\n</sb:title>\n<sb:volume-nr>386</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>9995</sb:issue-nr>\n<sb:date>20132015</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>743</sb:first-page>\n<sb:last-page>800</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0001\">Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743-800.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0002\">\n<ce:label>2</ce:label>\n<sb:reference id=\"sbref0002\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Maj</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.J.</ce:given-name>\n<ce:surname>Stein</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Parker</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The clinical characterization of the adult patient with depression aimed at personalization of management</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>19</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>269</sb:first-page>\n<sb:last-page>293</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0002\">Maj M, Stein DJ, Parker G, et al. The clinical characterization of the adult patient with depression aimed at personalization of management. World Psychiatry. 2020;19(3):269-293.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0003\">\n<ce:label>3</ce:label>\n<sb:reference id=\"sbref0003\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>CF 3rd</ce:given-name>\n<ce:surname>Reynolds</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.V.</ce:given-name>\n<ce:surname>Jeste</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.S.</ce:given-name>\n<ce:surname>Sachdev</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.G.</ce:given-name>\n<ce:surname>Blazer</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Mental health care for older adults: recent advances and new directions in clinical practice and research</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>21</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>336</sb:first-page>\n<sb:last-page>363</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0003\">Reynolds CF 3rd, Jeste DV, Sachdev PS, Blazer DG. Mental health care for older adults: recent advances and new directions in clinical practice and research. World Psychiatry. 2022;21(3):336-363.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0004\">\n<ce:label>4</ce:label>\n<sb:reference id=\"sbref0004\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zenebe</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Akele</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>W/Selassie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Necho</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Prevalence and determinants of depression among old age: a systematic review and meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Ann Gen Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>20</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>55</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0004\">Zenebe Y, Akele B, W/Selassie M, Necho M. Prevalence and determinants of depression among old age: a systematic review and meta-analysis. Ann Gen Psychiatry. 2021;20(1):55.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0005\">\n<ce:label>5</ce:label>\n<sb:reference id=\"sbref0005\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.S.</ce:given-name>\n<ce:surname>Hasin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.L.</ce:given-name>\n<ce:surname>Sarvet</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.L.</ce:given-name>\n<ce:surname>Meyers</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>JAMA Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>75</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>336</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0005\">Hasin DS, Sarvet AL, Meyers JL, et al. Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiatry. 2018;75(4):336.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0006\">\n<ce:label>6</ce:label>\n<sb:reference id=\"sbref0006\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.R.</ce:given-name>\n<ce:surname>Azar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.P.</ce:given-name>\n<ce:surname>Chopra</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.Y.</ce:given-name>\n<ce:surname>Cho</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Coakley</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>JL.</ce:given-name>\n<ce:surname>Rudolph</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Remission in major depression: results from a geriatric primary care population</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>26</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2011</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>48</sb:first-page>\n<sb:last-page>55</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0006\">Azar AR, Chopra MP, Cho LY, Coakley E, Rudolph JL. Remission in major depression: results from a geriatric primary care population. Int J Geriatr Psychiatry. 2011;26(1):48-55.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0007\">\n<ce:label>7</ce:label>\n<sb:reference id=\"sbref0007\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>U.</ce:given-name>\n<ce:surname>Klotz</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pharmacokinetics and drug metabolism in the elderly</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Drug Metab Rev</sb:maintitle>\n</sb:title>\n<sb:volume-nr>41</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2009</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>67</sb:first-page>\n<sb:last-page>76</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0007\">Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev. 2009;41(2):67-76.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0008\">\n<ce:label>8</ce:label>\n<sb:reference id=\"sbref0008\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Canadian Coalition for Seniors’ Mental</ce:given-name>\n<ce:surname>Health</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Canadian Guidelines on Prevention, Assessment and Treatment of Depression Among Older Adults</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>CCSMH; 2021</sb:maintitle>\n</sb:title>\n</sb:series>\n<sb:date>June 2021</sb:date>\n</sb:issue>\n</sb:host>\n<sb:comment>Updated</sb:comment>\n<sb:host>\n<sb:e-host>\n<ce:inter-ref id=\"interref0001\" xlink:href=\"https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf\">https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf</ce:inter-ref>\n</sb:e-host>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0008\">Canadian Coalition for Seniors’ Mental Health. Canadian Guidelines on Prevention, Assessment and Treatment of Depression Among Older Adults. CCSMH; 2021. Updated June 2021. https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0009\">\n<ce:label>9</ce:label>\n<sb:reference id=\"sbref0009\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Avasthi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Grover</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Clinical practice guidelines for management of depression in elderly</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Indian J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>60</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>Suppl 3</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>S341</sb:first-page>\n<sb:last-page>S362</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0009\">Avasthi A, Grover S. Clinical practice guidelines for management of depression in elderly. Indian J Psychiatry. 2018;60(Suppl 3):S341-S362.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0010\">\n<ce:label>10</ce:label>\n<sb:reference id=\"sbref0010\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Baba</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Kito</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Nukariya</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Guidelines for diagnosis and treatment of depression in older adults: A report from the Japanese Society of mood disorders</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Psychiatry Clin Neurosci</sb:maintitle>\n</sb:title>\n<sb:volume-nr>76</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>222</sb:first-page>\n<sb:last-page>234</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0010\">Baba H, Kito S, Nukariya K, et al. Guidelines for diagnosis and treatment of depression in older adults: A report from the Japanese Society of mood disorders. Psychiatry Clin Neurosci. 2022;76(6):222-234.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0011\">\n<ce:label>11</ce:label>\n<sb:reference id=\"sbref0011\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Rosenblat</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.B.</ce:given-name>\n<ce:surname>Nemeroff</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>178</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>383</sb:first-page>\n<sb:last-page>399</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0011\">McIntyre RS, Rosenblat JD, Nemeroff CB, et al. Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation. Am J Psychiatry. 2021;178(5):383-399.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0012\">\n<ce:label>12</ce:label>\n<sb:reference id=\"sbref0012\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.C.H.</ce:given-name>\n<ce:surname>Cheng</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.E.</ce:given-name>\n<ce:surname>Dri</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Ballum</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effects of ketamine and esketamine on measures of quality of life in major depressive disorder and treatment-resistant depression: A systematic review</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>382</sb:volume-nr>\n</sb:series>\n<sb:date>2025</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>438</sb:first-page>\n<sb:last-page>442</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0012\">Cheng MCH, Dri CE, Ballum H, et al. The effects of ketamine and esketamine on measures of quality of life in major depressive disorder and treatment-resistant depression: A systematic review. J Affect Disord. 2025;382:438-442.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0013\">\n<ce:label>13</ce:label>\n<sb:reference id=\"sbref0013\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Di Vincenzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.B.</ce:given-name>\n<ce:surname>Rodrigues</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Safety, tolerability, and real-world effectiveness of intravenous ketamine in older adults with treatment-resistant depression: A case series</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>29</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>9</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>899</sb:first-page>\n<sb:last-page>913</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0013\">Lipsitz O, Di Vincenzo JD, Rodrigues NB, et al. Safety, tolerability, and real-world effectiveness of intravenous ketamine in older adults with treatment-resistant depression: A case series. Am J Geriatr Psychiatry. 2021;29(9):899-913.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0014\">\n<ce:label>14</ce:label>\n<sb:reference id=\"sbref0014\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>I.P.</ce:given-name>\n<ce:surname>Carvalho</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.M.W.</ce:given-name>\n<ce:surname>Lui</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>276</sb:volume-nr>\n</sb:series>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>576</sb:first-page>\n<sb:last-page>584</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0014\">McIntyre RS, Carvalho IP, Lui LMW, et al. The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis. J Affect Disord. 2020;276:576-584.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0015\">\n<ce:label>15</ce:label>\n<sb:reference id=\"sbref0015\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Lee</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Syeda</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.A.</ce:given-name>\n<ce:surname>Maruschak</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>A new perspective on the anti-suicide effects with ketamine treatment: A procognitive effect</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Clin Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>36</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2016</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>50</sb:first-page>\n<sb:last-page>56</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0015\">Lee Y, Syeda K, Maruschak NA, et al. A new perspective on the anti-suicide effects with ketamine treatment: A procognitive effect. J Clin Psychopharmacol. 2016;36(1):50-56.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0016\">\n<ce:label>16</ce:label>\n<sb:reference id=\"sbref0016\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Xiong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Chen-Li</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>134</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>57</sb:first-page>\n<sb:last-page>68</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0016\">Xiong J, Lipsitz O, Chen-Li D, et al. The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis. J Psychiatr Res. 2021;134:57-68.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0017\">\n<ce:label>17</ce:label>\n<sb:reference id=\"sbref0017\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Gupta</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Dhar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Patadia</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>A systematic review of ketamine for the treatment of depression among older adults</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int Psychogeriatr</sb:maintitle>\n</sb:title>\n<sb:volume-nr>33</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>179</sb:first-page>\n<sb:last-page>191</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0017\">Gupta A, Dhar R, Patadia P, et al. A systematic review of ketamine for the treatment of depression among older adults. Int Psychogeriatr. 2021;33(2):179-191.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0018\">\n<ce:label>18</ce:label>\n<sb:reference id=\"sbref0018\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Di Vincenzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Siegel</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>137</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>232</sb:first-page>\n<sb:last-page>241</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0018\">Di Vincenzo JD, Siegel A, Lipsitz O, et al. The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review. J Psychiatr Res. 2021;137:232-241.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0019\">\n<ce:label>19</ce:label>\n<sb:reference id=\"sbref0019\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Page</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.E.</ce:given-name>\n<ce:surname>McKenzie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.M.</ce:given-name>\n<ce:surname>Bossuyt</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The PRISMA 2020 statement: an updated guideline for reporting systematic reviews</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>BMJ</sb:maintitle>\n</sb:title>\n<sb:volume-nr>372</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>n71</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0019\">Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0020\">\n<ce:label>20</ce:label>\n<sb:reference id=\"sbref0020\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.A.C.</ce:given-name>\n<ce:surname>Sterne</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Savović</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Page</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>RoB 2: a revised tool for assessing risk of bias in randomised trials</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>BMJ</sb:maintitle>\n</sb:title>\n<sb:volume-nr>366</sb:volume-nr>\n</sb:series>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>l4898</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0020\">Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0021\">\n<ce:label>21</ce:label>\n<sb:reference id=\"sbref0021\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>T.H.</ce:given-name>\n<ce:surname>Barker</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Habibi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Aromataris</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>JBI Evid Synth</sb:maintitle>\n</sb:title>\n<sb:volume-nr>22</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>378</sb:first-page>\n<sb:last-page>388</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0021\">Barker TH, Habibi N, Aromataris E, et al. The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies. JBI Evid Synth. 2024;22(3):378-388.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0022\">\n<ce:label>22</ce:label>\n<sb:reference id=\"sbref0022\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Gálvez</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Huggins</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>32</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>397</sb:first-page>\n<sb:last-page>407</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0022\">Gálvez V, Li A, Huggins C, et al. Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial. J Psychopharmacol. 2018;32(4):397-407.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0023\">\n<ce:label>23</ce:label>\n<sb:reference id=\"sbref0023\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Ochs-Ross</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zhang</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression-TRANSFORM-3</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>28</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>121</sb:first-page>\n<sb:last-page>141</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0023\">Ochs-Ross R, Daly EJ, Zhang Y, et al. Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression-TRANSFORM-3. Am J Geriatr Psychiatry. 2020;28(2):121-141.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0024\">\n<ce:label>24</ce:label>\n<sb:reference id=\"sbref0024\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Lai</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Katalinic</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Glue</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pilot dose-response trial of i.v. ketamine in treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World J Biol Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>15</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>579</sb:first-page>\n<sb:last-page>584</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0024\">Lai R, Katalinic N, Glue P, et al. Pilot dose-response trial of i.v. ketamine in treatment-resistant depression. World J Biol Psychiatry. 2014;15(7):579-584.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0025\">\n<ce:label>25</ce:label>\n<sb:reference id=\"sbref0025\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Glue</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Loo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Fam</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Nat Med</sb:maintitle>\n</sb:title>\n<sb:volume-nr>30</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>2004</sb:first-page>\n<sb:last-page>2009</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0025\">Glue P, Loo C, Fam J, et al. Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial. Nat Med. 2024;30(7):2004-2009.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0026\">\n<ce:label>26</ce:label>\n<sb:reference id=\"sbref0026\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Fernie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Currie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.S.</ce:given-name>\n<ce:surname>Perrin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Br J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>210</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>422</sb:first-page>\n<sb:last-page>428</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0026\">Fernie G, Currie J, Perrin JS, et al. Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial. Br J Psychiatry. 2017;210(6):422-428.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0027\">\n<ce:label>27</ce:label>\n<sb:reference id=\"sbref0027\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Zou</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Min</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Q.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Ren</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-A randomized, double-blind, controlled clinical study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Brain Behav</sb:maintitle>\n</sb:title>\n<sb:volume-nr>11</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:article-number>e01775</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0027\">Zou L, Min S, Chen Q, Li X, Ren L. Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-A randomized, double-blind, controlled clinical study. Brain Behav. 2021;11(1):e01775.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0028\">\n<ce:label>28</ce:label>\n<sb:reference id=\"sbref0028\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>George</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Gálvez</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>25</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>11</sb:issue-nr>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1199</sb:first-page>\n<sb:last-page>1209</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0028\">George D, Gálvez V, Martin D, et al. Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression. Am J Geriatr Psychiatry. 2017;25(11):1199-1209.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0029\">\n<ce:label>29</ce:label>\n<sb:reference id=\"sbref0029\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Wajs</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Aluisio</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Holder</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: Assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2)</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Clin Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>81</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<ce:doi>10.4088/JCP.19m12891</ce:doi>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0029\">Wajs E, Aluisio L, Holder R, et al. Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: Assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2). J Clin Psychiatry. 2020;81(3). doi:10.4088/JCP.19m12891</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0030\">\n<ce:label>30</ce:label>\n<sb:reference id=\"sbref0030\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.A.</ce:given-name>\n<ce:surname>Oughli</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.A.</ce:given-name>\n<ce:surname>Gebara</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Ciarleglio</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Intravenous ketamine for late-life treatment-resistant depression: A pilot study of tolerability, safety, clinical benefits, and effect on cognition</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>31</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>210</sb:first-page>\n<sb:last-page>221</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0030\">Oughli HA, Gebara MA, Ciarleglio A, et al. Intravenous ketamine for late-life treatment-resistant depression: A pilot study of tolerability, safety, clinical benefits, and effect on cognition. Am J Geriatr Psychiatry. 2023;31(3):210-221.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0031\">\n<ce:label>31</ce:label>\n<sb:reference id=\"sbref0031\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Zaki</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.N.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Lane</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Neuropsychopharmacology</sb:maintitle>\n</sb:title>\n<sb:volume-nr>48</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>8</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1225</sb:first-page>\n<sb:last-page>1233</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0031\">Zaki N, Chen LN, Lane R, et al. Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study. Neuropsychopharmacology. 2023;48(8):1225-1233.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0032\">\n<ce:label>32</ce:label>\n<sb:reference id=\"sbref0032\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>K.G.</ce:given-name>\n<ce:surname>Rasmussen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.W.</ce:given-name>\n<ce:surname>Lineberry</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.W.</ce:given-name>\n<ce:surname>Galardy</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Serial infusions of low-dose ketamine for major depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>27</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2013</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>444</sb:first-page>\n<sb:last-page>450</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0032\">Rasmussen KG, Lineberry TW, Galardy CW, et al. Serial infusions of low-dose ketamine for major depression. J Psychopharmacol. 2013;27(5):444-450.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0033\">\n<ce:label>33</ce:label>\n<sb:reference id=\"sbref0033\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Vanderschelden</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.A.</ce:given-name>\n<ce:surname>Gebara</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.A.</ce:given-name>\n<ce:surname>Oughli</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Change in patient-centered outcomes of psychological well-being, sleep, and suicidality following treatment with intravenous ketamine for late-life treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>38</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>e5964</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0033\">Vanderschelden B, Gebara MA, Oughli HA, et al. Change in patient-centered outcomes of psychological well-being, sleep, and suicidality following treatment with intravenous ketamine for late-life treatment-resistant depression. Int J Geriatr Psychiatry. 2023;38(7):e5964.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0034\">\n<ce:label>34</ce:label>\n<sb:reference id=\"sbref0034\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Ochs-Ross</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Wajs</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Comparison of long-term efficacy and safety of esketamine nasal spray plus oral antidepressant in younger versus older patients with treatment-resistant depression: Post-hoc analysis of SUSTAIN-2, a long-term open-label phase 3 safety and efficacy study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>30</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>541</sb:first-page>\n<sb:last-page>556</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0034\">Ochs-Ross R, Wajs E, Daly EJ, et al. Comparison of long-term efficacy and safety of esketamine nasal spray plus oral antidepressant in younger versus older patients with treatment-resistant depression: Post-hoc analysis of SUSTAIN-2, a long-term open-label phase 3 safety and efficacy study. Am J Geriatr Psychiatry. 2022;30(5):541-556.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0035\">\n<ce:label>35</ce:label>\n<sb:reference id=\"sbref0035\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Filteau</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>156</sb:volume-nr>\n</sb:series>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1</sb:first-page>\n<sb:last-page>7</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0035\">McIntyre RS, Filteau MJ, Martin L, et al. Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach. J Affect Disord. 2014;156:1-7.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0036\">\n<ce:label>36</ce:label>\n<sb:reference id=\"sbref0036\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.R.</ce:given-name>\n<ce:surname>Strawn</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.A.</ce:given-name>\n<ce:surname>Mills</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Suresh</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorder</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>159</sb:volume-nr>\n</sb:series>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>266</sb:first-page>\n<sb:last-page>273</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0036\">Strawn JR, Mills JA, Suresh V, et al. The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorder. J Psychiatr Res. 2023;159:266-273.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0037\">\n<ce:label>37</ce:label>\n<sb:reference id=\"sbref0037\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Popova</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Trivedi</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>176</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>428</sb:first-page>\n<sb:last-page>438</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0037\">Popova V, Daly EJ, Trivedi M, et al. Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study. Am J Psychiatry. 2019;176(6):428-438.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0038\">\n<ce:label>38</ce:label>\n<sb:reference id=\"sbref0038\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.F.</ce:given-name>\n<ce:surname>Grunebaum</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.C.</ce:given-name>\n<ce:surname>Galfalvy</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.H.</ce:given-name>\n<ce:surname>Choo</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine for rapid reduction of suicidal thoughts in major depression: A midazolam-controlled randomized clinical trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>175</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>327</sb:first-page>\n<sb:last-page>335</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0038\">Grunebaum MF, Galfalvy HC, Choo TH, et al. Ketamine for rapid reduction of suicidal thoughts in major depression: A midazolam-controlled randomized clinical trial. Am J Psychiatry. 2018;175(4):327-335.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0039\">\n<ce:label>39</ce:label>\n<sb:reference id=\"sbref0039\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.T.</ce:given-name>\n<ce:surname>Wilkinson</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Farmer</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.D.</ce:given-name>\n<ce:surname>Ballard</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Neuropsychopharmacology</sb:maintitle>\n</sb:title>\n<sb:volume-nr>44</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1233</sb:first-page>\n<sb:last-page>1238</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0039\">Wilkinson ST, Farmer C, Ballard ED, et al. Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant. Neuropsychopharmacology. 2019;44(7):1233-1238.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0040\">\n<ce:label>40</ce:label>\n<sb:reference id=\"sbref0040\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.L.</ce:given-name>\n<ce:surname>Naismith</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.M.</ce:given-name>\n<ce:surname>Norrie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Mowszowski</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>IB.</ce:given-name>\n<ce:surname>Hickie</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The neurobiology of depression in later-life: Clinical, neuropsychological, neuroimaging and pathophysiological features</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Prog Neurobiol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>98</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2012</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>99</sb:first-page>\n<sb:last-page>143</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0040\">Naismith SL, Norrie LM, Mowszowski L, Hickie IB. The neurobiology of depression in later-life: Clinical, neuropsychological, neuroimaging and pathophysiological features. Prog Neurobiol. 2012;98(1):99-143.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0041\">\n<ce:label>41</ce:label>\n<sb:reference id=\"sbref0041\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Bayes</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Dong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Alonzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Kabourakis</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Loo</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine treatment for depression: A model of care</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Aust N Z J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>55</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>12</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1134</sb:first-page>\n<sb:last-page>1143</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0041\">Bayes A, Dong V, Martin D, Alonzo A, Kabourakis M, Loo C. Ketamine treatment for depression: A model of care. Aust N Z J Psychiatry. 2021;55(12):1134-1143.</ce:source-text>\n</ce:bib-reference>\n</ce:bibliography-sec>",
    "output": "<ce:bibliography-sec xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"cebibsec1\">\n<?att type=\"article\"?><ce:bib-reference id=\"bib0001\">\n<ce:label>1</ce:label>\n<sb:reference id=\"sbref0001\">\n<sb:contribution>\n<sb:authors>\n<sb:collaboration>Global Burden of Disease Study 2013 Collaborators</sb:collaboration>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Lancet</sb:maintitle>\n</sb:title>\n<sb:volume-nr>386</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>9995</sb:issue-nr>\n<sb:date>20132015</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>743</sb:first-page>\n<sb:last-page>800</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0001\">Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743-800.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0002\">\n<ce:label>2</ce:label>\n<sb:reference id=\"sbref0002\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Maj</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.J.</ce:given-name>\n<ce:surname>Stein</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Parker</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The clinical characterization of the adult patient with depression aimed at personalization of management</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>19</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>269</sb:first-page>\n<sb:last-page>293</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0002\">Maj M, Stein DJ, Parker G, et al. The clinical characterization of the adult patient with depression aimed at personalization of management. World Psychiatry. 2020;19(3):269-293.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0003\">\n<ce:label>3</ce:label>\n<sb:reference id=\"sbref0003\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>CF 3rd</ce:given-name>\n<ce:surname>Reynolds</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.V.</ce:given-name>\n<ce:surname>Jeste</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.S.</ce:given-name>\n<ce:surname>Sachdev</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.G.</ce:given-name>\n<ce:surname>Blazer</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Mental health care for older adults: recent advances and new directions in clinical practice and research</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>21</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>336</sb:first-page>\n<sb:last-page>363</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0003\">Reynolds CF 3rd, Jeste DV, Sachdev PS, Blazer DG. Mental health care for older adults: recent advances and new directions in clinical practice and research. World Psychiatry. 2022;21(3):336-363.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0004\">\n<ce:label>4</ce:label>\n<sb:reference id=\"sbref0004\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zenebe</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Akele</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>W/Selassie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Necho</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Prevalence and determinants of depression among old age: a systematic review and meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Ann Gen Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>20</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>55</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0004\">Zenebe Y, Akele B, W/Selassie M, Necho M. Prevalence and determinants of depression among old age: a systematic review and meta-analysis. Ann Gen Psychiatry. 2021;20(1):55.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0005\">\n<ce:label>5</ce:label>\n<sb:reference id=\"sbref0005\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.S.</ce:given-name>\n<ce:surname>Hasin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.L.</ce:given-name>\n<ce:surname>Sarvet</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.L.</ce:given-name>\n<ce:surname>Meyers</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>JAMA Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>75</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>336</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0005\">Hasin DS, Sarvet AL, Meyers JL, et al. Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiatry. 2018;75(4):336.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0006\">\n<ce:label>6</ce:label>\n<sb:reference id=\"sbref0006\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.R.</ce:given-name>\n<ce:surname>Azar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.P.</ce:given-name>\n<ce:surname>Chopra</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.Y.</ce:given-name>\n<ce:surname>Cho</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Coakley</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>JL.</ce:given-name>\n<ce:surname>Rudolph</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Remission in major depression: results from a geriatric primary care population</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>26</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2011</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>48</sb:first-page>\n<sb:last-page>55</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0006\">Azar AR, Chopra MP, Cho LY, Coakley E, Rudolph JL. Remission in major depression: results from a geriatric primary care population. Int J Geriatr Psychiatry. 2011;26(1):48-55.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0007\">\n<ce:label>7</ce:label>\n<sb:reference id=\"sbref0007\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>U.</ce:given-name>\n<ce:surname>Klotz</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pharmacokinetics and drug metabolism in the elderly</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Drug Metab Rev</sb:maintitle>\n</sb:title>\n<sb:volume-nr>41</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2009</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>67</sb:first-page>\n<sb:last-page>76</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0007\">Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev. 2009;41(2):67-76.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0008\">\n<ce:label>8</ce:label>\n<sb:reference id=\"sbref0008\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Canadian Coalition for Seniors’ Mental</ce:given-name>\n<ce:surname>Health</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Canadian Guidelines on Prevention, Assessment and Treatment of Depression Among Older Adults</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>CCSMH; 2021</sb:maintitle>\n</sb:title>\n</sb:series>\n<sb:date>June 2021</sb:date>\n</sb:issue>\n</sb:host>\n<sb:comment>Updated</sb:comment>\n<sb:host>\n<sb:e-host>\n<ce:inter-ref id=\"interref0001\" xlink:href=\"https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf\">https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf</ce:inter-ref>\n</sb:e-host>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0008\">Canadian Coalition for Seniors’ Mental Health. Canadian Guidelines on Prevention, Assessment and Treatment of Depression Among Older Adults. CCSMH; 2021. Updated June 2021. https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0009\">\n<ce:label>9</ce:label>\n<sb:reference id=\"sbref0009\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Avasthi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Grover</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Clinical practice guidelines for management of depression in elderly</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Indian J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>60</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>Suppl 3</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>S341</sb:first-page>\n<sb:last-page>S362</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0009\">Avasthi A, Grover S. Clinical practice guidelines for management of depression in elderly. Indian J Psychiatry. 2018;60(Suppl 3):S341-S362.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0010\">\n<ce:label>10</ce:label>\n<sb:reference id=\"sbref0010\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Baba</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Kito</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Nukariya</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Guidelines for diagnosis and treatment of depression in older adults: A report from the Japanese Society of mood disorders</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Psychiatry Clin Neurosci</sb:maintitle>\n</sb:title>\n<sb:volume-nr>76</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>222</sb:first-page>\n<sb:last-page>234</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0010\">Baba H, Kito S, Nukariya K, et al. Guidelines for diagnosis and treatment of depression in older adults: A report from the Japanese Society of mood disorders. Psychiatry Clin Neurosci. 2022;76(6):222-234.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0011\">\n<ce:label>11</ce:label>\n<sb:reference id=\"sbref0011\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Rosenblat</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.B.</ce:given-name>\n<ce:surname>Nemeroff</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>178</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>383</sb:first-page>\n<sb:last-page>399</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0011\">McIntyre RS, Rosenblat JD, Nemeroff CB, et al. Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation. Am J Psychiatry. 2021;178(5):383-399.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0012\">\n<ce:label>12</ce:label>\n<sb:reference id=\"sbref0012\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.C.H.</ce:given-name>\n<ce:surname>Cheng</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.E.</ce:given-name>\n<ce:surname>Dri</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Ballum</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effects of ketamine and esketamine on measures of quality of life in major depressive disorder and treatment-resistant depression: A systematic review</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>382</sb:volume-nr>\n</sb:series>\n<sb:date>2025</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>438</sb:first-page>\n<sb:last-page>442</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0012\">Cheng MCH, Dri CE, Ballum H, et al. The effects of ketamine and esketamine on measures of quality of life in major depressive disorder and treatment-resistant depression: A systematic review. J Affect Disord. 2025;382:438-442.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0013\">\n<ce:label>13</ce:label>\n<sb:reference id=\"sbref0013\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Di Vincenzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.B.</ce:given-name>\n<ce:surname>Rodrigues</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Safety, tolerability, and real-world effectiveness of intravenous ketamine in older adults with treatment-resistant depression: A case series</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>29</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>9</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>899</sb:first-page>\n<sb:last-page>913</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0013\">Lipsitz O, Di Vincenzo JD, Rodrigues NB, et al. Safety, tolerability, and real-world effectiveness of intravenous ketamine in older adults with treatment-resistant depression: A case series. Am J Geriatr Psychiatry. 2021;29(9):899-913.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0014\">\n<ce:label>14</ce:label>\n<sb:reference id=\"sbref0014\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>I.P.</ce:given-name>\n<ce:surname>Carvalho</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.M.W.</ce:given-name>\n<ce:surname>Lui</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>276</sb:volume-nr>\n</sb:series>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>576</sb:first-page>\n<sb:last-page>584</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0014\">McIntyre RS, Carvalho IP, Lui LMW, et al. The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis. J Affect Disord. 2020;276:576-584.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0015\">\n<ce:label>15</ce:label>\n<sb:reference id=\"sbref0015\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Lee</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Syeda</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.A.</ce:given-name>\n<ce:surname>Maruschak</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>A new perspective on the anti-suicide effects with ketamine treatment: A procognitive effect</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Clin Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>36</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2016</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>50</sb:first-page>\n<sb:last-page>56</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0015\">Lee Y, Syeda K, Maruschak NA, et al. A new perspective on the anti-suicide effects with ketamine treatment: A procognitive effect. J Clin Psychopharmacol. 2016;36(1):50-56.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0016\">\n<ce:label>16</ce:label>\n<sb:reference id=\"sbref0016\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Xiong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Chen-Li</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>134</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>57</sb:first-page>\n<sb:last-page>68</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0016\">Xiong J, Lipsitz O, Chen-Li D, et al. The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis. J Psychiatr Res. 2021;134:57-68.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0017\">\n<ce:label>17</ce:label>\n<sb:reference id=\"sbref0017\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Gupta</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Dhar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Patadia</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>A systematic review of ketamine for the treatment of depression among older adults</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int Psychogeriatr</sb:maintitle>\n</sb:title>\n<sb:volume-nr>33</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>179</sb:first-page>\n<sb:last-page>191</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0017\">Gupta A, Dhar R, Patadia P, et al. A systematic review of ketamine for the treatment of depression among older adults. Int Psychogeriatr. 2021;33(2):179-191.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0018\">\n<ce:label>18</ce:label>\n<sb:reference id=\"sbref0018\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Di Vincenzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Siegel</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>137</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>232</sb:first-page>\n<sb:last-page>241</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0018\">Di Vincenzo JD, Siegel A, Lipsitz O, et al. The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review. J Psychiatr Res. 2021;137:232-241.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0019\">\n<ce:label>19</ce:label>\n<sb:reference id=\"sbref0019\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Page</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.E.</ce:given-name>\n<ce:surname>McKenzie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.M.</ce:given-name>\n<ce:surname>Bossuyt</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The PRISMA 2020 statement: an updated guideline for reporting systematic reviews</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>BMJ</sb:maintitle>\n</sb:title>\n<sb:volume-nr>372</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>n71</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0019\">Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0020\">\n<ce:label>20</ce:label>\n<sb:reference id=\"sbref0020\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.A.C.</ce:given-name>\n<ce:surname>Sterne</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Savović</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Page</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>RoB 2: a revised tool for assessing risk of bias in randomised trials</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>BMJ</sb:maintitle>\n</sb:title>\n<sb:volume-nr>366</sb:volume-nr>\n</sb:series>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>l4898</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0020\">Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0021\">\n<ce:label>21</ce:label>\n<sb:reference id=\"sbref0021\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>T.H.</ce:given-name>\n<ce:surname>Barker</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Habibi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Aromataris</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>JBI Evid Synth</sb:maintitle>\n</sb:title>\n<sb:volume-nr>22</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>378</sb:first-page>\n<sb:last-page>388</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0021\">Barker TH, Habibi N, Aromataris E, et al. The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies. JBI Evid Synth. 2024;22(3):378-388.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0022\">\n<ce:label>22</ce:label>\n<sb:reference id=\"sbref0022\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Gálvez</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Huggins</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>32</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>397</sb:first-page>\n<sb:last-page>407</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0022\">Gálvez V, Li A, Huggins C, et al. Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial. J Psychopharmacol. 2018;32(4):397-407.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0023\">\n<ce:label>23</ce:label>\n<sb:reference id=\"sbref0023\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Ochs-Ross</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zhang</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression-TRANSFORM-3</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>28</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>121</sb:first-page>\n<sb:last-page>141</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0023\">Ochs-Ross R, Daly EJ, Zhang Y, et al. Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression-TRANSFORM-3. Am J Geriatr Psychiatry. 2020;28(2):121-141.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0024\">\n<ce:label>24</ce:label>\n<sb:reference id=\"sbref0024\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Lai</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Katalinic</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Glue</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pilot dose-response trial of i.v. ketamine in treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World J Biol Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>15</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>579</sb:first-page>\n<sb:last-page>584</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0024\">Lai R, Katalinic N, Glue P, et al. Pilot dose-response trial of i.v. ketamine in treatment-resistant depression. World J Biol Psychiatry. 2014;15(7):579-584.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0025\">\n<ce:label>25</ce:label>\n<sb:reference id=\"sbref0025\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Glue</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Loo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Fam</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Nat Med</sb:maintitle>\n</sb:title>\n<sb:volume-nr>30</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>2004</sb:first-page>\n<sb:last-page>2009</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0025\">Glue P, Loo C, Fam J, et al. Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial. Nat Med. 2024;30(7):2004-2009.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0026\">\n<ce:label>26</ce:label>\n<sb:reference id=\"sbref0026\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Fernie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Currie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.S.</ce:given-name>\n<ce:surname>Perrin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Br J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>210</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>422</sb:first-page>\n<sb:last-page>428</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0026\">Fernie G, Currie J, Perrin JS, et al. Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial. Br J Psychiatry. 2017;210(6):422-428.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0027\">\n<ce:label>27</ce:label>\n<sb:reference id=\"sbref0027\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Zou</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Min</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Q.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Ren</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-A randomized, double-blind, controlled clinical study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Brain Behav</sb:maintitle>\n</sb:title>\n<sb:volume-nr>11</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:article-number>e01775</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0027\">Zou L, Min S, Chen Q, Li X, Ren L. Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-A randomized, double-blind, controlled clinical study. Brain Behav. 2021;11(1):e01775.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0028\">\n<ce:label>28</ce:label>\n<sb:reference id=\"sbref0028\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>George</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Gálvez</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>25</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>11</sb:issue-nr>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1199</sb:first-page>\n<sb:last-page>1209</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0028\">George D, Gálvez V, Martin D, et al. Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression. Am J Geriatr Psychiatry. 2017;25(11):1199-1209.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0029\">\n<ce:label>29</ce:label>\n<sb:reference id=\"sbref0029\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Wajs</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Aluisio</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Holder</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: Assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2)</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Clin Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>81</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<ce:doi>10.4088/JCP.19m12891</ce:doi>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0029\">Wajs E, Aluisio L, Holder R, et al. Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: Assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2). J Clin Psychiatry. 2020;81(3). doi:10.4088/JCP.19m12891</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0030\">\n<ce:label>30</ce:label>\n<sb:reference id=\"sbref0030\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.A.</ce:given-name>\n<ce:surname>Oughli</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.A.</ce:given-name>\n<ce:surname>Gebara</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Ciarleglio</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Intravenous ketamine for late-life treatment-resistant depression: A pilot study of tolerability, safety, clinical benefits, and effect on cognition</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>31</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>210</sb:first-page>\n<sb:last-page>221</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0030\">Oughli HA, Gebara MA, Ciarleglio A, et al. Intravenous ketamine for late-life treatment-resistant depression: A pilot study of tolerability, safety, clinical benefits, and effect on cognition. Am J Geriatr Psychiatry. 2023;31(3):210-221.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0031\">\n<ce:label>31</ce:label>\n<sb:reference id=\"sbref0031\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Zaki</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.N.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Lane</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Neuropsychopharmacology</sb:maintitle>\n</sb:title>\n<sb:volume-nr>48</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>8</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1225</sb:first-page>\n<sb:last-page>1233</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0031\">Zaki N, Chen LN, Lane R, et al. Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study. Neuropsychopharmacology. 2023;48(8):1225-1233.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0032\">\n<ce:label>32</ce:label>\n<sb:reference id=\"sbref0032\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>K.G.</ce:given-name>\n<ce:surname>Rasmussen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.W.</ce:given-name>\n<ce:surname>Lineberry</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.W.</ce:given-name>\n<ce:surname>Galardy</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Serial infusions of low-dose ketamine for major depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>27</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2013</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>444</sb:first-page>\n<sb:last-page>450</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0032\">Rasmussen KG, Lineberry TW, Galardy CW, et al. Serial infusions of low-dose ketamine for major depression. J Psychopharmacol. 2013;27(5):444-450.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0033\">\n<ce:label>33</ce:label>\n<sb:reference id=\"sbref0033\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Vanderschelden</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.A.</ce:given-name>\n<ce:surname>Gebara</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.A.</ce:given-name>\n<ce:surname>Oughli</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Change in patient-centered outcomes of psychological well-being, sleep, and suicidality following treatment with intravenous ketamine for late-life treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>38</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>e5964</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0033\">Vanderschelden B, Gebara MA, Oughli HA, et al. Change in patient-centered outcomes of psychological well-being, sleep, and suicidality following treatment with intravenous ketamine for late-life treatment-resistant depression. Int J Geriatr Psychiatry. 2023;38(7):e5964.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0034\">\n<ce:label>34</ce:label>\n<sb:reference id=\"sbref0034\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Ochs-Ross</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Wajs</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Comparison of long-term efficacy and safety of esketamine nasal spray plus oral antidepressant in younger versus older patients with treatment-resistant depression: Post-hoc analysis of SUSTAIN-2, a long-term open-label phase 3 safety and efficacy study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>30</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>541</sb:first-page>\n<sb:last-page>556</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0034\">Ochs-Ross R, Wajs E, Daly EJ, et al. Comparison of long-term efficacy and safety of esketamine nasal spray plus oral antidepressant in younger versus older patients with treatment-resistant depression: Post-hoc analysis of SUSTAIN-2, a long-term open-label phase 3 safety and efficacy study. Am J Geriatr Psychiatry. 2022;30(5):541-556.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0035\">\n<ce:label>35</ce:label>\n<sb:reference id=\"sbref0035\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Filteau</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>156</sb:volume-nr>\n</sb:series>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1</sb:first-page>\n<sb:last-page>7</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0035\">McIntyre RS, Filteau MJ, Martin L, et al. Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach. J Affect Disord. 2014;156:1-7.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0036\">\n<ce:label>36</ce:label>\n<sb:reference id=\"sbref0036\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.R.</ce:given-name>\n<ce:surname>Strawn</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.A.</ce:given-name>\n<ce:surname>Mills</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Suresh</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorder</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>159</sb:volume-nr>\n</sb:series>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>266</sb:first-page>\n<sb:last-page>273</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0036\">Strawn JR, Mills JA, Suresh V, et al. The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorder. J Psychiatr Res. 2023;159:266-273.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0037\">\n<ce:label>37</ce:label>\n<sb:reference id=\"sbref0037\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Popova</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Trivedi</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>176</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>428</sb:first-page>\n<sb:last-page>438</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0037\">Popova V, Daly EJ, Trivedi M, et al. Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study. Am J Psychiatry. 2019;176(6):428-438.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0038\">\n<ce:label>38</ce:label>\n<sb:reference id=\"sbref0038\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.F.</ce:given-name>\n<ce:surname>Grunebaum</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.C.</ce:given-name>\n<ce:surname>Galfalvy</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.H.</ce:given-name>\n<ce:surname>Choo</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine for rapid reduction of suicidal thoughts in major depression: A midazolam-controlled randomized clinical trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>175</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>327</sb:first-page>\n<sb:last-page>335</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0038\">Grunebaum MF, Galfalvy HC, Choo TH, et al. Ketamine for rapid reduction of suicidal thoughts in major depression: A midazolam-controlled randomized clinical trial. Am J Psychiatry. 2018;175(4):327-335.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0039\">\n<ce:label>39</ce:label>\n<sb:reference id=\"sbref0039\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.T.</ce:given-name>\n<ce:surname>Wilkinson</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Farmer</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.D.</ce:given-name>\n<ce:surname>Ballard</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Neuropsychopharmacology</sb:maintitle>\n</sb:title>\n<sb:volume-nr>44</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1233</sb:first-page>\n<sb:last-page>1238</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0039\">Wilkinson ST, Farmer C, Ballard ED, et al. Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant. Neuropsychopharmacology. 2019;44(7):1233-1238.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0040\">\n<ce:label>40</ce:label>\n<sb:reference id=\"sbref0040\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.L.</ce:given-name>\n<ce:surname>Naismith</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.M.</ce:given-name>\n<ce:surname>Norrie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Mowszowski</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>IB.</ce:given-name>\n<ce:surname>Hickie</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The neurobiology of depression in later-life: Clinical, neuropsychological, neuroimaging and pathophysiological features</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Prog Neurobiol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>98</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2012</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>99</sb:first-page>\n<sb:last-page>143</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0040\">Naismith SL, Norrie LM, Mowszowski L, Hickie IB. The neurobiology of depression in later-life: Clinical, neuropsychological, neuroimaging and pathophysiological features. Prog Neurobiol. 2012;98(1):99-143.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0041\">\n<ce:label>41</ce:label>\n<sb:reference id=\"sbref0041\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Bayes</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Dong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Alonzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Kabourakis</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Loo</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine treatment for depression: A model of care</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Aust N Z J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>55</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>12</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1134</sb:first-page>\n<sb:last-page>1143</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0041\">Bayes A, Dong V, Martin D, Alonzo A, Kabourakis M, Loo C. Ketamine treatment for depression: A model of care. Aust N Z J Psychiatry. 2021;55(12):1134-1143.</ce:source-text>\n</ce:bib-reference>\n</ce:bibliography-sec>",
    "error_message": "All bibliographic references within 'ce:bibliography' must be referred to.",
    "error_position": "1135:63",
    "error_id": "IDS503a",
    "folder_name": "AMGP2541"
  },
  {
    "input": "<ce:bibliography-sec xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"cebibsec1\">\n<?att type=\"article\"?><ce:bib-reference id=\"bib0001\">\n<ce:label>1</ce:label>\n<sb:reference id=\"sbref0001\">\n<sb:contribution>\n<sb:authors>\n<sb:collaboration>Global Burden of Disease Study 2013 Collaborators</sb:collaboration>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Lancet</sb:maintitle>\n</sb:title>\n<sb:volume-nr>386</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>9995</sb:issue-nr>\n<sb:date>20132015</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>743</sb:first-page>\n<sb:last-page>800</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0001\">Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743-800.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0002\">\n<ce:label>2</ce:label>\n<sb:reference id=\"sbref0002\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Maj</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.J.</ce:given-name>\n<ce:surname>Stein</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Parker</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The clinical characterization of the adult patient with depression aimed at personalization of management</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>19</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>269</sb:first-page>\n<sb:last-page>293</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0002\">Maj M, Stein DJ, Parker G, et al. The clinical characterization of the adult patient with depression aimed at personalization of management. World Psychiatry. 2020;19(3):269-293.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0003\">\n<ce:label>3</ce:label>\n<sb:reference id=\"sbref0003\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>CF 3rd</ce:given-name>\n<ce:surname>Reynolds</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.V.</ce:given-name>\n<ce:surname>Jeste</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.S.</ce:given-name>\n<ce:surname>Sachdev</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.G.</ce:given-name>\n<ce:surname>Blazer</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Mental health care for older adults: recent advances and new directions in clinical practice and research</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>21</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>336</sb:first-page>\n<sb:last-page>363</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0003\">Reynolds CF 3rd, Jeste DV, Sachdev PS, Blazer DG. Mental health care for older adults: recent advances and new directions in clinical practice and research. World Psychiatry. 2022;21(3):336-363.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0004\">\n<ce:label>4</ce:label>\n<sb:reference id=\"sbref0004\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zenebe</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Akele</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>W/Selassie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Necho</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Prevalence and determinants of depression among old age: a systematic review and meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Ann Gen Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>20</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>55</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0004\">Zenebe Y, Akele B, W/Selassie M, Necho M. Prevalence and determinants of depression among old age: a systematic review and meta-analysis. Ann Gen Psychiatry. 2021;20(1):55.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0005\">\n<ce:label>5</ce:label>\n<sb:reference id=\"sbref0005\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.S.</ce:given-name>\n<ce:surname>Hasin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.L.</ce:given-name>\n<ce:surname>Sarvet</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.L.</ce:given-name>\n<ce:surname>Meyers</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>JAMA Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>75</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>336</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0005\">Hasin DS, Sarvet AL, Meyers JL, et al. Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiatry. 2018;75(4):336.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0006\">\n<ce:label>6</ce:label>\n<sb:reference id=\"sbref0006\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.R.</ce:given-name>\n<ce:surname>Azar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.P.</ce:given-name>\n<ce:surname>Chopra</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.Y.</ce:given-name>\n<ce:surname>Cho</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Coakley</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>JL.</ce:given-name>\n<ce:surname>Rudolph</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Remission in major depression: results from a geriatric primary care population</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>26</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2011</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>48</sb:first-page>\n<sb:last-page>55</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0006\">Azar AR, Chopra MP, Cho LY, Coakley E, Rudolph JL. Remission in major depression: results from a geriatric primary care population. Int J Geriatr Psychiatry. 2011;26(1):48-55.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0007\">\n<ce:label>7</ce:label>\n<sb:reference id=\"sbref0007\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>U.</ce:given-name>\n<ce:surname>Klotz</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pharmacokinetics and drug metabolism in the elderly</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Drug Metab Rev</sb:maintitle>\n</sb:title>\n<sb:volume-nr>41</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2009</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>67</sb:first-page>\n<sb:last-page>76</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0007\">Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev. 2009;41(2):67-76.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0008\">\n<ce:label>8</ce:label>\n<sb:reference id=\"sbref0008\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Canadian Coalition for Seniors’ Mental</ce:given-name>\n<ce:surname>Health</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Canadian Guidelines on Prevention, Assessment and Treatment of Depression Among Older Adults</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>CCSMH; 2021</sb:maintitle>\n</sb:title>\n</sb:series>\n<sb:date>June 2021</sb:date>\n</sb:issue>\n</sb:host>\n<sb:comment>Updated</sb:comment>\n<sb:host>\n<sb:e-host>\n<ce:inter-ref id=\"interref0001\" xlink:href=\"https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf\">https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf</ce:inter-ref>\n</sb:e-host>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0008\">Canadian Coalition for Seniors’ Mental Health. Canadian Guidelines on Prevention, Assessment and Treatment of Depression Among Older Adults. CCSMH; 2021. Updated June 2021. https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0009\">\n<ce:label>9</ce:label>\n<sb:reference id=\"sbref0009\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Avasthi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Grover</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Clinical practice guidelines for management of depression in elderly</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Indian J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>60</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>Suppl 3</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>S341</sb:first-page>\n<sb:last-page>S362</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0009\">Avasthi A, Grover S. Clinical practice guidelines for management of depression in elderly. Indian J Psychiatry. 2018;60(Suppl 3):S341-S362.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0010\">\n<ce:label>10</ce:label>\n<sb:reference id=\"sbref0010\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Baba</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Kito</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Nukariya</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Guidelines for diagnosis and treatment of depression in older adults: A report from the Japanese Society of mood disorders</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Psychiatry Clin Neurosci</sb:maintitle>\n</sb:title>\n<sb:volume-nr>76</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>222</sb:first-page>\n<sb:last-page>234</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0010\">Baba H, Kito S, Nukariya K, et al. Guidelines for diagnosis and treatment of depression in older adults: A report from the Japanese Society of mood disorders. Psychiatry Clin Neurosci. 2022;76(6):222-234.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0011\">\n<ce:label>11</ce:label>\n<sb:reference id=\"sbref0011\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Rosenblat</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.B.</ce:given-name>\n<ce:surname>Nemeroff</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>178</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>383</sb:first-page>\n<sb:last-page>399</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0011\">McIntyre RS, Rosenblat JD, Nemeroff CB, et al. Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation. Am J Psychiatry. 2021;178(5):383-399.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0012\">\n<ce:label>12</ce:label>\n<sb:reference id=\"sbref0012\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.C.H.</ce:given-name>\n<ce:surname>Cheng</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.E.</ce:given-name>\n<ce:surname>Dri</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Ballum</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effects of ketamine and esketamine on measures of quality of life in major depressive disorder and treatment-resistant depression: A systematic review</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>382</sb:volume-nr>\n</sb:series>\n<sb:date>2025</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>438</sb:first-page>\n<sb:last-page>442</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0012\">Cheng MCH, Dri CE, Ballum H, et al. The effects of ketamine and esketamine on measures of quality of life in major depressive disorder and treatment-resistant depression: A systematic review. J Affect Disord. 2025;382:438-442.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0013\">\n<ce:label>13</ce:label>\n<sb:reference id=\"sbref0013\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Di Vincenzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.B.</ce:given-name>\n<ce:surname>Rodrigues</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Safety, tolerability, and real-world effectiveness of intravenous ketamine in older adults with treatment-resistant depression: A case series</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>29</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>9</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>899</sb:first-page>\n<sb:last-page>913</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0013\">Lipsitz O, Di Vincenzo JD, Rodrigues NB, et al. Safety, tolerability, and real-world effectiveness of intravenous ketamine in older adults with treatment-resistant depression: A case series. Am J Geriatr Psychiatry. 2021;29(9):899-913.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0014\">\n<ce:label>14</ce:label>\n<sb:reference id=\"sbref0014\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>I.P.</ce:given-name>\n<ce:surname>Carvalho</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.M.W.</ce:given-name>\n<ce:surname>Lui</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>276</sb:volume-nr>\n</sb:series>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>576</sb:first-page>\n<sb:last-page>584</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0014\">McIntyre RS, Carvalho IP, Lui LMW, et al. The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis. J Affect Disord. 2020;276:576-584.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0015\">\n<ce:label>15</ce:label>\n<sb:reference id=\"sbref0015\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Lee</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Syeda</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.A.</ce:given-name>\n<ce:surname>Maruschak</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>A new perspective on the anti-suicide effects with ketamine treatment: A procognitive effect</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Clin Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>36</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2016</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>50</sb:first-page>\n<sb:last-page>56</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0015\">Lee Y, Syeda K, Maruschak NA, et al. A new perspective on the anti-suicide effects with ketamine treatment: A procognitive effect. J Clin Psychopharmacol. 2016;36(1):50-56.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0016\">\n<ce:label>16</ce:label>\n<sb:reference id=\"sbref0016\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Xiong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Chen-Li</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>134</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>57</sb:first-page>\n<sb:last-page>68</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0016\">Xiong J, Lipsitz O, Chen-Li D, et al. The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis. J Psychiatr Res. 2021;134:57-68.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0017\">\n<ce:label>17</ce:label>\n<sb:reference id=\"sbref0017\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Gupta</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Dhar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Patadia</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>A systematic review of ketamine for the treatment of depression among older adults</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int Psychogeriatr</sb:maintitle>\n</sb:title>\n<sb:volume-nr>33</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>179</sb:first-page>\n<sb:last-page>191</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0017\">Gupta A, Dhar R, Patadia P, et al. A systematic review of ketamine for the treatment of depression among older adults. Int Psychogeriatr. 2021;33(2):179-191.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0018\">\n<ce:label>18</ce:label>\n<sb:reference id=\"sbref0018\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Di Vincenzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Siegel</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>137</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>232</sb:first-page>\n<sb:last-page>241</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0018\">Di Vincenzo JD, Siegel A, Lipsitz O, et al. The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review. J Psychiatr Res. 2021;137:232-241.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0019\">\n<ce:label>19</ce:label>\n<sb:reference id=\"sbref0019\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Page</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.E.</ce:given-name>\n<ce:surname>McKenzie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.M.</ce:given-name>\n<ce:surname>Bossuyt</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The PRISMA 2020 statement: an updated guideline for reporting systematic reviews</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>BMJ</sb:maintitle>\n</sb:title>\n<sb:volume-nr>372</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>n71</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0019\">Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0020\">\n<ce:label>20</ce:label>\n<sb:reference id=\"sbref0020\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.A.C.</ce:given-name>\n<ce:surname>Sterne</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Savović</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Page</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>RoB 2: a revised tool for assessing risk of bias in randomised trials</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>BMJ</sb:maintitle>\n</sb:title>\n<sb:volume-nr>366</sb:volume-nr>\n</sb:series>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>l4898</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0020\">Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0021\">\n<ce:label>21</ce:label>\n<sb:reference id=\"sbref0021\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>T.H.</ce:given-name>\n<ce:surname>Barker</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Habibi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Aromataris</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>JBI Evid Synth</sb:maintitle>\n</sb:title>\n<sb:volume-nr>22</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>378</sb:first-page>\n<sb:last-page>388</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0021\">Barker TH, Habibi N, Aromataris E, et al. The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies. JBI Evid Synth. 2024;22(3):378-388.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0022\">\n<ce:label>22</ce:label>\n<sb:reference id=\"sbref0022\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Gálvez</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Huggins</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>32</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>397</sb:first-page>\n<sb:last-page>407</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0022\">Gálvez V, Li A, Huggins C, et al. Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial. J Psychopharmacol. 2018;32(4):397-407.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0023\">\n<ce:label>23</ce:label>\n<sb:reference id=\"sbref0023\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Ochs-Ross</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zhang</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression-TRANSFORM-3</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>28</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>121</sb:first-page>\n<sb:last-page>141</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0023\">Ochs-Ross R, Daly EJ, Zhang Y, et al. Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression-TRANSFORM-3. Am J Geriatr Psychiatry. 2020;28(2):121-141.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0024\">\n<ce:label>24</ce:label>\n<sb:reference id=\"sbref0024\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Lai</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Katalinic</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Glue</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pilot dose-response trial of i.v. ketamine in treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World J Biol Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>15</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>579</sb:first-page>\n<sb:last-page>584</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0024\">Lai R, Katalinic N, Glue P, et al. Pilot dose-response trial of i.v. ketamine in treatment-resistant depression. World J Biol Psychiatry. 2014;15(7):579-584.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0025\">\n<ce:label>25</ce:label>\n<sb:reference id=\"sbref0025\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Glue</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Loo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Fam</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Nat Med</sb:maintitle>\n</sb:title>\n<sb:volume-nr>30</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>2004</sb:first-page>\n<sb:last-page>2009</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0025\">Glue P, Loo C, Fam J, et al. Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial. Nat Med. 2024;30(7):2004-2009.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0026\">\n<ce:label>26</ce:label>\n<sb:reference id=\"sbref0026\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Fernie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Currie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.S.</ce:given-name>\n<ce:surname>Perrin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Br J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>210</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>422</sb:first-page>\n<sb:last-page>428</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0026\">Fernie G, Currie J, Perrin JS, et al. Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial. Br J Psychiatry. 2017;210(6):422-428.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0027\">\n<ce:label>27</ce:label>\n<sb:reference id=\"sbref0027\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Zou</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Min</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Q.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Ren</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-A randomized, double-blind, controlled clinical study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Brain Behav</sb:maintitle>\n</sb:title>\n<sb:volume-nr>11</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:article-number>e01775</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0027\">Zou L, Min S, Chen Q, Li X, Ren L. Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-A randomized, double-blind, controlled clinical study. Brain Behav. 2021;11(1):e01775.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0028\">\n<ce:label>28</ce:label>\n<sb:reference id=\"sbref0028\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>George</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Gálvez</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>25</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>11</sb:issue-nr>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1199</sb:first-page>\n<sb:last-page>1209</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0028\">George D, Gálvez V, Martin D, et al. Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression. Am J Geriatr Psychiatry. 2017;25(11):1199-1209.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0029\">\n<ce:label>29</ce:label>\n<sb:reference id=\"sbref0029\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Wajs</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Aluisio</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Holder</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: Assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2)</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Clin Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>81</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<ce:doi>10.4088/JCP.19m12891</ce:doi>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0029\">Wajs E, Aluisio L, Holder R, et al. Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: Assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2). J Clin Psychiatry. 2020;81(3). doi:10.4088/JCP.19m12891</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0030\">\n<ce:label>30</ce:label>\n<sb:reference id=\"sbref0030\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.A.</ce:given-name>\n<ce:surname>Oughli</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.A.</ce:given-name>\n<ce:surname>Gebara</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Ciarleglio</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Intravenous ketamine for late-life treatment-resistant depression: A pilot study of tolerability, safety, clinical benefits, and effect on cognition</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>31</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>210</sb:first-page>\n<sb:last-page>221</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0030\">Oughli HA, Gebara MA, Ciarleglio A, et al. Intravenous ketamine for late-life treatment-resistant depression: A pilot study of tolerability, safety, clinical benefits, and effect on cognition. Am J Geriatr Psychiatry. 2023;31(3):210-221.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0031\">\n<ce:label>31</ce:label>\n<sb:reference id=\"sbref0031\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Zaki</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.N.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Lane</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Neuropsychopharmacology</sb:maintitle>\n</sb:title>\n<sb:volume-nr>48</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>8</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1225</sb:first-page>\n<sb:last-page>1233</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0031\">Zaki N, Chen LN, Lane R, et al. Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study. Neuropsychopharmacology. 2023;48(8):1225-1233.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0032\">\n<ce:label>32</ce:label>\n<sb:reference id=\"sbref0032\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>K.G.</ce:given-name>\n<ce:surname>Rasmussen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.W.</ce:given-name>\n<ce:surname>Lineberry</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.W.</ce:given-name>\n<ce:surname>Galardy</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Serial infusions of low-dose ketamine for major depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>27</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2013</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>444</sb:first-page>\n<sb:last-page>450</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0032\">Rasmussen KG, Lineberry TW, Galardy CW, et al. Serial infusions of low-dose ketamine for major depression. J Psychopharmacol. 2013;27(5):444-450.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0033\">\n<ce:label>33</ce:label>\n<sb:reference id=\"sbref0033\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Vanderschelden</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.A.</ce:given-name>\n<ce:surname>Gebara</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.A.</ce:given-name>\n<ce:surname>Oughli</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Change in patient-centered outcomes of psychological well-being, sleep, and suicidality following treatment with intravenous ketamine for late-life treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>38</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>e5964</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0033\">Vanderschelden B, Gebara MA, Oughli HA, et al. Change in patient-centered outcomes of psychological well-being, sleep, and suicidality following treatment with intravenous ketamine for late-life treatment-resistant depression. Int J Geriatr Psychiatry. 2023;38(7):e5964.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0034\">\n<ce:label>34</ce:label>\n<sb:reference id=\"sbref0034\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Ochs-Ross</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Wajs</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Comparison of long-term efficacy and safety of esketamine nasal spray plus oral antidepressant in younger versus older patients with treatment-resistant depression: Post-hoc analysis of SUSTAIN-2, a long-term open-label phase 3 safety and efficacy study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>30</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>541</sb:first-page>\n<sb:last-page>556</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0034\">Ochs-Ross R, Wajs E, Daly EJ, et al. Comparison of long-term efficacy and safety of esketamine nasal spray plus oral antidepressant in younger versus older patients with treatment-resistant depression: Post-hoc analysis of SUSTAIN-2, a long-term open-label phase 3 safety and efficacy study. Am J Geriatr Psychiatry. 2022;30(5):541-556.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0035\">\n<ce:label>35</ce:label>\n<sb:reference id=\"sbref0035\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Filteau</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>156</sb:volume-nr>\n</sb:series>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1</sb:first-page>\n<sb:last-page>7</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0035\">McIntyre RS, Filteau MJ, Martin L, et al. Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach. J Affect Disord. 2014;156:1-7.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0036\">\n<ce:label>36</ce:label>\n<sb:reference id=\"sbref0036\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.R.</ce:given-name>\n<ce:surname>Strawn</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.A.</ce:given-name>\n<ce:surname>Mills</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Suresh</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorder</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>159</sb:volume-nr>\n</sb:series>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>266</sb:first-page>\n<sb:last-page>273</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0036\">Strawn JR, Mills JA, Suresh V, et al. The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorder. J Psychiatr Res. 2023;159:266-273.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0037\">\n<ce:label>37</ce:label>\n<sb:reference id=\"sbref0037\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Popova</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Trivedi</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>176</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>428</sb:first-page>\n<sb:last-page>438</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0037\">Popova V, Daly EJ, Trivedi M, et al. Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study. Am J Psychiatry. 2019;176(6):428-438.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0038\">\n<ce:label>38</ce:label>\n<sb:reference id=\"sbref0038\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.F.</ce:given-name>\n<ce:surname>Grunebaum</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.C.</ce:given-name>\n<ce:surname>Galfalvy</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.H.</ce:given-name>\n<ce:surname>Choo</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine for rapid reduction of suicidal thoughts in major depression: A midazolam-controlled randomized clinical trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>175</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>327</sb:first-page>\n<sb:last-page>335</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0038\">Grunebaum MF, Galfalvy HC, Choo TH, et al. Ketamine for rapid reduction of suicidal thoughts in major depression: A midazolam-controlled randomized clinical trial. Am J Psychiatry. 2018;175(4):327-335.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0039\">\n<ce:label>39</ce:label>\n<sb:reference id=\"sbref0039\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.T.</ce:given-name>\n<ce:surname>Wilkinson</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Farmer</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.D.</ce:given-name>\n<ce:surname>Ballard</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Neuropsychopharmacology</sb:maintitle>\n</sb:title>\n<sb:volume-nr>44</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1233</sb:first-page>\n<sb:last-page>1238</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0039\">Wilkinson ST, Farmer C, Ballard ED, et al. Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant. Neuropsychopharmacology. 2019;44(7):1233-1238.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0040\">\n<ce:label>40</ce:label>\n<sb:reference id=\"sbref0040\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.L.</ce:given-name>\n<ce:surname>Naismith</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.M.</ce:given-name>\n<ce:surname>Norrie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Mowszowski</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>IB.</ce:given-name>\n<ce:surname>Hickie</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The neurobiology of depression in later-life: Clinical, neuropsychological, neuroimaging and pathophysiological features</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Prog Neurobiol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>98</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2012</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>99</sb:first-page>\n<sb:last-page>143</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0040\">Naismith SL, Norrie LM, Mowszowski L, Hickie IB. The neurobiology of depression in later-life: Clinical, neuropsychological, neuroimaging and pathophysiological features. Prog Neurobiol. 2012;98(1):99-143.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0041\">\n<ce:label>41</ce:label>\n<sb:reference id=\"sbref0041\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Bayes</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Dong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Alonzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Kabourakis</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Loo</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine treatment for depression: A model of care</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Aust N Z J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>55</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>12</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1134</sb:first-page>\n<sb:last-page>1143</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0041\">Bayes A, Dong V, Martin D, Alonzo A, Kabourakis M, Loo C. Ketamine treatment for depression: A model of care. Aust N Z J Psychiatry. 2021;55(12):1134-1143.</ce:source-text>\n</ce:bib-reference>\n</ce:bibliography-sec>",
    "output": "<ce:bibliography-sec xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"cebibsec1\">\n<?att type=\"article\"?><ce:bib-reference id=\"bib0001\">\n<ce:label>1</ce:label>\n<sb:reference id=\"sbref0001\">\n<sb:contribution>\n<sb:authors>\n<sb:collaboration>Global Burden of Disease Study 2013 Collaborators</sb:collaboration>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Lancet</sb:maintitle>\n</sb:title>\n<sb:volume-nr>386</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>9995</sb:issue-nr>\n<sb:date>20132015</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>743</sb:first-page>\n<sb:last-page>800</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0001\">Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743-800.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0002\">\n<ce:label>2</ce:label>\n<sb:reference id=\"sbref0002\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Maj</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.J.</ce:given-name>\n<ce:surname>Stein</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Parker</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The clinical characterization of the adult patient with depression aimed at personalization of management</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>19</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>269</sb:first-page>\n<sb:last-page>293</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0002\">Maj M, Stein DJ, Parker G, et al. The clinical characterization of the adult patient with depression aimed at personalization of management. World Psychiatry. 2020;19(3):269-293.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0003\">\n<ce:label>3</ce:label>\n<sb:reference id=\"sbref0003\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>CF 3rd</ce:given-name>\n<ce:surname>Reynolds</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.V.</ce:given-name>\n<ce:surname>Jeste</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.S.</ce:given-name>\n<ce:surname>Sachdev</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.G.</ce:given-name>\n<ce:surname>Blazer</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Mental health care for older adults: recent advances and new directions in clinical practice and research</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>21</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>336</sb:first-page>\n<sb:last-page>363</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0003\">Reynolds CF 3rd, Jeste DV, Sachdev PS, Blazer DG. Mental health care for older adults: recent advances and new directions in clinical practice and research. World Psychiatry. 2022;21(3):336-363.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0004\">\n<ce:label>4</ce:label>\n<sb:reference id=\"sbref0004\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zenebe</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Akele</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>W/Selassie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Necho</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Prevalence and determinants of depression among old age: a systematic review and meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Ann Gen Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>20</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>55</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0004\">Zenebe Y, Akele B, W/Selassie M, Necho M. Prevalence and determinants of depression among old age: a systematic review and meta-analysis. Ann Gen Psychiatry. 2021;20(1):55.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0005\">\n<ce:label>5</ce:label>\n<sb:reference id=\"sbref0005\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.S.</ce:given-name>\n<ce:surname>Hasin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.L.</ce:given-name>\n<ce:surname>Sarvet</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.L.</ce:given-name>\n<ce:surname>Meyers</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>JAMA Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>75</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>336</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0005\">Hasin DS, Sarvet AL, Meyers JL, et al. Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiatry. 2018;75(4):336.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0006\">\n<ce:label>6</ce:label>\n<sb:reference id=\"sbref0006\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.R.</ce:given-name>\n<ce:surname>Azar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.P.</ce:given-name>\n<ce:surname>Chopra</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.Y.</ce:given-name>\n<ce:surname>Cho</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Coakley</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>JL.</ce:given-name>\n<ce:surname>Rudolph</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Remission in major depression: results from a geriatric primary care population</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>26</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2011</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>48</sb:first-page>\n<sb:last-page>55</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0006\">Azar AR, Chopra MP, Cho LY, Coakley E, Rudolph JL. Remission in major depression: results from a geriatric primary care population. Int J Geriatr Psychiatry. 2011;26(1):48-55.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0007\">\n<ce:label>7</ce:label>\n<sb:reference id=\"sbref0007\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>U.</ce:given-name>\n<ce:surname>Klotz</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pharmacokinetics and drug metabolism in the elderly</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Drug Metab Rev</sb:maintitle>\n</sb:title>\n<sb:volume-nr>41</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2009</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>67</sb:first-page>\n<sb:last-page>76</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0007\">Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev. 2009;41(2):67-76.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0008\">\n<ce:label>8</ce:label>\n<sb:reference id=\"sbref0008\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Canadian Coalition for Seniors’ Mental</ce:given-name>\n<ce:surname>Health</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Canadian Guidelines on Prevention, Assessment and Treatment of Depression Among Older Adults</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>CCSMH; 2021</sb:maintitle>\n</sb:title>\n</sb:series>\n<sb:date>June 2021</sb:date>\n</sb:issue>\n</sb:host>\n<sb:comment>Updated</sb:comment>\n<sb:host>\n<sb:e-host>\n<ce:inter-ref id=\"interref0001\" xlink:href=\"https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf\">https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf</ce:inter-ref>\n</sb:e-host>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0008\">Canadian Coalition for Seniors’ Mental Health. Canadian Guidelines on Prevention, Assessment and Treatment of Depression Among Older Adults. CCSMH; 2021. Updated June 2021. https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0009\">\n<ce:label>9</ce:label>\n<sb:reference id=\"sbref0009\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Avasthi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Grover</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Clinical practice guidelines for management of depression in elderly</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Indian J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>60</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>Suppl 3</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>S341</sb:first-page>\n<sb:last-page>S362</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0009\">Avasthi A, Grover S. Clinical practice guidelines for management of depression in elderly. Indian J Psychiatry. 2018;60(Suppl 3):S341-S362.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0010\">\n<ce:label>10</ce:label>\n<sb:reference id=\"sbref0010\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Baba</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Kito</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Nukariya</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Guidelines for diagnosis and treatment of depression in older adults: A report from the Japanese Society of mood disorders</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Psychiatry Clin Neurosci</sb:maintitle>\n</sb:title>\n<sb:volume-nr>76</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>222</sb:first-page>\n<sb:last-page>234</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0010\">Baba H, Kito S, Nukariya K, et al. Guidelines for diagnosis and treatment of depression in older adults: A report from the Japanese Society of mood disorders. Psychiatry Clin Neurosci. 2022;76(6):222-234.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0011\">\n<ce:label>11</ce:label>\n<sb:reference id=\"sbref0011\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Rosenblat</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.B.</ce:given-name>\n<ce:surname>Nemeroff</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>178</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>383</sb:first-page>\n<sb:last-page>399</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0011\">McIntyre RS, Rosenblat JD, Nemeroff CB, et al. Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation. Am J Psychiatry. 2021;178(5):383-399.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0012\">\n<ce:label>12</ce:label>\n<sb:reference id=\"sbref0012\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.C.H.</ce:given-name>\n<ce:surname>Cheng</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.E.</ce:given-name>\n<ce:surname>Dri</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Ballum</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effects of ketamine and esketamine on measures of quality of life in major depressive disorder and treatment-resistant depression: A systematic review</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>382</sb:volume-nr>\n</sb:series>\n<sb:date>2025</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>438</sb:first-page>\n<sb:last-page>442</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0012\">Cheng MCH, Dri CE, Ballum H, et al. The effects of ketamine and esketamine on measures of quality of life in major depressive disorder and treatment-resistant depression: A systematic review. J Affect Disord. 2025;382:438-442.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0013\">\n<ce:label>13</ce:label>\n<sb:reference id=\"sbref0013\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Di Vincenzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.B.</ce:given-name>\n<ce:surname>Rodrigues</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Safety, tolerability, and real-world effectiveness of intravenous ketamine in older adults with treatment-resistant depression: A case series</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>29</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>9</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>899</sb:first-page>\n<sb:last-page>913</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0013\">Lipsitz O, Di Vincenzo JD, Rodrigues NB, et al. Safety, tolerability, and real-world effectiveness of intravenous ketamine in older adults with treatment-resistant depression: A case series. Am J Geriatr Psychiatry. 2021;29(9):899-913.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0014\">\n<ce:label>14</ce:label>\n<sb:reference id=\"sbref0014\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>I.P.</ce:given-name>\n<ce:surname>Carvalho</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.M.W.</ce:given-name>\n<ce:surname>Lui</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>276</sb:volume-nr>\n</sb:series>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>576</sb:first-page>\n<sb:last-page>584</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0014\">McIntyre RS, Carvalho IP, Lui LMW, et al. The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis. J Affect Disord. 2020;276:576-584.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0015\">\n<ce:label>15</ce:label>\n<sb:reference id=\"sbref0015\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Lee</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Syeda</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.A.</ce:given-name>\n<ce:surname>Maruschak</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>A new perspective on the anti-suicide effects with ketamine treatment: A procognitive effect</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Clin Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>36</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2016</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>50</sb:first-page>\n<sb:last-page>56</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0015\">Lee Y, Syeda K, Maruschak NA, et al. A new perspective on the anti-suicide effects with ketamine treatment: A procognitive effect. J Clin Psychopharmacol. 2016;36(1):50-56.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0016\">\n<ce:label>16</ce:label>\n<sb:reference id=\"sbref0016\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Xiong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Chen-Li</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>134</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>57</sb:first-page>\n<sb:last-page>68</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0016\">Xiong J, Lipsitz O, Chen-Li D, et al. The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis. J Psychiatr Res. 2021;134:57-68.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0017\">\n<ce:label>17</ce:label>\n<sb:reference id=\"sbref0017\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Gupta</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Dhar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Patadia</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>A systematic review of ketamine for the treatment of depression among older adults</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int Psychogeriatr</sb:maintitle>\n</sb:title>\n<sb:volume-nr>33</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>179</sb:first-page>\n<sb:last-page>191</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0017\">Gupta A, Dhar R, Patadia P, et al. A systematic review of ketamine for the treatment of depression among older adults. Int Psychogeriatr. 2021;33(2):179-191.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0018\">\n<ce:label>18</ce:label>\n<sb:reference id=\"sbref0018\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Di Vincenzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Siegel</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>137</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>232</sb:first-page>\n<sb:last-page>241</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0018\">Di Vincenzo JD, Siegel A, Lipsitz O, et al. The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review. J Psychiatr Res. 2021;137:232-241.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0019\">\n<ce:label>19</ce:label>\n<sb:reference id=\"sbref0019\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Page</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.E.</ce:given-name>\n<ce:surname>McKenzie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.M.</ce:given-name>\n<ce:surname>Bossuyt</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The PRISMA 2020 statement: an updated guideline for reporting systematic reviews</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>BMJ</sb:maintitle>\n</sb:title>\n<sb:volume-nr>372</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>n71</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0019\">Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0020\">\n<ce:label>20</ce:label>\n<sb:reference id=\"sbref0020\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.A.C.</ce:given-name>\n<ce:surname>Sterne</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Savović</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Page</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>RoB 2: a revised tool for assessing risk of bias in randomised trials</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>BMJ</sb:maintitle>\n</sb:title>\n<sb:volume-nr>366</sb:volume-nr>\n</sb:series>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>l4898</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0020\">Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0021\">\n<ce:label>21</ce:label>\n<sb:reference id=\"sbref0021\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>T.H.</ce:given-name>\n<ce:surname>Barker</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Habibi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Aromataris</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>JBI Evid Synth</sb:maintitle>\n</sb:title>\n<sb:volume-nr>22</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>378</sb:first-page>\n<sb:last-page>388</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0021\">Barker TH, Habibi N, Aromataris E, et al. The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies. JBI Evid Synth. 2024;22(3):378-388.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0022\">\n<ce:label>22</ce:label>\n<sb:reference id=\"sbref0022\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Gálvez</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Huggins</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>32</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>397</sb:first-page>\n<sb:last-page>407</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0022\">Gálvez V, Li A, Huggins C, et al. Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial. J Psychopharmacol. 2018;32(4):397-407.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0023\">\n<ce:label>23</ce:label>\n<sb:reference id=\"sbref0023\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Ochs-Ross</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zhang</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression-TRANSFORM-3</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>28</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>121</sb:first-page>\n<sb:last-page>141</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0023\">Ochs-Ross R, Daly EJ, Zhang Y, et al. Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression-TRANSFORM-3. Am J Geriatr Psychiatry. 2020;28(2):121-141.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0024\">\n<ce:label>24</ce:label>\n<sb:reference id=\"sbref0024\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Lai</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Katalinic</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Glue</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pilot dose-response trial of i.v. ketamine in treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World J Biol Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>15</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>579</sb:first-page>\n<sb:last-page>584</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0024\">Lai R, Katalinic N, Glue P, et al. Pilot dose-response trial of i.v. ketamine in treatment-resistant depression. World J Biol Psychiatry. 2014;15(7):579-584.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0025\">\n<ce:label>25</ce:label>\n<sb:reference id=\"sbref0025\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Glue</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Loo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Fam</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Nat Med</sb:maintitle>\n</sb:title>\n<sb:volume-nr>30</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>2004</sb:first-page>\n<sb:last-page>2009</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0025\">Glue P, Loo C, Fam J, et al. Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial. Nat Med. 2024;30(7):2004-2009.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0026\">\n<ce:label>26</ce:label>\n<sb:reference id=\"sbref0026\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Fernie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Currie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.S.</ce:given-name>\n<ce:surname>Perrin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Br J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>210</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>422</sb:first-page>\n<sb:last-page>428</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0026\">Fernie G, Currie J, Perrin JS, et al. Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial. Br J Psychiatry. 2017;210(6):422-428.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0027\">\n<ce:label>27</ce:label>\n<sb:reference id=\"sbref0027\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Zou</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Min</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Q.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Ren</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-A randomized, double-blind, controlled clinical study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Brain Behav</sb:maintitle>\n</sb:title>\n<sb:volume-nr>11</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:article-number>e01775</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0027\">Zou L, Min S, Chen Q, Li X, Ren L. Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-A randomized, double-blind, controlled clinical study. Brain Behav. 2021;11(1):e01775.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0028\">\n<ce:label>28</ce:label>\n<sb:reference id=\"sbref0028\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>George</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Gálvez</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>25</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>11</sb:issue-nr>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1199</sb:first-page>\n<sb:last-page>1209</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0028\">George D, Gálvez V, Martin D, et al. Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression. Am J Geriatr Psychiatry. 2017;25(11):1199-1209.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0029\">\n<ce:label>29</ce:label>\n<sb:reference id=\"sbref0029\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Wajs</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Aluisio</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Holder</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: Assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2)</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Clin Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>81</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<ce:doi>10.4088/JCP.19m12891</ce:doi>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0029\">Wajs E, Aluisio L, Holder R, et al. Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: Assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2). J Clin Psychiatry. 2020;81(3). doi:10.4088/JCP.19m12891</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0030\">\n<ce:label>30</ce:label>\n<sb:reference id=\"sbref0030\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.A.</ce:given-name>\n<ce:surname>Oughli</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.A.</ce:given-name>\n<ce:surname>Gebara</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Ciarleglio</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Intravenous ketamine for late-life treatment-resistant depression: A pilot study of tolerability, safety, clinical benefits, and effect on cognition</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>31</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>210</sb:first-page>\n<sb:last-page>221</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0030\">Oughli HA, Gebara MA, Ciarleglio A, et al. Intravenous ketamine for late-life treatment-resistant depression: A pilot study of tolerability, safety, clinical benefits, and effect on cognition. Am J Geriatr Psychiatry. 2023;31(3):210-221.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0031\">\n<ce:label>31</ce:label>\n<sb:reference id=\"sbref0031\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Zaki</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.N.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Lane</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Neuropsychopharmacology</sb:maintitle>\n</sb:title>\n<sb:volume-nr>48</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>8</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1225</sb:first-page>\n<sb:last-page>1233</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0031\">Zaki N, Chen LN, Lane R, et al. Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study. Neuropsychopharmacology. 2023;48(8):1225-1233.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0032\">\n<ce:label>32</ce:label>\n<sb:reference id=\"sbref0032\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>K.G.</ce:given-name>\n<ce:surname>Rasmussen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.W.</ce:given-name>\n<ce:surname>Lineberry</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.W.</ce:given-name>\n<ce:surname>Galardy</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Serial infusions of low-dose ketamine for major depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>27</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2013</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>444</sb:first-page>\n<sb:last-page>450</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0032\">Rasmussen KG, Lineberry TW, Galardy CW, et al. Serial infusions of low-dose ketamine for major depression. J Psychopharmacol. 2013;27(5):444-450.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0033\">\n<ce:label>33</ce:label>\n<sb:reference id=\"sbref0033\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Vanderschelden</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.A.</ce:given-name>\n<ce:surname>Gebara</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.A.</ce:given-name>\n<ce:surname>Oughli</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Change in patient-centered outcomes of psychological well-being, sleep, and suicidality following treatment with intravenous ketamine for late-life treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>38</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>e5964</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0033\">Vanderschelden B, Gebara MA, Oughli HA, et al. Change in patient-centered outcomes of psychological well-being, sleep, and suicidality following treatment with intravenous ketamine for late-life treatment-resistant depression. Int J Geriatr Psychiatry. 2023;38(7):e5964.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0034\">\n<ce:label>34</ce:label>\n<sb:reference id=\"sbref0034\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Ochs-Ross</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Wajs</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Comparison of long-term efficacy and safety of esketamine nasal spray plus oral antidepressant in younger versus older patients with treatment-resistant depression: Post-hoc analysis of SUSTAIN-2, a long-term open-label phase 3 safety and efficacy study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>30</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>541</sb:first-page>\n<sb:last-page>556</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0034\">Ochs-Ross R, Wajs E, Daly EJ, et al. Comparison of long-term efficacy and safety of esketamine nasal spray plus oral antidepressant in younger versus older patients with treatment-resistant depression: Post-hoc analysis of SUSTAIN-2, a long-term open-label phase 3 safety and efficacy study. Am J Geriatr Psychiatry. 2022;30(5):541-556.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0035\">\n<ce:label>35</ce:label>\n<sb:reference id=\"sbref0035\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Filteau</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>156</sb:volume-nr>\n</sb:series>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1</sb:first-page>\n<sb:last-page>7</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0035\">McIntyre RS, Filteau MJ, Martin L, et al. Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach. J Affect Disord. 2014;156:1-7.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0036\">\n<ce:label>36</ce:label>\n<sb:reference id=\"sbref0036\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.R.</ce:given-name>\n<ce:surname>Strawn</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.A.</ce:given-name>\n<ce:surname>Mills</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Suresh</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorder</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>159</sb:volume-nr>\n</sb:series>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>266</sb:first-page>\n<sb:last-page>273</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0036\">Strawn JR, Mills JA, Suresh V, et al. The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorder. J Psychiatr Res. 2023;159:266-273.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0037\">\n<ce:label>37</ce:label>\n<sb:reference id=\"sbref0037\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Popova</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Trivedi</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>176</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>428</sb:first-page>\n<sb:last-page>438</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0037\">Popova V, Daly EJ, Trivedi M, et al. Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study. Am J Psychiatry. 2019;176(6):428-438.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0038\">\n<ce:label>38</ce:label>\n<sb:reference id=\"sbref0038\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.F.</ce:given-name>\n<ce:surname>Grunebaum</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.C.</ce:given-name>\n<ce:surname>Galfalvy</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.H.</ce:given-name>\n<ce:surname>Choo</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine for rapid reduction of suicidal thoughts in major depression: A midazolam-controlled randomized clinical trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>175</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>327</sb:first-page>\n<sb:last-page>335</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0038\">Grunebaum MF, Galfalvy HC, Choo TH, et al. Ketamine for rapid reduction of suicidal thoughts in major depression: A midazolam-controlled randomized clinical trial. Am J Psychiatry. 2018;175(4):327-335.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0039\">\n<ce:label>39</ce:label>\n<sb:reference id=\"sbref0039\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.T.</ce:given-name>\n<ce:surname>Wilkinson</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Farmer</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.D.</ce:given-name>\n<ce:surname>Ballard</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Neuropsychopharmacology</sb:maintitle>\n</sb:title>\n<sb:volume-nr>44</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1233</sb:first-page>\n<sb:last-page>1238</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0039\">Wilkinson ST, Farmer C, Ballard ED, et al. Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant. Neuropsychopharmacology. 2019;44(7):1233-1238.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0040\">\n<ce:label>40</ce:label>\n<sb:reference id=\"sbref0040\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.L.</ce:given-name>\n<ce:surname>Naismith</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.M.</ce:given-name>\n<ce:surname>Norrie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Mowszowski</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>IB.</ce:given-name>\n<ce:surname>Hickie</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The neurobiology of depression in later-life: Clinical, neuropsychological, neuroimaging and pathophysiological features</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Prog Neurobiol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>98</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2012</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>99</sb:first-page>\n<sb:last-page>143</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0040\">Naismith SL, Norrie LM, Mowszowski L, Hickie IB. The neurobiology of depression in later-life: Clinical, neuropsychological, neuroimaging and pathophysiological features. Prog Neurobiol. 2012;98(1):99-143.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0041\">\n<ce:label>41</ce:label>\n<sb:reference id=\"sbref0041\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Bayes</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Dong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Alonzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Kabourakis</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Loo</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine treatment for depression: A model of care</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Aust N Z J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>55</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>12</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1134</sb:first-page>\n<sb:last-page>1143</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0041\">Bayes A, Dong V, Martin D, Alonzo A, Kabourakis M, Loo C. Ketamine treatment for depression: A model of care. Aust N Z J Psychiatry. 2021;55(12):1134-1143.</ce:source-text>\n</ce:bib-reference>\n</ce:bibliography-sec>",
    "error_message": "All bibliographic references within 'ce:bibliography' must be referred to.",
    "error_position": "1184:63",
    "error_id": "IDS503a",
    "folder_name": "AMGP2541"
  },
  {
    "input": "<ce:bibliography-sec xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"cebibsec1\">\n<?att type=\"article\"?><ce:bib-reference id=\"bib0001\">\n<ce:label>1</ce:label>\n<sb:reference id=\"sbref0001\">\n<sb:contribution>\n<sb:authors>\n<sb:collaboration>Global Burden of Disease Study 2013 Collaborators</sb:collaboration>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Lancet</sb:maintitle>\n</sb:title>\n<sb:volume-nr>386</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>9995</sb:issue-nr>\n<sb:date>20132015</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>743</sb:first-page>\n<sb:last-page>800</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0001\">Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743-800.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0002\">\n<ce:label>2</ce:label>\n<sb:reference id=\"sbref0002\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Maj</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.J.</ce:given-name>\n<ce:surname>Stein</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Parker</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The clinical characterization of the adult patient with depression aimed at personalization of management</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>19</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>269</sb:first-page>\n<sb:last-page>293</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0002\">Maj M, Stein DJ, Parker G, et al. The clinical characterization of the adult patient with depression aimed at personalization of management. World Psychiatry. 2020;19(3):269-293.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0003\">\n<ce:label>3</ce:label>\n<sb:reference id=\"sbref0003\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>CF 3rd</ce:given-name>\n<ce:surname>Reynolds</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.V.</ce:given-name>\n<ce:surname>Jeste</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.S.</ce:given-name>\n<ce:surname>Sachdev</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.G.</ce:given-name>\n<ce:surname>Blazer</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Mental health care for older adults: recent advances and new directions in clinical practice and research</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>21</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>336</sb:first-page>\n<sb:last-page>363</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0003\">Reynolds CF 3rd, Jeste DV, Sachdev PS, Blazer DG. Mental health care for older adults: recent advances and new directions in clinical practice and research. World Psychiatry. 2022;21(3):336-363.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0004\">\n<ce:label>4</ce:label>\n<sb:reference id=\"sbref0004\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zenebe</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Akele</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>W/Selassie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Necho</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Prevalence and determinants of depression among old age: a systematic review and meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Ann Gen Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>20</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>55</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0004\">Zenebe Y, Akele B, W/Selassie M, Necho M. Prevalence and determinants of depression among old age: a systematic review and meta-analysis. Ann Gen Psychiatry. 2021;20(1):55.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0005\">\n<ce:label>5</ce:label>\n<sb:reference id=\"sbref0005\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.S.</ce:given-name>\n<ce:surname>Hasin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.L.</ce:given-name>\n<ce:surname>Sarvet</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.L.</ce:given-name>\n<ce:surname>Meyers</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>JAMA Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>75</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>336</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0005\">Hasin DS, Sarvet AL, Meyers JL, et al. Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiatry. 2018;75(4):336.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0006\">\n<ce:label>6</ce:label>\n<sb:reference id=\"sbref0006\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.R.</ce:given-name>\n<ce:surname>Azar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.P.</ce:given-name>\n<ce:surname>Chopra</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.Y.</ce:given-name>\n<ce:surname>Cho</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Coakley</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>JL.</ce:given-name>\n<ce:surname>Rudolph</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Remission in major depression: results from a geriatric primary care population</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>26</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2011</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>48</sb:first-page>\n<sb:last-page>55</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0006\">Azar AR, Chopra MP, Cho LY, Coakley E, Rudolph JL. Remission in major depression: results from a geriatric primary care population. Int J Geriatr Psychiatry. 2011;26(1):48-55.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0007\">\n<ce:label>7</ce:label>\n<sb:reference id=\"sbref0007\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>U.</ce:given-name>\n<ce:surname>Klotz</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pharmacokinetics and drug metabolism in the elderly</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Drug Metab Rev</sb:maintitle>\n</sb:title>\n<sb:volume-nr>41</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2009</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>67</sb:first-page>\n<sb:last-page>76</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0007\">Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev. 2009;41(2):67-76.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0008\">\n<ce:label>8</ce:label>\n<sb:reference id=\"sbref0008\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Canadian Coalition for Seniors’ Mental</ce:given-name>\n<ce:surname>Health</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Canadian Guidelines on Prevention, Assessment and Treatment of Depression Among Older Adults</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>CCSMH; 2021</sb:maintitle>\n</sb:title>\n</sb:series>\n<sb:date>June 2021</sb:date>\n</sb:issue>\n</sb:host>\n<sb:comment>Updated</sb:comment>\n<sb:host>\n<sb:e-host>\n<ce:inter-ref id=\"interref0001\" xlink:href=\"https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf\">https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf</ce:inter-ref>\n</sb:e-host>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0008\">Canadian Coalition for Seniors’ Mental Health. Canadian Guidelines on Prevention, Assessment and Treatment of Depression Among Older Adults. CCSMH; 2021. Updated June 2021. https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0009\">\n<ce:label>9</ce:label>\n<sb:reference id=\"sbref0009\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Avasthi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Grover</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Clinical practice guidelines for management of depression in elderly</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Indian J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>60</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>Suppl 3</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>S341</sb:first-page>\n<sb:last-page>S362</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0009\">Avasthi A, Grover S. Clinical practice guidelines for management of depression in elderly. Indian J Psychiatry. 2018;60(Suppl 3):S341-S362.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0010\">\n<ce:label>10</ce:label>\n<sb:reference id=\"sbref0010\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Baba</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Kito</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Nukariya</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Guidelines for diagnosis and treatment of depression in older adults: A report from the Japanese Society of mood disorders</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Psychiatry Clin Neurosci</sb:maintitle>\n</sb:title>\n<sb:volume-nr>76</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>222</sb:first-page>\n<sb:last-page>234</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0010\">Baba H, Kito S, Nukariya K, et al. Guidelines for diagnosis and treatment of depression in older adults: A report from the Japanese Society of mood disorders. Psychiatry Clin Neurosci. 2022;76(6):222-234.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0011\">\n<ce:label>11</ce:label>\n<sb:reference id=\"sbref0011\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Rosenblat</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.B.</ce:given-name>\n<ce:surname>Nemeroff</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>178</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>383</sb:first-page>\n<sb:last-page>399</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0011\">McIntyre RS, Rosenblat JD, Nemeroff CB, et al. Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation. Am J Psychiatry. 2021;178(5):383-399.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0012\">\n<ce:label>12</ce:label>\n<sb:reference id=\"sbref0012\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.C.H.</ce:given-name>\n<ce:surname>Cheng</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.E.</ce:given-name>\n<ce:surname>Dri</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Ballum</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effects of ketamine and esketamine on measures of quality of life in major depressive disorder and treatment-resistant depression: A systematic review</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>382</sb:volume-nr>\n</sb:series>\n<sb:date>2025</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>438</sb:first-page>\n<sb:last-page>442</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0012\">Cheng MCH, Dri CE, Ballum H, et al. The effects of ketamine and esketamine on measures of quality of life in major depressive disorder and treatment-resistant depression: A systematic review. J Affect Disord. 2025;382:438-442.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0013\">\n<ce:label>13</ce:label>\n<sb:reference id=\"sbref0013\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Di Vincenzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.B.</ce:given-name>\n<ce:surname>Rodrigues</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Safety, tolerability, and real-world effectiveness of intravenous ketamine in older adults with treatment-resistant depression: A case series</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>29</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>9</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>899</sb:first-page>\n<sb:last-page>913</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0013\">Lipsitz O, Di Vincenzo JD, Rodrigues NB, et al. Safety, tolerability, and real-world effectiveness of intravenous ketamine in older adults with treatment-resistant depression: A case series. Am J Geriatr Psychiatry. 2021;29(9):899-913.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0014\">\n<ce:label>14</ce:label>\n<sb:reference id=\"sbref0014\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>I.P.</ce:given-name>\n<ce:surname>Carvalho</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.M.W.</ce:given-name>\n<ce:surname>Lui</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>276</sb:volume-nr>\n</sb:series>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>576</sb:first-page>\n<sb:last-page>584</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0014\">McIntyre RS, Carvalho IP, Lui LMW, et al. The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis. J Affect Disord. 2020;276:576-584.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0015\">\n<ce:label>15</ce:label>\n<sb:reference id=\"sbref0015\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Lee</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Syeda</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.A.</ce:given-name>\n<ce:surname>Maruschak</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>A new perspective on the anti-suicide effects with ketamine treatment: A procognitive effect</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Clin Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>36</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2016</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>50</sb:first-page>\n<sb:last-page>56</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0015\">Lee Y, Syeda K, Maruschak NA, et al. A new perspective on the anti-suicide effects with ketamine treatment: A procognitive effect. J Clin Psychopharmacol. 2016;36(1):50-56.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0016\">\n<ce:label>16</ce:label>\n<sb:reference id=\"sbref0016\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Xiong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Chen-Li</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>134</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>57</sb:first-page>\n<sb:last-page>68</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0016\">Xiong J, Lipsitz O, Chen-Li D, et al. The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis. J Psychiatr Res. 2021;134:57-68.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0017\">\n<ce:label>17</ce:label>\n<sb:reference id=\"sbref0017\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Gupta</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Dhar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Patadia</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>A systematic review of ketamine for the treatment of depression among older adults</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int Psychogeriatr</sb:maintitle>\n</sb:title>\n<sb:volume-nr>33</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>179</sb:first-page>\n<sb:last-page>191</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0017\">Gupta A, Dhar R, Patadia P, et al. A systematic review of ketamine for the treatment of depression among older adults. Int Psychogeriatr. 2021;33(2):179-191.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0018\">\n<ce:label>18</ce:label>\n<sb:reference id=\"sbref0018\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Di Vincenzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Siegel</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>137</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>232</sb:first-page>\n<sb:last-page>241</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0018\">Di Vincenzo JD, Siegel A, Lipsitz O, et al. The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review. J Psychiatr Res. 2021;137:232-241.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0019\">\n<ce:label>19</ce:label>\n<sb:reference id=\"sbref0019\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Page</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.E.</ce:given-name>\n<ce:surname>McKenzie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.M.</ce:given-name>\n<ce:surname>Bossuyt</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The PRISMA 2020 statement: an updated guideline for reporting systematic reviews</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>BMJ</sb:maintitle>\n</sb:title>\n<sb:volume-nr>372</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>n71</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0019\">Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0020\">\n<ce:label>20</ce:label>\n<sb:reference id=\"sbref0020\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.A.C.</ce:given-name>\n<ce:surname>Sterne</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Savović</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Page</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>RoB 2: a revised tool for assessing risk of bias in randomised trials</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>BMJ</sb:maintitle>\n</sb:title>\n<sb:volume-nr>366</sb:volume-nr>\n</sb:series>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>l4898</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0020\">Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0021\">\n<ce:label>21</ce:label>\n<sb:reference id=\"sbref0021\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>T.H.</ce:given-name>\n<ce:surname>Barker</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Habibi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Aromataris</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>JBI Evid Synth</sb:maintitle>\n</sb:title>\n<sb:volume-nr>22</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>378</sb:first-page>\n<sb:last-page>388</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0021\">Barker TH, Habibi N, Aromataris E, et al. The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies. JBI Evid Synth. 2024;22(3):378-388.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0022\">\n<ce:label>22</ce:label>\n<sb:reference id=\"sbref0022\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Gálvez</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Huggins</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>32</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>397</sb:first-page>\n<sb:last-page>407</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0022\">Gálvez V, Li A, Huggins C, et al. Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial. J Psychopharmacol. 2018;32(4):397-407.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0023\">\n<ce:label>23</ce:label>\n<sb:reference id=\"sbref0023\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Ochs-Ross</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zhang</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression-TRANSFORM-3</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>28</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>121</sb:first-page>\n<sb:last-page>141</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0023\">Ochs-Ross R, Daly EJ, Zhang Y, et al. Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression-TRANSFORM-3. Am J Geriatr Psychiatry. 2020;28(2):121-141.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0024\">\n<ce:label>24</ce:label>\n<sb:reference id=\"sbref0024\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Lai</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Katalinic</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Glue</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pilot dose-response trial of i.v. ketamine in treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World J Biol Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>15</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>579</sb:first-page>\n<sb:last-page>584</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0024\">Lai R, Katalinic N, Glue P, et al. Pilot dose-response trial of i.v. ketamine in treatment-resistant depression. World J Biol Psychiatry. 2014;15(7):579-584.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0025\">\n<ce:label>25</ce:label>\n<sb:reference id=\"sbref0025\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Glue</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Loo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Fam</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Nat Med</sb:maintitle>\n</sb:title>\n<sb:volume-nr>30</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>2004</sb:first-page>\n<sb:last-page>2009</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0025\">Glue P, Loo C, Fam J, et al. Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial. Nat Med. 2024;30(7):2004-2009.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0026\">\n<ce:label>26</ce:label>\n<sb:reference id=\"sbref0026\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Fernie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Currie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.S.</ce:given-name>\n<ce:surname>Perrin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Br J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>210</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>422</sb:first-page>\n<sb:last-page>428</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0026\">Fernie G, Currie J, Perrin JS, et al. Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial. Br J Psychiatry. 2017;210(6):422-428.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0027\">\n<ce:label>27</ce:label>\n<sb:reference id=\"sbref0027\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Zou</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Min</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Q.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Ren</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-A randomized, double-blind, controlled clinical study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Brain Behav</sb:maintitle>\n</sb:title>\n<sb:volume-nr>11</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:article-number>e01775</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0027\">Zou L, Min S, Chen Q, Li X, Ren L. Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-A randomized, double-blind, controlled clinical study. Brain Behav. 2021;11(1):e01775.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0028\">\n<ce:label>28</ce:label>\n<sb:reference id=\"sbref0028\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>George</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Gálvez</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>25</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>11</sb:issue-nr>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1199</sb:first-page>\n<sb:last-page>1209</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0028\">George D, Gálvez V, Martin D, et al. Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression. Am J Geriatr Psychiatry. 2017;25(11):1199-1209.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0029\">\n<ce:label>29</ce:label>\n<sb:reference id=\"sbref0029\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Wajs</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Aluisio</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Holder</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: Assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2)</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Clin Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>81</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<ce:doi>10.4088/JCP.19m12891</ce:doi>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0029\">Wajs E, Aluisio L, Holder R, et al. Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: Assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2). J Clin Psychiatry. 2020;81(3). doi:10.4088/JCP.19m12891</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0030\">\n<ce:label>30</ce:label>\n<sb:reference id=\"sbref0030\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.A.</ce:given-name>\n<ce:surname>Oughli</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.A.</ce:given-name>\n<ce:surname>Gebara</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Ciarleglio</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Intravenous ketamine for late-life treatment-resistant depression: A pilot study of tolerability, safety, clinical benefits, and effect on cognition</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>31</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>210</sb:first-page>\n<sb:last-page>221</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0030\">Oughli HA, Gebara MA, Ciarleglio A, et al. Intravenous ketamine for late-life treatment-resistant depression: A pilot study of tolerability, safety, clinical benefits, and effect on cognition. Am J Geriatr Psychiatry. 2023;31(3):210-221.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0031\">\n<ce:label>31</ce:label>\n<sb:reference id=\"sbref0031\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Zaki</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.N.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Lane</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Neuropsychopharmacology</sb:maintitle>\n</sb:title>\n<sb:volume-nr>48</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>8</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1225</sb:first-page>\n<sb:last-page>1233</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0031\">Zaki N, Chen LN, Lane R, et al. Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study. Neuropsychopharmacology. 2023;48(8):1225-1233.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0032\">\n<ce:label>32</ce:label>\n<sb:reference id=\"sbref0032\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>K.G.</ce:given-name>\n<ce:surname>Rasmussen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.W.</ce:given-name>\n<ce:surname>Lineberry</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.W.</ce:given-name>\n<ce:surname>Galardy</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Serial infusions of low-dose ketamine for major depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>27</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2013</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>444</sb:first-page>\n<sb:last-page>450</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0032\">Rasmussen KG, Lineberry TW, Galardy CW, et al. Serial infusions of low-dose ketamine for major depression. J Psychopharmacol. 2013;27(5):444-450.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0033\">\n<ce:label>33</ce:label>\n<sb:reference id=\"sbref0033\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Vanderschelden</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.A.</ce:given-name>\n<ce:surname>Gebara</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.A.</ce:given-name>\n<ce:surname>Oughli</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Change in patient-centered outcomes of psychological well-being, sleep, and suicidality following treatment with intravenous ketamine for late-life treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>38</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>e5964</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0033\">Vanderschelden B, Gebara MA, Oughli HA, et al. Change in patient-centered outcomes of psychological well-being, sleep, and suicidality following treatment with intravenous ketamine for late-life treatment-resistant depression. Int J Geriatr Psychiatry. 2023;38(7):e5964.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0034\">\n<ce:label>34</ce:label>\n<sb:reference id=\"sbref0034\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Ochs-Ross</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Wajs</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Comparison of long-term efficacy and safety of esketamine nasal spray plus oral antidepressant in younger versus older patients with treatment-resistant depression: Post-hoc analysis of SUSTAIN-2, a long-term open-label phase 3 safety and efficacy study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>30</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>541</sb:first-page>\n<sb:last-page>556</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0034\">Ochs-Ross R, Wajs E, Daly EJ, et al. Comparison of long-term efficacy and safety of esketamine nasal spray plus oral antidepressant in younger versus older patients with treatment-resistant depression: Post-hoc analysis of SUSTAIN-2, a long-term open-label phase 3 safety and efficacy study. Am J Geriatr Psychiatry. 2022;30(5):541-556.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0035\">\n<ce:label>35</ce:label>\n<sb:reference id=\"sbref0035\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Filteau</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>156</sb:volume-nr>\n</sb:series>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1</sb:first-page>\n<sb:last-page>7</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0035\">McIntyre RS, Filteau MJ, Martin L, et al. Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach. J Affect Disord. 2014;156:1-7.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0036\">\n<ce:label>36</ce:label>\n<sb:reference id=\"sbref0036\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.R.</ce:given-name>\n<ce:surname>Strawn</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.A.</ce:given-name>\n<ce:surname>Mills</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Suresh</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorder</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>159</sb:volume-nr>\n</sb:series>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>266</sb:first-page>\n<sb:last-page>273</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0036\">Strawn JR, Mills JA, Suresh V, et al. The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorder. J Psychiatr Res. 2023;159:266-273.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0037\">\n<ce:label>37</ce:label>\n<sb:reference id=\"sbref0037\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Popova</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Trivedi</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>176</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>428</sb:first-page>\n<sb:last-page>438</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0037\">Popova V, Daly EJ, Trivedi M, et al. Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study. Am J Psychiatry. 2019;176(6):428-438.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0038\">\n<ce:label>38</ce:label>\n<sb:reference id=\"sbref0038\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.F.</ce:given-name>\n<ce:surname>Grunebaum</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.C.</ce:given-name>\n<ce:surname>Galfalvy</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.H.</ce:given-name>\n<ce:surname>Choo</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine for rapid reduction of suicidal thoughts in major depression: A midazolam-controlled randomized clinical trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>175</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>327</sb:first-page>\n<sb:last-page>335</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0038\">Grunebaum MF, Galfalvy HC, Choo TH, et al. Ketamine for rapid reduction of suicidal thoughts in major depression: A midazolam-controlled randomized clinical trial. Am J Psychiatry. 2018;175(4):327-335.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0039\">\n<ce:label>39</ce:label>\n<sb:reference id=\"sbref0039\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.T.</ce:given-name>\n<ce:surname>Wilkinson</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Farmer</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.D.</ce:given-name>\n<ce:surname>Ballard</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Neuropsychopharmacology</sb:maintitle>\n</sb:title>\n<sb:volume-nr>44</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1233</sb:first-page>\n<sb:last-page>1238</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0039\">Wilkinson ST, Farmer C, Ballard ED, et al. Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant. Neuropsychopharmacology. 2019;44(7):1233-1238.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0040\">\n<ce:label>40</ce:label>\n<sb:reference id=\"sbref0040\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.L.</ce:given-name>\n<ce:surname>Naismith</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.M.</ce:given-name>\n<ce:surname>Norrie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Mowszowski</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>IB.</ce:given-name>\n<ce:surname>Hickie</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The neurobiology of depression in later-life: Clinical, neuropsychological, neuroimaging and pathophysiological features</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Prog Neurobiol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>98</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2012</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>99</sb:first-page>\n<sb:last-page>143</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0040\">Naismith SL, Norrie LM, Mowszowski L, Hickie IB. The neurobiology of depression in later-life: Clinical, neuropsychological, neuroimaging and pathophysiological features. Prog Neurobiol. 2012;98(1):99-143.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0041\">\n<ce:label>41</ce:label>\n<sb:reference id=\"sbref0041\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Bayes</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Dong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Alonzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Kabourakis</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Loo</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine treatment for depression: A model of care</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Aust N Z J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>55</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>12</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1134</sb:first-page>\n<sb:last-page>1143</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0041\">Bayes A, Dong V, Martin D, Alonzo A, Kabourakis M, Loo C. Ketamine treatment for depression: A model of care. Aust N Z J Psychiatry. 2021;55(12):1134-1143.</ce:source-text>\n</ce:bib-reference>\n</ce:bibliography-sec>",
    "output": "<ce:bibliography-sec xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"cebibsec1\">\n<?att type=\"article\"?><ce:bib-reference id=\"bib0001\">\n<ce:label>1</ce:label>\n<sb:reference id=\"sbref0001\">\n<sb:contribution>\n<sb:authors>\n<sb:collaboration>Global Burden of Disease Study 2013 Collaborators</sb:collaboration>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Lancet</sb:maintitle>\n</sb:title>\n<sb:volume-nr>386</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>9995</sb:issue-nr>\n<sb:date>20132015</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>743</sb:first-page>\n<sb:last-page>800</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0001\">Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743-800.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0002\">\n<ce:label>2</ce:label>\n<sb:reference id=\"sbref0002\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Maj</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.J.</ce:given-name>\n<ce:surname>Stein</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Parker</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The clinical characterization of the adult patient with depression aimed at personalization of management</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>19</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>269</sb:first-page>\n<sb:last-page>293</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0002\">Maj M, Stein DJ, Parker G, et al. The clinical characterization of the adult patient with depression aimed at personalization of management. World Psychiatry. 2020;19(3):269-293.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0003\">\n<ce:label>3</ce:label>\n<sb:reference id=\"sbref0003\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>CF 3rd</ce:given-name>\n<ce:surname>Reynolds</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.V.</ce:given-name>\n<ce:surname>Jeste</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.S.</ce:given-name>\n<ce:surname>Sachdev</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.G.</ce:given-name>\n<ce:surname>Blazer</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Mental health care for older adults: recent advances and new directions in clinical practice and research</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>21</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>336</sb:first-page>\n<sb:last-page>363</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0003\">Reynolds CF 3rd, Jeste DV, Sachdev PS, Blazer DG. Mental health care for older adults: recent advances and new directions in clinical practice and research. World Psychiatry. 2022;21(3):336-363.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0004\">\n<ce:label>4</ce:label>\n<sb:reference id=\"sbref0004\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zenebe</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Akele</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>W/Selassie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Necho</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Prevalence and determinants of depression among old age: a systematic review and meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Ann Gen Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>20</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>55</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0004\">Zenebe Y, Akele B, W/Selassie M, Necho M. Prevalence and determinants of depression among old age: a systematic review and meta-analysis. Ann Gen Psychiatry. 2021;20(1):55.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0005\">\n<ce:label>5</ce:label>\n<sb:reference id=\"sbref0005\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.S.</ce:given-name>\n<ce:surname>Hasin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.L.</ce:given-name>\n<ce:surname>Sarvet</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.L.</ce:given-name>\n<ce:surname>Meyers</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>JAMA Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>75</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>336</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0005\">Hasin DS, Sarvet AL, Meyers JL, et al. Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiatry. 2018;75(4):336.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0006\">\n<ce:label>6</ce:label>\n<sb:reference id=\"sbref0006\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.R.</ce:given-name>\n<ce:surname>Azar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.P.</ce:given-name>\n<ce:surname>Chopra</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.Y.</ce:given-name>\n<ce:surname>Cho</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Coakley</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>JL.</ce:given-name>\n<ce:surname>Rudolph</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Remission in major depression: results from a geriatric primary care population</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>26</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2011</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>48</sb:first-page>\n<sb:last-page>55</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0006\">Azar AR, Chopra MP, Cho LY, Coakley E, Rudolph JL. Remission in major depression: results from a geriatric primary care population. Int J Geriatr Psychiatry. 2011;26(1):48-55.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0007\">\n<ce:label>7</ce:label>\n<sb:reference id=\"sbref0007\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>U.</ce:given-name>\n<ce:surname>Klotz</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pharmacokinetics and drug metabolism in the elderly</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Drug Metab Rev</sb:maintitle>\n</sb:title>\n<sb:volume-nr>41</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2009</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>67</sb:first-page>\n<sb:last-page>76</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0007\">Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev. 2009;41(2):67-76.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0008\">\n<ce:label>8</ce:label>\n<sb:reference id=\"sbref0008\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Canadian Coalition for Seniors’ Mental</ce:given-name>\n<ce:surname>Health</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Canadian Guidelines on Prevention, Assessment and Treatment of Depression Among Older Adults</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>CCSMH; 2021</sb:maintitle>\n</sb:title>\n</sb:series>\n<sb:date>June 2021</sb:date>\n</sb:issue>\n</sb:host>\n<sb:comment>Updated</sb:comment>\n<sb:host>\n<sb:e-host>\n<ce:inter-ref id=\"interref0001\" xlink:href=\"https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf\">https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf</ce:inter-ref>\n</sb:e-host>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0008\">Canadian Coalition for Seniors’ Mental Health. Canadian Guidelines on Prevention, Assessment and Treatment of Depression Among Older Adults. CCSMH; 2021. Updated June 2021. https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0009\">\n<ce:label>9</ce:label>\n<sb:reference id=\"sbref0009\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Avasthi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Grover</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Clinical practice guidelines for management of depression in elderly</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Indian J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>60</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>Suppl 3</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>S341</sb:first-page>\n<sb:last-page>S362</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0009\">Avasthi A, Grover S. Clinical practice guidelines for management of depression in elderly. Indian J Psychiatry. 2018;60(Suppl 3):S341-S362.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0010\">\n<ce:label>10</ce:label>\n<sb:reference id=\"sbref0010\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Baba</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Kito</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Nukariya</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Guidelines for diagnosis and treatment of depression in older adults: A report from the Japanese Society of mood disorders</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Psychiatry Clin Neurosci</sb:maintitle>\n</sb:title>\n<sb:volume-nr>76</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>222</sb:first-page>\n<sb:last-page>234</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0010\">Baba H, Kito S, Nukariya K, et al. Guidelines for diagnosis and treatment of depression in older adults: A report from the Japanese Society of mood disorders. Psychiatry Clin Neurosci. 2022;76(6):222-234.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0011\">\n<ce:label>11</ce:label>\n<sb:reference id=\"sbref0011\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Rosenblat</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.B.</ce:given-name>\n<ce:surname>Nemeroff</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>178</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>383</sb:first-page>\n<sb:last-page>399</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0011\">McIntyre RS, Rosenblat JD, Nemeroff CB, et al. Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation. Am J Psychiatry. 2021;178(5):383-399.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0012\">\n<ce:label>12</ce:label>\n<sb:reference id=\"sbref0012\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.C.H.</ce:given-name>\n<ce:surname>Cheng</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.E.</ce:given-name>\n<ce:surname>Dri</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Ballum</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effects of ketamine and esketamine on measures of quality of life in major depressive disorder and treatment-resistant depression: A systematic review</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>382</sb:volume-nr>\n</sb:series>\n<sb:date>2025</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>438</sb:first-page>\n<sb:last-page>442</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0012\">Cheng MCH, Dri CE, Ballum H, et al. The effects of ketamine and esketamine on measures of quality of life in major depressive disorder and treatment-resistant depression: A systematic review. J Affect Disord. 2025;382:438-442.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0013\">\n<ce:label>13</ce:label>\n<sb:reference id=\"sbref0013\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Di Vincenzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.B.</ce:given-name>\n<ce:surname>Rodrigues</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Safety, tolerability, and real-world effectiveness of intravenous ketamine in older adults with treatment-resistant depression: A case series</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>29</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>9</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>899</sb:first-page>\n<sb:last-page>913</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0013\">Lipsitz O, Di Vincenzo JD, Rodrigues NB, et al. Safety, tolerability, and real-world effectiveness of intravenous ketamine in older adults with treatment-resistant depression: A case series. Am J Geriatr Psychiatry. 2021;29(9):899-913.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0014\">\n<ce:label>14</ce:label>\n<sb:reference id=\"sbref0014\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>I.P.</ce:given-name>\n<ce:surname>Carvalho</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.M.W.</ce:given-name>\n<ce:surname>Lui</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>276</sb:volume-nr>\n</sb:series>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>576</sb:first-page>\n<sb:last-page>584</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0014\">McIntyre RS, Carvalho IP, Lui LMW, et al. The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis. J Affect Disord. 2020;276:576-584.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0015\">\n<ce:label>15</ce:label>\n<sb:reference id=\"sbref0015\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Lee</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Syeda</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.A.</ce:given-name>\n<ce:surname>Maruschak</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>A new perspective on the anti-suicide effects with ketamine treatment: A procognitive effect</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Clin Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>36</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2016</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>50</sb:first-page>\n<sb:last-page>56</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0015\">Lee Y, Syeda K, Maruschak NA, et al. A new perspective on the anti-suicide effects with ketamine treatment: A procognitive effect. J Clin Psychopharmacol. 2016;36(1):50-56.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0016\">\n<ce:label>16</ce:label>\n<sb:reference id=\"sbref0016\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Xiong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Chen-Li</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>134</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>57</sb:first-page>\n<sb:last-page>68</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0016\">Xiong J, Lipsitz O, Chen-Li D, et al. The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis. J Psychiatr Res. 2021;134:57-68.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0017\">\n<ce:label>17</ce:label>\n<sb:reference id=\"sbref0017\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Gupta</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Dhar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Patadia</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>A systematic review of ketamine for the treatment of depression among older adults</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int Psychogeriatr</sb:maintitle>\n</sb:title>\n<sb:volume-nr>33</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>179</sb:first-page>\n<sb:last-page>191</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0017\">Gupta A, Dhar R, Patadia P, et al. A systematic review of ketamine for the treatment of depression among older adults. Int Psychogeriatr. 2021;33(2):179-191.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0018\">\n<ce:label>18</ce:label>\n<sb:reference id=\"sbref0018\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Di Vincenzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Siegel</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>137</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>232</sb:first-page>\n<sb:last-page>241</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0018\">Di Vincenzo JD, Siegel A, Lipsitz O, et al. The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review. J Psychiatr Res. 2021;137:232-241.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0019\">\n<ce:label>19</ce:label>\n<sb:reference id=\"sbref0019\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Page</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.E.</ce:given-name>\n<ce:surname>McKenzie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.M.</ce:given-name>\n<ce:surname>Bossuyt</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The PRISMA 2020 statement: an updated guideline for reporting systematic reviews</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>BMJ</sb:maintitle>\n</sb:title>\n<sb:volume-nr>372</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>n71</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0019\">Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0020\">\n<ce:label>20</ce:label>\n<sb:reference id=\"sbref0020\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.A.C.</ce:given-name>\n<ce:surname>Sterne</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Savović</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Page</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>RoB 2: a revised tool for assessing risk of bias in randomised trials</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>BMJ</sb:maintitle>\n</sb:title>\n<sb:volume-nr>366</sb:volume-nr>\n</sb:series>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>l4898</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0020\">Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0021\">\n<ce:label>21</ce:label>\n<sb:reference id=\"sbref0021\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>T.H.</ce:given-name>\n<ce:surname>Barker</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Habibi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Aromataris</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>JBI Evid Synth</sb:maintitle>\n</sb:title>\n<sb:volume-nr>22</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>378</sb:first-page>\n<sb:last-page>388</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0021\">Barker TH, Habibi N, Aromataris E, et al. The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies. JBI Evid Synth. 2024;22(3):378-388.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0022\">\n<ce:label>22</ce:label>\n<sb:reference id=\"sbref0022\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Gálvez</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Huggins</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>32</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>397</sb:first-page>\n<sb:last-page>407</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0022\">Gálvez V, Li A, Huggins C, et al. Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial. J Psychopharmacol. 2018;32(4):397-407.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0023\">\n<ce:label>23</ce:label>\n<sb:reference id=\"sbref0023\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Ochs-Ross</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zhang</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression-TRANSFORM-3</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>28</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>121</sb:first-page>\n<sb:last-page>141</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0023\">Ochs-Ross R, Daly EJ, Zhang Y, et al. Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression-TRANSFORM-3. Am J Geriatr Psychiatry. 2020;28(2):121-141.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0024\">\n<ce:label>24</ce:label>\n<sb:reference id=\"sbref0024\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Lai</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Katalinic</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Glue</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pilot dose-response trial of i.v. ketamine in treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World J Biol Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>15</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>579</sb:first-page>\n<sb:last-page>584</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0024\">Lai R, Katalinic N, Glue P, et al. Pilot dose-response trial of i.v. ketamine in treatment-resistant depression. World J Biol Psychiatry. 2014;15(7):579-584.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0025\">\n<ce:label>25</ce:label>\n<sb:reference id=\"sbref0025\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Glue</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Loo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Fam</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Nat Med</sb:maintitle>\n</sb:title>\n<sb:volume-nr>30</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>2004</sb:first-page>\n<sb:last-page>2009</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0025\">Glue P, Loo C, Fam J, et al. Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial. Nat Med. 2024;30(7):2004-2009.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0026\">\n<ce:label>26</ce:label>\n<sb:reference id=\"sbref0026\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Fernie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Currie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.S.</ce:given-name>\n<ce:surname>Perrin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Br J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>210</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>422</sb:first-page>\n<sb:last-page>428</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0026\">Fernie G, Currie J, Perrin JS, et al. Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial. Br J Psychiatry. 2017;210(6):422-428.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0027\">\n<ce:label>27</ce:label>\n<sb:reference id=\"sbref0027\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Zou</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Min</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Q.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Ren</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-A randomized, double-blind, controlled clinical study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Brain Behav</sb:maintitle>\n</sb:title>\n<sb:volume-nr>11</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:article-number>e01775</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0027\">Zou L, Min S, Chen Q, Li X, Ren L. Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-A randomized, double-blind, controlled clinical study. Brain Behav. 2021;11(1):e01775.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0028\">\n<ce:label>28</ce:label>\n<sb:reference id=\"sbref0028\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>George</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Gálvez</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>25</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>11</sb:issue-nr>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1199</sb:first-page>\n<sb:last-page>1209</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0028\">George D, Gálvez V, Martin D, et al. Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression. Am J Geriatr Psychiatry. 2017;25(11):1199-1209.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0029\">\n<ce:label>29</ce:label>\n<sb:reference id=\"sbref0029\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Wajs</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Aluisio</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Holder</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: Assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2)</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Clin Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>81</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<ce:doi>10.4088/JCP.19m12891</ce:doi>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0029\">Wajs E, Aluisio L, Holder R, et al. Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: Assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2). J Clin Psychiatry. 2020;81(3). doi:10.4088/JCP.19m12891</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0030\">\n<ce:label>30</ce:label>\n<sb:reference id=\"sbref0030\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.A.</ce:given-name>\n<ce:surname>Oughli</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.A.</ce:given-name>\n<ce:surname>Gebara</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Ciarleglio</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Intravenous ketamine for late-life treatment-resistant depression: A pilot study of tolerability, safety, clinical benefits, and effect on cognition</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>31</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>210</sb:first-page>\n<sb:last-page>221</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0030\">Oughli HA, Gebara MA, Ciarleglio A, et al. Intravenous ketamine for late-life treatment-resistant depression: A pilot study of tolerability, safety, clinical benefits, and effect on cognition. Am J Geriatr Psychiatry. 2023;31(3):210-221.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0031\">\n<ce:label>31</ce:label>\n<sb:reference id=\"sbref0031\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Zaki</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.N.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Lane</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Neuropsychopharmacology</sb:maintitle>\n</sb:title>\n<sb:volume-nr>48</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>8</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1225</sb:first-page>\n<sb:last-page>1233</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0031\">Zaki N, Chen LN, Lane R, et al. Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study. Neuropsychopharmacology. 2023;48(8):1225-1233.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0032\">\n<ce:label>32</ce:label>\n<sb:reference id=\"sbref0032\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>K.G.</ce:given-name>\n<ce:surname>Rasmussen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.W.</ce:given-name>\n<ce:surname>Lineberry</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.W.</ce:given-name>\n<ce:surname>Galardy</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Serial infusions of low-dose ketamine for major depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>27</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2013</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>444</sb:first-page>\n<sb:last-page>450</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0032\">Rasmussen KG, Lineberry TW, Galardy CW, et al. Serial infusions of low-dose ketamine for major depression. J Psychopharmacol. 2013;27(5):444-450.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0033\">\n<ce:label>33</ce:label>\n<sb:reference id=\"sbref0033\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Vanderschelden</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.A.</ce:given-name>\n<ce:surname>Gebara</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.A.</ce:given-name>\n<ce:surname>Oughli</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Change in patient-centered outcomes of psychological well-being, sleep, and suicidality following treatment with intravenous ketamine for late-life treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>38</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>e5964</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0033\">Vanderschelden B, Gebara MA, Oughli HA, et al. Change in patient-centered outcomes of psychological well-being, sleep, and suicidality following treatment with intravenous ketamine for late-life treatment-resistant depression. Int J Geriatr Psychiatry. 2023;38(7):e5964.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0034\">\n<ce:label>34</ce:label>\n<sb:reference id=\"sbref0034\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Ochs-Ross</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Wajs</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Comparison of long-term efficacy and safety of esketamine nasal spray plus oral antidepressant in younger versus older patients with treatment-resistant depression: Post-hoc analysis of SUSTAIN-2, a long-term open-label phase 3 safety and efficacy study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>30</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>541</sb:first-page>\n<sb:last-page>556</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0034\">Ochs-Ross R, Wajs E, Daly EJ, et al. Comparison of long-term efficacy and safety of esketamine nasal spray plus oral antidepressant in younger versus older patients with treatment-resistant depression: Post-hoc analysis of SUSTAIN-2, a long-term open-label phase 3 safety and efficacy study. Am J Geriatr Psychiatry. 2022;30(5):541-556.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0035\">\n<ce:label>35</ce:label>\n<sb:reference id=\"sbref0035\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Filteau</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>156</sb:volume-nr>\n</sb:series>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1</sb:first-page>\n<sb:last-page>7</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0035\">McIntyre RS, Filteau MJ, Martin L, et al. Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach. J Affect Disord. 2014;156:1-7.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0036\">\n<ce:label>36</ce:label>\n<sb:reference id=\"sbref0036\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.R.</ce:given-name>\n<ce:surname>Strawn</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.A.</ce:given-name>\n<ce:surname>Mills</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Suresh</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorder</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>159</sb:volume-nr>\n</sb:series>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>266</sb:first-page>\n<sb:last-page>273</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0036\">Strawn JR, Mills JA, Suresh V, et al. The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorder. J Psychiatr Res. 2023;159:266-273.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0037\">\n<ce:label>37</ce:label>\n<sb:reference id=\"sbref0037\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Popova</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Trivedi</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>176</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>428</sb:first-page>\n<sb:last-page>438</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0037\">Popova V, Daly EJ, Trivedi M, et al. Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study. Am J Psychiatry. 2019;176(6):428-438.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0038\">\n<ce:label>38</ce:label>\n<sb:reference id=\"sbref0038\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.F.</ce:given-name>\n<ce:surname>Grunebaum</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.C.</ce:given-name>\n<ce:surname>Galfalvy</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.H.</ce:given-name>\n<ce:surname>Choo</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine for rapid reduction of suicidal thoughts in major depression: A midazolam-controlled randomized clinical trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>175</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>327</sb:first-page>\n<sb:last-page>335</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0038\">Grunebaum MF, Galfalvy HC, Choo TH, et al. Ketamine for rapid reduction of suicidal thoughts in major depression: A midazolam-controlled randomized clinical trial. Am J Psychiatry. 2018;175(4):327-335.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0039\">\n<ce:label>39</ce:label>\n<sb:reference id=\"sbref0039\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.T.</ce:given-name>\n<ce:surname>Wilkinson</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Farmer</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.D.</ce:given-name>\n<ce:surname>Ballard</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Neuropsychopharmacology</sb:maintitle>\n</sb:title>\n<sb:volume-nr>44</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1233</sb:first-page>\n<sb:last-page>1238</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0039\">Wilkinson ST, Farmer C, Ballard ED, et al. Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant. Neuropsychopharmacology. 2019;44(7):1233-1238.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0040\">\n<ce:label>40</ce:label>\n<sb:reference id=\"sbref0040\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.L.</ce:given-name>\n<ce:surname>Naismith</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.M.</ce:given-name>\n<ce:surname>Norrie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Mowszowski</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>IB.</ce:given-name>\n<ce:surname>Hickie</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The neurobiology of depression in later-life: Clinical, neuropsychological, neuroimaging and pathophysiological features</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Prog Neurobiol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>98</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2012</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>99</sb:first-page>\n<sb:last-page>143</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0040\">Naismith SL, Norrie LM, Mowszowski L, Hickie IB. The neurobiology of depression in later-life: Clinical, neuropsychological, neuroimaging and pathophysiological features. Prog Neurobiol. 2012;98(1):99-143.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0041\">\n<ce:label>41</ce:label>\n<sb:reference id=\"sbref0041\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Bayes</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Dong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Alonzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Kabourakis</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Loo</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine treatment for depression: A model of care</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Aust N Z J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>55</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>12</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1134</sb:first-page>\n<sb:last-page>1143</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0041\">Bayes A, Dong V, Martin D, Alonzo A, Kabourakis M, Loo C. Ketamine treatment for depression: A model of care. Aust N Z J Psychiatry. 2021;55(12):1134-1143.</ce:source-text>\n</ce:bib-reference>\n</ce:bibliography-sec>",
    "error_message": "All bibliographic references within 'ce:bibliography' must be referred to.",
    "error_position": "1217:63",
    "error_id": "IDS503a",
    "folder_name": "AMGP2541"
  },
  {
    "input": "<ce:bibliography-sec xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"cebibsec1\">\n<?att type=\"article\"?><ce:bib-reference id=\"bib0001\">\n<ce:label>1</ce:label>\n<sb:reference id=\"sbref0001\">\n<sb:contribution>\n<sb:authors>\n<sb:collaboration>Global Burden of Disease Study 2013 Collaborators</sb:collaboration>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Lancet</sb:maintitle>\n</sb:title>\n<sb:volume-nr>386</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>9995</sb:issue-nr>\n<sb:date>20132015</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>743</sb:first-page>\n<sb:last-page>800</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0001\">Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743-800.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0002\">\n<ce:label>2</ce:label>\n<sb:reference id=\"sbref0002\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Maj</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.J.</ce:given-name>\n<ce:surname>Stein</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Parker</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The clinical characterization of the adult patient with depression aimed at personalization of management</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>19</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>269</sb:first-page>\n<sb:last-page>293</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0002\">Maj M, Stein DJ, Parker G, et al. The clinical characterization of the adult patient with depression aimed at personalization of management. World Psychiatry. 2020;19(3):269-293.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0003\">\n<ce:label>3</ce:label>\n<sb:reference id=\"sbref0003\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>CF 3rd</ce:given-name>\n<ce:surname>Reynolds</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.V.</ce:given-name>\n<ce:surname>Jeste</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.S.</ce:given-name>\n<ce:surname>Sachdev</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.G.</ce:given-name>\n<ce:surname>Blazer</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Mental health care for older adults: recent advances and new directions in clinical practice and research</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>21</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>336</sb:first-page>\n<sb:last-page>363</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0003\">Reynolds CF 3rd, Jeste DV, Sachdev PS, Blazer DG. Mental health care for older adults: recent advances and new directions in clinical practice and research. World Psychiatry. 2022;21(3):336-363.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0004\">\n<ce:label>4</ce:label>\n<sb:reference id=\"sbref0004\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zenebe</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Akele</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>W/Selassie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Necho</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Prevalence and determinants of depression among old age: a systematic review and meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Ann Gen Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>20</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>55</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0004\">Zenebe Y, Akele B, W/Selassie M, Necho M. Prevalence and determinants of depression among old age: a systematic review and meta-analysis. Ann Gen Psychiatry. 2021;20(1):55.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0005\">\n<ce:label>5</ce:label>\n<sb:reference id=\"sbref0005\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.S.</ce:given-name>\n<ce:surname>Hasin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.L.</ce:given-name>\n<ce:surname>Sarvet</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.L.</ce:given-name>\n<ce:surname>Meyers</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>JAMA Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>75</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>336</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0005\">Hasin DS, Sarvet AL, Meyers JL, et al. Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiatry. 2018;75(4):336.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0006\">\n<ce:label>6</ce:label>\n<sb:reference id=\"sbref0006\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.R.</ce:given-name>\n<ce:surname>Azar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.P.</ce:given-name>\n<ce:surname>Chopra</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.Y.</ce:given-name>\n<ce:surname>Cho</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Coakley</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>JL.</ce:given-name>\n<ce:surname>Rudolph</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Remission in major depression: results from a geriatric primary care population</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>26</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2011</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>48</sb:first-page>\n<sb:last-page>55</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0006\">Azar AR, Chopra MP, Cho LY, Coakley E, Rudolph JL. Remission in major depression: results from a geriatric primary care population. Int J Geriatr Psychiatry. 2011;26(1):48-55.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0007\">\n<ce:label>7</ce:label>\n<sb:reference id=\"sbref0007\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>U.</ce:given-name>\n<ce:surname>Klotz</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pharmacokinetics and drug metabolism in the elderly</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Drug Metab Rev</sb:maintitle>\n</sb:title>\n<sb:volume-nr>41</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2009</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>67</sb:first-page>\n<sb:last-page>76</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0007\">Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev. 2009;41(2):67-76.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0008\">\n<ce:label>8</ce:label>\n<sb:reference id=\"sbref0008\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Canadian Coalition for Seniors’ Mental</ce:given-name>\n<ce:surname>Health</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Canadian Guidelines on Prevention, Assessment and Treatment of Depression Among Older Adults</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>CCSMH; 2021</sb:maintitle>\n</sb:title>\n</sb:series>\n<sb:date>June 2021</sb:date>\n</sb:issue>\n</sb:host>\n<sb:comment>Updated</sb:comment>\n<sb:host>\n<sb:e-host>\n<ce:inter-ref id=\"interref0001\" xlink:href=\"https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf\">https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf</ce:inter-ref>\n</sb:e-host>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0008\">Canadian Coalition for Seniors’ Mental Health. Canadian Guidelines on Prevention, Assessment and Treatment of Depression Among Older Adults. CCSMH; 2021. Updated June 2021. https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0009\">\n<ce:label>9</ce:label>\n<sb:reference id=\"sbref0009\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Avasthi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Grover</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Clinical practice guidelines for management of depression in elderly</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Indian J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>60</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>Suppl 3</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>S341</sb:first-page>\n<sb:last-page>S362</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0009\">Avasthi A, Grover S. Clinical practice guidelines for management of depression in elderly. Indian J Psychiatry. 2018;60(Suppl 3):S341-S362.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0010\">\n<ce:label>10</ce:label>\n<sb:reference id=\"sbref0010\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Baba</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Kito</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Nukariya</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Guidelines for diagnosis and treatment of depression in older adults: A report from the Japanese Society of mood disorders</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Psychiatry Clin Neurosci</sb:maintitle>\n</sb:title>\n<sb:volume-nr>76</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>222</sb:first-page>\n<sb:last-page>234</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0010\">Baba H, Kito S, Nukariya K, et al. Guidelines for diagnosis and treatment of depression in older adults: A report from the Japanese Society of mood disorders. Psychiatry Clin Neurosci. 2022;76(6):222-234.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0011\">\n<ce:label>11</ce:label>\n<sb:reference id=\"sbref0011\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Rosenblat</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.B.</ce:given-name>\n<ce:surname>Nemeroff</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>178</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>383</sb:first-page>\n<sb:last-page>399</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0011\">McIntyre RS, Rosenblat JD, Nemeroff CB, et al. Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation. Am J Psychiatry. 2021;178(5):383-399.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0012\">\n<ce:label>12</ce:label>\n<sb:reference id=\"sbref0012\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.C.H.</ce:given-name>\n<ce:surname>Cheng</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.E.</ce:given-name>\n<ce:surname>Dri</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Ballum</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effects of ketamine and esketamine on measures of quality of life in major depressive disorder and treatment-resistant depression: A systematic review</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>382</sb:volume-nr>\n</sb:series>\n<sb:date>2025</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>438</sb:first-page>\n<sb:last-page>442</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0012\">Cheng MCH, Dri CE, Ballum H, et al. The effects of ketamine and esketamine on measures of quality of life in major depressive disorder and treatment-resistant depression: A systematic review. J Affect Disord. 2025;382:438-442.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0013\">\n<ce:label>13</ce:label>\n<sb:reference id=\"sbref0013\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Di Vincenzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.B.</ce:given-name>\n<ce:surname>Rodrigues</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Safety, tolerability, and real-world effectiveness of intravenous ketamine in older adults with treatment-resistant depression: A case series</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>29</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>9</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>899</sb:first-page>\n<sb:last-page>913</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0013\">Lipsitz O, Di Vincenzo JD, Rodrigues NB, et al. Safety, tolerability, and real-world effectiveness of intravenous ketamine in older adults with treatment-resistant depression: A case series. Am J Geriatr Psychiatry. 2021;29(9):899-913.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0014\">\n<ce:label>14</ce:label>\n<sb:reference id=\"sbref0014\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>I.P.</ce:given-name>\n<ce:surname>Carvalho</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.M.W.</ce:given-name>\n<ce:surname>Lui</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>276</sb:volume-nr>\n</sb:series>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>576</sb:first-page>\n<sb:last-page>584</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0014\">McIntyre RS, Carvalho IP, Lui LMW, et al. The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis. J Affect Disord. 2020;276:576-584.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0015\">\n<ce:label>15</ce:label>\n<sb:reference id=\"sbref0015\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Lee</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Syeda</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.A.</ce:given-name>\n<ce:surname>Maruschak</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>A new perspective on the anti-suicide effects with ketamine treatment: A procognitive effect</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Clin Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>36</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2016</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>50</sb:first-page>\n<sb:last-page>56</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0015\">Lee Y, Syeda K, Maruschak NA, et al. A new perspective on the anti-suicide effects with ketamine treatment: A procognitive effect. J Clin Psychopharmacol. 2016;36(1):50-56.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0016\">\n<ce:label>16</ce:label>\n<sb:reference id=\"sbref0016\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Xiong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Chen-Li</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>134</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>57</sb:first-page>\n<sb:last-page>68</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0016\">Xiong J, Lipsitz O, Chen-Li D, et al. The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis. J Psychiatr Res. 2021;134:57-68.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0017\">\n<ce:label>17</ce:label>\n<sb:reference id=\"sbref0017\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Gupta</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Dhar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Patadia</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>A systematic review of ketamine for the treatment of depression among older adults</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int Psychogeriatr</sb:maintitle>\n</sb:title>\n<sb:volume-nr>33</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>179</sb:first-page>\n<sb:last-page>191</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0017\">Gupta A, Dhar R, Patadia P, et al. A systematic review of ketamine for the treatment of depression among older adults. Int Psychogeriatr. 2021;33(2):179-191.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0018\">\n<ce:label>18</ce:label>\n<sb:reference id=\"sbref0018\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Di Vincenzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Siegel</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>137</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>232</sb:first-page>\n<sb:last-page>241</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0018\">Di Vincenzo JD, Siegel A, Lipsitz O, et al. The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review. J Psychiatr Res. 2021;137:232-241.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0019\">\n<ce:label>19</ce:label>\n<sb:reference id=\"sbref0019\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Page</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.E.</ce:given-name>\n<ce:surname>McKenzie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.M.</ce:given-name>\n<ce:surname>Bossuyt</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The PRISMA 2020 statement: an updated guideline for reporting systematic reviews</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>BMJ</sb:maintitle>\n</sb:title>\n<sb:volume-nr>372</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>n71</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0019\">Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0020\">\n<ce:label>20</ce:label>\n<sb:reference id=\"sbref0020\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.A.C.</ce:given-name>\n<ce:surname>Sterne</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Savović</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Page</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>RoB 2: a revised tool for assessing risk of bias in randomised trials</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>BMJ</sb:maintitle>\n</sb:title>\n<sb:volume-nr>366</sb:volume-nr>\n</sb:series>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>l4898</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0020\">Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0021\">\n<ce:label>21</ce:label>\n<sb:reference id=\"sbref0021\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>T.H.</ce:given-name>\n<ce:surname>Barker</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Habibi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Aromataris</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>JBI Evid Synth</sb:maintitle>\n</sb:title>\n<sb:volume-nr>22</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>378</sb:first-page>\n<sb:last-page>388</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0021\">Barker TH, Habibi N, Aromataris E, et al. The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies. JBI Evid Synth. 2024;22(3):378-388.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0022\">\n<ce:label>22</ce:label>\n<sb:reference id=\"sbref0022\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Gálvez</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Huggins</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>32</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>397</sb:first-page>\n<sb:last-page>407</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0022\">Gálvez V, Li A, Huggins C, et al. Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial. J Psychopharmacol. 2018;32(4):397-407.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0023\">\n<ce:label>23</ce:label>\n<sb:reference id=\"sbref0023\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Ochs-Ross</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zhang</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression-TRANSFORM-3</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>28</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>121</sb:first-page>\n<sb:last-page>141</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0023\">Ochs-Ross R, Daly EJ, Zhang Y, et al. Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression-TRANSFORM-3. Am J Geriatr Psychiatry. 2020;28(2):121-141.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0024\">\n<ce:label>24</ce:label>\n<sb:reference id=\"sbref0024\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Lai</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Katalinic</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Glue</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pilot dose-response trial of i.v. ketamine in treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World J Biol Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>15</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>579</sb:first-page>\n<sb:last-page>584</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0024\">Lai R, Katalinic N, Glue P, et al. Pilot dose-response trial of i.v. ketamine in treatment-resistant depression. World J Biol Psychiatry. 2014;15(7):579-584.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0025\">\n<ce:label>25</ce:label>\n<sb:reference id=\"sbref0025\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Glue</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Loo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Fam</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Nat Med</sb:maintitle>\n</sb:title>\n<sb:volume-nr>30</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>2004</sb:first-page>\n<sb:last-page>2009</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0025\">Glue P, Loo C, Fam J, et al. Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial. Nat Med. 2024;30(7):2004-2009.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0026\">\n<ce:label>26</ce:label>\n<sb:reference id=\"sbref0026\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Fernie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Currie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.S.</ce:given-name>\n<ce:surname>Perrin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Br J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>210</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>422</sb:first-page>\n<sb:last-page>428</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0026\">Fernie G, Currie J, Perrin JS, et al. Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial. Br J Psychiatry. 2017;210(6):422-428.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0027\">\n<ce:label>27</ce:label>\n<sb:reference id=\"sbref0027\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Zou</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Min</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Q.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Ren</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-A randomized, double-blind, controlled clinical study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Brain Behav</sb:maintitle>\n</sb:title>\n<sb:volume-nr>11</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:article-number>e01775</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0027\">Zou L, Min S, Chen Q, Li X, Ren L. Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-A randomized, double-blind, controlled clinical study. Brain Behav. 2021;11(1):e01775.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0028\">\n<ce:label>28</ce:label>\n<sb:reference id=\"sbref0028\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>George</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Gálvez</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>25</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>11</sb:issue-nr>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1199</sb:first-page>\n<sb:last-page>1209</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0028\">George D, Gálvez V, Martin D, et al. Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression. Am J Geriatr Psychiatry. 2017;25(11):1199-1209.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0029\">\n<ce:label>29</ce:label>\n<sb:reference id=\"sbref0029\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Wajs</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Aluisio</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Holder</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: Assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2)</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Clin Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>81</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<ce:doi>10.4088/JCP.19m12891</ce:doi>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0029\">Wajs E, Aluisio L, Holder R, et al. Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: Assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2). J Clin Psychiatry. 2020;81(3). doi:10.4088/JCP.19m12891</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0030\">\n<ce:label>30</ce:label>\n<sb:reference id=\"sbref0030\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.A.</ce:given-name>\n<ce:surname>Oughli</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.A.</ce:given-name>\n<ce:surname>Gebara</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Ciarleglio</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Intravenous ketamine for late-life treatment-resistant depression: A pilot study of tolerability, safety, clinical benefits, and effect on cognition</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>31</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>210</sb:first-page>\n<sb:last-page>221</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0030\">Oughli HA, Gebara MA, Ciarleglio A, et al. Intravenous ketamine for late-life treatment-resistant depression: A pilot study of tolerability, safety, clinical benefits, and effect on cognition. Am J Geriatr Psychiatry. 2023;31(3):210-221.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0031\">\n<ce:label>31</ce:label>\n<sb:reference id=\"sbref0031\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Zaki</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.N.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Lane</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Neuropsychopharmacology</sb:maintitle>\n</sb:title>\n<sb:volume-nr>48</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>8</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1225</sb:first-page>\n<sb:last-page>1233</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0031\">Zaki N, Chen LN, Lane R, et al. Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study. Neuropsychopharmacology. 2023;48(8):1225-1233.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0032\">\n<ce:label>32</ce:label>\n<sb:reference id=\"sbref0032\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>K.G.</ce:given-name>\n<ce:surname>Rasmussen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.W.</ce:given-name>\n<ce:surname>Lineberry</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.W.</ce:given-name>\n<ce:surname>Galardy</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Serial infusions of low-dose ketamine for major depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>27</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2013</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>444</sb:first-page>\n<sb:last-page>450</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0032\">Rasmussen KG, Lineberry TW, Galardy CW, et al. Serial infusions of low-dose ketamine for major depression. J Psychopharmacol. 2013;27(5):444-450.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0033\">\n<ce:label>33</ce:label>\n<sb:reference id=\"sbref0033\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Vanderschelden</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.A.</ce:given-name>\n<ce:surname>Gebara</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.A.</ce:given-name>\n<ce:surname>Oughli</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Change in patient-centered outcomes of psychological well-being, sleep, and suicidality following treatment with intravenous ketamine for late-life treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>38</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>e5964</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0033\">Vanderschelden B, Gebara MA, Oughli HA, et al. Change in patient-centered outcomes of psychological well-being, sleep, and suicidality following treatment with intravenous ketamine for late-life treatment-resistant depression. Int J Geriatr Psychiatry. 2023;38(7):e5964.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0034\">\n<ce:label>34</ce:label>\n<sb:reference id=\"sbref0034\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Ochs-Ross</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Wajs</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Comparison of long-term efficacy and safety of esketamine nasal spray plus oral antidepressant in younger versus older patients with treatment-resistant depression: Post-hoc analysis of SUSTAIN-2, a long-term open-label phase 3 safety and efficacy study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>30</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>541</sb:first-page>\n<sb:last-page>556</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0034\">Ochs-Ross R, Wajs E, Daly EJ, et al. Comparison of long-term efficacy and safety of esketamine nasal spray plus oral antidepressant in younger versus older patients with treatment-resistant depression: Post-hoc analysis of SUSTAIN-2, a long-term open-label phase 3 safety and efficacy study. Am J Geriatr Psychiatry. 2022;30(5):541-556.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0035\">\n<ce:label>35</ce:label>\n<sb:reference id=\"sbref0035\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Filteau</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>156</sb:volume-nr>\n</sb:series>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1</sb:first-page>\n<sb:last-page>7</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0035\">McIntyre RS, Filteau MJ, Martin L, et al. Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach. J Affect Disord. 2014;156:1-7.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0036\">\n<ce:label>36</ce:label>\n<sb:reference id=\"sbref0036\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.R.</ce:given-name>\n<ce:surname>Strawn</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.A.</ce:given-name>\n<ce:surname>Mills</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Suresh</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorder</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>159</sb:volume-nr>\n</sb:series>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>266</sb:first-page>\n<sb:last-page>273</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0036\">Strawn JR, Mills JA, Suresh V, et al. The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorder. J Psychiatr Res. 2023;159:266-273.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0037\">\n<ce:label>37</ce:label>\n<sb:reference id=\"sbref0037\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Popova</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Trivedi</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>176</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>428</sb:first-page>\n<sb:last-page>438</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0037\">Popova V, Daly EJ, Trivedi M, et al. Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study. Am J Psychiatry. 2019;176(6):428-438.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0038\">\n<ce:label>38</ce:label>\n<sb:reference id=\"sbref0038\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.F.</ce:given-name>\n<ce:surname>Grunebaum</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.C.</ce:given-name>\n<ce:surname>Galfalvy</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.H.</ce:given-name>\n<ce:surname>Choo</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine for rapid reduction of suicidal thoughts in major depression: A midazolam-controlled randomized clinical trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>175</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>327</sb:first-page>\n<sb:last-page>335</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0038\">Grunebaum MF, Galfalvy HC, Choo TH, et al. Ketamine for rapid reduction of suicidal thoughts in major depression: A midazolam-controlled randomized clinical trial. Am J Psychiatry. 2018;175(4):327-335.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0039\">\n<ce:label>39</ce:label>\n<sb:reference id=\"sbref0039\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.T.</ce:given-name>\n<ce:surname>Wilkinson</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Farmer</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.D.</ce:given-name>\n<ce:surname>Ballard</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Neuropsychopharmacology</sb:maintitle>\n</sb:title>\n<sb:volume-nr>44</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1233</sb:first-page>\n<sb:last-page>1238</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0039\">Wilkinson ST, Farmer C, Ballard ED, et al. Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant. Neuropsychopharmacology. 2019;44(7):1233-1238.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0040\">\n<ce:label>40</ce:label>\n<sb:reference id=\"sbref0040\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.L.</ce:given-name>\n<ce:surname>Naismith</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.M.</ce:given-name>\n<ce:surname>Norrie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Mowszowski</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>IB.</ce:given-name>\n<ce:surname>Hickie</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The neurobiology of depression in later-life: Clinical, neuropsychological, neuroimaging and pathophysiological features</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Prog Neurobiol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>98</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2012</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>99</sb:first-page>\n<sb:last-page>143</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0040\">Naismith SL, Norrie LM, Mowszowski L, Hickie IB. The neurobiology of depression in later-life: Clinical, neuropsychological, neuroimaging and pathophysiological features. Prog Neurobiol. 2012;98(1):99-143.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0041\">\n<ce:label>41</ce:label>\n<sb:reference id=\"sbref0041\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Bayes</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Dong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Alonzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Kabourakis</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Loo</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine treatment for depression: A model of care</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Aust N Z J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>55</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>12</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1134</sb:first-page>\n<sb:last-page>1143</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0041\">Bayes A, Dong V, Martin D, Alonzo A, Kabourakis M, Loo C. Ketamine treatment for depression: A model of care. Aust N Z J Psychiatry. 2021;55(12):1134-1143.</ce:source-text>\n</ce:bib-reference>\n</ce:bibliography-sec>",
    "output": "<ce:bibliography-sec xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"cebibsec1\">\n<?att type=\"article\"?><ce:bib-reference id=\"bib0001\">\n<ce:label>1</ce:label>\n<sb:reference id=\"sbref0001\">\n<sb:contribution>\n<sb:authors>\n<sb:collaboration>Global Burden of Disease Study 2013 Collaborators</sb:collaboration>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Lancet</sb:maintitle>\n</sb:title>\n<sb:volume-nr>386</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>9995</sb:issue-nr>\n<sb:date>20132015</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>743</sb:first-page>\n<sb:last-page>800</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0001\">Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743-800.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0002\">\n<ce:label>2</ce:label>\n<sb:reference id=\"sbref0002\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Maj</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.J.</ce:given-name>\n<ce:surname>Stein</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Parker</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The clinical characterization of the adult patient with depression aimed at personalization of management</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>19</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>269</sb:first-page>\n<sb:last-page>293</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0002\">Maj M, Stein DJ, Parker G, et al. The clinical characterization of the adult patient with depression aimed at personalization of management. World Psychiatry. 2020;19(3):269-293.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0003\">\n<ce:label>3</ce:label>\n<sb:reference id=\"sbref0003\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>CF 3rd</ce:given-name>\n<ce:surname>Reynolds</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.V.</ce:given-name>\n<ce:surname>Jeste</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.S.</ce:given-name>\n<ce:surname>Sachdev</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.G.</ce:given-name>\n<ce:surname>Blazer</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Mental health care for older adults: recent advances and new directions in clinical practice and research</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>21</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>336</sb:first-page>\n<sb:last-page>363</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0003\">Reynolds CF 3rd, Jeste DV, Sachdev PS, Blazer DG. Mental health care for older adults: recent advances and new directions in clinical practice and research. World Psychiatry. 2022;21(3):336-363.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0004\">\n<ce:label>4</ce:label>\n<sb:reference id=\"sbref0004\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zenebe</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Akele</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>W/Selassie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Necho</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Prevalence and determinants of depression among old age: a systematic review and meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Ann Gen Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>20</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>55</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0004\">Zenebe Y, Akele B, W/Selassie M, Necho M. Prevalence and determinants of depression among old age: a systematic review and meta-analysis. Ann Gen Psychiatry. 2021;20(1):55.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0005\">\n<ce:label>5</ce:label>\n<sb:reference id=\"sbref0005\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.S.</ce:given-name>\n<ce:surname>Hasin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.L.</ce:given-name>\n<ce:surname>Sarvet</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.L.</ce:given-name>\n<ce:surname>Meyers</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>JAMA Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>75</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>336</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0005\">Hasin DS, Sarvet AL, Meyers JL, et al. Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiatry. 2018;75(4):336.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0006\">\n<ce:label>6</ce:label>\n<sb:reference id=\"sbref0006\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.R.</ce:given-name>\n<ce:surname>Azar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.P.</ce:given-name>\n<ce:surname>Chopra</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.Y.</ce:given-name>\n<ce:surname>Cho</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Coakley</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>JL.</ce:given-name>\n<ce:surname>Rudolph</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Remission in major depression: results from a geriatric primary care population</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>26</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2011</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>48</sb:first-page>\n<sb:last-page>55</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0006\">Azar AR, Chopra MP, Cho LY, Coakley E, Rudolph JL. Remission in major depression: results from a geriatric primary care population. Int J Geriatr Psychiatry. 2011;26(1):48-55.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0007\">\n<ce:label>7</ce:label>\n<sb:reference id=\"sbref0007\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>U.</ce:given-name>\n<ce:surname>Klotz</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pharmacokinetics and drug metabolism in the elderly</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Drug Metab Rev</sb:maintitle>\n</sb:title>\n<sb:volume-nr>41</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2009</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>67</sb:first-page>\n<sb:last-page>76</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0007\">Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev. 2009;41(2):67-76.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0008\">\n<ce:label>8</ce:label>\n<sb:reference id=\"sbref0008\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Canadian Coalition for Seniors’ Mental</ce:given-name>\n<ce:surname>Health</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Canadian Guidelines on Prevention, Assessment and Treatment of Depression Among Older Adults</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>CCSMH; 2021</sb:maintitle>\n</sb:title>\n</sb:series>\n<sb:date>June 2021</sb:date>\n</sb:issue>\n</sb:host>\n<sb:comment>Updated</sb:comment>\n<sb:host>\n<sb:e-host>\n<ce:inter-ref id=\"interref0001\" xlink:href=\"https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf\">https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf</ce:inter-ref>\n</sb:e-host>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0008\">Canadian Coalition for Seniors’ Mental Health. Canadian Guidelines on Prevention, Assessment and Treatment of Depression Among Older Adults. CCSMH; 2021. Updated June 2021. https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0009\">\n<ce:label>9</ce:label>\n<sb:reference id=\"sbref0009\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Avasthi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Grover</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Clinical practice guidelines for management of depression in elderly</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Indian J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>60</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>Suppl 3</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>S341</sb:first-page>\n<sb:last-page>S362</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0009\">Avasthi A, Grover S. Clinical practice guidelines for management of depression in elderly. Indian J Psychiatry. 2018;60(Suppl 3):S341-S362.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0010\">\n<ce:label>10</ce:label>\n<sb:reference id=\"sbref0010\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Baba</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Kito</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Nukariya</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Guidelines for diagnosis and treatment of depression in older adults: A report from the Japanese Society of mood disorders</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Psychiatry Clin Neurosci</sb:maintitle>\n</sb:title>\n<sb:volume-nr>76</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>222</sb:first-page>\n<sb:last-page>234</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0010\">Baba H, Kito S, Nukariya K, et al. Guidelines for diagnosis and treatment of depression in older adults: A report from the Japanese Society of mood disorders. Psychiatry Clin Neurosci. 2022;76(6):222-234.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0011\">\n<ce:label>11</ce:label>\n<sb:reference id=\"sbref0011\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Rosenblat</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.B.</ce:given-name>\n<ce:surname>Nemeroff</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>178</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>383</sb:first-page>\n<sb:last-page>399</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0011\">McIntyre RS, Rosenblat JD, Nemeroff CB, et al. Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation. Am J Psychiatry. 2021;178(5):383-399.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0012\">\n<ce:label>12</ce:label>\n<sb:reference id=\"sbref0012\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.C.H.</ce:given-name>\n<ce:surname>Cheng</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.E.</ce:given-name>\n<ce:surname>Dri</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Ballum</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effects of ketamine and esketamine on measures of quality of life in major depressive disorder and treatment-resistant depression: A systematic review</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>382</sb:volume-nr>\n</sb:series>\n<sb:date>2025</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>438</sb:first-page>\n<sb:last-page>442</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0012\">Cheng MCH, Dri CE, Ballum H, et al. The effects of ketamine and esketamine on measures of quality of life in major depressive disorder and treatment-resistant depression: A systematic review. J Affect Disord. 2025;382:438-442.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0013\">\n<ce:label>13</ce:label>\n<sb:reference id=\"sbref0013\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Di Vincenzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.B.</ce:given-name>\n<ce:surname>Rodrigues</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Safety, tolerability, and real-world effectiveness of intravenous ketamine in older adults with treatment-resistant depression: A case series</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>29</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>9</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>899</sb:first-page>\n<sb:last-page>913</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0013\">Lipsitz O, Di Vincenzo JD, Rodrigues NB, et al. Safety, tolerability, and real-world effectiveness of intravenous ketamine in older adults with treatment-resistant depression: A case series. Am J Geriatr Psychiatry. 2021;29(9):899-913.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0014\">\n<ce:label>14</ce:label>\n<sb:reference id=\"sbref0014\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>I.P.</ce:given-name>\n<ce:surname>Carvalho</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.M.W.</ce:given-name>\n<ce:surname>Lui</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>276</sb:volume-nr>\n</sb:series>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>576</sb:first-page>\n<sb:last-page>584</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0014\">McIntyre RS, Carvalho IP, Lui LMW, et al. The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis. J Affect Disord. 2020;276:576-584.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0015\">\n<ce:label>15</ce:label>\n<sb:reference id=\"sbref0015\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Lee</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Syeda</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.A.</ce:given-name>\n<ce:surname>Maruschak</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>A new perspective on the anti-suicide effects with ketamine treatment: A procognitive effect</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Clin Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>36</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2016</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>50</sb:first-page>\n<sb:last-page>56</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0015\">Lee Y, Syeda K, Maruschak NA, et al. A new perspective on the anti-suicide effects with ketamine treatment: A procognitive effect. J Clin Psychopharmacol. 2016;36(1):50-56.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0016\">\n<ce:label>16</ce:label>\n<sb:reference id=\"sbref0016\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Xiong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Chen-Li</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>134</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>57</sb:first-page>\n<sb:last-page>68</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0016\">Xiong J, Lipsitz O, Chen-Li D, et al. The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis. J Psychiatr Res. 2021;134:57-68.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0017\">\n<ce:label>17</ce:label>\n<sb:reference id=\"sbref0017\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Gupta</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Dhar</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Patadia</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>A systematic review of ketamine for the treatment of depression among older adults</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int Psychogeriatr</sb:maintitle>\n</sb:title>\n<sb:volume-nr>33</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>179</sb:first-page>\n<sb:last-page>191</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0017\">Gupta A, Dhar R, Patadia P, et al. A systematic review of ketamine for the treatment of depression among older adults. Int Psychogeriatr. 2021;33(2):179-191.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0018\">\n<ce:label>18</ce:label>\n<sb:reference id=\"sbref0018\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.D.</ce:given-name>\n<ce:surname>Di Vincenzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Siegel</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Lipsitz</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>137</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>232</sb:first-page>\n<sb:last-page>241</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0018\">Di Vincenzo JD, Siegel A, Lipsitz O, et al. The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review. J Psychiatr Res. 2021;137:232-241.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0019\">\n<ce:label>19</ce:label>\n<sb:reference id=\"sbref0019\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Page</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.E.</ce:given-name>\n<ce:surname>McKenzie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.M.</ce:given-name>\n<ce:surname>Bossuyt</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The PRISMA 2020 statement: an updated guideline for reporting systematic reviews</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>BMJ</sb:maintitle>\n</sb:title>\n<sb:volume-nr>372</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>n71</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0019\">Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0020\">\n<ce:label>20</ce:label>\n<sb:reference id=\"sbref0020\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.A.C.</ce:given-name>\n<ce:surname>Sterne</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Savović</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Page</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>RoB 2: a revised tool for assessing risk of bias in randomised trials</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>BMJ</sb:maintitle>\n</sb:title>\n<sb:volume-nr>366</sb:volume-nr>\n</sb:series>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>l4898</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0020\">Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0021\">\n<ce:label>21</ce:label>\n<sb:reference id=\"sbref0021\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>T.H.</ce:given-name>\n<ce:surname>Barker</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Habibi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Aromataris</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>JBI Evid Synth</sb:maintitle>\n</sb:title>\n<sb:volume-nr>22</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>378</sb:first-page>\n<sb:last-page>388</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0021\">Barker TH, Habibi N, Aromataris E, et al. The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies. JBI Evid Synth. 2024;22(3):378-388.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0022\">\n<ce:label>22</ce:label>\n<sb:reference id=\"sbref0022\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Gálvez</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Huggins</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>32</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>397</sb:first-page>\n<sb:last-page>407</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0022\">Gálvez V, Li A, Huggins C, et al. Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial. J Psychopharmacol. 2018;32(4):397-407.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0023\">\n<ce:label>23</ce:label>\n<sb:reference id=\"sbref0023\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Ochs-Ross</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zhang</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression-TRANSFORM-3</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>28</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>2</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>121</sb:first-page>\n<sb:last-page>141</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0023\">Ochs-Ross R, Daly EJ, Zhang Y, et al. Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression-TRANSFORM-3. Am J Geriatr Psychiatry. 2020;28(2):121-141.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0024\">\n<ce:label>24</ce:label>\n<sb:reference id=\"sbref0024\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Lai</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Katalinic</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Glue</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pilot dose-response trial of i.v. ketamine in treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>World J Biol Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>15</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>579</sb:first-page>\n<sb:last-page>584</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0024\">Lai R, Katalinic N, Glue P, et al. Pilot dose-response trial of i.v. ketamine in treatment-resistant depression. World J Biol Psychiatry. 2014;15(7):579-584.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0025\">\n<ce:label>25</ce:label>\n<sb:reference id=\"sbref0025\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Glue</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Loo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Fam</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Nat Med</sb:maintitle>\n</sb:title>\n<sb:volume-nr>30</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>2004</sb:first-page>\n<sb:last-page>2009</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0025\">Glue P, Loo C, Fam J, et al. Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial. Nat Med. 2024;30(7):2004-2009.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0026\">\n<ce:label>26</ce:label>\n<sb:reference id=\"sbref0026\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Fernie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Currie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.S.</ce:given-name>\n<ce:surname>Perrin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Br J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>210</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>422</sb:first-page>\n<sb:last-page>428</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0026\">Fernie G, Currie J, Perrin JS, et al. Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial. Br J Psychiatry. 2017;210(6):422-428.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0027\">\n<ce:label>27</ce:label>\n<sb:reference id=\"sbref0027\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Zou</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Min</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Q.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Ren</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-A randomized, double-blind, controlled clinical study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Brain Behav</sb:maintitle>\n</sb:title>\n<sb:volume-nr>11</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:article-number>e01775</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0027\">Zou L, Min S, Chen Q, Li X, Ren L. Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-A randomized, double-blind, controlled clinical study. Brain Behav. 2021;11(1):e01775.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0028\">\n<ce:label>28</ce:label>\n<sb:reference id=\"sbref0028\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>George</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Gálvez</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>25</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>11</sb:issue-nr>\n<sb:date>2017</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1199</sb:first-page>\n<sb:last-page>1209</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0028\">George D, Gálvez V, Martin D, et al. Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression. Am J Geriatr Psychiatry. 2017;25(11):1199-1209.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0029\">\n<ce:label>29</ce:label>\n<sb:reference id=\"sbref0029\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Wajs</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Aluisio</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Holder</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: Assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2)</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Clin Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>81</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2020</sb:date>\n</sb:issue>\n<ce:doi>10.4088/JCP.19m12891</ce:doi>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0029\">Wajs E, Aluisio L, Holder R, et al. Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: Assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2). J Clin Psychiatry. 2020;81(3). doi:10.4088/JCP.19m12891</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0030\">\n<ce:label>30</ce:label>\n<sb:reference id=\"sbref0030\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.A.</ce:given-name>\n<ce:surname>Oughli</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.A.</ce:given-name>\n<ce:surname>Gebara</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Ciarleglio</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Intravenous ketamine for late-life treatment-resistant depression: A pilot study of tolerability, safety, clinical benefits, and effect on cognition</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>31</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>3</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>210</sb:first-page>\n<sb:last-page>221</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0030\">Oughli HA, Gebara MA, Ciarleglio A, et al. Intravenous ketamine for late-life treatment-resistant depression: A pilot study of tolerability, safety, clinical benefits, and effect on cognition. Am J Geriatr Psychiatry. 2023;31(3):210-221.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0031\">\n<ce:label>31</ce:label>\n<sb:reference id=\"sbref0031\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Zaki</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.N.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Lane</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Neuropsychopharmacology</sb:maintitle>\n</sb:title>\n<sb:volume-nr>48</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>8</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1225</sb:first-page>\n<sb:last-page>1233</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0031\">Zaki N, Chen LN, Lane R, et al. Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study. Neuropsychopharmacology. 2023;48(8):1225-1233.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0032\">\n<ce:label>32</ce:label>\n<sb:reference id=\"sbref0032\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>K.G.</ce:given-name>\n<ce:surname>Rasmussen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.W.</ce:given-name>\n<ce:surname>Lineberry</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.W.</ce:given-name>\n<ce:surname>Galardy</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Serial infusions of low-dose ketamine for major depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychopharmacol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>27</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2013</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>444</sb:first-page>\n<sb:last-page>450</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0032\">Rasmussen KG, Lineberry TW, Galardy CW, et al. Serial infusions of low-dose ketamine for major depression. J Psychopharmacol. 2013;27(5):444-450.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0033\">\n<ce:label>33</ce:label>\n<sb:reference id=\"sbref0033\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Vanderschelden</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.A.</ce:given-name>\n<ce:surname>Gebara</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.A.</ce:given-name>\n<ce:surname>Oughli</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Change in patient-centered outcomes of psychological well-being, sleep, and suicidality following treatment with intravenous ketamine for late-life treatment-resistant depression</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Int J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>38</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>e5964</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0033\">Vanderschelden B, Gebara MA, Oughli HA, et al. Change in patient-centered outcomes of psychological well-being, sleep, and suicidality following treatment with intravenous ketamine for late-life treatment-resistant depression. Int J Geriatr Psychiatry. 2023;38(7):e5964.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0034\">\n<ce:label>34</ce:label>\n<sb:reference id=\"sbref0034\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Ochs-Ross</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.</ce:given-name>\n<ce:surname>Wajs</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Comparison of long-term efficacy and safety of esketamine nasal spray plus oral antidepressant in younger versus older patients with treatment-resistant depression: Post-hoc analysis of SUSTAIN-2, a long-term open-label phase 3 safety and efficacy study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Geriatr Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>30</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>5</sb:issue-nr>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>541</sb:first-page>\n<sb:last-page>556</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0034\">Ochs-Ross R, Wajs E, Daly EJ, et al. Comparison of long-term efficacy and safety of esketamine nasal spray plus oral antidepressant in younger versus older patients with treatment-resistant depression: Post-hoc analysis of SUSTAIN-2, a long-term open-label phase 3 safety and efficacy study. Am J Geriatr Psychiatry. 2022;30(5):541-556.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0035\">\n<ce:label>35</ce:label>\n<sb:reference id=\"sbref0035\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.S.</ce:given-name>\n<ce:surname>McIntyre</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.J.</ce:given-name>\n<ce:surname>Filteau</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Affect Disord</sb:maintitle>\n</sb:title>\n<sb:volume-nr>156</sb:volume-nr>\n</sb:series>\n<sb:date>2014</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1</sb:first-page>\n<sb:last-page>7</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0035\">McIntyre RS, Filteau MJ, Martin L, et al. Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach. J Affect Disord. 2014;156:1-7.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0036\">\n<ce:label>36</ce:label>\n<sb:reference id=\"sbref0036\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.R.</ce:given-name>\n<ce:surname>Strawn</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.A.</ce:given-name>\n<ce:surname>Mills</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Suresh</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorder</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J Psychiatr Res</sb:maintitle>\n</sb:title>\n<sb:volume-nr>159</sb:volume-nr>\n</sb:series>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>266</sb:first-page>\n<sb:last-page>273</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0036\">Strawn JR, Mills JA, Suresh V, et al. The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorder. J Psychiatr Res. 2023;159:266-273.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0037\">\n<ce:label>37</ce:label>\n<sb:reference id=\"sbref0037\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Popova</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.J.</ce:given-name>\n<ce:surname>Daly</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Trivedi</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>176</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>428</sb:first-page>\n<sb:last-page>438</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0037\">Popova V, Daly EJ, Trivedi M, et al. Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study. Am J Psychiatry. 2019;176(6):428-438.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0038\">\n<ce:label>38</ce:label>\n<sb:reference id=\"sbref0038\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.F.</ce:given-name>\n<ce:surname>Grunebaum</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.C.</ce:given-name>\n<ce:surname>Galfalvy</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.H.</ce:given-name>\n<ce:surname>Choo</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine for rapid reduction of suicidal thoughts in major depression: A midazolam-controlled randomized clinical trial</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Am J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>175</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>4</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>327</sb:first-page>\n<sb:last-page>335</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0038\">Grunebaum MF, Galfalvy HC, Choo TH, et al. Ketamine for rapid reduction of suicidal thoughts in major depression: A midazolam-controlled randomized clinical trial. Am J Psychiatry. 2018;175(4):327-335.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0039\">\n<ce:label>39</ce:label>\n<sb:reference id=\"sbref0039\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.T.</ce:given-name>\n<ce:surname>Wilkinson</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Farmer</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>E.D.</ce:given-name>\n<ce:surname>Ballard</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Neuropsychopharmacology</sb:maintitle>\n</sb:title>\n<sb:volume-nr>44</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>7</sb:issue-nr>\n<sb:date>2019</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1233</sb:first-page>\n<sb:last-page>1238</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0039\">Wilkinson ST, Farmer C, Ballard ED, et al. Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant. Neuropsychopharmacology. 2019;44(7):1233-1238.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0040\">\n<ce:label>40</ce:label>\n<sb:reference id=\"sbref0040\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.L.</ce:given-name>\n<ce:surname>Naismith</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.M.</ce:given-name>\n<ce:surname>Norrie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Mowszowski</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>IB.</ce:given-name>\n<ce:surname>Hickie</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The neurobiology of depression in later-life: Clinical, neuropsychological, neuroimaging and pathophysiological features</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Prog Neurobiol</sb:maintitle>\n</sb:title>\n<sb:volume-nr>98</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>1</sb:issue-nr>\n<sb:date>2012</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>99</sb:first-page>\n<sb:last-page>143</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0040\">Naismith SL, Norrie LM, Mowszowski L, Hickie IB. The neurobiology of depression in later-life: Clinical, neuropsychological, neuroimaging and pathophysiological features. Prog Neurobiol. 2012;98(1):99-143.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0041\">\n<ce:label>41</ce:label>\n<sb:reference id=\"sbref0041\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Bayes</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Dong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Martin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Alonzo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Kabourakis</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Loo</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Ketamine treatment for depression: A model of care</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Aust N Z J Psychiatry</sb:maintitle>\n</sb:title>\n<sb:volume-nr>55</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>12</sb:issue-nr>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1134</sb:first-page>\n<sb:last-page>1143</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0041\">Bayes A, Dong V, Martin D, Alonzo A, Kabourakis M, Loo C. Ketamine treatment for depression: A model of care. Aust N Z J Psychiatry. 2021;55(12):1134-1143.</ce:source-text>\n</ce:bib-reference>\n</ce:bibliography-sec>",
    "error_message": "All bibliographic references within 'ce:bibliography' must be referred to.",
    "error_position": "1250:63",
    "error_id": "IDS503a",
    "folder_name": "AMGP2541"
  },
  {
    "input": "<row xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" rowsep=\"1\">\n<entry id=\"en0199\" colname=\"col1\" align=\"center\" valign=\"top\"><ce:bold>Temporal Precedence</ce:bold></entry>\n<entry id=\"en0200\" colname=\"col2\" align=\"center\" valign=\"top\"><ce:bold>Selection and Allocation</ce:bold></entry>\n<entry id=\"en0201\" colname=\"col3\" align=\"center\" valign=\"top\"><ce:bold>Confounding Factors</ce:bold></entry>\n<entry id=\"en0202\" colname=\"col4\" align=\"center\" valign=\"top\"><ce:bold>Administration of Intervention</ce:bold></entry>\n<entry id=\"en0203\" align=\"center\" namest=\"col5\" nameend=\"col7\" rowsep=\"1\" role=\"colgroup\" valign=\"top\"><ce:bold>Assessment, Detection, and Measurement of Outcome</ce:bold></entry>\n<entry id=\"en0204\" colname=\"col8\" valign=\"top\"><ce:bold>Participant Retention</ce:bold></entry>\n</row>",
    "output": "<row xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" rowsep=\"1\">\n<entry id=\"en0199\" colname=\"col1\" align=\"center\" valign=\"top\"><ce:bold>Temporal Precedence</ce:bold></entry>\n<entry id=\"en0200\" colname=\"col2\" align=\"center\" valign=\"top\"><ce:bold>Selection and Allocation</ce:bold></entry>\n<entry id=\"en0201\" colname=\"col3\" align=\"center\" valign=\"top\"><ce:bold>Confounding Factors</ce:bold></entry>\n<entry id=\"en0202\" colname=\"col4\" align=\"center\" valign=\"top\"><ce:bold>Administration of Intervention</ce:bold></entry>\n<entry id=\"en0203\" align=\"center\" namest=\"col5\" nameend=\"col7\" rowsep=\"1\" role=\"colgroup\" valign=\"top\"><ce:bold>Assessment, Detection, and Measurement of Outcome</ce:bold></entry>\n<entry id=\"en0204\" colname=\"col8\" valign=\"top\"><ce:bold>Participant Retention</ce:bold></entry>\n</row>",
    "error_message": "The entries \"col5\" and \"col7\" overlap each other.",
    "error_position": "382:104",
    "error_id": "TBS509c",
    "folder_name": "AMGP2541"
  },
  {
    "input": "<ce:bib-reference xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"bib0003\">\n<ce:label>3</ce:label>\n<sb:reference id=\"sbref0003\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.M.</ce:given-name>\n<ce:surname>Kimenai</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Lindahl</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.R.</ce:given-name>\n<ce:surname>Chapman</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.</ce:given-name>\n<ce:surname>Baron</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Gard</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Wereski</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Sex differences in investigations and outcomes among patients with type 2 myocardial infarction</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Heart</sb:maintitle>\n</sb:title>\n<sb:volume-nr>107</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>18</sb:issue-nr>\n<sb:date>2021Sep</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1480</sb:first-page>\n<sb:last-page>1486</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0003\">Kimenai DM, Lindahl B, Chapman AR, Baron T, Gard A, Wereski R, et al. Sex differences in investigations and outcomes among patients with type 2 myocardial infarction. Heart 2021Sep;107(18):1480-1486.</ce:source-text>\n</ce:bib-reference>",
    "output": "<ce:bib-reference xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"bib0003\">\n<ce:label>[3]</ce:label>\n<sb:reference id=\"sbref0003\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.M.</ce:given-name>\n<ce:surname>Kimenai</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Lindahl</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.R.</ce:given-name>\n<ce:surname>Chapman</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>T.</ce:given-name>\n<ce:surname>Baron</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Gard</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Wereski</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Sex differences in investigations and outcomes among patients with type 2 myocardial infarction</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Heart</sb:maintitle>\n</sb:title>\n<sb:volume-nr>107</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>18</sb:issue-nr>\n<sb:date>2021 Sep</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1480</sb:first-page>\n<sb:last-page>1486</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0003\">Kimenai DM, Lindahl B, Chapman AR, Baron T, Gard A, Wereski R, et al. Sex differences in investigations and outcomes among patients with type 2 myocardial infarction. Heart 2021 Sep;107(18):1480-1486.</ce:source-text>\n</ce:bib-reference>",
    "error_message": "The 'sb:date' element (\"2021Sep\") should contain a year, but not a year immediately followed by a letter.",
    "error_position": "232:10",
    "error_id": "DTS504",
    "folder_name": "TCM7254"
  },
  {
    "input": "<ce:bib-reference xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"bib0005\">\n<ce:label>5</ce:label>\n<sb:reference id=\"sbref0005\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>F.</ce:given-name>\n<ce:surname>Angeli</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Bucciarelli</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>F.</ce:given-name>\n<ce:surname>Mosucci</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Sciomer</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>F.</ce:given-name>\n<ce:surname>Ricci</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>F.</ce:given-name>\n<ce:surname>Coppi</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Gender and Sex-related differences in Type 2 Myocardial Infarction: the undervalued side of a neglected disease</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle><ce:italic>Trends in Cardiovasc Med</ce:italic> 2025 In Press</sb:maintitle>\n</sb:title>\n</sb:series>\n<sb:date/>\n</sb:issue>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0005\">Angeli F, Bucciarelli V, Mosucci F, Sciomer S, Ricci F, Coppi F et al. Gender and Sex-related differences in Type 2 Myocardial Infarction: the undervalued side of a neglected disease. Trends in Cardiovasc Med 2025 In Press.</ce:source-text>\n</ce:bib-reference>",
    "output": "<ce:bib-reference xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"bib0005\">\n<ce:label>[5]</ce:label>\n<sb:reference id=\"sbref0005\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>F.</ce:given-name>\n<ce:surname>Angeli</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Bucciarelli</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>F.</ce:given-name>\n<ce:surname>Mosucci</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Sciomer</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>F.</ce:given-name>\n<ce:surname>Ricci</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>F.</ce:given-name>\n<ce:surname>Coppi</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Gender and Sex-related differences in Type 2 Myocardial Infarction: the undervalued side of a neglected disease</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Trends in Cardiovasc Med</sb:maintitle>\n</sb:title>\n</sb:series>\n<sb:date>2025</sb:date>\n</sb:issue>\n</sb:host>\n<sb:comment>In Press</sb:comment>\n</sb:reference>\n<ce:source-text id=\"srctxt0005\">Angeli F, Bucciarelli V, Mosucci F, Sciomer S, Ricci F, Coppi F et al. Gender and Sex-related differences in Type 2 Myocardial Infarction: the undervalued side of a neglected disease. Trends in Cardiovasc Med 2025 In Press.</ce:source-text>\n</ce:bib-reference>",
    "error_message": "The 'sb:date' element (\"\") should contain a year, but not a year immediately followed by a letter.",
    "error_position": "334:11",
    "error_id": "DTS504",
    "folder_name": "TCM7254"
  },
  {
    "input": "<ce:bib-reference xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"bib0005\">\n<ce:label>5</ce:label>\n<sb:reference id=\"sbref0005\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>F.</ce:given-name>\n<ce:surname>Angeli</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Bucciarelli</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>F.</ce:given-name>\n<ce:surname>Mosucci</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Sciomer</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>F.</ce:given-name>\n<ce:surname>Ricci</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>F.</ce:given-name>\n<ce:surname>Coppi</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Gender and Sex-related differences in Type 2 Myocardial Infarction: the undervalued side of a neglected disease</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle><ce:italic>Trends in Cardiovasc Med</ce:italic> 2025 In Press</sb:maintitle>\n</sb:title>\n</sb:series>\n<sb:date/>\n</sb:issue>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0005\">Angeli F, Bucciarelli V, Mosucci F, Sciomer S, Ricci F, Coppi F et al. Gender and Sex-related differences in Type 2 Myocardial Infarction: the undervalued side of a neglected disease. Trends in Cardiovasc Med 2025 In Press.</ce:source-text>\n</ce:bib-reference>",
    "output": "<ce:bib-reference xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"bib0005\">\n<ce:label>[5]</ce:label>\n<sb:reference id=\"sbref0005\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>F.</ce:given-name>\n<ce:surname>Angeli</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Bucciarelli</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>F.</ce:given-name>\n<ce:surname>Mosucci</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Sciomer</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>F.</ce:given-name>\n<ce:surname>Ricci</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>F.</ce:given-name>\n<ce:surname>Coppi</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Gender and Sex-related differences in Type 2 Myocardial Infarction: the undervalued side of a neglected disease</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Trends in Cardiovasc Med</sb:maintitle>\n</sb:title>\n</sb:series>\n<sb:date>2025</sb:date>\n</sb:issue>\n</sb:host>\n<sb:comment>In Press</sb:comment>\n</sb:reference>\n<ce:source-text id=\"srctxt0005\">Angeli F, Bucciarelli V, Mosucci F, Sciomer S, Ricci F, Coppi F et al. Gender and Sex-related differences in Type 2 Myocardial Infarction: the undervalued side of a neglected disease. Trends in Cardiovasc Med 2025 In Press.</ce:source-text>\n</ce:bib-reference>",
    "error_message": "Element 'sb:date' may not have empty content.",
    "error_position": "334:11",
    "error_id": "EMC501",
    "folder_name": "TCM7254"
  },
  {
    "input": "<ce:bib-reference xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"bib0001\">\n<ce:label>1</ce:label>\n<sb:reference id=\"sbref0001\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.R.</ce:given-name>\n<ce:surname>Chapman</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.S.V.</ce:given-name>\n<ce:surname>Shah</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.K.</ce:given-name>\n<ce:surname>Lee</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Anand</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Francis</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Adamson</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Long-Term Outcomes in Patients With Type 2 Myocardial Infarction and Myocardial Injury</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Circulation</sb:maintitle>\n</sb:title>\n<sb:volume-nr>137</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>20</sb:issue-nr>\n<sb:issue-nr>12</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1236</sb:first-page>\n<sb:last-page>1245</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0001\">Chapman AR, Shah ASV, Lee KK, Anand A, Francis O, Adamson P, et al. Long-Term Outcomes in Patients With Type 2 Myocardial Infarction and Myocardial Injury. Circulation 2018;20;137(12):1236-1245.</ce:source-text>\n</ce:bib-reference>",
    "output": "<ce:bib-reference xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"bib0001\">\n<ce:label>[1]</ce:label>\n<sb:reference id=\"sbref0001\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>A.R.</ce:given-name>\n<ce:surname>Chapman</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.S.V.</ce:given-name>\n<ce:surname>Shah</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.K.</ce:given-name>\n<ce:surname>Lee</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Anand</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Francis</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Adamson</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Long-Term Outcomes in Patients With Type 2 Myocardial Infarction and Myocardial Injury</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Circulation</sb:maintitle>\n</sb:title>\n<sb:volume-nr>20</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>12</sb:issue-nr>\n<sb:date>2018</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1236</sb:first-page>\n<sb:last-page>1245</sb:last-page>\n</sb:pages>\n</sb:host>\n<sb:comment>137</sb:comment>\n</sb:reference>\n<ce:source-text id=\"srctxt0001\">Chapman AR, Shah ASV, Lee KK, Anand A, Francis O, Adamson P, et al. Long-Term Outcomes in Patients With Type 2 Myocardial Infarction and Myocardial Injury. Circulation 2018;20;137(12):1236-1245.</ce:source-text>\n</ce:bib-reference>",
    "error_message": "Error: The content of element type \"sb:issue\" must match \"(sb:editors?,((sb:title,sb:translated-title?)|sb:translated-title)?,sb:conference?,sb:series,sb:issue-nr?,sb:date)\".",
    "error_position": "125:12",
    "error_id": "parser",
    "folder_name": "TCM7254"
  },
  {
    "input": "<ce:bibliography-sec xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"cebibsec1\">\n<?att type=\"article\"?><ce:bib-reference id=\"bib0001\">\n<ce:label>[1]</ce:label>\n<sb:reference id=\"sbref0001\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>T.C.</ce:given-name>\n<ce:surname>Pham</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Nguyen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Choi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Lee</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Yoon</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Recent Strategies to Develop Innovative Photosensitizers for Enhanced Photodynamic Therapy</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Chem. Rev.</sb:maintitle>\n</sb:title>\n<sb:volume-nr>121</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>13454</sb:first-page>\n<sb:last-page>13619</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0001\">Pham, T. C.; Nguyen, V.; Choi, Y.; Lee, S.; Yoon, J. Recent Strategies to Develop Innovative Photosensitizers for Enhanced Photodynamic Therapy. Chem. Rev. 2021, 121, 13454-13619.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0002\">\n<ce:label>[2]</ce:label>\n<sb:reference id=\"sbref0002\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>W.</ce:given-name>\n<ce:surname>Zhang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Ahmed</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Cong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Shen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Yu</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Application of multifunctional BODIPY in photodynamic therapy</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Dyes Pigments</sb:maintitle>\n</sb:title>\n<sb:volume-nr>185</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:article-number>108937</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0002\">Zhang, W.; Ahmed, A.; Cong, H.; Wang, S.; Shen, Y.; Yu, B. Application of multifunctional BODIPY in photodynamic therapy. Dyes Pigments. 2021, 185, 108937.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0003\">\n<ce:label>[3]</ce:label>\n<sb:reference id=\"sbref0003\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.F.</ce:given-name>\n<ce:surname>Algorri</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Ochoa</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Roldán-Varona</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Rodríguez-Cobo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.M.In</ce:given-name>\n<ce:surname>López-Higuera</ce:surname>\n</sb:author>\n</sb:authors>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Cancers</sb:maintitle>\n</sb:title>\n<sb:volume-nr>13</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0003\">Algorri, J. F.; Ochoa, M.; Roldán-Varona, P.; Rodríguez-Cobo, L.; López-Higuera, J. M. In Cancers, 2021; Vol. 13.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0004\">\n<ce:label>[4]</ce:label>\n<sb:reference id=\"sbref0004\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>T.</ce:given-name>\n<ce:surname>Tao</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Hu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Sun</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Ou</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Guo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Xu</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The halogen effect of bis-truxene substituted BODIPY photosensitizers for potential photodynamic therapy</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Dyes Pigments</sb:maintitle>\n</sb:title>\n<sb:volume-nr>224</sb:volume-nr>\n</sb:series>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:article-number>111996</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0004\">Tao, T.; Hu, X.; Sun, D.; Ou, C.; Guo, Y.; Xu, H. The halogen effect of bis-truxene substituted BODIPY photosensitizers for potential photodynamic therapy. Dyes Pigments. 2024, 224, 111996.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0005\">\n<ce:label>[5]</ce:label>\n<sb:reference id=\"sbref0005\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Yu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Jia</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Liu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Zhang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Feng</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.Z.</ce:given-name>\n<ce:surname>Tang</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Recent Progress in Type I Aggregation-Induced Emission Photosensitizers for Photodynamic Therapy</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Molecules</sb:maintitle>\n</sb:title>\n<sb:volume-nr>28</sb:volume-nr>\n</sb:series>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>332</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0005\">Yu, Y.; Jia, H.; Liu, Y.; Zhang, L.; Feng, G.; Tang, B. Z. Recent Progress in Type I Aggregation-Induced Emission Photosensitizers for Photodynamic Therapy. Molecules, 2023, 28, 332.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0006\">\n<ce:label>[6]</ce:label>\n<sb:reference id=\"sbref0006\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Ni</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Zhang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.Z.</ce:given-name>\n<ce:surname>Sun</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.Z.</ce:given-name>\n<ce:surname>Tang</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Aggregation-Induced Generation of Reactive Oxygen Species: Mechanism and Photosensitizer Construction</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Molecules</sb:maintitle>\n</sb:title>\n<sb:volume-nr>26</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>268</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0006\">Ni, J.; Wang, Y.; Zhang, H.; Sun, J. Z.; Tang, B. Z. Aggregation-Induced Generation of Reactive Oxygen Species: Mechanism and Photosensitizer Construction. Molecules, 2021, 26, 268.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0007\">\n<ce:label>[7]</ce:label>\n<sb:reference id=\"sbref0007\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Yang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.H.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>X.H.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.J.</ce:given-name>\n<ce:surname>Qi</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>A Long-Retention Cell Membrane-Targeting AIEgen for Boosting Tumor Theranostics</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Chem-AsianJ</sb:maintitle>\n</sb:title>\n<sb:volume-nr>19</sb:volume-nr>\n</sb:series>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:article-number>e202400305</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0007\">Wang, X.; Yang, L.; Li, Y. H.; Wang, X. H.; Qi, Z. J. A Long-Retention Cell Membrane-Targeting AIEgen for Boosting Tumor Theranostics. Chem-AsianJ. 2024, 19, e202400305.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0008\">\n<ce:label>[8]</ce:label>\n<sb:reference id=\"sbref0008\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.Q.</ce:given-name>\n<ce:surname>Tang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.K.</ce:given-name>\n<ce:surname>Liang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.F.</ce:given-name>\n<ce:surname>Zhao</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Yang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.J.</ce:given-name>\n<ce:surname>Qi</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>A lipid droplet-specific near-infrared automatic oxygen-supplied AIEgen for photodynamic therapy and metastasis inhibition of hypoxic tumors</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Chem. Eng. J.</sb:maintitle>\n</sb:title>\n<sb:volume-nr>453</sb:volume-nr>\n</sb:series>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:article-number>139838</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0008\">Wang, X.; Tang, Y. Q.; Liang, J. K.; Zhao, Y. F.; Yang, L.; Qi, Z. J. A lipid droplet-specific near-infrared automatic oxygen-supplied AIEgen for photodynamic therapy and metastasis inhibition of hypoxic tumors. Chem. Eng. J. 2023, 453, 139838.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0009\">\n<ce:label>[9]</ce:label>\n<sb:reference id=\"sbref0009\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Gao</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Tian</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>F.</ce:given-name>\n<ce:surname>Hu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>W.</ce:given-name>\n<ce:surname>Wu</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Design strategies for aggregation-induced emission photosensitizers with enhanced safety in photodynamic therapy</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Coord. Chem. Rev.</sb:maintitle>\n</sb:title>\n<sb:volume-nr>507</sb:volume-nr>\n</sb:series>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:article-number>215756</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0009\">Gao, J.; Tian, Y.; Li, Y.; Hu, F.; Wu, W. Design strategies for aggregation-induced emission photosensitizers with enhanced safety in photodynamic therapy. Coord. Chem. Rev. 2024, 507, 215756.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0010\">\n<ce:label>[10]</ce:label>\n<sb:reference id=\"sbref0010\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Q.</ce:given-name>\n<ce:surname>Wan</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Ding</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Xie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Fan</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Tong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.</ce:given-name>\n<ce:surname>Zeng</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Zhao</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Aggregation Effect on Multiperformance Improvement in Aryl-Armed Phenazine-Based Emitters</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J. Am. Chem. Soc.</sb:maintitle>\n</sb:title>\n<sb:volume-nr>145</sb:volume-nr>\n</sb:series>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1607</sb:first-page>\n<sb:last-page>1616</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0010\">Wan, Q.; Li, Y.; Ding, K.; Xie, Y.; Fan, J.; Tong, J.; Zeng, Z.; Li, Y.; Zhao, C.; Wang, Z. et al. Aggregation Effect on Multiperformance Improvement in Aryl-Armed Phenazine-Based Emitters. J. Am. Chem. Soc. 2023, 145, 1607-1616.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"inbook\"?><ce:bib-reference id=\"bib0011\">\n<ce:label>[11]</ce:label>\n<sb:reference id=\"sbref0011\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>He</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Q.</ce:given-name>\n<ce:surname>Wan</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.Z.</ce:given-name>\n<ce:surname>Tang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n</sb:authors>\n</sb:contribution>\n<sb:host>\n<sb:book>\n<sb:book-series>\n<sb:series>\n<sb:title>\n<sb:maintitle>An innovative stepwise activated coupling reaction for fabricating functional fluorescence probes with potential photosensitive applications</sb:maintitle>\n</sb:title>\n<sb:volume-nr>412</sb:volume-nr>\n</sb:series>\n</sb:book-series>\n<sb:date>2024</sb:date>\n<sb:publisher>\n<sb:name>Sensor Actuator B-Chem</sb:name>\n</sb:publisher>\n</sb:book>\n<sb:article-number>135725</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0011\">Li, Y.; He, D.; Wan, Q.; Tang, B. Z.; Wang, Z. An innovative stepwise activated coupling reaction for fabricating functional fluorescence probes with potential photosensitive applications. Sensor Actuator B-Chem. 2024, 412, 135725.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0012\">\n<ce:label>[12]</ce:label>\n<sb:reference id=\"sbref0012\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.H.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Hasrat</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Yang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.J.</ce:given-name>\n<ce:surname>Qi</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Sequence-Responsive Multifunctional Supramolecular Nanomicelles Act on the Regression of TNBC and Its Lung Metastasis via Synergic Pyroptosis-Mediated Immune Activation</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Small</sb:maintitle>\n</sb:title>\n<sb:volume-nr>19</sb:volume-nr>\n</sb:series>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:article-number>2305101</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0012\">Wang, X.; Li, Y. H.; Hasrat, K.; Yang, L.; Qi, Z. J. Sequence-Responsive Multifunctional Supramolecular Nanomicelles Act on the Regression of TNBC and Its Lung Metastasis via Synergic Pyroptosis-Mediated Immune Activation. Small, 2023, 19, 2305101.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0013\">\n<ce:label>[13]</ce:label>\n<sb:reference id=\"sbref0013\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.H.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.J.</ce:given-name>\n<ce:surname>Qi</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Light-Enhanced Tandem-Responsive Nano Delivery Platform for Amplified Anti-tumor Efficiency</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Chem-AsianJ</sb:maintitle>\n</sb:title>\n<sb:volume-nr>19</sb:volume-nr>\n</sb:series>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:article-number>e202400311</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0013\">Wang, X.; Li, Y. H.; Qi, Z. J. Light-Enhanced Tandem-Responsive Nano Delivery Platform for Amplified Anti-tumor Efficiency. Chem-AsianJ. 2024, 19, e202400311.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0014\">\n<ce:label>[14]</ce:label>\n<sb:reference id=\"sbref0014\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zheng</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Bai</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Teng</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Tang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Zhao</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.</ce:given-name>\n<ce:surname>Ma</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Liang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Xie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Q.</ce:given-name>\n<ce:surname>Wan</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Atomic Engineering and Aggregation Effect to Regulate Synergistically Type I Reactive Oxygen Species of AIE-Active Deep Red/Near Infrared Red Photosensitizer</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Small</sb:maintitle>\n</sb:title>\n<sb:volume-nr>21</sb:volume-nr>\n</sb:series>\n<sb:date>2025</sb:date>\n</sb:issue>\n<sb:article-number>2410816</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0014\">Zheng, Y.; Li, Y.; Bai, X.; Teng, M.; Tang, Y.; Zhao, S.; Ma, Z.; Liang, H.; Xie, Y.; Wan, Q. Atomic Engineering and Aggregation Effect to Regulate Synergistically Type I Reactive Oxygen Species of AIE-Active Deep Red/Near Infrared Red Photosensitizer. Small 2025, 21, 2410816.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0015\">\n<ce:label>[15]</ce:label>\n<sb:reference id=\"sbref0015\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Min</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>F.</ce:given-name>\n<ce:surname>Yi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Han</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Q.</ce:given-name>\n<ce:surname>Gao</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Liang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Sun</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Liu</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Targeted photodynamic therapy using a water-soluble aggregation-Induced emission photosensitizer activated by an acidic tumor microenvironment</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Chem. Eng. J.</sb:maintitle>\n</sb:title>\n<sb:volume-nr>432</sb:volume-nr>\n</sb:series>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:article-number>134327</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0015\">Min, X.; Yi, F.; Han, X.; Li, M.; Gao, Q.; Liang, X.; Chen, Z.; Sun, Y.; Liu, Y. Targeted photodynamic therapy using a water-soluble aggregation-Induced emission photosensitizer activated by an acidic tumor microenvironment. Chem. Eng. J. 2022, 432, 134327.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0016\">\n<ce:label>[16]</ce:label>\n<sb:reference id=\"sbref0016\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Xiong</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Application of “Click” Chemistry in Biomedical Hydrogels</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>ACS Omega</sb:maintitle>\n</sb:title>\n<sb:volume-nr>7</sb:volume-nr>\n</sb:series>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>36918</sb:first-page>\n<sb:last-page>36928</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0016\">Li, X.; Xiong, Y. Application of “Click” Chemistry in Biomedical Hydrogels. ACS Omega 2022, 7, 36918-36928.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0017\">\n<ce:label>[17]</ce:label>\n<sb:reference id=\"sbref0017\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Kaur</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Saxena</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Rishi</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>An Overview of Recent Advances in Biomedical Applications of Click Chemistry</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Bioconjug. Chem.</sb:maintitle>\n</sb:title>\n<sb:volume-nr>32</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1455</sb:first-page>\n<sb:last-page>1471</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0017\">Kaur, J.; Saxena, M.; Rishi, N. An Overview of Recent Advances in Biomedical Applications of Click Chemistry. Bioconjug. Chem. 2021, 32, 1455-1471.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0018\">\n<ce:label>[18]</ce:label>\n<sb:reference id=\"sbref0018\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Albada</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.F.</ce:given-name>\n<ce:surname>Keijzer</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Zuilhof</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>F.</ce:given-name>\n<ce:surname>van Delft</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Oxidation-Induced “One-Pot” Click Chemistry</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Chem. Rev.</sb:maintitle>\n</sb:title>\n<sb:volume-nr>121</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>7032</sb:first-page>\n<sb:last-page>7058</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0018\">Albada, B.; Keijzer, J. F.; Zuilhof, H.; van Delft, F. Oxidation-Induced “One-Pot” Click Chemistry. Chem. Rev. 2021, 121, 7032-7058.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0019\">\n<ce:label>[19]</ce:label>\n<sb:reference id=\"sbref0019\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.M.</ce:given-name>\n<ce:surname>McDaniel</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.S.</ce:given-name>\n<ce:surname>Carey</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.R.</ce:given-name>\n<ce:surname>Wilson</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.W.</ce:given-name>\n<ce:surname>Barsoum</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.J.D.</ce:given-name>\n<ce:surname>Magenau</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Well-Dispersed Nanocomposites Using Covalently Modified, Multilayer, 2D Titanium Carbide (MXene) and In-Situ “Click</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Polymerization. Chem. Mat.</sb:maintitle>\n</sb:title>\n<sb:volume-nr>33</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1648</sb:first-page>\n<sb:last-page>1656</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0019\">McDaniel, R. M.; Carey, M. S.; Wilson, O. R.; Barsoum, M. W.; Magenau, A. J. D. Well-Dispersed Nanocomposites Using Covalently Modified, Multilayer, 2D Titanium Carbide (MXene) and In-Situ “Click” Polymerization. Chem. Mat. 2021, 33, 1648-1656.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0020\">\n<ce:label>[20]</ce:label>\n<sb:reference id=\"sbref0020\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Sradha</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Sariga</ce:given-name>\n<ce:surname>A.</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>George</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Varghese</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Advancements in thiol-yne click chemistry: Recent trends and applications in polymer synthesis and functionalization</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Mater. Today Chem.</sb:maintitle>\n</sb:title>\n<sb:volume-nr>38</sb:volume-nr>\n</sb:series>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:article-number>102112</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0020\">Sradha S, A.; Sariga; George, L.; Varghese, A. Advancements in thiol-yne click chemistry: Recent trends and applications in polymer synthesis and functionalization. Mater. Today Chem. 2024, 38, 102112.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0021\">\n<ce:label>[21]</ce:label>\n<sb:reference id=\"sbref0021\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Lü</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Zhu</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Thiol-Yne click chemistry of acetylene-enabled macrocyclization</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Nat. Commun.</sb:maintitle>\n</sb:title>\n<sb:volume-nr>13</sb:volume-nr>\n</sb:series>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>5001</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0021\">Lü, S.; Wang, Z.; Zhu, S. Thiol-Yne click chemistry of acetylene-enabled macrocyclization. Nat. Commun. 2022, 13, 5001.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0022\">\n<ce:label>[22]</ce:label>\n<sb:reference id=\"sbref0022\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>He</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Ding</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Q.</ce:given-name>\n<ce:surname>Tian</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Feng</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Qin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.Z.</ce:given-name>\n<ce:surname>Tang</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Bioconjugation and Reaction-Induced Tumor Therapy via Alkynamide-Based Thiol-Yne Click Reaction</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Small</sb:maintitle>\n</sb:title>\n<sb:volume-nr>20</sb:volume-nr>\n</sb:series>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:article-number>2307309</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0022\">Wang, B.; Li, C.; He, D.; Ding, K.; Tian, Q.; Feng, G.; Qin, A.; Tang, B. Z. Bioconjugation and Reaction-Induced Tumor Therapy via Alkynamide-Based Thiol-Yne Click Reaction. Small 2024, 20, 2307309.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0023\">\n<ce:label>[23]</ce:label>\n<sb:reference id=\"sbref0023\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Mitmoen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Kedem</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>UV- and Visible-Light Photopatterning of Molecular Gradients Using the Thiol–yne Click Reaction</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>ACS Appl. Mater. Interfaces</sb:maintitle>\n</sb:title>\n<sb:volume-nr>14</sb:volume-nr>\n</sb:series>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>32696</sb:first-page>\n<sb:last-page>32705</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0023\">Mitmoen, M.; Kedem, O. UV- and Visible-Light Photopatterning of Molecular Gradients Using the Thiol–yne Click Reaction. ACS Appl. Mater. Interfaces 2022, 14, 32696-32705.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0024\">\n<ce:label>[24]</ce:label>\n<sb:reference id=\"sbref0024\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Deng</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Yang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Liu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Deng</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Pu</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Benzothiadiazole-based dibenzobenzimidazole derivatives with aggregation-induced deep-red fluorescence and different mechanically responsive fluorescence features</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Dyes Pigments</sb:maintitle>\n</sb:title>\n<sb:volume-nr>205</sb:volume-nr>\n</sb:series>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:article-number>110580</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0024\">Deng, D.; Yang, Y.; Liu, S.; Deng, X.; Chen, Z.; Pu, S. Benzothiadiazole-based dibenzobenzimidazole derivatives with aggregation-induced deep-red fluorescence and different mechanically responsive fluorescence features. Dyes Pigments. 2022, 205, 110580.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0025\">\n<ce:label>[25]</ce:label>\n<sb:reference id=\"sbref0025\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>He</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>F.</ce:given-name>\n<ce:surname>Xie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Zhang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Shen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>F.</ce:given-name>\n<ce:surname>Ding</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Tang</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Red-shift emission and rapid up-conversion of B,N-containing electroluminescent materials via tuning intramolecular charge transfer</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Mater. Chem. Front.</sb:maintitle>\n</sb:title>\n<sb:volume-nr>7</sb:volume-nr>\n</sb:series>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>2454</sb:first-page>\n<sb:last-page>2463</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0025\">He, Y.; Xie, F.; Li, H.; Zhang, K.; Shen, Y.; Ding, F.; Wang, C.; Li, Y.; Tang, J. Red-shift emission and rapid up-conversion of B,N-containing electroluminescent materials via tuning intramolecular charge transfer. Mater. Chem. Front. 2023, 7, 2454-2463.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0026\">\n<ce:label>[26]</ce:label>\n<sb:reference id=\"sbref0026\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Long</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Shan</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zhao</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Ji</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Tan</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Dramatically Enhanced and Red-shifted Photoluminescence Achieved by Introducing an Electron-withdrawing Group into a Non-traditional Luminescent Small Organic Compound</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Chem-Asian J</sb:maintitle>\n</sb:title>\n<sb:volume-nr>16</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>2426</sb:first-page>\n<sb:last-page>2430</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0026\">Long, J.; Shan, J.; Zhao, Y.; Ji, Y.; Tan, H.; Wang, H. Dramatically Enhanced and Red-shifted Photoluminescence Achieved by Introducing an Electron-withdrawing Group into a Non-traditional Luminescent Small Organic Compound. Chem-Asian J. 2021, 16, 2426-2430.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0027\">\n<ce:label>[27]</ce:label>\n<sb:reference id=\"sbref0027\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Wu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Du</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Luo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.L.</ce:given-name>\n<ce:surname>Phillips</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Qin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.Z.</ce:given-name>\n<ce:surname>Tang</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Structural modification on tetraphenylpyrazine: from polarity enhanced emission to polarity quenching emission and its intramolecular charge transfer mechanism</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J. Mater. Chem. C</sb:maintitle>\n</sb:title>\n<sb:volume-nr>10</sb:volume-nr>\n</sb:series>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>8174</sb:first-page>\n<sb:last-page>8180</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0027\">Wu, H.; Du, L.; Luo, J.; Wang, Z.; Phillips, D. L.; Qin, A.; Tang, B. Z. Structural modification on tetraphenylpyrazine: from polarity enhanced emission to polarity quenching emission and its intramolecular charge transfer mechanism. J. Mater. Chem. C 2022, 10, 8174-8180.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0028\">\n<ce:label>[28]</ce:label>\n<sb:reference id=\"sbref0028\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.F.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.Y.</ce:given-name>\n<ce:surname>Cao</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.L.</ce:given-name>\n<ce:surname>Han</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Shangguan</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.S.</ce:given-name>\n<ce:surname>Liu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zhong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.Y.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.Y.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>X.Y.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Lin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.Y.</ce:given-name>\n<ce:surname>Lu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.Q.</ce:given-name>\n<ce:surname>Luo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>He</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.H.Y.</ce:given-name>\n<ce:surname>Sung</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.L.</ce:given-name>\n<ce:surname>Niu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.W.Y.</ce:given-name>\n<ce:surname>Lam</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.Y.</ce:given-name>\n<ce:surname>Shi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.Z.</ce:given-name>\n<ce:surname>Tang</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Blood–Brain Barrier-Penetrative Fluorescent Anticancer Agents Triggering Paraptosis and Ferroptosis for Glioblastoma Therapy</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J. Am. Chem. Soc.</sb:maintitle>\n</sb:title>\n<sb:volume-nr>146</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>42</sb:issue-nr>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>28783</sb:first-page>\n<sb:last-page>28794</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0028\">Wang, J. F.; Cao, M. Y.; Han, L. L.; Shangguan, P.; Liu, Y. S.; Zhong, Y.; Chen, C. Y.; Wang, G. Y.; Chen, X. Y.; Lin, M.; Lu, M. Y.; Luo, Z. Q.; He, M.; Sung, H. H. Y.; Niu, G. L.; Lam, J. W. Y.; Shi, B. Y.; Tang, B. Z. Blood–Brain Barrier-Penetrative Fluorescent Anticancer Agents Triggering Paraptosis and Ferroptosis for Glioblastoma Therapy, J. Am. Chem. Soc. 2024, 146, 42, 28783–28794.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0029\">\n<ce:label>[29]</ce:label>\n<sb:reference id=\"sbref0029\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.X.</ce:given-name>\n<ce:surname>Cao</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>X.Y.</ce:given-name>\n<ce:surname>Tian</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.Y.</ce:given-name>\n<ce:surname>Cao</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.G.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.L.</ce:given-name>\n<ce:surname>Niu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.Z.</ce:given-name>\n<ce:surname>Tang</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Solvatochromic Near-Infrared Aggregation-Induced Emission-Active Acrylonitriles by Acceptor Modulation for Low-Power Stimulated Emission Depletion Nanoscopy</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Chem. Mater.</sb:maintitle>\n</sb:title>\n<sb:volume-nr>35</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>2472</sb:first-page>\n<sb:last-page>2485</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0029\">Cao, S. X.; Tian, X. Y.; Cao, M. Y.; Wang, J. G.; Niu, G. L.; Tang, B. Z. Solvatochromic Near-Infrared Aggregation-Induced Emission-Active Acrylonitriles by Acceptor Modulation for Low-Power Stimulated Emission Depletion Nanoscopy, Chem. Mater. 2023, 35, 6, 2472–2485.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0030\">\n<ce:label>[30]</ce:label>\n<sb:reference id=\"sbref0030\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Q.</ce:given-name>\n<ce:surname>Wan</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>W.</ce:given-name>\n<ce:surname>Dai</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Xie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Q.</ce:given-name>\n<ce:surname>Ke</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Zhao</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Zhang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.</ce:given-name>\n<ce:surname>Zeng</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.Z.</ce:given-name>\n<ce:surname>Tang</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>AIE-active deep red/near-infrared electroluminescent emitters with fine regulation of excited state</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Chem. Eng. J.</sb:maintitle>\n</sb:title>\n<sb:volume-nr>451</sb:volume-nr>\n</sb:series>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:article-number>138529</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0030\">Wan, Q.; Dai, W.; Xie, Y.; Ke, Q.; Zhao, C.; Zhang, B.; Zeng, Z.; Wang, Z.; Tang, B. Z. AIE-active deep red/near-infrared electroluminescent emitters with fine regulation of excited state. Chem. Eng. J. 2023, 451, 138529.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0031\">\n<ce:label>[31]</ce:label>\n<sb:reference id=\"sbref0031\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Zuo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.</ce:given-name>\n<ce:surname>Le</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The Designs and Applications of Tetraphenylethylene Macrocycles and Cages</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Chem-Eur J</sb:maintitle>\n</sb:title>\n<sb:volume-nr>31</sb:volume-nr>\n</sb:series>\n<sb:date>2025</sb:date>\n</sb:issue>\n<sb:article-number>e202403715</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0031\">Li, D.; Zuo, R.; Wang, J.; Le, Z. The Designs and Applications of Tetraphenylethylene Macrocycles and Cages. Chem-Eur J. 2025, 31, e202403715.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0032\">\n<ce:label>[32]</ce:label>\n<sb:reference id=\"sbref0032\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>F.</ce:given-name>\n<ce:surname>Ito</ce:surname>\n</sb:author>\n</sb:authors>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Fluorescence Detection of Dynamic Aggregation Processes Using AIEgens</sb:maintitle>\n</sb:title>\n</sb:series>\n<sb:date>2022</sb:date>\n</sb:issue>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0032\">Ito, F. Fluorescence Detection of Dynamic Aggregation Processes Using AIEgens, 2022.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0033\">\n<ce:label>[33]</ce:label>\n<sb:reference id=\"sbref0033\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Huang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zhou</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>W.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Zhu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Fang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.</ce:given-name>\n<ce:surname>Wu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>W.</ce:given-name>\n<ce:surname>Zhu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>A fluorescent probe based on triphenylamine with AIE and ICT characteristics for hydrazine detection</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Spectrochimica Acta Part a: Molecular and Biomolecular Spectroscopy</sb:maintitle>\n</sb:title>\n<sb:volume-nr>286</sb:volume-nr>\n</sb:series>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:article-number>122011</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0033\">Huang, J.; Zhou, Y.; Wang, W.; Zhu, J.; Li, X.; Fang, M.; Wu, Z.; Zhu, W.; Li, C. A fluorescent probe based on triphenylamine with AIE and ICT characteristics for hydrazine detection. Spectrochimica Acta Part a: Molecular and Biomolecular Spectroscopy 2023, 286, 122011.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0034\">\n<ce:label>[34]</ce:label>\n<sb:reference id=\"sbref0034\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Tang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Xie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Bai</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Zhao</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zheng</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Liang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.</ce:given-name>\n<ce:surname>Ma</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Q.</ce:given-name>\n<ce:surname>Wan</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Building Block for Designing Bright Type I AIE-Active Photosensitizers with Deep/Near-infrared Red Fluorescence</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Chemistry – an Asian Journal</sb:maintitle>\n</sb:title>\n<sb:volume-nr>20</sb:volume-nr>\n</sb:series>\n<sb:date>2025</sb:date>\n</sb:issue>\n<sb:article-number>e202401276</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0034\">Tang, Y.; Xie, Y.; Bai, X.; Zhao, C.; Zheng, Y.; Liang, H.; Ma, Z.; Wang, Z.; Wan, Q. Building Block for Designing Bright Type I AIE-Active Photosensitizers with Deep/Near-infrared Red Fluorescence. Chemistry – an Asian Journal 2025, 20, e202401276.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0035\">\n<ce:label>[35]</ce:label>\n<sb:reference id=\"sbref0035\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Q.</ce:given-name>\n<ce:surname>Wan</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Zhang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.</ce:given-name>\n<ce:surname>Zhuang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Huang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>W.</ce:given-name>\n<ce:surname>Zhang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Hou</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.Z.</ce:given-name>\n<ce:surname>Tang</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Molecular Engineering to Boost AIE-Active Free Radical Photogenerators and Enable High-Performance Photodynamic Therapy under Hypoxia</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Adv. Funct. Mater.</sb:maintitle>\n</sb:title>\n<sb:volume-nr>30</sb:volume-nr>\n</sb:series>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:article-number>2002057</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0035\">Wan, Q.; Zhang, R.; Zhuang, Z.; Li, Y.; Huang, Y.; Wang, Z.; Zhang, W.; Hou, J.; Tang, B. Z. Molecular Engineering to Boost AIE-Active Free Radical Photogenerators and Enable High-Performance Photodynamic Therapy under Hypoxia. Adv. Funct. Mater. 2020, 30, 2002057.</ce:source-text>\n</ce:bib-reference>\n</ce:bibliography-sec>",
    "output": "<ce:bibliography-sec xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"cebibsec1\">\n<?att type=\"article\"?><ce:bib-reference id=\"bib0001\">\n<ce:label>[1]</ce:label>\n<sb:reference id=\"sbref0001\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>T.C.</ce:given-name>\n<ce:surname>Pham</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>V.</ce:given-name>\n<ce:surname>Nguyen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Choi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Lee</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Yoon</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Recent Strategies to Develop Innovative Photosensitizers for Enhanced Photodynamic Therapy</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Chem. Rev.</sb:maintitle>\n</sb:title>\n<sb:volume-nr>121</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>13454</sb:first-page>\n<sb:last-page>13619</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0001\">Pham, T. C.; Nguyen, V.; Choi, Y.; Lee, S.; Yoon, J. Recent Strategies to Develop Innovative Photosensitizers for Enhanced Photodynamic Therapy. Chem. Rev. 2021, 121, 13454-13619.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0002\">\n<ce:label>[2]</ce:label>\n<sb:reference id=\"sbref0002\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>W.</ce:given-name>\n<ce:surname>Zhang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Ahmed</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Cong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Shen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Yu</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Application of multifunctional BODIPY in photodynamic therapy</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Dyes Pigments</sb:maintitle>\n</sb:title>\n<sb:volume-nr>185</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:article-number>108937</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0002\">Zhang, W.; Ahmed, A.; Cong, H.; Wang, S.; Shen, Y.; Yu, B. Application of multifunctional BODIPY in photodynamic therapy. Dyes Pigments. 2021, 185, 108937.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0003\">\n<ce:label>[3]</ce:label>\n<sb:reference id=\"sbref0003\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.F.</ce:given-name>\n<ce:surname>Algorri</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Ochoa</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Roldán-Varona</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Rodríguez-Cobo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.M.In</ce:given-name>\n<ce:surname>López-Higuera</ce:surname>\n</sb:author>\n</sb:authors>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Cancers</sb:maintitle>\n</sb:title>\n<sb:volume-nr>13</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0003\">Algorri, J. F.; Ochoa, M.; Roldán-Varona, P.; Rodríguez-Cobo, L.; López-Higuera, J. M. In Cancers, 2021; Vol. 13.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0004\">\n<ce:label>[4]</ce:label>\n<sb:reference id=\"sbref0004\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>T.</ce:given-name>\n<ce:surname>Tao</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Hu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Sun</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Ou</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Guo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Xu</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The halogen effect of bis-truxene substituted BODIPY photosensitizers for potential photodynamic therapy</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Dyes Pigments</sb:maintitle>\n</sb:title>\n<sb:volume-nr>224</sb:volume-nr>\n</sb:series>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:article-number>111996</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0004\">Tao, T.; Hu, X.; Sun, D.; Ou, C.; Guo, Y.; Xu, H. The halogen effect of bis-truxene substituted BODIPY photosensitizers for potential photodynamic therapy. Dyes Pigments. 2024, 224, 111996.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0005\">\n<ce:label>[5]</ce:label>\n<sb:reference id=\"sbref0005\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Yu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Jia</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Liu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Zhang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Feng</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.Z.</ce:given-name>\n<ce:surname>Tang</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Recent Progress in Type I Aggregation-Induced Emission Photosensitizers for Photodynamic Therapy</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Molecules</sb:maintitle>\n</sb:title>\n<sb:volume-nr>28</sb:volume-nr>\n</sb:series>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>332</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0005\">Yu, Y.; Jia, H.; Liu, Y.; Zhang, L.; Feng, G.; Tang, B. Z. Recent Progress in Type I Aggregation-Induced Emission Photosensitizers for Photodynamic Therapy. Molecules, 2023, 28, 332.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0006\">\n<ce:label>[6]</ce:label>\n<sb:reference id=\"sbref0006\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Ni</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Zhang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.Z.</ce:given-name>\n<ce:surname>Sun</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.Z.</ce:given-name>\n<ce:surname>Tang</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Aggregation-Induced Generation of Reactive Oxygen Species: Mechanism and Photosensitizer Construction</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Molecules</sb:maintitle>\n</sb:title>\n<sb:volume-nr>26</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>268</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0006\">Ni, J.; Wang, Y.; Zhang, H.; Sun, J. Z.; Tang, B. Z. Aggregation-Induced Generation of Reactive Oxygen Species: Mechanism and Photosensitizer Construction. Molecules, 2021, 26, 268.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0007\">\n<ce:label>[7]</ce:label>\n<sb:reference id=\"sbref0007\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Yang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.H.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>X.H.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.J.</ce:given-name>\n<ce:surname>Qi</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>A Long-Retention Cell Membrane-Targeting AIEgen for Boosting Tumor Theranostics</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Chem-AsianJ</sb:maintitle>\n</sb:title>\n<sb:volume-nr>19</sb:volume-nr>\n</sb:series>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:article-number>e202400305</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0007\">Wang, X.; Yang, L.; Li, Y. H.; Wang, X. H.; Qi, Z. J. A Long-Retention Cell Membrane-Targeting AIEgen for Boosting Tumor Theranostics. Chem-AsianJ. 2024, 19, e202400305.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0008\">\n<ce:label>[8]</ce:label>\n<sb:reference id=\"sbref0008\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.Q.</ce:given-name>\n<ce:surname>Tang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.K.</ce:given-name>\n<ce:surname>Liang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.F.</ce:given-name>\n<ce:surname>Zhao</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Yang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.J.</ce:given-name>\n<ce:surname>Qi</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>A lipid droplet-specific near-infrared automatic oxygen-supplied AIEgen for photodynamic therapy and metastasis inhibition of hypoxic tumors</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Chem. Eng. J.</sb:maintitle>\n</sb:title>\n<sb:volume-nr>453</sb:volume-nr>\n</sb:series>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:article-number>139838</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0008\">Wang, X.; Tang, Y. Q.; Liang, J. K.; Zhao, Y. F.; Yang, L.; Qi, Z. J. A lipid droplet-specific near-infrared automatic oxygen-supplied AIEgen for photodynamic therapy and metastasis inhibition of hypoxic tumors. Chem. Eng. J. 2023, 453, 139838.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0009\">\n<ce:label>[9]</ce:label>\n<sb:reference id=\"sbref0009\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Gao</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Tian</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>F.</ce:given-name>\n<ce:surname>Hu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>W.</ce:given-name>\n<ce:surname>Wu</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Design strategies for aggregation-induced emission photosensitizers with enhanced safety in photodynamic therapy</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Coord. Chem. Rev.</sb:maintitle>\n</sb:title>\n<sb:volume-nr>507</sb:volume-nr>\n</sb:series>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:article-number>215756</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0009\">Gao, J.; Tian, Y.; Li, Y.; Hu, F.; Wu, W. Design strategies for aggregation-induced emission photosensitizers with enhanced safety in photodynamic therapy. Coord. Chem. Rev. 2024, 507, 215756.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0010\">\n<ce:label>[10]</ce:label>\n<sb:reference id=\"sbref0010\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Q.</ce:given-name>\n<ce:surname>Wan</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Ding</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Xie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Fan</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Tong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.</ce:given-name>\n<ce:surname>Zeng</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Zhao</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:et-al/>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Aggregation Effect on Multiperformance Improvement in Aryl-Armed Phenazine-Based Emitters</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J. Am. Chem. Soc.</sb:maintitle>\n</sb:title>\n<sb:volume-nr>145</sb:volume-nr>\n</sb:series>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1607</sb:first-page>\n<sb:last-page>1616</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0010\">Wan, Q.; Li, Y.; Ding, K.; Xie, Y.; Fan, J.; Tong, J.; Zeng, Z.; Li, Y.; Zhao, C.; Wang, Z. et al. Aggregation Effect on Multiperformance Improvement in Aryl-Armed Phenazine-Based Emitters. J. Am. Chem. Soc. 2023, 145, 1607-1616.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"inbook\"?><ce:bib-reference id=\"bib0011\">\n<ce:label>[11]</ce:label>\n<sb:reference id=\"sbref0011\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>He</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Q.</ce:given-name>\n<ce:surname>Wan</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.Z.</ce:given-name>\n<ce:surname>Tang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n</sb:authors>\n</sb:contribution>\n<sb:host>\n<sb:book>\n<sb:book-series>\n<sb:series>\n<sb:title>\n<sb:maintitle>An innovative stepwise activated coupling reaction for fabricating functional fluorescence probes with potential photosensitive applications</sb:maintitle>\n</sb:title>\n<sb:volume-nr>412</sb:volume-nr>\n</sb:series>\n</sb:book-series>\n<sb:date>2024</sb:date>\n<sb:publisher>\n<sb:name>Sensor Actuator B-Chem</sb:name>\n</sb:publisher>\n</sb:book>\n<sb:article-number>135725</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0011\">Li, Y.; He, D.; Wan, Q.; Tang, B. Z.; Wang, Z. An innovative stepwise activated coupling reaction for fabricating functional fluorescence probes with potential photosensitive applications. Sensor Actuator B-Chem. 2024, 412, 135725.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0012\">\n<ce:label>[12]</ce:label>\n<sb:reference id=\"sbref0012\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.H.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Hasrat</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Yang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.J.</ce:given-name>\n<ce:surname>Qi</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Sequence-Responsive Multifunctional Supramolecular Nanomicelles Act on the Regression of TNBC and Its Lung Metastasis via Synergic Pyroptosis-Mediated Immune Activation</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Small</sb:maintitle>\n</sb:title>\n<sb:volume-nr>19</sb:volume-nr>\n</sb:series>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:article-number>2305101</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0012\">Wang, X.; Li, Y. H.; Hasrat, K.; Yang, L.; Qi, Z. J. Sequence-Responsive Multifunctional Supramolecular Nanomicelles Act on the Regression of TNBC and Its Lung Metastasis via Synergic Pyroptosis-Mediated Immune Activation. Small, 2023, 19, 2305101.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0013\">\n<ce:label>[13]</ce:label>\n<sb:reference id=\"sbref0013\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.H.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.J.</ce:given-name>\n<ce:surname>Qi</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Light-Enhanced Tandem-Responsive Nano Delivery Platform for Amplified Anti-tumor Efficiency</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Chem-AsianJ</sb:maintitle>\n</sb:title>\n<sb:volume-nr>19</sb:volume-nr>\n</sb:series>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:article-number>e202400311</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0013\">Wang, X.; Li, Y. H.; Qi, Z. J. Light-Enhanced Tandem-Responsive Nano Delivery Platform for Amplified Anti-tumor Efficiency. Chem-AsianJ. 2024, 19, e202400311.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0014\">\n<ce:label>[14]</ce:label>\n<sb:reference id=\"sbref0014\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zheng</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Bai</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Teng</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Tang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Zhao</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.</ce:given-name>\n<ce:surname>Ma</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Liang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Xie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Q.</ce:given-name>\n<ce:surname>Wan</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Atomic Engineering and Aggregation Effect to Regulate Synergistically Type I Reactive Oxygen Species of AIE-Active Deep Red/Near Infrared Red Photosensitizer</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Small</sb:maintitle>\n</sb:title>\n<sb:volume-nr>21</sb:volume-nr>\n</sb:series>\n<sb:date>2025</sb:date>\n</sb:issue>\n<sb:article-number>2410816</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0014\">Zheng, Y.; Li, Y.; Bai, X.; Teng, M.; Tang, Y.; Zhao, S.; Ma, Z.; Liang, H.; Xie, Y.; Wan, Q. Atomic Engineering and Aggregation Effect to Regulate Synergistically Type I Reactive Oxygen Species of AIE-Active Deep Red/Near Infrared Red Photosensitizer. Small 2025, 21, 2410816.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0015\">\n<ce:label>[15]</ce:label>\n<sb:reference id=\"sbref0015\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Min</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>F.</ce:given-name>\n<ce:surname>Yi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Han</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Q.</ce:given-name>\n<ce:surname>Gao</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Liang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Sun</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Liu</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Targeted photodynamic therapy using a water-soluble aggregation-Induced emission photosensitizer activated by an acidic tumor microenvironment</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Chem. Eng. J.</sb:maintitle>\n</sb:title>\n<sb:volume-nr>432</sb:volume-nr>\n</sb:series>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:article-number>134327</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0015\">Min, X.; Yi, F.; Han, X.; Li, M.; Gao, Q.; Liang, X.; Chen, Z.; Sun, Y.; Liu, Y. Targeted photodynamic therapy using a water-soluble aggregation-Induced emission photosensitizer activated by an acidic tumor microenvironment. Chem. Eng. J. 2022, 432, 134327.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0016\">\n<ce:label>[16]</ce:label>\n<sb:reference id=\"sbref0016\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Xiong</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Application of “Click” Chemistry in Biomedical Hydrogels</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>ACS Omega</sb:maintitle>\n</sb:title>\n<sb:volume-nr>7</sb:volume-nr>\n</sb:series>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>36918</sb:first-page>\n<sb:last-page>36928</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0016\">Li, X.; Xiong, Y. Application of “Click” Chemistry in Biomedical Hydrogels. ACS Omega 2022, 7, 36918-36928.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0017\">\n<ce:label>[17]</ce:label>\n<sb:reference id=\"sbref0017\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Kaur</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Saxena</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Rishi</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>An Overview of Recent Advances in Biomedical Applications of Click Chemistry</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Bioconjug. Chem.</sb:maintitle>\n</sb:title>\n<sb:volume-nr>32</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1455</sb:first-page>\n<sb:last-page>1471</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0017\">Kaur, J.; Saxena, M.; Rishi, N. An Overview of Recent Advances in Biomedical Applications of Click Chemistry. Bioconjug. Chem. 2021, 32, 1455-1471.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0018\">\n<ce:label>[18]</ce:label>\n<sb:reference id=\"sbref0018\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Albada</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.F.</ce:given-name>\n<ce:surname>Keijzer</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Zuilhof</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>F.</ce:given-name>\n<ce:surname>van Delft</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Oxidation-Induced “One-Pot” Click Chemistry</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Chem. Rev.</sb:maintitle>\n</sb:title>\n<sb:volume-nr>121</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>7032</sb:first-page>\n<sb:last-page>7058</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0018\">Albada, B.; Keijzer, J. F.; Zuilhof, H.; van Delft, F. Oxidation-Induced “One-Pot” Click Chemistry. Chem. Rev. 2021, 121, 7032-7058.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0019\">\n<ce:label>[19]</ce:label>\n<sb:reference id=\"sbref0019\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>R.M.</ce:given-name>\n<ce:surname>McDaniel</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.S.</ce:given-name>\n<ce:surname>Carey</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.R.</ce:given-name>\n<ce:surname>Wilson</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.W.</ce:given-name>\n<ce:surname>Barsoum</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.J.D.</ce:given-name>\n<ce:surname>Magenau</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Well-Dispersed Nanocomposites Using Covalently Modified, Multilayer, 2D Titanium Carbide (MXene) and In-Situ “Click</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Polymerization. Chem. Mat.</sb:maintitle>\n</sb:title>\n<sb:volume-nr>33</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1648</sb:first-page>\n<sb:last-page>1656</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0019\">McDaniel, R. M.; Carey, M. S.; Wilson, O. R.; Barsoum, M. W.; Magenau, A. J. D. Well-Dispersed Nanocomposites Using Covalently Modified, Multilayer, 2D Titanium Carbide (MXene) and In-Situ “Click” Polymerization. Chem. Mat. 2021, 33, 1648-1656.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0020\">\n<ce:label>[20]</ce:label>\n<sb:reference id=\"sbref0020\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Sradha</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Sariga</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>George</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Varghese</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Advancements in thiol-yne click chemistry: Recent trends and applications in polymer synthesis and functionalization</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Mater. Today Chem.</sb:maintitle>\n</sb:title>\n<sb:volume-nr>38</sb:volume-nr>\n</sb:series>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:article-number>102112</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0020\">Sradha S, A.; Sariga; George, L.; Varghese, A. Advancements in thiol-yne click chemistry: Recent trends and applications in polymer synthesis and functionalization. Mater. Today Chem. 2024, 38, 102112.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0021\">\n<ce:label>[21]</ce:label>\n<sb:reference id=\"sbref0021\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Lü</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Zhu</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Thiol-Yne click chemistry of acetylene-enabled macrocyclization</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Nat. Commun.</sb:maintitle>\n</sb:title>\n<sb:volume-nr>13</sb:volume-nr>\n</sb:series>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>5001</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0021\">Lü, S.; Wang, Z.; Zhu, S. Thiol-Yne click chemistry of acetylene-enabled macrocyclization. Nat. Commun. 2022, 13, 5001.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0022\">\n<ce:label>[22]</ce:label>\n<sb:reference id=\"sbref0022\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>He</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Ding</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Q.</ce:given-name>\n<ce:surname>Tian</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.</ce:given-name>\n<ce:surname>Feng</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Qin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.Z.</ce:given-name>\n<ce:surname>Tang</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Bioconjugation and Reaction-Induced Tumor Therapy via Alkynamide-Based Thiol-Yne Click Reaction</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Small</sb:maintitle>\n</sb:title>\n<sb:volume-nr>20</sb:volume-nr>\n</sb:series>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:article-number>2307309</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0022\">Wang, B.; Li, C.; He, D.; Ding, K.; Tian, Q.; Feng, G.; Qin, A.; Tang, B. Z. Bioconjugation and Reaction-Induced Tumor Therapy via Alkynamide-Based Thiol-Yne Click Reaction. Small 2024, 20, 2307309.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0023\">\n<ce:label>[23]</ce:label>\n<sb:reference id=\"sbref0023\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Mitmoen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>O.</ce:given-name>\n<ce:surname>Kedem</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>UV- and Visible-Light Photopatterning of Molecular Gradients Using the Thiol–yne Click Reaction</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>ACS Appl. Mater. Interfaces</sb:maintitle>\n</sb:title>\n<sb:volume-nr>14</sb:volume-nr>\n</sb:series>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>32696</sb:first-page>\n<sb:last-page>32705</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0023\">Mitmoen, M.; Kedem, O. UV- and Visible-Light Photopatterning of Molecular Gradients Using the Thiol–yne Click Reaction. ACS Appl. Mater. Interfaces 2022, 14, 32696-32705.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0024\">\n<ce:label>[24]</ce:label>\n<sb:reference id=\"sbref0024\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Deng</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Yang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Liu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Deng</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Pu</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Benzothiadiazole-based dibenzobenzimidazole derivatives with aggregation-induced deep-red fluorescence and different mechanically responsive fluorescence features</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Dyes Pigments</sb:maintitle>\n</sb:title>\n<sb:volume-nr>205</sb:volume-nr>\n</sb:series>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:article-number>110580</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0024\">Deng, D.; Yang, Y.; Liu, S.; Deng, X.; Chen, Z.; Pu, S. Benzothiadiazole-based dibenzobenzimidazole derivatives with aggregation-induced deep-red fluorescence and different mechanically responsive fluorescence features. Dyes Pigments. 2022, 205, 110580.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0025\">\n<ce:label>[25]</ce:label>\n<sb:reference id=\"sbref0025\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>He</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>F.</ce:given-name>\n<ce:surname>Xie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Zhang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Shen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>F.</ce:given-name>\n<ce:surname>Ding</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Tang</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Red-shift emission and rapid up-conversion of B,N-containing electroluminescent materials via tuning intramolecular charge transfer</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Mater. Chem. Front.</sb:maintitle>\n</sb:title>\n<sb:volume-nr>7</sb:volume-nr>\n</sb:series>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>2454</sb:first-page>\n<sb:last-page>2463</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0025\">He, Y.; Xie, F.; Li, H.; Zhang, K.; Shen, Y.; Ding, F.; Wang, C.; Li, Y.; Tang, J. Red-shift emission and rapid up-conversion of B,N-containing electroluminescent materials via tuning intramolecular charge transfer. Mater. Chem. Front. 2023, 7, 2454-2463.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0026\">\n<ce:label>[26]</ce:label>\n<sb:reference id=\"sbref0026\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Long</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Shan</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zhao</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Ji</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Tan</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Dramatically Enhanced and Red-shifted Photoluminescence Achieved by Introducing an Electron-withdrawing Group into a Non-traditional Luminescent Small Organic Compound</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Chem-Asian J</sb:maintitle>\n</sb:title>\n<sb:volume-nr>16</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>2426</sb:first-page>\n<sb:last-page>2430</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0026\">Long, J.; Shan, J.; Zhao, Y.; Ji, Y.; Tan, H.; Wang, H. Dramatically Enhanced and Red-shifted Photoluminescence Achieved by Introducing an Electron-withdrawing Group into a Non-traditional Luminescent Small Organic Compound. Chem-Asian J. 2021, 16, 2426-2430.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0027\">\n<ce:label>[27]</ce:label>\n<sb:reference id=\"sbref0027\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Wu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Du</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Luo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>D.L.</ce:given-name>\n<ce:surname>Phillips</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Qin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.Z.</ce:given-name>\n<ce:surname>Tang</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Structural modification on tetraphenylpyrazine: from polarity enhanced emission to polarity quenching emission and its intramolecular charge transfer mechanism</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J. Mater. Chem. C</sb:maintitle>\n</sb:title>\n<sb:volume-nr>10</sb:volume-nr>\n</sb:series>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>8174</sb:first-page>\n<sb:last-page>8180</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0027\">Wu, H.; Du, L.; Luo, J.; Wang, Z.; Phillips, D. L.; Qin, A.; Tang, B. Z. Structural modification on tetraphenylpyrazine: from polarity enhanced emission to polarity quenching emission and its intramolecular charge transfer mechanism. J. Mater. Chem. C 2022, 10, 8174-8180.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0028\">\n<ce:label>[28]</ce:label>\n<sb:reference id=\"sbref0028\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.F.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.Y.</ce:given-name>\n<ce:surname>Cao</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.L.</ce:given-name>\n<ce:surname>Han</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>P.</ce:given-name>\n<ce:surname>Shangguan</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.S.</ce:given-name>\n<ce:surname>Liu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zhong</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.Y.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.Y.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>X.Y.</ce:given-name>\n<ce:surname>Chen</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Lin</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.Y.</ce:given-name>\n<ce:surname>Lu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.Q.</ce:given-name>\n<ce:surname>Luo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>He</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.H.Y.</ce:given-name>\n<ce:surname>Sung</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.L.</ce:given-name>\n<ce:surname>Niu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.W.Y.</ce:given-name>\n<ce:surname>Lam</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.Y.</ce:given-name>\n<ce:surname>Shi</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.Z.</ce:given-name>\n<ce:surname>Tang</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Blood–Brain Barrier-Penetrative Fluorescent Anticancer Agents Triggering Paraptosis and Ferroptosis for Glioblastoma Therapy</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>J. Am. Chem. Soc.</sb:maintitle>\n</sb:title>\n<sb:volume-nr>146</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>42</sb:issue-nr>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>28783</sb:first-page>\n<sb:last-page>28794</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0028\">Wang, J. F.; Cao, M. Y.; Han, L. L.; Shangguan, P.; Liu, Y. S.; Zhong, Y.; Chen, C. Y.; Wang, G. Y.; Chen, X. Y.; Lin, M.; Lu, M. Y.; Luo, Z. Q.; He, M.; Sung, H. H. Y.; Niu, G. L.; Lam, J. W. Y.; Shi, B. Y.; Tang, B. Z. Blood–Brain Barrier-Penetrative Fluorescent Anticancer Agents Triggering Paraptosis and Ferroptosis for Glioblastoma Therapy, J. Am. Chem. Soc. 2024, 146, 42, 28783–28794.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0029\">\n<ce:label>[29]</ce:label>\n<sb:reference id=\"sbref0029\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.X.</ce:given-name>\n<ce:surname>Cao</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>X.Y.</ce:given-name>\n<ce:surname>Tian</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.Y.</ce:given-name>\n<ce:surname>Cao</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.G.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>G.L.</ce:given-name>\n<ce:surname>Niu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.Z.</ce:given-name>\n<ce:surname>Tang</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Solvatochromic Near-Infrared Aggregation-Induced Emission-Active Acrylonitriles by Acceptor Modulation for Low-Power Stimulated Emission Depletion Nanoscopy</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Chem. Mater.</sb:maintitle>\n</sb:title>\n<sb:volume-nr>35</sb:volume-nr>\n</sb:series>\n<sb:issue-nr>6</sb:issue-nr>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>2472</sb:first-page>\n<sb:last-page>2485</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0029\">Cao, S. X.; Tian, X. Y.; Cao, M. Y.; Wang, J. G.; Niu, G. L.; Tang, B. Z. Solvatochromic Near-Infrared Aggregation-Induced Emission-Active Acrylonitriles by Acceptor Modulation for Low-Power Stimulated Emission Depletion Nanoscopy, Chem. Mater. 2023, 35, 6, 2472–2485.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0030\">\n<ce:label>[30]</ce:label>\n<sb:reference id=\"sbref0030\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Q.</ce:given-name>\n<ce:surname>Wan</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>W.</ce:given-name>\n<ce:surname>Dai</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Xie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Q.</ce:given-name>\n<ce:surname>Ke</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Zhao</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.</ce:given-name>\n<ce:surname>Zhang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.</ce:given-name>\n<ce:surname>Zeng</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.Z.</ce:given-name>\n<ce:surname>Tang</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>AIE-active deep red/near-infrared electroluminescent emitters with fine regulation of excited state</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Chem. Eng. J.</sb:maintitle>\n</sb:title>\n<sb:volume-nr>451</sb:volume-nr>\n</sb:series>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:article-number>138529</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0030\">Wan, Q.; Dai, W.; Xie, Y.; Ke, Q.; Zhao, C.; Zhang, B.; Zeng, Z.; Wang, Z.; Tang, B. Z. AIE-active deep red/near-infrared electroluminescent emitters with fine regulation of excited state. Chem. Eng. J. 2023, 451, 138529.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0031\">\n<ce:label>[31]</ce:label>\n<sb:reference id=\"sbref0031\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>D.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Zuo</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.</ce:given-name>\n<ce:surname>Le</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>The Designs and Applications of Tetraphenylethylene Macrocycles and Cages</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Chem-Eur J</sb:maintitle>\n</sb:title>\n<sb:volume-nr>31</sb:volume-nr>\n</sb:series>\n<sb:date>2025</sb:date>\n</sb:issue>\n<sb:article-number>e202403715</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0031\">Li, D.; Zuo, R.; Wang, J.; Le, Z. The Designs and Applications of Tetraphenylethylene Macrocycles and Cages. Chem-Eur J. 2025, 31, e202403715.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0032\">\n<ce:label>[32]</ce:label>\n<sb:reference id=\"sbref0032\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>F.</ce:given-name>\n<ce:surname>Ito</ce:surname>\n</sb:author>\n</sb:authors>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Fluorescence Detection of Dynamic Aggregation Processes Using AIEgens</sb:maintitle>\n</sb:title>\n</sb:series>\n<sb:date>2022</sb:date>\n</sb:issue>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0032\">Ito, F. Fluorescence Detection of Dynamic Aggregation Processes Using AIEgens, 2022.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0033\">\n<ce:label>[33]</ce:label>\n<sb:reference id=\"sbref0033\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Huang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zhou</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>W.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Zhu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Fang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.</ce:given-name>\n<ce:surname>Wu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>W.</ce:given-name>\n<ce:surname>Zhu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>A fluorescent probe based on triphenylamine with AIE and ICT characteristics for hydrazine detection</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Spectrochimica Acta Part a: Molecular and Biomolecular Spectroscopy</sb:maintitle>\n</sb:title>\n<sb:volume-nr>286</sb:volume-nr>\n</sb:series>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:article-number>122011</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0033\">Huang, J.; Zhou, Y.; Wang, W.; Zhu, J.; Li, X.; Fang, M.; Wu, Z.; Zhu, W.; Li, C. A fluorescent probe based on triphenylamine with AIE and ICT characteristics for hydrazine detection. Spectrochimica Acta Part a: Molecular and Biomolecular Spectroscopy 2023, 286, 122011.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0034\">\n<ce:label>[34]</ce:label>\n<sb:reference id=\"sbref0034\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Tang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Xie</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Bai</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>C.</ce:given-name>\n<ce:surname>Zhao</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Zheng</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>H.</ce:given-name>\n<ce:surname>Liang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.</ce:given-name>\n<ce:surname>Ma</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Q.</ce:given-name>\n<ce:surname>Wan</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Building Block for Designing Bright Type I AIE-Active Photosensitizers with Deep/Near-infrared Red Fluorescence</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Chemistry – an Asian Journal</sb:maintitle>\n</sb:title>\n<sb:volume-nr>20</sb:volume-nr>\n</sb:series>\n<sb:date>2025</sb:date>\n</sb:issue>\n<sb:article-number>e202401276</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0034\">Tang, Y.; Xie, Y.; Bai, X.; Zhao, C.; Zheng, Y.; Liang, H.; Ma, Z.; Wang, Z.; Wan, Q. Building Block for Designing Bright Type I AIE-Active Photosensitizers with Deep/Near-infrared Red Fluorescence. Chemistry – an Asian Journal 2025, 20, e202401276.</ce:source-text>\n</ce:bib-reference>\n<?att type=\"article\"?><ce:bib-reference id=\"bib0035\">\n<ce:label>[35]</ce:label>\n<sb:reference id=\"sbref0035\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>Q.</ce:given-name>\n<ce:surname>Wan</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>R.</ce:given-name>\n<ce:surname>Zhang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.</ce:given-name>\n<ce:surname>Zhuang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Huang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>W.</ce:given-name>\n<ce:surname>Zhang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Hou</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>B.Z.</ce:given-name>\n<ce:surname>Tang</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Molecular Engineering to Boost AIE-Active Free Radical Photogenerators and Enable High-Performance Photodynamic Therapy under Hypoxia</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Adv. Funct. Mater.</sb:maintitle>\n</sb:title>\n<sb:volume-nr>30</sb:volume-nr>\n</sb:series>\n<sb:date>2020</sb:date>\n</sb:issue>\n<sb:article-number>2002057</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0035\">Wan, Q.; Zhang, R.; Zhuang, Z.; Li, Y.; Huang, Y.; Wang, Z.; Zhang, W.; Hou, J.; Tang, B. Z. Molecular Engineering to Boost AIE-Active Free Radical Photogenerators and Enable High-Performance Photodynamic Therapy under Hypoxia. Adv. Funct. Mater. 2020, 30, 2002057.</ce:source-text>\n</ce:bib-reference>\n</ce:bibliography-sec>",
    "error_message": "All bibliographic references within 'ce:bibliography' must be referred to.",
    "error_position": "250:63",
    "error_id": "IDS503a",
    "folder_name": "MOLSTR143586"
  },
  {
    "input": "<ce:bib-reference xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"bib0009\">\n<ce:label>[9]</ce:label>\n<sb:reference id=\"sbref0009\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Gao</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Tian</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>F.</ce:given-name>\n<ce:surname>Hu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>W.</ce:given-name>\n<ce:surname>Wu</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Design strategies for aggregation-induced emission photosensitizers with enhanced safety in photodynamic therapy</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Coord. Chem. Rev.</sb:maintitle>\n</sb:title>\n<sb:volume-nr>507</sb:volume-nr>\n</sb:series>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:article-number>215756</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0009\">Gao, J.; Tian, Y.; Li, Y.; Hu, F.; Wu, W. Design strategies for aggregation-induced emission photosensitizers with enhanced safety in photodynamic therapy. Coord. Chem. Rev. 2024, 507, 215756.</ce:source-text>\n</ce:bib-reference>",
    "output": "<ce:bib-reference xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"bib0009\">\n<ce:label>[9]</ce:label>\n<sb:reference id=\"sbref0009\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Gao</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Tian</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>F.</ce:given-name>\n<ce:surname>Hu</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>W.</ce:given-name>\n<ce:surname>Wu</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Design strategies for aggregation-induced emission photosensitizers with enhanced safety in photodynamic therapy</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Coord. Chem. Rev.</sb:maintitle>\n</sb:title>\n<sb:volume-nr>507</sb:volume-nr>\n</sb:series>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:article-number>215756</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0009\">Gao, J.; Tian, Y.; Li, Y.; Hu, F.; Wu, W. Design strategies for aggregation-induced emission photosensitizers with enhanced safety in photodynamic therapy. Coord. Chem. Rev. 2024, 507, 215756.</ce:source-text>\n</ce:bib-reference>",
    "error_message": "All bibliographic references within 'ce:bibliography' must be referred to.",
    "error_position": "626:63",
    "error_id": "IDS503a",
    "folder_name": "MOLSTR143586"
  },
  {
    "input": "<ce:bib-reference xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"bib0012\">\n<ce:label>[12]</ce:label>\n<sb:reference id=\"sbref0012\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.H.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Hasrat</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Yang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.J.</ce:given-name>\n<ce:surname>Qi</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Sequence-Responsive Multifunctional Supramolecular Nanomicelles Act on the Regression of TNBC and Its Lung Metastasis via Synergic Pyroptosis-Mediated Immune Activation</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Small</sb:maintitle>\n</sb:title>\n<sb:volume-nr>19</sb:volume-nr>\n</sb:series>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:article-number>2305101</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0012\">Wang, X.; Li, Y. H.; Hasrat, K.; Yang, L.; Qi, Z. J. Sequence-Responsive Multifunctional Supramolecular Nanomicelles Act on the Regression of TNBC and Its Lung Metastasis via Synergic Pyroptosis-Mediated Immune Activation. Small, 2023, 19, 2305101.</ce:source-text>\n</ce:bib-reference>",
    "output": "<ce:bib-reference xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"bib0012\">\n<ce:label>[12]</ce:label>\n<sb:reference id=\"sbref0012\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.H.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>K.</ce:given-name>\n<ce:surname>Hasrat</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>Yang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.J.</ce:given-name>\n<ce:surname>Qi</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Sequence-Responsive Multifunctional Supramolecular Nanomicelles Act on the Regression of TNBC and Its Lung Metastasis via Synergic Pyroptosis-Mediated Immune Activation</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Small</sb:maintitle>\n</sb:title>\n<sb:volume-nr>19</sb:volume-nr>\n</sb:series>\n<sb:date>2023</sb:date>\n</sb:issue>\n<sb:article-number>2305101</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0012\">Wang, X.; Li, Y. H.; Hasrat, K.; Yang, L.; Qi, Z. J. Sequence-Responsive Multifunctional Supramolecular Nanomicelles Act on the Regression of TNBC and Its Lung Metastasis via Synergic Pyroptosis-Mediated Immune Activation. Small, 2023, 19, 2305101.</ce:source-text>\n</ce:bib-reference>",
    "error_message": "All bibliographic references within 'ce:bibliography' must be referred to.",
    "error_position": "787:63",
    "error_id": "IDS503a",
    "folder_name": "MOLSTR143586"
  },
  {
    "input": "<ce:bib-reference xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"bib0013\">\n<ce:label>[13]</ce:label>\n<sb:reference id=\"sbref0013\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.H.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.J.</ce:given-name>\n<ce:surname>Qi</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Light-Enhanced Tandem-Responsive Nano Delivery Platform for Amplified Anti-tumor Efficiency</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Chem-AsianJ</sb:maintitle>\n</sb:title>\n<sb:volume-nr>19</sb:volume-nr>\n</sb:series>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:article-number>e202400311</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0013\">Wang, X.; Li, Y. H.; Qi, Z. J. Light-Enhanced Tandem-Responsive Nano Delivery Platform for Amplified Anti-tumor Efficiency. Chem-AsianJ. 2024, 19, e202400311.</ce:source-text>\n</ce:bib-reference>",
    "output": "<ce:bib-reference xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"bib0013\">\n<ce:label>[13]</ce:label>\n<sb:reference id=\"sbref0013\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.H.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.J.</ce:given-name>\n<ce:surname>Qi</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Light-Enhanced Tandem-Responsive Nano Delivery Platform for Amplified Anti-tumor Efficiency</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Chem-AsianJ</sb:maintitle>\n</sb:title>\n<sb:volume-nr>19</sb:volume-nr>\n</sb:series>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:article-number>e202400311</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0013\">Wang, X.; Li, Y. H.; Qi, Z. J. Light-Enhanced Tandem-Responsive Nano Delivery Platform for Amplified Anti-tumor Efficiency. Chem-AsianJ. 2024, 19, e202400311.</ce:source-text>\n</ce:bib-reference>",
    "error_message": "All bibliographic references within 'ce:bibliography' must be referred to.",
    "error_position": "824:63",
    "error_id": "IDS503a",
    "folder_name": "MOLSTR143586"
  },
  {
    "input": "<ce:bib-reference xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"bib0016\">\n<ce:label>[16]</ce:label>\n<sb:reference id=\"sbref0016\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Xiong</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Application of “Click” Chemistry in Biomedical Hydrogels</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>ACS Omega</sb:maintitle>\n</sb:title>\n<sb:volume-nr>7</sb:volume-nr>\n</sb:series>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>36918</sb:first-page>\n<sb:last-page>36928</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0016\">Li, X.; Xiong, Y. Application of “Click” Chemistry in Biomedical Hydrogels. ACS Omega 2022, 7, 36918-36928.</ce:source-text>\n</ce:bib-reference>",
    "output": "<ce:bib-reference xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"bib0016\">\n<ce:label>[16]</ce:label>\n<sb:reference id=\"sbref0016\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>X.</ce:given-name>\n<ce:surname>Li</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Y.</ce:given-name>\n<ce:surname>Xiong</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Application of “Click” Chemistry in Biomedical Hydrogels</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>ACS Omega</sb:maintitle>\n</sb:title>\n<sb:volume-nr>7</sb:volume-nr>\n</sb:series>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>36918</sb:first-page>\n<sb:last-page>36928</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0016\">Li, X.; Xiong, Y. Application of “Click” Chemistry in Biomedical Hydrogels. ACS Omega 2022, 7, 36918-36928.</ce:source-text>\n</ce:bib-reference>",
    "error_message": "All bibliographic references within 'ce:bibliography' must be referred to.",
    "error_position": "986:63",
    "error_id": "IDS503a",
    "folder_name": "MOLSTR143586"
  },
  {
    "input": "<ce:bib-reference xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"bib0017\">\n<ce:label>[17]</ce:label>\n<sb:reference id=\"sbref0017\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Kaur</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Saxena</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Rishi</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>An Overview of Recent Advances in Biomedical Applications of Click Chemistry</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Bioconjug. Chem.</sb:maintitle>\n</sb:title>\n<sb:volume-nr>32</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1455</sb:first-page>\n<sb:last-page>1471</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0017\">Kaur, J.; Saxena, M.; Rishi, N. An Overview of Recent Advances in Biomedical Applications of Click Chemistry. Bioconjug. Chem. 2021, 32, 1455-1471.</ce:source-text>\n</ce:bib-reference>",
    "output": "<ce:bib-reference xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"bib0017\">\n<ce:label>[17]</ce:label>\n<sb:reference id=\"sbref0017\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>J.</ce:given-name>\n<ce:surname>Kaur</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>M.</ce:given-name>\n<ce:surname>Saxena</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>N.</ce:given-name>\n<ce:surname>Rishi</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>An Overview of Recent Advances in Biomedical Applications of Click Chemistry</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Bioconjug. Chem.</sb:maintitle>\n</sb:title>\n<sb:volume-nr>32</sb:volume-nr>\n</sb:series>\n<sb:date>2021</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>1455</sb:first-page>\n<sb:last-page>1471</sb:last-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0017\">Kaur, J.; Saxena, M.; Rishi, N. An Overview of Recent Advances in Biomedical Applications of Click Chemistry. Bioconjug. Chem. 2021, 32, 1455-1471.</ce:source-text>\n</ce:bib-reference>",
    "error_message": "All bibliographic references within 'ce:bibliography' must be referred to.",
    "error_position": "1026:63",
    "error_id": "IDS503a",
    "folder_name": "MOLSTR143586"
  },
  {
    "input": "<ce:bib-reference xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"bib0020\">\n<ce:label>[20]</ce:label>\n<sb:reference id=\"sbref0020\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Sradha</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Sariga</ce:given-name>\n<ce:surname>A.</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>George</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Varghese</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Advancements in thiol-yne click chemistry: Recent trends and applications in polymer synthesis and functionalization</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Mater. Today Chem.</sb:maintitle>\n</sb:title>\n<sb:volume-nr>38</sb:volume-nr>\n</sb:series>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:article-number>102112</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0020\">Sradha S, A.; Sariga; George, L.; Varghese, A. Advancements in thiol-yne click chemistry: Recent trends and applications in polymer synthesis and functionalization. Mater. Today Chem. 2024, 38, 102112.</ce:source-text>\n</ce:bib-reference>",
    "output": "<ce:bib-reference xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"bib0020\">\n<ce:label>[20]</ce:label>\n<sb:reference id=\"sbref0020\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Sradha</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Sariga</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>L.</ce:given-name>\n<ce:surname>George</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>A.</ce:given-name>\n<ce:surname>Varghese</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Advancements in thiol-yne click chemistry: Recent trends and applications in polymer synthesis and functionalization</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Mater. Today Chem.</sb:maintitle>\n</sb:title>\n<sb:volume-nr>38</sb:volume-nr>\n</sb:series>\n<sb:date>2024</sb:date>\n</sb:issue>\n<sb:article-number>102112</sb:article-number>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0020\">Sradha S, A.; Sariga; George, L.; Varghese, A. Advancements in thiol-yne click chemistry: Recent trends and applications in polymer synthesis and functionalization. Mater. Today Chem. 2024, 38, 102112.</ce:source-text>\n</ce:bib-reference>",
    "error_message": "All bibliographic references within 'ce:bibliography' must be referred to.",
    "error_position": "1159:63",
    "error_id": "IDS503a",
    "folder_name": "MOLSTR143586"
  },
  {
    "input": "<ce:bib-reference xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"bib0021\">\n<ce:label>[21]</ce:label>\n<sb:reference id=\"sbref0021\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Lü</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Zhu</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Thiol-Yne click chemistry of acetylene-enabled macrocyclization</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Nat. Commun.</sb:maintitle>\n</sb:title>\n<sb:volume-nr>13</sb:volume-nr>\n</sb:series>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>5001</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0021\">Lü, S.; Wang, Z.; Zhu, S. Thiol-Yne click chemistry of acetylene-enabled macrocyclization. Nat. Commun. 2022, 13, 5001.</ce:source-text>\n</ce:bib-reference>",
    "output": "<ce:bib-reference xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" id=\"bib0021\">\n<ce:label>[21]</ce:label>\n<sb:reference id=\"sbref0021\">\n<sb:contribution>\n<sb:authors>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Lü</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>Z.</ce:given-name>\n<ce:surname>Wang</ce:surname>\n</sb:author>\n<sb:author>\n<ce:given-name>S.</ce:given-name>\n<ce:surname>Zhu</ce:surname>\n</sb:author>\n</sb:authors>\n<sb:title>\n<sb:maintitle>Thiol-Yne click chemistry of acetylene-enabled macrocyclization</sb:maintitle>\n</sb:title>\n</sb:contribution>\n<sb:host>\n<sb:issue>\n<sb:series>\n<sb:title>\n<sb:maintitle>Nat. Commun.</sb:maintitle>\n</sb:title>\n<sb:volume-nr>13</sb:volume-nr>\n</sb:series>\n<sb:date>2022</sb:date>\n</sb:issue>\n<sb:pages>\n<sb:first-page>5001</sb:first-page>\n</sb:pages>\n</sb:host>\n</sb:reference>\n<ce:source-text id=\"srctxt0021\">Lü, S.; Wang, Z.; Zhu, S. Thiol-Yne click chemistry of acetylene-enabled macrocyclization. Nat. Commun. 2022, 13, 5001.</ce:source-text>\n</ce:bib-reference>",
    "error_message": "All bibliographic references within 'ce:bibliography' must be referred to.",
    "error_position": "1198:63",
    "error_id": "IDS503a",
    "folder_name": "MOLSTR143586"
  }
]